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Foreword 
 
Photodynamic therapy (PDT) is a photochemical approach that uses light to 
activate specific chemicals that, in the activated state, impart cytotoxicity. Historically, the 
concept of combining light with chemical agents dates back over 5000 years, when ancient 
civilizations in Egypt and India applied this combination to treat several disorders.  
Over the years, PDT has received regulatory approval worldwide for several indications, 
and there have been major milestones in the basic understanding of the underlying 
processes and expanded vision of its applications. However, it has by no means achieved 
the recognition and the breadth of applications that it deserves. Therefore, within the field 
of PDT, there is a general consensus that the best is yet to come.  
With this work I hope to make a contribution, however small it may be, to the 
development of this fast growing field and I hope that in the future PDT will find its well-
deserved place in modern-day medicine, by the means of new and better clinical 
treatments than the ones offered today. 
 
Eveline van de Winckel 
Madrid, February 2017 
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Abbreviations & Acronyms 
Throughout the present thesis ‘Standard Organic Chemistry Abbreviations and 
Acronyms’ following the recommendation of the “guidelines for authors” published by J. 
Org. Chem. 2016, have been used, which can be found on the journal webpage 
(http://pubs.acs.org/paragonplus/submission/joceah/joceah_authguide.pdf).  
Furthermore, the next abbreviations and acronyms have also been used: 
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Introduction  3 
Photodynamic therapy (PDT) is a clinically approved1 form of phototherapy using 
nontoxic light-sensitive compounds, called photosensitizers or photosensitizing agents 
(PS), which, when exposed selectively to light of a certain wavelength, become toxic to 
targeted malignant and other diseased cells or organisms. 
PDT is becoming widely recognized as a valuable treatment option for localized cancers, 
being both minimally invasive and minimally toxic.2 Furthermore, PDT has proven ability 
to kill microbial cells, including bacteria, yeast, fungi and viruses.3 In the latter case, people 
also refer to the treatment as photodynamic inactivation (PDI), antimicrobial PDT (aPDT) 
or photodynamic antimicrobial chemotherapy (PACT).  
 
History of Photodynamic Therapy 
The use of light as a therapy in medicine and surgery can be dated back to ancient times, 
and found its origin in Ancient Egypt, Greece and India (Figure 1a), where it was used to 
treat various diseases such as psoriasis, rickets, vitiligo, and skin cancer.4 
 
Figure 1. a) Ancient Egyptians worshipped the sun, which eventually led them to 
discover the connection between sunlight and health.5 b) Set of apparatus devised by 
N.R. Finsen for treating lupus with light.6 
Although later on the interest in phototherapy disappeared for many centuries, it was 
rediscovered by western civilization at the beginning of end of the 20th century when Niels 
                                                             
1  CenterWatch, “Photodynamic Therapy New FDA Drug Approval | CenterWatch,” can be found under 
http://www.centerwatch.com/drug-information/fda-approved-drugs/drug/37/photodynamic-
therapy, 1996. 
2  S. B. Brown, E. A. Brown, I. Walker, Lancet Oncol. 2004, 5, 497–508. 
3  a] M. R. Hamblin, G. Jori, Photodynamic Inactivation of Microbial Pathogens: Medical and 
Environmental Applications, RSC Publishing, London, 2011; b) M. Wainwright, T. Maisch, S. Nonell, K. 
Plaetzer, A. Almeida, G. P. Tegos, M. R. Hamblin, Lancet Infect. Dis. 2016, 0, DOI 10.1016/S1473-
3099(16)30268-7. 
4  a] R. V. Bensasson, G. Jori, E. J. Land, T. G. Truscott, Eds. , Primary Photo-Processes in Biology and 
Medicine, Springer US, Boston, MA, 1985; b) M. D. Daniell, J. S. Hill, Aust. N. Z. J. Surg. 1991, 61, 340–
348. 
5    “Akhenaten,” can be found under https://upload.wikimedia.org/wikipedia/commons, 2008. 
6    “N. R. Finsen,” can be found under http://wellcomeimages.org/, 2002. 
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R. Finsen found that sun exposure of his patients showed beneficial effects in their 
treatment of lupus vulgaris (skin tuberculosis) and smallpox.7 He went on to successfully 
demonstrate this form of phototherapy by employing heat-filtered light from a carbon-
arc lamp in the treatment of cutaneous tuberculosis (Figure 1b),8  for which he won the 
Nobel Prize in Physiology and Medicine in 1903.  
The idea of using a dye as a PS came from an observation by Oscar Raab, a student of 
Professor H. Tappenheimer at the Pharmacological Institute of the Ludwig-Maximilian 
University of Munich, in the winter of 1897-1898. He noticed that the toxic effect of the 
acridine dye (Figure 2a) on paramecia (microscopic single-cell organisms that live in ponds, 
rivers, lakes, streams and puddles) was minimal on a day where there was a thunderstorm 
in comparison to its efficacy on a normal day. From this observation he concluded that 
light, in some way, activated the acridine dye and that the combined cytotoxic effect was 
greater than that of the individual components.9 A few years later, in 1904, Professor H. 
Tappenheimer was the first to introduce the term “Photodynamische Wirkung” 
(Photodynamic Action), when he successfully treated a skin tumor using a combination of 
white light and topical application of Eosin Y as PS (Figure 2 b and c).10 
          
Figure 2. Chemical structure of a) Acridine and b) Eosin Y, the first dyes used as a PS by 
Oscar Raab and H. Tappenheimer, respectively. c) Topical PDT treatment of facial basal 
cell carcinoma with Eosin Y as PS, before and after long-term exposure either to 
sunlight or arc-lamp light.11 
The more recent era of PDT was initiated by Lipson in the 1960s, when he discovered 
Hematoporphyrin derivative (HpD), a complex mixture of porphyrins (Por) derived from 
Hematoporphyrin (Hp, Figure 3a), which had tumor-localizing properties.7a,8,12 The final 
breakthrough of the therapeutical application of PDT came in 1975, when Dougherty and 
co-workers first reported that the administration of HpD and red light could completely 
                                                             
7  a] T. Patrice, J. Moan, Q. Peng, An Outline of the History of PDT, The Royal Society Of Chemistry, 2003; 
b) N. R. Finsen, Br. Med. J. 1903, 1, 1297–1298. 
8  R. Bonnet, Chem. Soc. Rev. 1995, 24, 19–33. 
9  O. Raab, Ztg. Biol. 1900, 39, 524–526. 
10    A. Jesionek, H. von Tappenheimer, Arch Klin. Med. 1905, 82, 223–227. 
11    M. H. Abdel-Kader, Photodynamic Therapy - From Theory to Application, Springer, 2014. 
12    a] R. L. Lipson, E. J. Baldes, Arch. Dermatol. 1960, 82, 508–516; b) R. L. Lipson, E. J. Baldes, A. M. Olsen, 
J. Natl. Cancer Inst. 1961, 26, 1–11; c] R. L. Lipson, E. J. Baldes, A. M. Olsen, J. Thorac. Cardiovasc. 
Surg. 1961, 42, 623–629. 
a) c)b)
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eradicate mammary tumor growth in mice,13 while Kelly and co-workers reported that 
light activation of HpD could also eliminate bladder carcinoma in mice.14 A few years later, 
Photofrin® (Figure 3b), a fraction of HpD purified by removal of the Hp monomers, became 
the first PS to be approved by regulatory authorities. In 1993, it was first approved in 
Canada, for the treatment of bladder cancer. In 1995, it was approved by de Food and 
Drug Administration in the United States, for the palliation of obstructive esophageal 
cancer.15 
 
Figure 3. a) Hp structure. b) Photofrin® structure; a purified HpD derivative consisting of 
a complex mixture of dimers and oligomers ranging from two to nine Por units 
connected by ether bonds (does not contain any monomers unlike HpD). 
The success of treatments and subsequent approvals of using Photofrin® generated 
worldwide interest in PDT as a treatment modality.  
 
                                                             
13   T. J. Dougherty, G. B. Grindey, R. Fiel, K. R. Weishaupt, D. G. Boyle, J. Natl. Cancer Inst. 1975, 55, 115–
121. 
14   a] J. K. Kelly, M. E. Snell, Br. J. Cancer 1975, 31, 237–244; b) J. Urol. 1976, 115, 150–151. 
15    Z. Huang, Technol. Cancer Res. Treat. 2005, 4, 283–293. 
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Key components of Photodynamic Therapy 
PDT is a form of phototherapy that, apart from a light source, involves two other main 
components: a PS and the presence of molecular oxygen (3O2). Only when these three 
components are combined together, they become toxic to targeted cells. 
Photosensitizers 
As a general definition, PS are compounds that are capable of absorbing light of a specific 
wavelength and transforming it into other forms of energy. In medicine, a PS is considered 
a drug when, upon excitation by light, it can utilize and convert this energy to induce 
photochemical reactions that may ultimately cause lethal toxic effects in the direct 
neighbourhood of the PS.16 In this respect, the ideal PS should preferentially accumulate 
only in the targeted diseased tissue. 
First, second and third generation photosensitizers 
Historically, PS are classified into three generations.17 First generation PS solely include 
HpD and porfimer sodium (Photofrin®). They were the first effective PS, but showed 
various problematic side effects such as low selectivity and prolonged skin 
photosensitization. Second generation PS are synthetic derivatives of the first generation 
PS, designed with the intention to overcome these shortcomings. They are chemically 
pure compounds, at least as efficient as the first generation PS, that absorb at longer 
wavelengths and cause significantly less post-treatment photosensitization. Finally, third 
generation PS are second generation PS covalently conjugated to site-specific delivery 
agents for selective accumulation within targeted tissue (Figure 4).17 If such delivery 
agents are of biological nature (eg. monoclonal antibodies, specific peptides, protein 
cages, low-density lipoproteins, liposomes, nucleic acids, folic acid, carbohydrates, etc.), 
the PS-conjugates are called biohybrids.18 Other non-biological delivery platforms could 
be for example semisolid hydrogel formulations, polymeric micelles, nanoparticles, etc.19  
                                                             
16   a] J. F. Lovell, T. W. B. Liu, J. Chen, G. Zheng, Chem. Rev. 2010, 110, 2839–2857; b) F. Dumoulin, 
Photosensitizers in Medicine, Environment and Security, Springer New York, 2012. 
17   a] J. G. Moser, Photodynamic Tumor Therapy : 2nd and 3rd Generation Photosensitizers, Harwood 
Academic Publishers, Amsterdam, 1998; b) D. Wöhrle, A. Hirth, T. Bogdahn-Rai, G. Schnurpfeil, M. 
Shopova, Russ. Chem. Bull. 1998, 47, 807–816. 
18  E. van de Winckel, E. Anaya, A. de la Escosura, T. Torres, Chem. Soc. Rev., manuscript in preparation. 
19  a] M. E. Wieder, D. C. Hone, M. J. Cook, M. M. Handsley, J. Gavrilovic, D. A. Russell, Photochem. 
Photobiol. Sci. 2006, 5, 727–734; b) M. Camerin, M. Magaraggia, M. Soncin, G. Jori, M. Moreno, I. 
Chambrier, M. J. Cook, D. A. Russell, Eur. J. Cancer 2010, 46, 1910–1918; c] B. Kogan, A. Pankratov, A. 
Butenin, R. Feyzulova, T. Andreeva, O. Yuzhakova, R. Yakubovskaya, V. Negrimovsky, E. Lukyanets, G. 
Vorozhtsov, Photodiagnosis Photodyn. Ther. 2011, 8, 209; d) X. Jia, L. Jia, Curr. Drug Metab. 2012, 13, 
1119–1122. 
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Figure 4. Some examples of biological (blue) and non-biological (green) delivery agents 
for selective delivery of PS to the targeted malignant tissues or organisms. 
 
Classification of photosensitizers according to chemical structure 
Apart from the above-mentioned classification in three generations, which wrongly 
implies that third-generation PS are better than the first- and second-generation ones, PS 
have also been categorized according to their chemical structure. In this way, three broad 
categories are distinguished: (i) Pors, (ii) chlorins and (iii) synthetic dyes.  
The first category solely consists of Pors, such as Hp and its derivatives (Figure 3), while 
the second category consists of chlorophyll-like substances that were discovered through 
photosynthesis processes (chlorins) and in bacteria and algae (bacteriochlorins) (Figure 5). 
They are in fact reduced forms of Pors and were found to possess equally great 
photosensitizing properties.  
 
 
Figure 5. Chemical structures of Por, and the reduced Por derivatives chlorin and 
bacteriochlorin.  
The third and biggest family is that of the synthetic dyes, which can be subdivided into 
two categories: porphyrinoid and non-porphyrinoid dyes. The chemical structures of some 
of the most common synthetic dyes that are able to photogenerate singlet oxygen (1O2) 
are summarized in Figure 6.  
Folic acidCarbohydrates
Nucleic acids
Peptides
Monoclonal
Antibodies
Protein cages
Proteins Liposomes
Polymeric
micelles
Nanoparticles
Hydrogels
22 π e- 20 π e- 18 π e-
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Figure 6. Chemical structures of some of the most common synthetic dyes able to 
photogenerate 1O2. On the left some common porphyrinoid dyes can be seen, while the 
right column depicts neutrally charged (middle) and cationic (right) non-porphyrinoid 
dyes. 
Until now, the porphyrinoid dyes are the most investigated and most important ones 
among the synthetic dyes.20 Indeed, the only clinically approved PS up to date are all 
porphyrinoid derivatives. In this thesis, in particular, we will focus on two of these 
porphyrinoid families, which are also heavily studied compounds in our research group, 
namely phthalocyanines (Pcs) and subphthalocyanines (SubPcs). Their general 
characteristics and synthesis will be discussed in detail later on in this introduction. 
Characteristics of ideal photosensitizers 
In order to develop PS with high potency and selectivity, the characteristics of efficient PS 
must first be known. A good PS is preferably a single and well characterized compound 
with a known and constant composition, low manufacturing costs and good stability when 
                                                             
20    a] M. R. Detty, S. L. Gibson, S. J. Wagner, J. Med. Chem. 2004, 47, 3897–3915; b) A. E. O’Connor, W. 
M. Gallagher, A. T. Byrne, Photochem. Photobiol. 2009, 85, 1053–1074; c] S. Yano, S. Hirohara, M. 
Obata, Y. Hagiya, S. Ogura, A. Ikeda, H. Kataoka, M. Tanaka, T. Joh, J. Photochem. Photobiol. C 2011, 
12, 46–67; d) A. B. Ormond, H. S. Freeman, Materials 2013, 6, 817–840; e] A. Kamkaew, S. H. Lim, H. 
B. Lee, L. V. Kiew, L. Y. Chung, K. Burgess, Chem. Soc. Rev. 2013, 42, 77–88. 
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stored. Furthermore, it should ideally fulfil most of the following criteria, mentioned in 
Table 1. 
Table 1. Recommended characteristics for ideal PS.21 
Parameter  Description of the ideal PS characteristics 
Toxicity  The PS should not show any intrinsic dark toxicity, and no toxic 
byproducts should be generated when it is metabolized. 
Furthermore, the PS should not be mutagenic or carcinogenic, as it 
should not cause a new disease when curing another. 
Administration  The PS should preferably be administrated close to the site of action 
(e.g. topically for skin cancer, inhalation for lung cancer, etc.) In the 
case of intravenous administration, the PS should show a good 
selectivity for the target tissue. 
Selectivity  The PS should preferably accumulate in the targeted malignant 
tissue. Special attention should be given to determining the correct 
site of action, which can either be intracellular (e.g. mitochondrial 
membranes) or extracellular (e.g. cell membrane). 
Activation  The PS should exclusively be activated by light of a certain wavelength 
to prevent accidental treatment, while at the same time the light of 
this wavelength should provide the PS with sufficient energy to excite 
3O2 to its singlet excited state. To this end, the PS should show 
maximal absorption in the range of 600-800 nm. 
Functioning   The PS should show a high triplet quantum yield (φt) and triplet state 
energy (ΔEt), higher than that of 1O2 (ΔEt = 94 kJ mol-1), so that energy 
transfer can occur to generate 1O2. In this regard, the PS should not 
aggregate in physiological environment, since aggregation decreases 
φt and therefore the 1O2 quantum yield (φΔ). 
Integrative ability  The PS should easily be integrated in a multi-treatment therapy, and 
perform well in conjugated use with chemotherapy, surgery and/or 
radiation. 
Imaging  The PS should ideally be (or contain) a fluorescent moiety, which 
allows for in situ imaging of its localization, functioning and 
elimination. 
Elimination  The PS should be effectively eliminated from the body to avoid 
generalized skin photosensitization, while it should on the other hand 
have an acceptable half-life to enable repeated treatments without 
having to re-administer the drug. 
 
                                                             
21    a] A. J. MacRobert, S. G. Bown, Philips, D., Photosensitizing Compounds: Their Chemistry, Biology and 
Clinical Use, No. 146, Wiley, Chichester, 1989; b) G. Jori, J. Photochem. Photobiol. Chem. 1992, 62, 
371–376; c] S. B. Brown, T. G. Truscott, Chem. Br. 1993, 29, 955–959; d) E. D. Sternberg, D. Dolphin, 
C. Brückner, Tetrahedron 1998, 54, 4151–4202; e] E. Waszkowska, Z. Zarębska, J. Poznański, I. Zhukov, 
J. Photochem. Photobiol. B 2000, 55, 145–154; f) R. R. Allison, G. H. Downie, R. Cuenca, X.-H. Hu, C. J. 
Childs, C. H. Sibata, Photodiagnosis Photodyn. Ther. 2004, 1, 27–42. 
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Tissue oxygen and its conversion into 1O2 
Absolutely essential for PDT to work is the presence of 3O2 in the near proximity of the site 
of action. Luckily the human body requires and regulates a very precise and specific 
balance of 3O2 in the blood and tissues.22 Using the respiratory system, red blood cells, 
specifically hemoglobin, gather oxygen in the lungs and distribute it to the rest of the body. 
The quantity of oxygen in blood and tissues can be expressed by their oxygen partial 
pressure (pO2). Typical pO2 values for various tissues can be seen in Table 2.  
Table 2. Typical pO2 values in different tissues. 
 pO2 (mmHg) pO2 (%) 
Air 160 21.1 
Arterial blood 100 13.2 
Brain 33.8 ± 2.6 1.3-2.5 
Lungs 42.8 5.6 
Intestine 8 ± 3.2 1.1 ± 0.4 
Liver 40.6 ± 5.4 5.4 ± 0.7 
Kidney 72 ± 20 9.5 ± 2.6 
Bone marrow 48.9 ± 4.5 6.5 ± 0.6 
 
In its ground state, 3O2 has an unusual electronic structure: the ground state is a triplet, 
paramagnetic because of two parallel electronic spins (Figure 7a). When an excited PS 
(also in its triplet state) collides with 3O2, a process of triplet-triplet energy transfer takes 
place, converting the 3O2 into the is extremely short-lived and reactive 1O2 (Figure 7b).23  
This process involves “flipping the spin” of the outermost electron and shifting it into the 
orbital containing the other electron, which in turn leaves one orbital entirely unoccupied 
(a violation of Hund’s rule).  
 
Figure 7. Molecular orbital diagrams of molecular triplet oxygen and highly reactive 1O2. 
                                                             
22  a] P. Vaupel, F. Kallinowski, P. Okunieff, Cancer Res. 1989, 49, 6449–6465; b) A. Carreau, B. E. Hafny-
Rahbi, A. Matejuk, C. Grillon, C. Kieda, J. Cell. Mol. Med. 2011, 15, 1239–1253; c] K. Mayer, S. Trzeciak, 
N. K. Puri, Curr. Opin. Crit. Care 2016, 22, 437–443. 
23  a] M. C. De Rosa, R. J. Crutchley, Coord. Chem. Rev. 2002, 233–234, 351–371; b) C. Schweitzer, R. 
Schmidt, Chem. Rev. 2003, 103, 1685–1757; c] R. Schmidt, Photochem. Photobiol. 2006, 82, 1161–
1177; d) P. R. Ogilby, Chem. Soc. Rev. 2010, 39, 3181–3209. 
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1O2 is the main reactive species in PDT and, as a result of its electron configuration 
instability and therefore short lifetime, it reacts only with substrates in close proximity to 
its site of generation. Furthermore, its lifetime depends on the solvent in which it is 
generated. In organic solvents it is estimated to be 10-100 µs, while in water it is about 3-
4 µs, and under physiological conditions it is only around 100-250 ns. As a consequence, 
the diffusion range of 1O2 is predicted to be around 45 nm,24 making it possible to use PDT 
as a highly selective form of local treatment. 
 
Light source 
The first light sources used in PDT were conventional non-coherent lamps where the 
output was defined by the use of filters.25 However, these lamps generated significant 
heat, and calculating the exact light dose was difficult.  
Nowadays, a wide range of coherent and non-coherent light sources can be used. 
Coherent light sources such as lasers are the most common light sources used in PDT, as 
they produce monochromatic light of a known wavelength and the light dosimetry is easy 
to calculate.26 Furthermore, the light can be passed down an optical fiber for localized 
treatments. Laser sources include dye lasers pumped by argon, or metal vapour lasers and 
frequency-doubled neodymium-doped-yttrium aluminium garnet lasers (Nd: YAG). The 
non-laser sources include tungsten filament, xenon arc, metal halide, and fluorescent 
lamps. New exciting developments such as light emitting diodes (LEDs) and femtosecond 
lasers are also being used.27 
No single light source is ideal for all PDT applications, even if the same PS is used. The 
choice of light source should not only be based on PS absorption, but should also take into 
consideration the specific characteristics of the disease being treated such as the location, 
the size of the treated area, the accessibility, and local tissue characteristics. Endoscopic 
guided and interstitial PDT, for example, require the use of lasers, preferably of the exact 
wavelength of the absorption maximum of the PS (Figure 8a). For topical PDT in 
dermatology on the other hand, the most important factor is that the total light dose 
should be administered in a homogeneous fashion over the total treatment area. This 
favours the use of LED-arrays for larger areas, or lasers with a flat profile fiber applicator 
for smaller areas (Figure 8b).11  
                                                             
24  E. Skovsen, J. W. Snyder, J. D. C. Lambert, P. R. Ogilby, J. Phys. Chem. B 2005, 109, 8570–8573. 
25    C. Whitehurst, J. D. Humphries, J. V. Moore, Lasers Med. Sci. 1995, 10, 121–126. 
26    R. Ackroyd, C. Kelty, N. Brown, M. Reed, Photochem. Photobiol. 2001, 74, 656–669. 
27    L. Brancaleon, H. Moseley, Lasers Med. Sci. 2014, 17, 173–186. 
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Figure 8. a) Interstitial PDT with the use of an optical fiber laser light source.28 b) Topical 
PDT with the use of a LED light source.29  
As mentioned in the previous paragraph, the choice of the light source should take into 
consideration the tissue characteristics of the zone that needs to be treated. The biological 
media is inhomogeneous and causes light scattering and reflection, which both limit 
effective tissue penetration.30 Depending on the treatment area, endogenous absorption 
by tissue components such as nucleic acids, hemoglobin and melanin can also cause a 
drastic decrease of intensity and penetration depth of the light beam. Since both the 
absorption and the scattering of light by tissue increase as the wavelength decreases, light 
penetration is very low at 500 nm. However, as can be seen in Figure 9, it almost doubles 
from 550 nm to 600 nm and doubles again in going to 750 nm.30b 
 
Figure 9. Light penetration and propagation through biological tissues. 
                                                             
28  J. Crawford, “Photodynamic Therapy: The use of fiber-optic probes,” can be found under 
https://visualsonline.cancer.gov/details.cfm?imageid=2267, 1987. 
29   “Topical PDT is administered using an Aktilite 128 LED source (Photocure ASA/Galderma),” can be 
found under http://www.bioopticsworld.com/articles/print/volume-3/issue6/features/dermatology 
-photodynamic-therapy-the-benefits-of-topical-photodynamic-therapy-in-dermatology.html, 2010. 
30    a] A. Juarranz, P. Jaén, F. Sanz-Rodríguez, J. Cuevas, S. González, Clin. Transl. Oncol. 2008, 10, 148–
154; b) M. Ethirajan, Y. Chen, P. Joshi, R. K. Pandey, Chem. Soc. Rev. 2010, 40, 340–362. 
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Although the penetration depth of light increases with increasing wavelength, 
wavelengths higher than 850-900 nm are not desirable because at those wavelengths the 
light no longer has sufficient energy to initiate a photodynamic reaction and convert tissue 
oxygen into 1O2 and other reactive oxygen species (ROS).31 This, in combination with the 
fact that hemoglobin and water in tissue absorb light over a broad spectral regime, results 
in an optical therapeutic window for PDT in the range of 650 nm to 900 nm (Figure 10).32 
 
Figure 10. Hemoglobin and water in tissue absorb light over a broad spectral regime, 
creating an optical window in the near-infrared (NIR) region, between 650 and 900 nm, 
which represents an optimal trade-off between image resolution and tissue penetration 
for in vivo imaging and PDT.32b  
 
  
                                                             
31   A. Juzeniene, K. P. Nielsen, J. Moan, J. Environ. Pathol. Toxicol. Oncol. 2006, 25, 7–28. 
32   a] B. P. Joshi, T. D. Wang, Cancers 2010, 2, 1251–1287; b) H. Kobayashi, M. Ogawa, R. Alford, P. L. 
Choyke, Y. Urano, Chem. Rev. 2010, 110, 2620–2640. 
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Molecular mechanisms in photodynamic therapy 
Despite considerable investigation and debate, the mechanism of PDT is still not fully 
understood. Many different biological mechanisms of cell destruction (for PDT) or 
microbial inactivation (for PDI) play a role and influence one another. In the next 
subchapters, these biological mechanisms and their underlying photophysical 
mechanisms will be explained in detail.  
Photophysical mechanisms 
The general “map” for the processes taking place after electronic excitation of a molecule 
is the so-called Jablonski-scheme,33 such as the one shown for a PS in Figure 11.  
The molecular structure of most PS is typified by conjugated double bonds containing a 
delocalized system of π-electrons that are spin paired in low energy orbitals. The total spin 
of the PS is therefore 0, so its ground electronic state is (as for most molecules) a singlet 
state (S0). Upon application of light corresponding to the absorption peak of the PS, the 
electron in the highest occupied molecular orbital (HOMO) of the PS is promoted to the 
lowest unoccupied molecular orbital (LUMO), exciting the PS to an unstable and short 
lived singlet excited state S1 (1PS*) (process 1 in Figure 11). In this state, several processes 
may rapidly occur.34 1PS* can return to the S0 state by emitting the absorbed energy as 
fluorescence (2) or by internal conversion (thermal decay, 3). Alternatively, and most 
importantly to the PDT process, the PS can undergo a reversal of the excited electrons spin 
to give rise to the first triplet excited state T1 of the PS (3PS*), a process which is known as 
intersystem crossing (4). The resulting triplet excited state T1 is less energetic than the 
singlet excited state S1, but has a much longer lifetime (microseconds as opposed to 
nanoseconds), since transitions from T1 to S0 are “spin forbidden”. Importantly, the 
biologically relevant photochemistry is often mediated by this triplet state.34,35 The energy 
of 3PS* can be dissipated by emitting it as phosphorescence (5) returning to the ground 
state S0 by changing the spin orientation of the excited electron in the PS triplet state (a 
relatively slow process). Alternatively, 3PS* may interact with molecules abundant in its 
immediate environment. Because of the selection rules that specify that triplet–triplet 
interactions are spin-allowed while triplet–singlet interactions are spin-forbidden, the PS 
triplet can react readily with 3O2, which is one of the few molecules that are a triplet in the 
ground state. 
                                                             
33  J. R. Lakowicz, Principles of Fluorescence Spectroscopy, Springer US, 2006. 
34  C. S. Foote, Photochem. Photobiol. 1991, 54, 659. 
35  J. P. Celli, B. Q. Spring, I. Rizvi, C. L. Evans, K. S. Samkoe, S. Verma, B. W. Pogue, T. Hasan, Chem. Rev. 
2010, 110, 2795–2838. 
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Figure 11. Modified Jablonski diagram outlining the characteristic possible radiative (full 
line) and non-radiative (dashed line) transitions between electronic states of PS, i.e. 
photon absorption (1), fluorescence (2), internal conversion (3), intersystem crossing (4) 
and phosphorescence (5). 3PS* can participate in Type I and Type II photodynamic 
reactions, resulting in 1O2 and ROS. 
As can already be seen from Figure 11, the excited 3PS* can react with surrounding 
molecular 3O2 by participating in two types of photodynamic reactions titled Type I and 
Type II reactions.34 Details of both types of photoreactions can be seen in Figure 12. In 
Type I reactions, the excited PS transfers an electron to a nearby substrate (S), sometimes 
in concert with proton donation to 3O2, yielding the superoxide anion O2
•−. The direction 
of the electron transfer is controlled by the relative redox potentials of the PS and the 
substrate. The O2
•− superoxide anion then goes on to form other ROS including the 
hydroxyl radical (OH•), and hydrogen peroxide (H2O2). Alternatively, in type II reactions, 
3PS* undergoes an electronic energy transfer upon collision with 3O2, resulting in the 
formation of cytotoxic 1O2.  
 
Figure 12. Overview of Type I and Type II photoreactions during PDT, which result in 
oxidative damage of biological targets.  
Both Type I and Type II mechanisms cause oxidative damage within the target tissues 
which lead to cell death and tumor destruction in case of PDT and microbial inactivation 
in case of PDI. However, it is generally accepted that the generation of 1O2 from Type II 
mechanism predominates in both treatment modalities. 
 
E
n
e
r
g
y
Sn
S2
S1
S0
T1
Tn
A
b
so
rp
ti
o
n
 (
1
)
Fl
u
o
re
sc
e
n
ce
 (
2
)
Internal 
Conversion (3)
(3)
(3)
Phosphorescence 
(5)
Intersystem 
Crossing (4)
1PS*
3PS*
PS
O2
Type II reaction
Energy transfer
Type I
O2
1O2
ROS Type I reaction
Electron transfer
  
•−
  •
    
Type II
Type I photoreactions
     
 
+     • +  • 
     
 
+  O    +  O 
• 
   • +  O    
• +   O 
• 
  • +  O                  
  • +   O 
•                   
Type II photoreactions
     
 
+  O    +   O 
  O +                    
16 Introduction 
Biological mechanisms 
The ROS formed through the Type I processes have a range of different reactivities.36 OH• , 
arguably the most reactive of the three ROS formed, is a strong electrophile that is able to 
chemically attack a wide range of biomolecules such as nuclear DNA, mitochondrial DNA, 
proteins and membrane lipids.37 H2O2 is less reactive than OH
• , and O2
•− is the least 
reactive of all. Nonetheless, O2
•− may be converted into H2O2 and O2 by superoxide 
dismutase. H2O2 is only considered truly reactive when it reacts with ferrous iron in what 
is known as the Fenton reaction: 
H2O2    F 
2+     OH−    OH•   F 3+.  
This reaction results in homolytic fission of the oxygen-oxygen bond in H2O2, to yield a 
hydroxide ion and OH•  via the oxidation of ferrous iron to ferric iron.38 Importantly, their 
exist various ways of deactivation for these ROS. For example, H2O2 can be removed 
through catalase, forming water and oxygen gas. OH• , just like 1O2, cannot be broken 
down by an enzymatic reaction, but may be quenched by antioxidants, including 
antioxidant peptides (e.g. glutathione) or by antioxidant vitamins (e.g. ascorbic acid).39 
Because 1O2 is not a radical, it reacts with biological molecules through quite different 
mechanisms, making the Type II pathway responsible for different macromolecular 
reaction pathways. The oxidative attack is of electrophilic nature, hence (as can be seen 
in Figure 13) it is specifically directed to groups with high electron densities such as: 
(i)     double bonds in unsaturated lipids (e.g. oleic, linoleic and arachidonic acids)  
(ii)     double bounds in steroids (e.g. cholesterol) 
(iii)     sulphur atoms in amino acids (e.g. methionine, cysteine) 
(iv)     aromatic or heterocyclic groups in amino acids (e.g. tryptophan, tyrosine, 
 histidine)  
(v)  aromatic or heterocyclic groups in pyrimidine and purine bases of DNA and 
 RNA  (e.g. guanosine).  
                                                             
36  M. Ochsner, J. Photochem. Photobiol. B 1997, 39, 1–18. 
37  S. K. Borra, J. Mahendra, P. Gurumurthy, Jayamathi, S. S. Iqbal, L. Mahendra, J. Clin. Diagn. Res. 2014, 
8, CC01–CC05. 
38  M. Valko, H. Morris, M. T. D. Cronin, Curr. Med. Chem. 2005, 12, 1161–1208. 
39  T. Dai, B. B. Fuchs, J. J. Coleman, R. A. Prates, C. Astrakas, T. G. St. Denis, M. S. Ribeiro, E. Mylonakis, 
M. R. Hamblin, G. P. Tegos, Front. Microbiol. 2012, 3, 120. 
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Figure 13. Typical reactions of 1O2 with selected biomolecules.40 
 
 
Specific mechanisms of tumor destruction in PDT 
It is now known that there are three main biological mechanisms involved in the tumor 
shrinkage and disappearance followed by photodynamic treatment,41 being (i) direct 
tumor cell destruction, (ii) vascular destruction, and (iii) elicitation of an antitumor 
immune response. These three mechanisms can influence each other and their 
combination is required for achieving long-term tumor control. In the following 
subsections, these three mechanisms are briefly discussed. 
(i)  Direct damage and cell death 
In this case, the ROS generated during PDT can kill tumor cells directly by apoptosis 
and/or necrosis.42 Necrosis is a violent and quick form of degeneration that results from 
extensive cellular damage. It is characterized by the destruction of organelles and 
disruption of the plasma membrane leading to the release of intracellular contents into 
the extracellular environment. In contrast, apoptosis is a mechanism of genetically 
programmed death of old cells in both physiological and pathological conditions of a living 
organism. It is characterized by a common sequence of morphological and biochemical 
                                                             
40  a] A. G. Leach, K. N. Houk, Chem. Commun. 2002, 1243–1255; b) M.-F. Zuluaga, N. Lange, Curr. Med. 
Chem. 2008, 15, 1655–1673; c] B. Lipinski, Oxid. Med. Cell. Longev. 2011, 809696; d) J. T. F. Lau, 
Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-Based Photosensitizers, 
Springer International Publishing, Switzerland, 2013. 
41  a] T. J. Dougherty, C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, Q. Peng, J. 
Natl. Cancer Inst. 1998, 90, 889–905; b) A. P. Castano, T. N. Demidova, M. R. Hamblin, Photodiagnosis 
Photodyn. Ther. 2005, 2, 91–106. 
42  a] I. J. Macdonald, T. J. Dougherty, J. Porphyr. Phthalocyanines 2001, 5, 105–129; b) P. Agostinis, E. 
Buytaert, H. Breyssens, N. Hendrickx, Photochem. Photobiol. Sci. 2004, 3, 721–729; c] A. P. Castano, 
T. N. Demidova, M. R. Hamblin, Photodiagnosis Photodyn. Ther. 2005, 2, 1–23; d) D. Kessel, J. Porphyr. 
Phthalocyanines 2016, 20, 302–306. 
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changes including condensation of chromatin and formation of apoptotic bodies. The 
crucial factors in determining the type of cell death are the cell type, the subcellular 
localization of the PS and the light dose applied to activate it locally. In general, it is 
believed that lower dose PDT leads to more apoptosis, while higher doses lead to 
proportionally more necrosis.43  
(ii) Vascular damage 
PDT also damages the tumor-associated vasculature, leading to tissue deprivation 
of oxygen and nutrients.44 Since the viability of tumor cells depends on the amount of 
nutrients supplied by surrounding blood vessels, this vascular damage can lead to 
consequent tumor infarction and can contribute to long-term tumor control.45 Over the 
last two decades, there have been various reports of PDT-induced damage to tumor 
microvasculature leading to persistent post-PDT tumor hypoxia/anoxia and nutrient 
deficiency and finally to complete tumor disappearance.35,42b,46 The mechanisms 
underlying the vascular occlusion differ greatly with different PS, but include vessel 
constriction, macromolecular leakage, leukocyte adhesion, blood flow stasis, and 
thrombus formation.47 Importantly, to obtain maximal effects, PDT should also be applied 
to the healthy vasculature surrounding the tumor zone, as studies have shown the lack of 
tumor curability when only irradiating the malignant tumor zone.48 A crucial parameter 
for controlling the effect of vascular damage is the drug-light interval, as this can 
determine whether the drug is mostly free flowing in the blood, binding to the blood 
vessel walls or leaking out into the tumor interstitium, resulting in very different outcomes 
after PDT treatment.49  
(iii) Inflammatory and immune response 
Photodynamically induced changes in the plasma membrane and the membrane of 
cell organelles can trigger an immune response against tumor cells by activating multiple 
                                                             
43  K. Plaetzer, T. Kiesslich, B. Krammer, P. Hammer, Photochem. Photobiol. Sci. 2002, 1, 172–177. 
44  a] W. Wang, L. T. Moriyama, V. S. Bagnato, Laser Phys. Lett. 2013, 10, 23001; b) A. Kawczyk-Krupka, 
A. M. Bugaj, M. Potempa, K. Wasilewska, W. Latos, A. Sieroń, Photodiagnosis Photodyn. Ther. 2015, 
12, 161–175. 
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signal transduction pathways.50 These include a variety of protein kinase signalling 
cascades, which elicit an inflammatory or immune response leading to cell death.51 In fact, 
studies in the late 1980s and early 1990s have reported the infiltration of lymphocytes, 
leukocytes, and macrophages into PDT-treated tissue, which indicates an activation of the 
immune response.52 One of the key experiments demonstrating this effect was carried out 
by Korbelik et al., who grew the same tumor in immunocompetent and immunodeficient 
mice of the same background, with PDT leading to tumor ablation in both of them but only 
obtaining a long-term curing in the immunocompetent mice.53 Furthermore, the 
differences in the nature and intensity of the inflammatory response between normal and 
cancerous tissues may contribute to the selectivity of PDT-induced damage.41,54 
 
Specific mechanisms of microbial inactivation in PDI 
Microbial cells display a truly large variety of size, sub-cellular architecture, and 
biochemical composition. Nevertheless, the photosensitized processes in most 
microorganisms, ranging from fungi, viruses and parasitic protozoa to Gram-positive and 
Gram-negative bacteria, occur in a similar to almost identical way.3 
(i) Cytoplasmic membrane 
The first and most frequent target of microbial cell inactivation by PDI is the 
cytoplasmic membrane.55 Various studies have demonstrated that the photoinduced 
damage progresses from the outer to the inner leaflet of the cytoplasmic membrane and 
that it takes place via various simultaneous mechanisms.56 The generation of ROS and 1O2 
leads to the inactivation of several co-factors and enzymes that are associated with the 
cytoplasmic membrane, such as NADH, succinic dehydrogenase and lactic dehydrogenase. 
Meanwhile several outer membrane and cytoplasmic membrane proteins also undergo 
extensive crosslinking causing a loss of membrane barrier properties and resulting in the 
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collapse of the K+ and ionic balance.57 This consequently leads to a massive reduction of 
the transport capacity for a variety of solutes, which results in a shortage of essential 
substrates for anabolic and catabolic pathways.58 The inhibition of these metabolic 
processes leads, in turn, to the inhibition of glucose transport and DNA synthesis (and 
therefore also RNA and protein synthesis).  
(ii) Intracellular damage 
Although the PS is initially partitioned in the cytoplasmic membrane, some reports 
have shown that, as irradiation progresses, the PS gradually diffuses to inner cellular 
districts.59 It is thus reasonable to expect that a variety of non-membranous sites, 
including DNA, are involved in the photooxidative reactions at later stages of the overall 
photoprocess. However, it has been pointed out by several research groups that such 
additional damage is not directly correlated with cell death, which is already quite 
extensive when the cytoplasmic membrane has been heavily disrupted.60 
The overall process is obviously of multi-target nature, making it extremely difficult 
for microbial cells to develop resistance to the photodynamic treatment. Taking into 
account the current antibiotic resistance crisis,61 this represents one of the major 
advantages of antimicrobial PDT. 
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(Sub)Phthalocyanines as photosensitizers in PDT 
Out of all the PS employed in different PDT applications, Pcs (Figure 14, top) are, together 
with Pors, the current golden standard in PDT, among the most studied ones. They present 
several advantages such as their absorption at higher wavelengths and higher molar 
extinction coefficients as compared to Pors. Structurally related to Pcs, SubPcs (Figure 14, 
bottom) also show these favourable characteristics. However, their use as PS remains little 
investigated. On these bases, in the next subsections we will introduce the chemistry of 
Pcs and SubPcs, in general, and their utility in the field PDT, in particular. 
 
Figure 14. Molecular structure, electron delocalization and 3D-shape of Pcs (top) versus 
SubPcs (bottom). 
 
Phthalocyanines  
Phthalocyanines are planar 18 π-electron aromatic macroheterocycles consisting of four 
isoindole subunits linked together through aza bridges, with or without a metal atom in 
the central cavity.62 The delocalization of these 18 π-electrons generates their typical 
absorption spectra with two major intense bands: the Q- and B- or Soret band, both due 
to π-π* transitions. The Q-band (S0 to S1 transition), between 620-720 nm, is generally 
sharp and intense, and gives to the characteristic blue/green color of these molecules. The 
Soret band (S0 to S2 transition), around 350 nm, is usually broad and low in intensity. 
Metallophthalocyanines (MPcs) generally show one single Q-band, while in the case of 
free base Pcs (H2Pc) a splitting of the Q-band can be observed due to their doubly 
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Publishers (LSK) Ltd., Cambridge, 1996; b) N. B. McKeown, Phthalocyanine Materials. Synthesis, 
Structure and Function, Cambridge University Press, 1998; c] C. G. Claessens, U. Hahn, T. Torres, 
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degenerated LUMO as a consequence of their lower symmetry (D2h) as compared to that 
of MPcs (D4h).  
As can be seen in Figure 6, Pcs are structurally very similar to Pors. However, due to their 
four additional peripheral benzene rings, their absorption maximum or Q-band lies at 
longer wavelengths, usually in the red visible region, falling inside the optical therapeutic 
window and allowing a deeper light penetration (Figure 15). Furthermore, the Pc Q-band 
has a significantly higher molar extinction coefficient, about two orders of magnitude, 
compared to Pors (εPc ~ 105 M-1 cm-1, εHpD ~103 M-1 cm-1). 
 
Figure 15. Typical normalized UV-Vis absorption spectra of Por, metal-free Pcs (H2Pc) 
and Pcs containing a metal ion in their central cavity (MPc) in DMF. 
Because of these molecular characteristics, Pcs possess very desirable photophysical and 
photochemical properties for their use in PDT. Furthermore, these properties can in many 
cases easily be tuned through rational modification of the peripheral and/or axial 
substituents of the Pcs and by varying the central metal atom. More than 70 different 
atoms can be included in their central cavity, influencing their fluorescence, 
phosphorescence and excited triplet state generation.63 Pcs containing a closed d shell and 
diamagnetic metal center, such as Zn2+, Al3+ and Ga3+, generally have higher triplet state 
quantum yields (φt >0.4) and longer lifetimes (τT > 200 µs), as compared to Pcs containing 
transition metal ions (τT in the nanosecond range).62,63,64 Apart from this, the heavy atom 
effects promotes the intersystem crossing from the singlet to the triplet excited state as 
the central atom mass increases.65  
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Synthesis and versatility of Pcs 
Pcs were first synthesized by Braun and Tchernlac in 1907.66 They are generally 
synthesized by cyclotetramerization of the appropriate precursors, usually phthalonitriles 
or 1,3-diiminoisoindolines (Scheme 1).62g MPcs are synthesized, either starting from 
phthalonitriles or a 1,3- diiminoisoindolines, in the presence of a metallic salt that acts as 
a template, or by later metalation of a H2Pc. H2Pc, on the other hand, can be synthesized 
starting from 1,3-diiminoisoindolines, by heating a phthalonitrile in the presence of DBU 
or hydroquinone, or by the formation of a lithium Pc followed by subsequent 
demetallation by treatment with a mineral acid. More recently, various new methods to 
prepare Pcs have been described, such as the treatment of phthalonitriles with metal salts 
and hexamethyldisilazane in DMF,67 the double-addition of oximes to phthalonitriles68 and 
microwave-assisted synthesis.69 
 
Scheme 1. General schematic representation of the synthesis of H2Pc and MPcs. 
The mechanism at the basis of the formation of Pcs is still not completely understood, 
nevertheless there exist various mechanistic hypotheses, all bearing some common 
features that are generally accepted.70 The macrocyclization in the presence of a 
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nucleophile sodium or lithium alkoxide usually starts with the formation of the 
corresponding salt of 1-imido-3-alkoxyindoline (Scheme 2 – step 1),71 followed by the 
nucleophilic attack of this intermediate to the cyano group of another phthalonitrile 
molecule (step 2). The resulting dimer can either react with a third phthalonitrile molecule 
in the same way, to form a trimer (step 3a) or undergo self-condensation with another 
dimer (step 3b), both mediated by the metallic cation as a template.  
 
Scheme 2. Hypothetical mechanism for the synthesis of MPcs by cyclotetramerization 
of phthalonitrile in the presence of a metal salt. 
When using more than one different phthalonitrile and/or 1,3-diiminoisondoline (A and 
B) in this synthesis, the library of possible Pcs is amplified even more, and differently 
substituted Pcs (Figure 16) are obtained in a statistical manner.62f,72 The selective synthesis 
of these unsymmetrically substituted Pcs is also possible,73 however it will not be detailed 
over here as it lies outside the scope of the present thesis.  
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A. Sastre, T. Torres, M. Hanack, Tetrahedron Lett. 1995, 36, 8501–8504; e] A. Weitemeyer, H. Kliesch, 
D. Woehrle, J. Org. Chem. 1995, 60, 4900–4904; f) Á. Sastre, B. del Rey, T. Torres, J. Org. Chem. 1996, 
61, 8591–8597; g] A. Hirth, A. K. Sobbi, D. Wöhrle, J. Porphyr. Phthalocyanines 1997, 1, 275–279; h) 
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Figure 16. Schematic representation of the set of Pc compounds obtained via statistical 
cyclotetramerization of two differently functionalized phthalonitriles, A and B. The 
relative percentages of each compound in the mixture will depend on the reactivity of 
the respective phthalonitriles.  
Furthermore, depending on the central atom incorporated in the macrocycle cavity, it is 
in some cases possible to further amplify the versatility of Pcs by incorporating different 
functional groups at axial positions of the metal atom. This is the case for ruthenium 
(RuPc), aluminium (AlPc) and silicon (SiPc) Pcs, among others. For SiPcs and AlPcs (Figure 
17a and c) the axial substituents are covalently linked to the central atom, while for RuPcs 
bearing N-containing ligands (Figure 17b) the bond is supramolecular in nature.  
 
Figure 17. General structure of axially coordinating Pcs: a) SiPc (where R = alkoxy, 
phenoxy, silyloxy), b) RuPc (where L = N-containing ligands able to coordinate to the 
central metal or CO), and c) AlPc (where R = alkoxy, phenoxy, silyloxy).  
In case the central metal allows the conjugation of two axial ligands, such as for SiPcs and 
RuPcs, symmetrically and asymmetrically substituted Pcs can be obtained in a statistical 
manner, as can be seen in Figure 18 for SiPcs. 
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Figure 18. Schematic representation of the set of Pc compounds obtained via statistical 
functionalization of Pcs with a tetravalent central metal atom, such as SiPcs. The 
relative percentages of each compound will depend on the reactivity of the respective 
axial substituents.  
 
Silicon: the metalloid of choice 
In the present thesis, SiPcs have been chosen as the object of study for various reasons. 
As most Pcs, they fulfil several of the requirements for ideal PS mentioned in Table 1: i.e. 
intense absorption inside the range of the therapeutic window, high molar extinction 
coefficients, high φt and long lifetimes of their triplet excited state (τt). Besides, one of the 
biggest drawbacks of the use of Pcs in PDT is their tendency to aggregate in aqueous 
solution, an inherent characteristic caused by the intrinsic planarity of these large 
aromatic systems. Any kind of aggregation immediately kills the generation of 1O2 and its 
diffusion to the site of action, making the PS completely useless.74 Since Si is a tetravalent 
metalloid, this problem is easily circumvented in SiPcs, since they offer the possibility to 
incorporate up to two voluminous substituents at the axial positions of the Si atom, 
preventing any form of aggregation. Furthermore, apart from introducing bulky 
substituents to avoid aggregation, substituents with desired characteristics could be 
introduced at the axial positions, further enhancing the interesting properties of these 
systems. Some examples of substituents that could be introduced are chromophores (e.g. 
pyrene, …) for imaging applications and theranostics, selective targeting units (e.g. 
antibodies, peptide sequences, carbohydrates, etc.), or specific ligands enabling 
activatable 1O2 generation. 
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Conveniently, SiPcs are easily accessible. They can be synthesized either by 
tetramerization of the corresponding 1,3-diiminoisoindolines in the presence of SiCl4,75 or 
by silylation of the corresponding free-base Pcs with HSiCl3,76 although this last alternative 
easily leads to the formation of dimers and oligomers and is therefore seldom used. 
Notably, silicon phthalocyanine dichloride (SiPcCl2), the most commonly used starting 
material for derivatization at the axial positions, is commercially available from Sigma 
Aldrich.77 
Although a large number of Pcs have been synthesized as PS for PDT applications, only a 
few have made it to the stage of clinical trials (Figure 19).78 Pc 4, a SiPc, has been one of 
the most successful PS out of this series, which greatly stimulated the interest in the design 
of new SiPcs. The clinical evaluation of Pc 4, which localizes almost exclusively in the 
mitochondria and causes localized damage upon irradiation, has been assessed in 
cutaneous and subcutaneous lesions from diverse solid tumor origins.79,80 A Phase I clinical 
trial of topically applied Pc 4 for treatment of mycosis fungoides, the most common form 
of cutaneous T-cell lymphoma has recently been completed, although no final results have 
been reported yet.81 However, preliminary findings from this Phase I trial have been 
promising with no local or systemic toxicities observed.82  
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Figure 19. Chemical structures of four Pc-based PS, which are currently in clinical use or 
trial, with the SiPc Pc 4 being one of the most successful Pc-based PS in PDT so far.78 
 
Subphthalocyanines  
SubPcs are lower homologues of Pcs, consisting of three isoindole subunits linked together 
through aza bridges (instead of 4 in the case of Pcs) (Figure 14). In their central cavity they 
always bear a boron atom, which is tetracoordinated to three nitrogen atoms of the 
macrocycle and one axial substituent.83 Their aromatic system consists of 14 π-electrons 
which are delocalized over the internal aromatic ring, consisting of 6 carbon and 6 nitrogen 
atoms. Importantly, and in contrast to Pcs, they are not planar, but show a conical 
structure.84 Similarly to Pcs, the delocalization of these 14 π-electrons generates an 
absorption spectrum with the same two characteristic bands, corresponding to the π-π* 
transitions of S0 to S1 and S0 to S2, respectively (Figure 20): the Q-band (in this case 
centered between 460 and 570 nm) and the B- or Soret band (around 350 nm). Depending 
on the exact wavelength of the absorption maximum of their Q-band, SubPcs display a 
                                                             
83  a] C. G. Claessens, D. González-Rodríguez, T. Torres, Chem. Rev. 2002, 102, 835–853; b) T. Torres, 
Angew. Chem. Int. Ed. 2006, 45, 2834–2837; c] A. Medina, C. G. Claessens, J. Porphyr. Phthalocyanines 
2009, 13, 446–454; d) C. G. Claessens, D. González-Rodríguez, M. S. Rodríguez-Morgade, A. Medina, 
T. Torres, Chem. Rev. 2014, 114, 2192–2277. 
84  a] H. Kietaibl, Monatshefte Für Chem. 1974, 105, 405–418 b) K. Kasuga, T. Idehara, M. Handa, Y. Ueda, 
T. Fujiwara, K. Isa, Bull. Chem. Soc. Jpn. 1996, 69, 2559–2563 c] M. K. Engel, J. Yao, H. Maki, H. 
Takeuchi, H. Yonehara, C. Pac, Rep. Kawamura Inst Chem Res 1997, 9, 53–57 d) R. Potz, M. Göldner, 
H. Hückstädt, U. Cornelissen, A. Tutaß, H. Homborg, Z. Für Anorg. Allg. Chem. 2000, 626, 588–596 e] 
M. S. Rodríguez-Morgade, C. G. Claessens, A. Medina, D. González-Rodríguez, E. Gutiérrez-Puebla, A. 
Monge, I. Alkorta, J. Elguero, T. Torres, Chem. Eur. J. 2008, 14, 1342–1350 f) F. Camerel, G. Ulrich, P. 
Retailleau, R. Ziessel, Angew. Chem. Int. Ed. 2008, 47, 8876–8880 g] A. S. Paton, A. J. Lough, T. P. 
Bender, Acta Crystallogr. E 2010, 66, 3246 h) A. S. Paton, G. E. Morse, J. F. Maka, A. J. Lough, T. P. 
Bender, Acta Crystallogr. E 2010, 66, 3059 i] J. D. Virdo, Y. H. Kawar, A. J. Lough, T. P. Bender, Cryst 
Eng Comm 2013, 15, 3187–3199 j) J. D. Virdo, A. J. Lough, T. P. Bender, Acta Crystallogr. C 2016, 72, 
297–307. 
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color varying from intense pink to dark purple. On the other hand, the molar extinction 
coefficient of SubPcs is generally in de order of 104 M-1 cm-1, situated between that of Pors 
(εHpD ~103 M-1 cm-1) and Pcs (εPc ~ 105 M-1 cm-1). 
 
Figure 20. Normalized UV-Vis spectra of a SubPc (pink) and a SiPc (blue) in DMF. 
 
Synthesis and versatility of SubPcs 
Although SubPcs were discovered in 1972,85 it took various years to optimize their 
synthesis.86 Today, they can be easily synthesized with reasonable to high yields by the 
cyclotrimerization of phthalonitrile in the presence of a boron trihalide, generally BBr3 or 
BCl3, in a variety of high-boiling solvents, such as p-xylene, naphthalene or o-
dichlorobenzene (Scheme 3).83a,83d,87 Recently there also have been advances in their 
synthesis by microwave heating.88 
 
Scheme 3. General synthesis of SubPcs. 
Although BBr3 and BCl3 are the most commonly used boron trihalides in the synthesis of 
SubPcs, there exist other possibilities such as BF3, BPh3, PhBF2, PhBCl2 or BuBBr2.16,73d, 
84,87a,89 However, both BBr3 and BCl3 are commercially available as solutions in p-xylene or 
                                                             
85  A. Meller, A. Ossko, Monatshefte Für Chem. 1972, 103, 150–155. 
86  a] C. G. Claessens, T. Torres, Chem. Eur. J. 2000, 6, 2168–2172  b) Tetrahedron Lett. 2000, 41, 6361–
6365 c] C. G. Claessens, D. González-Rodríguez, B. del Rey, T. Torres, G. Mark, H.-P. Schuchmann, C. 
von Sonntag, J. G. MacDonald, R. S. Nohr, Eur. J. Org. Chem. 2003, 2003, 2547–2551. 
87  a] M. Geyer, F. Plenzig, J. Rauschnabel, M. Hanack, B. del Rey, A. Sastre, T. Torres, Synthesis 1996, 
1996, 1139–1151 b) D. González-Rodríguez, Tesis Doctoral, 2003. 
88  a] L. Giribabu, C. Vijay Kumar, A. Surendar, V. Gopal Reddy, M. Chandrasekharam, P. Yella Reddy, 
Synth. Commun. 2007, 37, 4141 b) J. H. Kim, J. Heo, B. M. Kang, D.-H. Son, G.-D. Lee, S.-S. Hong, S. S. 
Park, KongopHwahak 2009, 20, 154. 
89  a] J. Rauschnabel, M. Hanack, Tetrahedron Lett. 1995, 36, 1629–1632; b) N. Kobayashi, T. Ishizaki, K. 
Ishii, H. Konami, J. Am. Chem. Soc. 1999, 121, 9096–9110; c] N. Kobayashi, J. Porphyr. Phthalocyanines 
0,00
0,20
0,40
0,60
0,80
1,00
1,20
260 360 460 560 660 760
A
b
so
rp
ti
o
n
 /
 a
.u
.
Wavelength / nm
SubPc
SiPc
30 Introduction 
DCM, greatly facilitating their use and making it possible to control the stoichiometry of 
the reaction. Furthermore, p-xylene not only serves as a typical high-boiling solvent (bp = 
138.5°C), but has also de capacity to reduce in situ the chlorine atoms liberated by BCl3 
during the reaction, effectively preventing the chlorination of the macrocycle periphery.  
Various studies have been conducted on the mechanism of formation of SubPcs and with 
the aid of theoretical calculations, they have resulted in the mechanism postulated in 
Scheme 4.83d,90 The process starts with the formation of a phthalonitrile-BX3 adduct, 
leading to intermediate A, which subsequently reacts with another phthalonitrile 
molecule. Addition of a third phthalonitrile molecule leads to the formation of the 
intermediate macrocycle B, which, after elimination of Cl2 (catalyzed by BX3), leads to the 
final SubPc product. 
 
Scheme 4. Postulated mechanism for the formation of SubPcs. 
Similarly as for Pcs, more than one different phthalonitrile can be employed in the 
synthesis of SubPcs, giving rise to differently substituted derivatives in a statistical manner 
(Figure 21).86a,91 However, less variety in the type of substituents of the phthalonitriles is 
possible, as compared to those accessible in the synthesis of Pcs, since the reaction 
conditions for the formation of SubPcs are very harsh. Halogen atoms such as iodine and 
bromine are without doubt the most used substituents, as they provide a way for 
subsequent functionalization of the SubPc through Pd-catalyzed cross coupling 
                                                             
1999, 3, 453–467; d) M. S. Rodríguez-Morgade, S. Esperanza, T. Torres, J. Barberá, Chem. Eur. J. 2005, 
11, 354–360. 
90  a] C. G. Claessens, D. González-Rodríguez, C. M. McCallum, R. S. Nohr, H.-P. Schuchmann, T. Torres, 
J. Porphyr. Phthalocyanines 2007, 11, 181–188 b) R. S. Nohr, C. M. McCallum, H.-P. Schuchmann, J. 
Porphyr. Phthalocyanines 2010, 14, 271–277. 
91  a] H. Ali, S. K. Sim, J. E. van Lier, J. Chem. Res. Synop. 1999, 496–497; b) J. R. Stork, R. J. Potucek, W. 
S. Durfee, B. C. Noll, Tetrahedron Lett. 1999, 40, 8055–8058; c] C. D. Zyskowski, V. O. Kennedy, J. 
Porphyr. Phthalocyanines 2000, 4, 707–712; d) D. González-Rodríguez, C. G. Claessens, T. Torres, J. 
Porphyr. Phthalocyanines 2009, 13, 203–214. 
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reactions.92 Other possible SubPc substituents include nitro, thioether, alkyl and sulfonyl 
groups.83a,d 
 
Figure 21. Schematic representation of the set of SubPc derivatives obtained via 
statistical cyclotetramerization of two differently functionalized phthalonitriles, A and B. 
The relative percentages of each compound will depend on the relative reactivity of the 
respective phthalonitriles.  
  
                                                             
92  a] D. González-Rodríguez, T. Torres, Eur. J. Org. Chem. 2009, 2009, 1871–1879; b) R. Ziessel, G. Ulrich, 
K. J. Elliott, A. Harriman, Chem. Eur. J. 2009, 15, 4980–4984. 
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Applications of photodynamic therapy 
As mentioned before, PDT has numerous applications, which can be divided into two main 
fields: the photodynamic treatment of malignant cancer cells, known as PDT,  on the one 
hand, and the photodynamic treatment or inactivation of microorganisms, known as PDI, 
on the other hand. In the next paragraphs some of the most important developments and 
success stories of both fields will be highlighted . 
Oncological applications (PDT) 
Although PDT was discovered more than a century ago as an antimicrobial,9 its most 
developed application until now has been cancer treatment and it is now being widely 
used in the clinic.2 PDT has several advantages over actual cancer therapies such as 
radiotherapy and chemotherapy: it is comparatively non-invasive, it can be targeted 
accurately, repeated doses can be given without the total-dose limitations associated with 
radiotherapy, and the healing process results in little or no scarring. Furthermore, PDT can 
usually be done in an outpatient or day-case setting, which is convenient for the patient, 
and has no side-effects. To date, this therapeutic methodology has been used in various 
branches of oncology, such as dermatology,2,93 brain malignancies,94 thoracic oncology,95 
pancreatic cancer,96 oesophageal cancer,97 bladder cancer,98 etc. 
Non-oncological applications (PDI) 
Although most research around PDT in the last decade has been focussed on oncological 
applications, recently a renewed interest in antimicrobial PDT has surfaced, accelerated 
by the advent of antibiotic resistance.61 PDI has already proven its efficacy against both 
                                                             
93  a] S. Collaud, A. Juzeniene, J. Moan, N. Lange, Curr. Med. Chem. 2004, 4, 301–316; b) D. Ozong, A. M. 
Rkein, S. G. Fabi, H. Michael, M. Goldman, N. J. Lowe, G. M. Martin, G. S. Munavalli, Dermatol. Surg. 
2016, 42, 804–827. 
94  a] H. Kostron, A. Obwegeser, R. Jakober, J. Photochem. Photobiol. B 1996, 36, 157–168; b) H. Kostron, 
Methods Mol. Biol. 2010, 635, 261–280; c] R. Ritz, R. Daniels, S. Noell, G. C. Feigl, V. Schmidt, A. 
Bornemann, K. Ramina, D. Mayer, K. Dietz, W. S. L. Strauss, M. Tatagiba, Eur. J. Surg. Oncol. 2012, 38, 
352–360; d) J. D. Meyers, Y. Cheng, A.-M. Broome, R. S. Agnes, M. D. Schluchter, S. Margevicius, X. 
Wang, M. E. Kenney, C. Burda, J. P. Basilion, Part. Part. Syst. Charact. 2015, 32, 448–457. 
95  a] Y. Hayata, H. Kato, C. Konaka, J. Ono, N. Takizawa, Chest 1982, 81, 269–277; b) C. B. Simone, J. S. 
Friedberg, E. Glatstein, J. P. Stevenson, D. H. Sterman, S. M. Hahn, K. A. Cengel, J. Thorac. Dis. 2012, 
4, 63–75. 
96  S. G. Bown, A. Z. Rogowska, D. E. Whitelaw, W. R. Lees, L. B. Lovat, P. Ripley, L. Jones, P. Wyld, A. 
Gillams, A. W. R. Hatfield, Gut 2002, 50, 549–557. 
97  a] C. Hopper, Lancet Oncol. 2000, 1, 212–219; b) C. Compagnin, M. Mognato, L. Celotti, G. Canti, G. 
Palumbo, E. Reddi, Cell Prolif. 2010, 43, 262–274. 
98  a] M. J. Bader, H. Stepp, W. Beyer, T. Pongratz, R. Sroka, M. Kriegmair, D. Zaak, M. Welschof, D. Tilki, 
C. G. Stief, R. Waidelich, Urol. Oncol. Semin. Orig. Investig. 2013, 31, 1178–1183; b) P. M. R. Pereira, 
S. Silva, M. Bispo, M. Zuzarte, C. Gomes, H. Girão, J. A. S. Cavaleiro, C. A. F. Ribeiro, J. P. C. Tomé, R. 
Fernandes, Bioconjug. Chem. 2016, 27, 2762–2769. 
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drug-resistant and non-resistant pathogens,99 and it is worthy to note that in general the 
photosensitizing ability of the bacteria is completely independent of antibiotic-resistance 
spectrum, since both therapies work through entirely different mechanisms. Furthermore, 
PDI deserves a notable mention for its ability to kill not only bacteria, but also insects, 
parasites, viruses, yeast, fungi, etc (Figure 22).100 Perhaps the most successful application 
of PDT so far has been in dentistry,101 with two commercialized products (Periowave®102 
and SaveDents®103) so far. Another success story which is worth a special mention is that 
of Avedro’s KXL System®, which has recently been FDA-approved for therapeutic 
treatment for progressive keratoconus.104 Furthermore, apart from its use in clinical 
treatments, PDI has also shown efficacy in various disinfection techniques such as blood 
disinfection,105 surface disinfection,106 food decontamination,107 and water disinfection.108  
                                                             
99  a] A. Orenstein, D. Klein, J. Kopolovic, E. Winkler, Z. Malik, N. Keller, Y. Nitzan, FEMS Immunol. Med. 
Microbiol. 1997, 19, 307–314; b) Y. Nitzan, A. Balzam-Sudakevitz, H. Ashkenazi, J. Photochem. 
Photobiol. B 1998, 42, 211–218; c] K. Lasocki, M. Szpakowska, J. Grzybowski, A. Graczyk, Pharmacol. 
Res. 1999, 39, 181–184; d) M. Szpakowska, K. Lasocki, J. Grzybowski, A. Graczyk, Pharmacol. Res. 
2001, 44, 243–246; e] H. M. Tang, M. R. Hamblin, C. M. N. Yow, J. Infect. Chemother. 2007, 13, 87–
91; f) M. Grinholc, B. Szramka, J. Kurlenda, A. Graczyk, K. P. Bielawski, J. Photochem. Photobiol. B 
2008, 90, 57–63. 
100  a] G. D. Pimprikar, G. P. Georghiou, Pestic. Biochem. Physiol. 1979, 12, 10–22; b) T. L. Carpenter, J. R. 
Heitz, Environ. Entomol. 1980, 9, 533–537; c] M. H. Abdel-Kader, T. A. El-Tayeb, Field Application for 
Malaria Vector Control Using Sunlight Active Formulated Extract., 2009, WO 2009/149720 A1. 
101  a] V. V. Tuchin, E. A. Genina, A. N. Bashkatov, G. V. Simonenko, O. D. Odoevskaya, G. B. Altshuler, 
Lasers Surg. Med. 2003, 33, 296–310; b) T. K. Boehm, S. G. Ciancio, J. Int. Acad. Periodontol. 2011, 13, 
58–63. 
102  “Products | Ondine Biomedical,” can be found under http://www.ondinebio.com/products/, 2016. 
103  S. J. Bonsor, R. Nichol, T. M. S. Reid, G. J. Pearson, Br. Dent. J. 2006, 200, 337–341, discussion 329. 
104  Avedro, “Avedro Receives FDA Approval for Photrexa® Viscous, Photrexa® and the KXL® System for 
Corneal Cross-Linking,” can be found under http://avedro.com/en-us/press-releases/avedro-
receives-fda-approval/, 2016. 
105  a] U. Schiffner, G. Cachovan, J. Bastian, A. Sculean, S. Eick, Acta Odontol. Scand. 2014, 72, 673–680; 
b) V. Bärenfaller, C. Clausen, A. Sculean, S. Eick, J. Photochem. Photobiol. B 2016, 158, 252–257. 
106  a] S. Noimark, C. W. Dunnill, C. W. M. Kay, S. Perni, P. Prokopovich, S. Ismail, M. Wilson, I. P. Parkin, 
J. Mater. Chem. 2012, 22, 15388–15396; b) S. Noimark, E. Salvadori, R. Gómez-Bombarelli, A. J. 
MacRobert, I. P. Parkin, C. W. M. Kay, Phys. Chem. Chem. Phys. 2016, 18, 28101–28109. 
107  P. Delcanale, C. Montali, B. Rodríguez-Amigo, S. Abbruzzetti, S. Bruno, P. Bianchini, A. Diaspro, M. 
Agut, S. Nonell, C. Viappiani, J. Agric. Food Chem. 2016, 64, 8633–8639. 
108  a] R. Bonnett, M. A. Krysteva, I. G. Lalov, S. V. Artarsky, Water Res. 2006, 40, 1269–1275; b) A. K. 
Benabbou, C. Guillard, S. Pigeot-Rémy, C. Cantau, T. Pigot, P. Lejeune, Z. Derriche, S. Lacombe, J. 
Photochem. Photobiol. Chem. 2011, 219, 101–108. 
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Figure 22. Scope of microorganisms that can be treated by PDI, compared to that of 
antibiotics. 
As a consequence to the positive results already obtained, the interest in PDT is growing 
steadily and more and more selective and potent PSs are being developed. In the following 
Tables, an overview of some PS that are already clinically approved, and others that are 
under investigation in clinical trials, are listed, both for application in PDT (Table 3) and 
PDI (Table 4). 
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Table 3. PS for PDT applications currently under investigation in clinical trials (†) and/or already approved 
for clinical use (‡), in alphabetical order.11,109     
Trade Name(s) Photosensitizer  Potential indications  
Alacare®, Ameluz® 5-aminolevulinic acid 
(ALA) 
 Actinic keratosis on face 
and scalp 
(‡) 
Alasens® 5-aminolevulinic acid 
(ALA) 
 Kidney tumors (†) 
Amphinex TPCS2a  Head and neck cancers (†) 
Antrin® Motexafin lutetium  Skin conditions and 
superficial cancers 
(‡) 
Antrin® Motexafin lutetium  Prostate cancer, diseased 
arteries 
(†) 
Aptocine® Talaporfin sodium  Lung cancer (‡) 
BOPP Boronated 
protoporphyrin 
 Brain tumors (†) 
DTBF Deuteporphyrin  Bladder cancer (†) 
Foscan®, Fosgel®, 
Foslip®, Fospeg® 
meta-tetrahydroxyphenyl 
chlorin 
 Head, neck, prostate, lung 
and pancreatic cancers 
(‡) 
Fotolon® Chlorin e6  Basal cell carcinoma (†) 
Hemoporfin Hp monomethyl ether 
(HMME) 
 Ovarian cancer (†) 
Levulan Kerastick® 5-aminolevulinic acid 
(ALA) 
 Basal cell carcinoma, head, 
neck, and gynaecological 
tumors 
(‡) 
Laserphyrin® Talaporfin sodium  Lung cancers (‡) 
Laserphyrin® Talaporfin sodium  Liver, colon and brain 
tumors 
(†) 
                                                             
109 a] R. R. Allison, G. H. Downie, R. Cuenca, X.-H. Hu, C. J. Childs, C. H. Sibata, Photodiagnosis Photodyn. 
Ther. 2004, 1, 27–42; b) A. Serra, M. Pineiro, N. Pereira, A. R. Gonsalves, M. Laranjo, M. Abrantes, F. 
Botelho, Oncol. Rev. 2008, 2, 235–249; c] P. Agostinis, K. Berg, K. A. Cengel, T. H. Foster, A. W. Girotti, 
S. O. Gollnick, S. M. Hahn, M. R. Hamblin, A. Juzeniene, D. Kessel, M. Korbelik, J. Moan, P. Mroz, D. 
Nowis, J. Piette, B. C. Wilson, J. Golab, CA. Cancer J. Clin. 2011, 61, 250–281; d) H. Pye, I. Stamati, G. 
Yahioglu, M. A. Butt, M. Deonarain, Antibodies 2013, 2, 270–305; e] “PDT - Clinical Trials,” can be 
found under https://clinicaltrials.gov/ct2/results?term=photodynamic+therapy&Search=Search, 
2016. 
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Lutex® Lutetium texaphyrin  Breast, cervical, prostate, 
and brain tumors 
(†) 
Metvix® Methylated ALA (MAL)  Basal cell carcinoma (‡) 
Pc4 Silicon Phthalocyanine 4  Cutaneous/subcutaneous 
lesions from diverse solid 
tumor origins, EGFR-
overexpressing cancers, 
cervical cancer 
(†) 
Photochlor® 2-[1-Hexyloxyethyl]-2-
devinyl 
pyropheophorbide-a 
(HPPH) 
 Head and neck, esophagus 
and lung cancer 
(‡) 
Photofrin® HpD, porfimer sodium  Cervical, endobronchial, 
esophageal, bladder, and 
gastric cancers 
(‡) 
Photofrin® HpD, porfimer sodium  Brain tumors, high grade 
gliomas, lung cancer 
(†) 
Photogem® HpD  Various tumors (†) 
Photosan® HpD  Bile duct cancer, 
intracranial tumors 
(†) 
Photosens® Sulfonated Al Pcs  Bladder, breast, lung and 
neck cancers 
(‡) 
Photrex® Thin ethyl etiopurpurin 
(SnET2) 
 Breast cancer (‡) 
Radachlorin Mixture of 3 chlorophyll a 
derivatives 
 Skin cancer (‡) 
TOOKAD Padoporphyrin  Prostate cancer (†) 
Visudyne® Verteporfin: 
Benzoporphyrin 
derivative monoacid ring 
A 
 Basal cell carcinoma (‡) 
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Table 4. PS for PDI applications currently under investigation in clinical trials (†) and/or already approved 
for clinical use (‡), in alphabetical order.3,109e,110 
Trade 
Name(s) 
Photosensitizer  Formulation Potential indications  
Fospeg® meta-tetrahydroxyphenyl 
chlorin 
 Spray 
applicator 
Wound and burn 
infections 
(†) 
KXL 
System® 
riboflavin 5’-phosphate  Eye drops Corneal injuries; 
Keratoconus 
(‡) 
Levulan 
Kerastick® 
5-aminolevulinic acid (ALA)  Oil-in-water 
cream (20%) 
Actinic keratosis of 
the face or scalp 
(‡) 
MAL Methyl 5-aminolevulinate  Cream Actinic keratosis (†) 
MB 
Depletion 
Set® 
Methylene blue  MB dry pill Decontamination of 
plasma 
(‡) 
Mycostatin  Nystatin  Topical oral 
suspension 
Denture-related 
stomatitis 
(†) 
Periowave® Methylene blue  Irrigating 
needle 
Periodontitis (‡) 
Photrex® Thin ethyl etiopurpurin 
(SnET2) 
 Intravenous 
infusion 
Age-related macular 
degeneration 
(†) 
PPA904 3,7-bis(di-n-
butylamino)phenothiazine-
5-ium bromide 
 Cream  Infected chronic leg 
and diabetic foot 
ulcers 
(†) 
SaveDent® Toluidine blue O (TBO)  Irrigating 
needle 
Periodontitis (‡) 
Visudyne®  Verteporfin: 
Benzoporphyrin derivative 
monoacid ring A 
 Infusion Ocular indications (‡) 
 tetra butyl analogue 
methylene blue 
  Sterilization of 
infected wounds 
(†) 
     
                                                             
110  a] M. Wainwright, H. Mohr, W. H. Walker, J. Photochem. Photobiol. B 2007, 86, 45–58; b) V. 
Engelhardt, B. Krammer, K. Plaetzer, Photochem. Photobiol. Sci. 2010, 9, 365–369; c] J. A. González-
Delgado, P. J. Kennedy, M. Ferreira, J. P. C. Tomé, B. Sarmento, J. Med. Chem. 2015; d) “Adis Insight,” 
can be found under http://adisinsight.springer.com, 2016. 
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The aim of this Doctoral Thesis is the preparation, characterization and in vitro study of 
novel PS, based on Pcs and SubPcs, for their use in PDT and PDI.  
PDT is a clinically approved form of phototherapy that finds use in both oncological 
treatments and in the treatment of microbial infections (in that case also referred to as 
photodynamic inactivation, PDI). Up to now, the most successful PS have all been part of 
the porphyrinoid PS family. Both Pcs and SubPcs are part of this family, and present 
various beneficial characteristics for their use as PS, such as their synthetic accessibility, 
high molar absorption coefficients, and high triplet state, 1O2 and fluorescence quantum 
yields, encouraging further investigation towards their use as PS. 
The first chapter is devoted to the synthesis of Pcs and SubPcs as PS for application in 
oncological PDT treatments. For this purpose, a series of neutrally charged Pcs and SubPcs 
with different substituents at their axial positions will be prepared (Figure 23) and the 
influence of the axial substituents on the PS fluorescence and 1O2 generation properties 
will be thoroughly investigated. Furthermore, it is our aim to make use of axial 
substituents that can actively quench the singlet excited state of the PS, and therefore its 
1O2 generation efficiency and fluorescence, in a reversible way. To this end, activation 
studies of these quenching processes in function of different external stimuli will be 
undertaken. Finally, the efficacy as PS of selected Pcs and SubPcs will be studied in vitro 
against various tumor cell lines, such as HEp-2 (from a human larynx carcinoma), SCC-13 
(from a human squamous cell carcinoma of the skin) and HeLa (from a human cervical 
carcinoma). For this, a collaboration with the laboratory of microbiology of prof. Ángeles 
Juarranz de la Fuente, in the Biology Department of our university, will be established.  
          
Figure 23. Schematic representation of the target neutrally charged SiPc- and SubPc-
based PS that will be studied in Chapter 1.  
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The second chapter is centred in the preparation and characterization of Pcs and SubPcs 
as PS for application in PDI, a subfield of PDT consisting in the photodynamic inactivation 
of microorganisms. To this end, a series of cationic Pcs and SubPcs will be synthesized, 
employing cationic groups at the periphery of the macrocycle, while making use of the 
same axial substituents as those used in the previous chapter (Figure 24). The influence of 
the axial substituent on the PS fluorescence and 1O2 generation properties will be 
thoroughly investigated, and in vitro studies of the inactivation efficiency of selected PS 
will be performed against both Gram-positive and Gram-negative bacteria. To this end, a 
collaboration with the research group of Prof. Angela Cunha at the Department of Biology 
of the University of Aveiro (Portugal) has been established. 
            
Figure 24. Schematic representation of the target positively charged SiPc (octacationic) 
and SubPc (hexacationic) PS that will be studied in Chapter 2. 
 
The aim in the third chapter is the synthesis of new third-generation PS, based on Pcs and 
SubPcs. For this, selected Pcs and SubPcs will be covalently or non-covalently linked to 
site-specific delivery agents or nanostructured delivery platforms, with the goal to 
improve both the selectivity and cell-uptake of the PS system. In the first place, maleimide-
containing Pc and SubPc derivatives will be covalently conjugated with a cysteine C-
terminated cell penetrating peptide (CPP), through a ene-thiol “click” reaction. In 
particular, the Tat CPP is a short peptide sequence that possesses the remarkable property 
of being able to cross cell membranes and deliver bioactive cargoes inside diseased cells 
(Figure 25a). Cell-uptake and in vitro photodynamic activity studies will be performed in 
collaboration with the laboratory of Prof. Bruno de Geest at Ghent University (Belgium), 
to validate the employed strategy. In the second place, cationic zinc Pc (ZnPc) derivatives 
will be non-covalently deposited onto the negatively charged surface of cellulose 
nanocrystals (CNC), which are rod-shaped sugar-based nanostructures that can greatly 
increase the biocompatibility of their cargo (Figure 25b). In this case, detailed 
photophysical studies and in vitro photodynamic activity studies of the resulting 
biohybrids will be performed in collaboration with the research groups of Profs. Santi 
Nonell and Montserrat Agut Bonsfills, at the Institut Químic de Sarrià of the Universitat 
Ramon Llull (Barcelona, Spain). These studies will be conducted against a broad spectrum 
of microorganisms, including a Gram-positive (S. aureus) bacterium, a Gram-negative 
bacterium (E. coli) and a yeast (C. albicans). 
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Figure 25. Schematic representation of the target PS-based biohybrids that will be 
studied in Chapter 3. a) Schematic representation of covalently conjugated SiPc-CPP 
and SubPc-CPP biohybrids. b) Schematic representation of non-covalently conjugated 
ZnPc-CNC biohybrids. 
The molecular design of each of the target compounds and the corresponding specific 
research objectives will be detailed in the respective subchapters. 
 
  
 
 
 
  
  
 
 
 
 
 
 
 
 
CHAPTER 1  
 
Design, synthesis and in vitro evaluation of 
neutrally charged (sub)phthalocyanines for use in 
photodynamic therapy 
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1 
Neutral silicon phthalocyanines 
as photosensitizers for 
photodynamic therapy 
 
1.1  State of the art 
As mentioned in the general introduction of this thesis, Pc 4 is one of the most promising 
Pcs for PDT applications. Since its discovery, lots of research has been done into the 
synthesis of Pc 4 analogues and their structure-activity relationships concerning their 
photodynamic efficacy (Figure 26).111 From these studies, it could be concluded that an 
unhindered macrocycle face (bearing one –OH substituent) is not essential for efficient 
interaction with biological targets, Pc 12 being as effective as Pc 4 , but that the axial 
substituents should not be too long either, Pc 18 being less effective then Pc 12.111a,c 
Furthermore, terminal amines seem to drastically quench the Pc’s excited state, the effect 
depending on the relative proximity of the amine group to the macrocycle.111b Pc 227, on 
the other hand, is an interesting new analogue, being photosensitive. It bears one alkyl- 
instead of an alkysiloxy substituent, and yields Pc 4 when irradiated by light.111d  
                                                             
111  a] Y.-S. Li, S. I. A. Zaidi, M. A. J. Rodgers, H. Mukhtar, M. E. Kenney, N. L. Oleinick, J. He, H. E. Larkin, 
B. D. Rihter, Photochem. Photobiol. 1997, 65, 581–586; b) H. M. Anula, J. C. Berlin, H. Wu, Y.-S. Li, X. 
Peng, M. E. Kenney, M. A. J. Rodgers, J. Phys. Chem. A 2006, 110, 5215–5223; c] M. E. Rodriguez, P. 
Zhang, K. Azizuddin, G. B. Delos Santos, S. Chiu, L. Xue, J. C. Berlin, X. Peng, H. Wu, M. Lam, A.-L. 
Nieminen, M. E. Kenney, N. L. Oleinick, Photochem. Photobiol. 2009, 85, 1189–1200; d) J. Li, Y. Yang, 
P. Zhang, J. R. Sounik, M. E. Kenney, Photochem. Photobiol. Sci. 2014, 13, 1690–1698. 
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Figure 26. Some examples of already synthesized analogues of Pc 4.111 
Apart from Pc 4 analogues, a lot of other interesting SiPcs for PDT have been synthesized 
in the last years, the most important contribution to this field being made by Ng and co-
workers. Exploiting the fact that tumor cells are slightly acidic, they have synthesized 
various SiPcs bearing polyamines as axial substituents. In this way, their fluorescence 
emission and efficiency of generating ROS are sensitive to the pH environment (Figure 
27).112  
 
Figure 27. An extensive series of acid-sensitive SiPcs bearing (poly-)amine substituents 
at the axial positions, synthesized by Ng and co-workers.112 
More specifically, at neutral pH, both the ROS generation and fluorescence emission are 
strongly reduced by the photoinduced electron-transfer (PET) deactivation pathway 
caused by the presence of the amino groups, which quench the singlet excited state of the 
                                                             
112  a] X.-J. Jiang, P.-C. Lo, Y.-M. Tsang, S.-L. Yeung, W.-P. Fong, D. K. P. Ng, Chem. Eur. J. 2010, 16, 4777–
4783; b) X.-J. Jiang, P.-C. Lo, S.-L. Yeung, W.-P. Fong, D. K. P. Ng, Chem. Commun. 2010, 46, 3188–
3190; c] X.-J. Jiang, S.-L. Yeung, P.-C. Lo, W.-P. Fong, D. K. P. Ng, J. Med. Chem. 2001, 54, 320–330. 
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Pc core. At slightly acidic pH (such as that inside tumor cells), however, the amino groups 
will be protonated and the fluorescence emission and ROS generation activated. This 
results in a selective functioning of the PS only inside tumor cells, while in healthy cells no 
ROS should be generated and no cell damage does occur.  
Ng and co-workers have later further developed this type of activatable PS by introducing 
other quenching moieties (i.e. ferrocenyl chalcone) and other activation pathways (i.e. 
reduction of disulfide bridges or acid sensitive hydrazone linkers), their most interesting 
system up to date being the dual activatable PS depicted in Figure 28.113 
 
Figure 28. A dual activatable PS and its activation pathways, synthesized by Ng and co-
workers.113b 
Other SiPc-based PS have been designed bearing various interesting moieties at the axial 
position, such as morpholine114 (i.e. a well-known antipsychotic drug and radiosensitizer), 
carboranes115 (for simultaneous boron neutron capture therapy), β-cyclodextrins116 (cyclic 
oligosaccharides that facilitate the anchoring of PS to cellular tissues and surfaces), 
solketal groups (which can be converted in glycerol in vivo)117 and parabens118 (one of the 
most functional preservative agents used in drugs, cosmetics, foodstuffs as well as in 
dental materials). 
                                                             
113  a] J. T. F. Lau, X.-J. Jiang, D. K. P. Ng, P.-C. Lo, Chem. Commun. 2013, 49, 4274–4276; b) J. T. F. Lau, P.-
C. Lo, X.-J. Jiang, Q. Wang, D. K. P. Ng, J. Med. Chem. 2014, 57, 4088–4087. 
114  Y.-J. Zhu, J.-D. Huang, X.-J. Jiang, J.-C. Sun, Inorg. Chem. Commun. 2006, 9, 473–477. 
115  G. Y. Atmaca, C. Dizman, T. Eren, A. Erdoğmuş, Spectrochim. Acta A 2015, 137, 244–249. 
116  a] J. T. F. Lau, P.-C. Lo, W.-P. Fong, D. K. P. Ng, Chem. Eur. J. 2011, 17, 7569–7577; b) J. T. F. Lau, P.-C. 
Lo, Y.-M. Tsang, W.-P. Fong, D. K. P. Ng, Chem. Commun. 2011, 47, 9657; c] A. Galstyan, U. Kauscher, 
D. Block, B. J. Ravoo, C. A. Strassert, ACS Appl Mater Interfaces 2016, 8, 12631–12637. 
117  J. W. Hofman, F. van Zeeland, S. Turker, H. Talsma, S. A. G. Lambrechts, D. V. Sakharov, W. E. Hennink, 
C. F. van Nostrum, J. Med. Chem. 2007, 50, 1485–1494. 
118  G. C. Taşkın, M. Durmuş, F. Yüksel, V. Mantareva, V. Kussovski, I. Angelov, D. Atilla, J. Photochem. 
Photobiol. Chem. 2015, 306, 31–40. 
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1.2 Molecular design, synthesis and characterization of a series 
of neutral silicon phthalocyanine photosensitizers 
The specific objective of this subchapter is the design, synthesis and characterization of a 
series of axially substituted SiPcs (Figure 29). Furthermore, the efficacy of the resulting PS 
to generate 1O2 and their applicability in PDT, by leading to tumoral cell death, will be 
examined in vitro.  
 
Figure 29. Target compounds of Chapter 1 - Subchapter 1: A series of axially substituted 
SiPcs bearing different axial substituents. 
As explained in the Introduction of this Thesis, Pcs are known to generate 1O2 from their 
photoinduced singlet excited state (S1), followed by intersystem crossing to the excited 
triplet (T1) and subsequent energy transfer to the triplet ground state of 3O2. Within SiPcs 
this process can be quenched if photo- or electroactive units are connected to the axial 
positions of the central silicon atom.119 As mentioned above, Ng and co-workers have 
exploited this characteristic to develop a pH- and redox-responsive activatable PS by 
attaching two ferrocenyl moieties to the axial positions of a SiPc.113 Amino groups also 
provoke a pH-dependent quenching of Pc excited states.112a,b As a continuation of this 
work we designed a series of novel SiPcs 1-3 bearing an additional fluorophore (i.e., 
pyrene), which allows the theranostic use of the resulting PS,120 and/or an amino group 
with two methoxy(triethylenoxy) axial chains for increasing hydrophilicity. As shown for 
other Pc-pyrene covalent dyads, the emission of the pyrene unit (F377) is probably 
deactivated by electronic energy transfer (EET),121 yet quenching by photoinduced 
electron transfer (PET) cannot be excluded. The amino group quenches the SiPc excited 
state through PET.112a,b A SiPc without any of the previously mentioned quenching units, 
SiPc 4, was also synthesized for its use as reference compound. Furthermore, from a 
logical perspective, in all previously published cases,112a,b,113 1O2 production and SiPc 
fluorescence are recovered simultaneously. Thus, these systems present only a single 
combined output signal and, therefore, a limited capacity for molecular computing. To 
                                                             
119  X. Li, S. Kolemen, J. Yoon, E. U. Akkaya, Adv. Funct. Mater. 2016, DOI: 10.1002/adfm.201604053. 
120  S. S. Kelkar, T. M. Reineke, Bioconjug. Chem. 2011, 22, 1879–1903. 
121  J. Bartelmess, B. Ballesteros, G. de la Torre, D. Kiessling, S. Campidelli, M. Prato, T. Torres, D. M. Guldi, 
J. Am. Chem. Soc. 2010, 132, 16202–16211. 
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circumvent these limitations, the asymmetrical SiPc 1 was our target compound. To 
activate F377, a disulfide linker has been introduced, which can be cleaved selectively under 
reducing conditions (e.g., with DTT). Since the extent of EET is dependent on and 
extremely sensitive to the distance of the donor to the acceptor,122 the EET will no longer 
be efficient upon cleavage of the disulfide linker, resulting in recuperation of F377 and 1O2 
generation. Upon protonation of the pendant amino group by slightly lowering the pH of 
the solution, the SiPc emission (F680) is also recovered. In turn, we found that the 
propensity of 1 to generate 1O2 is modulated by the presence and/or absence of acid, DTT, 
and irradiation of the complex in the requisite absorption range (Figure 30). Importantly, 
two of these inputs are particularly relevant from a medical perspective, considering 
tumor environments are characterized by being both acidic123 and highly reducing124 in 
nature, more so than healthy cells and extracellular matrix.  
 
Figure 30. Structure of PS 1 and its activation pathways.  
In the next sections, the synthesis and characterization of SiPcs 1-4 will be detailed, 
whereas the influence of the three different external stimuli (DTT, H+ and hν) on SiPc 1 will 
be thoroughly investigated.  
  
                                                             
122  D. C. Harris, in Quant. Chem. Anal., W. H. Freeman And Co, New York, 2010, pp. 419–444. 
123  G. Helmlinger, A. Sckell, M. Dellian, N. S. Forbes, R. K. Jain, Clin. Cancer Res. 2002, 8, 1284–1291. 
124  M. P. Gamcsik, M. S. Kasibhatla, S. D. Teeter, O. M. Colvin, Biomarkers 2012, 17, 671–691. 
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1.2.1 Synthesis of building blocks for axial substitution 
There exist three commonly used methods to introduce building blocks for axial 
substitution in SiPcs, starting from SiPc bearing chlorine atoms at the axial positions 
(SiPcCl2). SiPcCl2 can be treated both with derivatives bearing a free carboxylic acid or a 
free primary hydroxyl group, yielding the corresponding SiPc silyl ester125 or SiPc silyl 
ether104a derivatives, respectively, after nucleophilic displacement of the chlorine atoms. 
In a third method, SiPcCl2 can be subjected to hydrolysis, yielding silicon phthalocyanine 
dihydroxide (SiPc(OH)2), which can be axially substituted with different trialkylchlorosilane 
derivatives. In the present thesis, we have made use of both the second and third method, 
in this subchapter and in subchapter 2.1, respectively. Since in this subchapter we will 
make use of the first method, primary alcohol derivatives need to be synthesized as 
building blocks for axial substitution.  
To obtain the first building block for axial substitution, 1-pyrenebutyric acid was reacted 
with 2-hydroxyethyl disulfide (Scheme 5), in the presence of 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC) and catalytic amounts of DMAP, obtaining 1-
pyrenebutanoic acid, 2-[(2-hydroxyethyl)dithio]ethyl ester (5). In this variant of the 
Steglich esterification, EDC was used as carbodiimide for carboxyl activation, instead of 
DCC.126 In this case, EDC reacts with the carboxylic acid group of 1-pyrenebutyric acid to 
form an active O-acylisourea intermediate that is easily displaced by nucleophilic attack 
by DMAP. This leads to a reactive amide intermediate, which reacts rapidly with one of 
the alcohol groups of 2-hydroxyethyl disulfide, giving rise to the desired ester. The benefit 
of using EDC instead of DCC is the fact that its urea, which is formed as a by-product, is 
water-soluble, for which it can be easily removed by washing the crude reaction mixture 
with water. The reaction was performed in DCM, overnight, yielding 2-[(2-
hydroxyethyl)dithio]ethyl ester in 77% yield after purification by column chromatography 
using chloroform/methanol (100:1) as the eluent. Importantly, making use of a small 
excess of 2-hydroxyethyl disulfide (1.2 equivalents), no double esterification of the second 
alcohol group has been observed. 
 
Scheme 5. Synthesis of the first building block for axial substitution: 1-pyrenebutanoic 
acid, 2-[(2-hydroxyethyl)dithio]ethyl ester (5).  
The second building block for axial substitution, bearing the methoxy(triethylenoxy) 
chains in order to increase the biocompatibility of the final PS, has been synthesized in 
                                                             
125  a] C. Farren, S. FitzGerald, M. R. Bryce, A. Beeby, A. S. Batsanov, J. Chem. Soc. Perkin Trans. 2 2002, 
59–66; b) F. J. Céspedes-Guirao, L. Martín-Gomis, K. Ohkubo, S. Fukuzumi, F. Fernández-Lázaro, Á. 
Sastre-Santos, Chem. Eur. J. 2011, 17, 9153–9163. 
126  S.-Y. Han, Y.-A. Kim, Tetrahedron 2004, 60, 2447–2467. 
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two steps (Scheme 6). The commercially available triethylene glycol monomethyl ether 
was first reacted with p-toluenesulfonyl chloride, to convert its alcohol group in a tosyl 
group, which is a much better leaving group. During this reaction, the alcohol reacts as a 
nucleophile, attacking the electrophilic centre of p-toluenesulfonyl chloride and displacing 
the chloride atom, yielding 6 with a good yield. The reaction was performed in a mixture 
of water and THF, and a water-soluble base such as NaOH was added to the reaction 
mixture in order to neutralize the HCl that is being formed and speed up the reaction. 
Finally, a double SN2 nucleophilic substitution reaction between 6 and the amine group of 
the commercially available 3-amino-1-propanol, which acts as nucleophile, lead to the 
formation of 3-bis(methoxy(diethylenoxy)ethyl)amino]-1-propanol (7). After column 
chromatography using DCM/methanol (20:1) as the eluent the yield of the purified 
compound was determined to be 61%. The formation of some mono-substituted product 
could be detected, although to a small extent. Upon recovery of this product from the 
column, it could be subjected to another reaction cycle. 
 
Scheme 6. Synthesis of the second building block for axial substitution: 3-
bis(methoxy(diethylenoxy)ethyl)amino]-1-propanol (7). 
Next, the building block for axial substitution to synthesize the reference SiPc 4 was 
synthesized by reacting 2-hydroxyethyl disulfide with acetylchloride, through a 
nucleophilic addition/elimination, resulting in 2-[(2-hydroxyethyl)disulfanyl]ethyl acetate 
(8) (Scheme 7). Similarly as in the tosylation above, the reaction is exothermic and was 
therefore performed at 0°C. Since in this case the reaction was performed in an organic 
solvent, HCl was neutralized by the presence of an organic base such as Et3N. Upon 
completion of the reaction (30 min), the reaction mixture was quenched with a saturated 
aqueous solution of NaHCO3. After work-up and purification by column chromatography, 
7 was isolated as colorless oil with a yield of 33%. The major cause for this reasonably low 
yield is the formation of a by-product in which the disulfide bridge has been cleaved, as 
detected by 1H-NMR spectroscopy, which was isolated with a yield of 59%.  
 
Scheme 7. Synthesis of the building block for axial substitution 2-[(2-
hydroxyethyl)disulfanyl]ethyl acetate (8). 
Finally, 1-pyrenebutanoic acid, N-(3-hydroxypropyl) amide (11), was synthesised in order 
to be used as a reference compound in fluorescence measurements regarding F377 
(Scheme 8). For this, alcohol group of the commercially available 3-amino-1-propanol was 
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first protected by a tert-butyldimethylsilyl group, enabling the selective reaction of its 
amine group with the carboxylic acid group of 1-pyrene butyric acid. In this amine 
formation the carboxylic acid group of 1-pyrene butyric acid was activated by EDC and 
catalyzed by DMAP, in similar way as in the Steglich esterification detailed above. After 
the formation of the amide, the tert-butyldimethylsilyl ether could be easily deprotected 
by employing a catalytic amount of acetyl chloride in dry methanol. The final compounds 
was purified by column chromatography using a gradient of Chloroform to 
chloroform/methanol (10:1) as the eluent, yielding 11 with a 64% overall yield. 
 
Scheme 8. Synthesis of 1-pyrenebutanoic acid, N-(3-hydroxypropyl) amide (11), to be 
used as a reference compound for fluorescence measurements. 
 
1.2.2 Synthesis of target neutral silicon phthalocyanines 
Once all primary alcohol building blocks for axial substitution were synthesized, 
they were incorporated at the axial positions of SiPcCl2, following a previously published 
protocol, which has been optimized for these particular axial substituents (Scheme 9).113a 
Unless stated otherwise, pyridine was used as the base for this substitution reaction 
throughout the present thesis, even though other bases such as NaH or DIPEA could also 
be used. 
 
Scheme 9. General synthesis of axially substituted SiPcs using an optimized method. 
The symmetrical SiPcs were easily synthesized, using an excess of 5 equivalents of the 
corresponding building block for axials substitution, with respect to the SiPcCl2 (Scheme 
10). After refluxing the reaction mixture overnight, the solvent was evaporated to dryness 
and the SiPcs were purified by column chromatography using silica gel previously 
neutralized with Et3N, since they are unstable in normal silica gel. As a consequence, the 
compounds elute together with a trimethylammonium cation (Et3NH+), which can be 
removed by consequent washing with water or filtration over a short pad of silica gel using 
DCM as the solvent. In case of SiPcs 2 and 4, a final purification step by recrystallization in 
toluene or methanol, respectively, was performed. In the case of SiPc 3, which is a sticky 
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solid due to the presence of the methoxy(triethylenoxy) chains, a final purification step by 
size exclusion chromatography (SEC), using Bio-Beads as the stationary phase and DCM as 
the eluent was performed, to remove any traces of remaining free alcohol. In this way, 
the symmetrical SiPcs 2-4 could be obtained with reasonable yields, ranging from 24% to 
32%. 
Scheme 10. Synthesis of the symmetrical SiPcs 2-4. 
As a representative example of the NMR characterization of these compounds, Figure 31a 
shows the 1H-NMR spectrum, recorded in CDCl3, of the building block for axial substitution 
5 and the corresponding symmetrical SiPc 2, respectively. The signals for the SiPc aromatic 
protons, at 9.65 pm and 8.30 ppm, are well resolved, indicating the complete absence of 
aggregation, as expected. Furthermore, the ring current effect exerted by the π-electron 
cloud of the SiPc macrocycle over the nearby protons of the axial substituents can be 
clearly observed. The closer the proton to the SiPc macrocycle, the stronger the shielding 
effect and the weaker the nuclear magnetic field it experiences.125 Therefore, the chemical 
shift of these protons is normally significantly more upfield than in the corresponding 
building block, and this in order of the proximity of the respective protons to the SiPc 
macrocycle. Importantly, all CH2-signals could be unquestionably assigned making use of 
two-dimensional NMR techniques such as COSY, TOCSY, HSQC and HMBC. Furthermore, 
using these techniques, it was also possible to unambiguously assign all carbon signals in 
the 13C-NMR spectrum (Figure 31b). 
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Figure 31. a) 1H-NMR spectrum of building block for axial substitution 5 (top) and 
symmetrical SiPc 2 bearing 5 as axial substituents (bottom) in CDCl3, showing the effect 
of the ring current on the protons of the axial substituents: the closer the protons to 
ring, the greater the upfield displacement of their chemical shift. b) 13C-NMR spectrum 
of the symmetrical SiPc 2 in CDCl3. 
Following the successful synthesis and purification of these symmetrical SiPcs 2-4, the 
synthesis of the asymmetric SiPc 1 was tackled. As explained before (Figure 18), 
asymmetric SiPcs result from a statistical reaction employing two different building blocks 
for axial substitution. Generally, a first trial with 2,5 equivalents of each building block is 
taken as a starting point to explore the reactivity of each of the building blocks, in function 
of which the equivalents employed for each of them are then adapted. In the case of SiPc 
1, the two building blocks 5 and 7 appeared to display a similar reactivity, for which 2,5 
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equivalents of each resulted to be the optimal building block ratio, giving rise to SiPc 1 
with a reasonable 16% yield (Scheme 11). Purification was performed in a similar way as 
for the symmetrical SiPcs 2-4, that is, purification by column chromatography using silica 
gel previously neutralized with Et3N, which is followed by a washing step with water to 
remove the triethylammonium cation, and a final purification step by SEC with Biobeads 
as the stationary phase and DCM as the eluent. As side-products from this reaction, the 
symmetrical SiPcs 2 and 3 are also obtained, with a 14% and 19% yield, respectively.  
 
Scheme 11. Synthesis of asymmetric SiPc 1. 
Figure 32 shows the 1H-NMR spectrum, recorded in CDCl3, of the building blocks for axial 
substitution 5 and 7, and the corresponding symmetrical SiPc 1, respectively. Again, the 
signals for the SiPc aromatic protons, at 9.63 pm and 8.32 ppm, are well resolved, and the 
ring current effect exerted by the π-electron cloud of the SiPc macrocycle greatly effects 
the chemical shift of the nearby protons of both axial substituents. Although it resulted 
significantly more difficult than in the case of the symmetrical Pcs, with the help of two-
dimensional NMR techniques, such as COSY, TOCSY, HSQC and HMBC, all proton signals 
could be unquestionably assigned. However, due to the complicity of the spectrum, 
unambiguous assignment of the 13C-NMR spectrum was in this case not possible for all 
signals. 
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Figure 32. 1H-NMR spectrum of building blocks for axial substitution 7 (top), 5 (middle) 
and asymmetrical SiPc 1 bearing 5 and 7 as axial substituents (bottom) in CDCl3, 
showing the effect of the ring current on the protons of the axial substituents: the 
closer the protons to ring, the greater the upfield displacement of their chemical shift. 
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1.2.3 Spectral features and photophysical properties 
The UV-Vis spectra of 1-4 in DMF show the Q- and Soret bands characteristic of SiPc 
(Figure 33). Additionally, 1 and 2 exhibit a band at 344 nm, assigned to pyrene. Further, a 
summation of the spectral features recorded for reference compounds 10 and 4, in  a 1:1 
or 2:1 stoichiometry, closely resemble the spectra of the corresponding pyrene-containing 
SiPc derivatives 1 and 2, respectively. 
 
Figure 33. Electronic absorption spectra of SiPcs 1-4 in DMF. 
Fluorescence quantum yields (φF) were measured in DMF by exciting compounds 1-4 at 
345 nm (Table 5 and Figure 36), a wavelength coinciding with both pyrene absorption and 
the SiPc Soret band.  
1O2 quantum yields (φΔ) were also measured in DMF, by the relative method,127 using 1,3-
diphenylisobenzofuran (DPBF, Figure 34) as a chemical scavenger and excitation with 
visible light filtered below 530 nm (h>530).  
 
 
Figure 34. Photoinduced decomposition of DPBF upon reaction with 1O2. 
The concentration of the scavenger (DPBF) is monitored spectroscopically at 414 nm in 
function of the irradiation time of the PS, from which the values of φΔ can be determined. 
An example of the spectroscopic data for this measurements for SiPc 1 can be seen in 
                                                             
127  S. Makhseed, A. Tuhl, J. Samuel, P. Zimcik, N. Al-Awadi, V. Novakova, Dyes Pigments 2012, 95, 351–
357. 
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Figure 35. Importantly, the decrease of the absorption of DPBF is completely linear 
(R2=0.9998) and at the same time no change in the absorption of 1 is observed throughout 
the measurement, indicating its stability and confirming it is non-aggregated. 
 
 
Figure 35. Time dependent photobleaching of DPBF-absorption in the presence of SiPc 1 
in DMF, which is directly related to the photoinduced generation of 1O2 by the PS. Inset: 
detail of DPBF absorption decrease. 
An overview of al measured electronic absorption and photophysical data for SiPcs 1-4 
and reference compound 10 in DMF can be seen in Table 5. φF and φΔ are furthermore 
schematically represented in Figure 36. 
 
Table 5. Electronic absorption and photophysical data for SiPcs 1-4 and reference 
compound 10 in DMF. 
Compound λmax (nm) λem (nm)a φF377 (%)b φF680 (%)c φΔ (%)d 
1 678 680 1.6 4.0 4.7 
2 676 681 2.1 23.4 19.7 
3 676 681 -f 2.1 3.5 
4 679 684 -f 37.1 36.2 
10 344 377 59.6 -e -e 
a Excited at 345 nm. b Excited at 345 nm. Using anthracene in cyclohexane as the reference (φF = 0.36). 
c Excited at 610 nm. Using ZnPc in DMF as the reference (φF = 0.28). d Using ZnPc in DMF as the 
reference (φΔ = 0.56). e Not applicable because the compound does not contain any SiPc moiety. f Not 
applicable because the compound does not contain any pyrene moiety. 
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Figure 36. φF377 (yellow bars), φF680 (blue bars) and φΔ (purple bars) of SiPcs 1-4 and 
reference compound 10.  
Compared to reference derivatives 4 and 10, the three output signals are significantly 
deactivated in compounds 1 and 3, while for compound 2 the reduction in F680 intensity 
and 1O2 production is less than 50%, revealing an inefficient quenching by the pyrene unit. 
Excitation of the SiPc Soret band, which leads its second singlet excited state, could be the 
reason for such a decrease in quenching efficiency. The level of SiPc φF and φΔ quenching 
in 1 and 3 actually appears to be further correlated with the number of pendant amino 
groups, suggesting the stronger quenching capacity of the amino functionality in 
comparison to pyrene. In compounds 1 and 2, F377 remains nearly fully deactivated, likely 
as a result of an EET process in which the pyrene emission band and the SiPc Soret band 
significantly overlap,121 yet we cannot exclude PET as the quenching mechanism. 
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1.3 Dependence of fluorescence and 1O2 generation of SiPc 1 on 
different chemical inputs 
To investigate the effect of chemical inputs on the photochemical properties of 1 in 
physiologically relevant medium, its absorption and fluorescence spectra were monitored 
for 24 h in phosphate buffered saline (PBS) solutions with varying pH and/or DTT 
concentrations. Adequate solubility was achieved by adding 0.5% Cremophor EL (v/v), a 
pharmaceutically approved surfactant.128  
In general, samples were prepared as following: 1 was dissolved in spectroscopic grade 
DMF to give a 1 mM solution, which was diluted to 0.4 μM with buffer solution (PBS with 
0.5% Cremophor EL). To evaluate the dependence on the DTT-concentration, DTT was 
dissolved in deionized water to give a 1 M solution and mixtures of 1 (25 mL, 0.4 μM) with 
DTT (2 μM, 5 mM, 10 mM, 20 mM or 50 mM) or without DTT in 25 mL of buffer solution 
were prepared and stirred continuously. For pH-dependence experiments, mixtures of 1 
(25 mL, 0.4 μM) were adjusted to pH 7.4, pH 6.8 or pH 5 by adding concentrated HCl (0, 6 
or 16 µL, respectively) and stirred continuously. 
 
1.3.1 Dependence of fluorescence  
(i) DTT-dependence 
At neutral pH, there were no significant changes in the absorption features of 1 with 
varying DTT concentrations (Figure 37). Importantly, once oxidized, DTT forms a stable six-
member ring with an internal disulfide bond which absorbs at 283 nm.129 Due to the high 
excess of DTT in c) and d), the absorption peak of its oxidation product causes a ‘lift’ of the 
spectrum between 400-300 nm. Nevertheless, it is clear that the sharp Q-band remains 
unchanged at all DTT concentrations, indicating that the compound remains intact and 
non-aggregated, and assuring that any changes in fluorescence must be a consequence of 
quenching relaxation upon reductive cleavage of the disulfide linker rather than a change 
in the compound aggregation.  
                                                             
128  H. Gelderblom, J. Verweij, K. Nooter, A. Sparreboom, Eur. J. Cancer 2001, 37, 1590–1598. 
129  A. Seo, J. L. Jackson, J. V. Schuster, D. Vardar-Ulu, Anal. Bioanal. Chem. 2013, 405, 6379–6384. 
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Figure 37. UV-Vis spectra of 1 in PBS (0.5% Cremophor EL) with a) 0 µM DTT, b) 2 µM 
DTT, c) 20 mM DTT and d) 50 mM DTT, from t = 0 h to t = 24 h. 
On the contrary, the intensity of F377 exhibited a 2-, 3-, 5- and 6.5-fold increment in the 
presence of 5, 10, 20 and 50 mM DTT, respectively. The increase in F377 intensity reflects 
that pyrene emission is recovered upon disulfide cleavage (Figure 38). At 50 mM DTT, F377 
reaches a plateau after 8 h and thus is taken as an indication that at this concentration, all 
of the disulfide bonds have been cleaved (Figure 39). In the absence of DTT, there is no 
F377 enhancement, which reflects the need of a reducing environment to promote 
activation via disulfide cleavage.  
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Figure 38. 3D representation of the fluorescence spectra of 1 in PBS (0.5% Cremophor 
EL) with a) 0 µM DTT, b) 2 µM DTT, c) 5 mM DTT, d) 10 mM DTT, e) 20 mM DTT and f) 
50 mM DTT, from t = 0 h to t = 24 h.  
 
Figure 39. Normalized emission maximum of 1 in PBS (0.5% Cremophor EL) in function 
of time for a) the pyrene unit (F377) and b) the SiPc (F680). λexc = 345 nm. 
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(ii)  pH-dependence 
The UV-Vis and fluorescence spectra of 1 in PBS buffer were also monitored at decreasing 
pH values. As can be seen in Figure 40, the absorption bands of 1 remain unchanged at 
the three different pH values, indicating that the compound is stable and that there is no 
protonation of the Pc meso nitrogens at all experiment conditions. The same conclusion 
could be drawn from 1H-NMR data, the spectrum not showing any significant change when 
set at pH=5. 
 
 
Figure 40. UV-Vis spectra of 1 in PBS (0.5% Cremophor EL) at a) pH = 5, b) pH = 6.8 and 
c) pH = 7.4, from t = 0 h to t = 24 h. 
In contrast to disulfide cleavage, protonation of the amino group is instantaneous. The 
F680 signal is recuperated immediately after sample preparation, and remains unchanged 
over the whole experiment (Figure 41). Thus, the degree of fluorescence recovery 
depends directly on the acidity of the medium, reaching a maximum effect at the slightly 
acidic pH of 5 (Figure 42). 
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Figure 41. 3D representation of the fluorescence spectra of 1 in PBS (0.5% Cremophor 
EL) at a) pH = 5, b) pH = 6.8 and c) pH = 7.4, from t = 0 h to t =24 h.  
 
 
Figure 42. Normalized emission maximum of 1 in PBS (0.5% Cremophor EL) in function 
of time for a) the pyrene unit (F377) and b) the SiPc (F680). λexc = 345 nm. 
 
 (iii) Combined DTT- and pH-dependence 
Finally, the combined effect of DTT and pH on F680 and F377 was evaluated (Figure 43). At 
pH 5, a complete recovery of F680 is observed, independent of the DTT concentration. 
Conversely, no significant changes in this peak were recorded at neutral pH (Figure 44b). 
F377 shows no increases in the absence of DTT or at low (2 μm) concentration, at both pH 
5 and 7.4. With stronger reducing conditions and at pH 5, a moderate increase of F377 was 
noted, while samples at pH 7.4 present a pronounced F377 enhancement, up to 6.5-fold 
for 50 mM DTT. 
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Figure 43. 3D representation of the fluorescence spectra of 1 in PBS (0.5% Cremophor 
EL) with a) 2 µM DTT – pH 5, b) 2 µM DTT – pH 7.4, c) 20 mM DTT – pH 5, d) 20 mM DTT 
– pH 7.4, e) 50 mM DTT – pH 5 and f) 50 mM DTT – pH 7.4, from t = 0 h to t = 24 h. 
 
 
Figure 44. Normalized emission maximum of 1 in PBS (0.5% Cremophor EL) in function 
of time for a) the pyrene unit (F377) and b) the SiPc (F680). λexc = 345 nm. 
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1.3.2 Dependence of singlet oxygen generation 
In order to activate 1O2 production, h>530 needs to be considered as a third 
(physical) input, in combination with the two previous chemical ones. 1O2 studies were 
performed in the same buffer conditions, measuring the rate of DPBF photodegradation, 
which is proportional to the amount of 1O2 formation. Figure 45a shows the scavenger 
absorption decay at 414 nm for three DTT concentrations (i.e., 0, 2 μM and 20 mM), 
sensitized by 1 upon h>530 illumination, demonstrating that more efficient 1O2 generation 
results from samples exposed to a higher concentration of DTT. Similar experiments were 
performed to examine the effect of pH on 1O2 production (Figure 45b), showing that at 
lower pH 1O2 production is more efficient. We attribute this to the higher degree of amino 
protonation. To complete the photochemical study of 1, Figure 45c shows the combined 
effect of DTT and pH. Importantly, all concentrations of DTT (including 0 µM DTT) at pH 5, 
generated 1O2 at a faster rate than even the most concentrated (20 mM DTT) solution at 
pH 7.4. From these results we conclude that although 1O2 sensitization is effected by the 
concentration of DTT, the most important factor to obtain a high response is low pH. 
Moreover, dark control experiments confirm that, under all conditions, 1 is unable to 
produce 1O2 without h>530 illumination. 
 
Figure 45. Normalized absorption (A/A0) of DPBF over time, which shows its 
photodegradation rate sensitized by 1 upon excitation with light with wavelengths 
above 530 nm, at a) different DTT concentrations, b) different pH values, and c) the 
combined effect of DTT and pH.  
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1.4 Multifunctional logic in a photosensitizer with triple-mode 
fluorescent and photodynamic activity  
In an effort to utilize the above photochemical pathways for the development of 
multimodal cellular imaging and PDT applications, a logical analysis of the interrelations 
between different input and output functions shown in Figure 30 is beneficial. Inputs and 
outputs can be encoded as binary digits (i.e., off = 0, on = 1), following positive logic 
conventions.130 DTT is considered as input A, with 0 and 20 mM assigned to the 0 and 1 
states. The pH stimulus is input B, for which pH 7.4 and 5, correlating with low and high 
proton concentrations, respectively, correspond to the 0 and 1 states. Finally, hν>530nm 
irradiation represents input C, for which “off” and “on” correspond to the 0 and 1 states. 
Importantly, this input should not be confused with the excitation light required for 
fluorescence measurements (i.e., at 345 nm). The corresponding outputs are F377 (output 
A), F680 (output B) and 1O2 generation (output C), which can each be non-activated or 
activated, corresponding to 0 or 1 states.  
With these conventions in mind, and with the goal of fabricating a system that can 
selectively activate the three different imaging and/or therapeutic functions, the output 
signals of the PS should evolve from complementary logic operations with different input 
combinations. To evaluate such differential responses, we first analyzed the three outputs 
upon applying binary stimuli combinations, with the third input in the “0” state (Figure 
46). 
                                                             
130  J. Andréasson, U. Pischel, Chem. Soc. Rev. 2015, 44, 1053–1069. 
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Figure 46. Performance of logic gate functions based on F377 (green data), F680 (blue) 
and 1O2 (red) upon applying different stimuli pairs: (a) H+ and DTT, h = 0; (b) DTT and 
h, H+ = 0; (c) H+ and hDTT = 0; h meaning light above 530 nm. Input combinations 
and output responses (off = 0, on = 1) are shown at the bottom and top of each graph, 
respectively. The bars show output values for each gate as the Y-axis label, with respect 
to threshold values indicated by dashed lines. Emission data are normalized as I/I0, 
while relative 1O2 generation is given by DPBF absorption decay normalized as A0/A. 
Due to normalization, a value of 1 in any Y-axis means zero response of the system.  
The first conclusion that can be drawn from this analysis is that F680 and F377 can be 
selectively activated. In the absence of input C (Figure 46a), 1 always outputs F680 as 1 in 
acidic pH and 0 in neutral pH, independent of DTT concentration (Figure 46a, blue bars). 
This is consistent with an identity (ID) gate that identifies F680 to the logic input of protons. 
F377, in turn, is sensitive to DTT; yet acidic pH quenches the DTT-mediated disulfide 
cleavage reaction (Figure 46a, green bars).131 This leads to an INHIBIT logic operation of 
pH on the F377 response to DTT. Taken in concert, these fluorescent responses are 
complementary to one another and could find use in bioimaging applications. 
In both of the other two dual-input scenarios, input C (h>530) does not affect the 
fluorescence output signals. As expected, F377 and F680 operate as ID logic gates that 
identify with DTT (Figure 46b, green bars) and protons (Figure 46c, blue bars), respectively. 
In turn, h>530 irradiation leads to 1O2 sensitization by 1, providing an alternative output 
signal, and enabling the construction of two AND logic gates based on the positive 
                                                             
131  P. T. Corbett, J. Leclaire, L. Vial, K. R. West, J.-L. Wietor, J. K. M. Sanders, S. Otto, Chem. Rev. 2006, 
106, 3652–3711. 
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dependence of 1O2 production with either pH or DTT and light (Figure 46b-c, red bars). The 
threshold value in this case was set according to Figure 46c, because the effect of pH on 
1O2 production is much more relevant than DTT. Indeed, the 1O2 response at pH 5 more 
than doubles that at neutral pH. 
Now that threshold values for each output have been established, the three different 
output signals can separately be represented in function of all three inputs, which 
combine in eight possible ternary input combinations (Figure 47).  
 
Figure 47. Performance of logic functions based on a) F377 (green data), b) F680 (blue) 
and c) 1O2 (red) upon applying different ternary combination of H+, DTT and hν input 
stimuli. Input combinations and output responses (off = 0, on = 1) are shown at the 
bottom and top of each graph, respectively. The graph bars show output values for 
each function as the Y-axis label, with respect to threshold values indicated by dashed 
lines. Emission data are normalized as I/I0, while relative 1O2 generation is given by 
DPBF absorption decay normalized as A0/A. Due to normalization, a value of 1 in any Y-
axis means zero response of the system. 
As can be concluded from the above graphs, the eight possible ternary input combinations 
lead to the logic system depicted in Figure 48, and its corresponding truth table (Table 6). 
 
Figure 48. Logic circuit for SiPc 1. Dashed rectangles represent combinations of logic 
operations that allow the selective and sequential activation of two different output 
signals through different dual combinations of input stimuli: F377 / 1O2 (green/red), F377 / 
F680 (green/blue) or F680 / 1O2 (blue/red).  
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 Table 6. Truth table for the three-input-dependent molecular logic system SiPc 1. 
Entry Input A (DTT) 
Input B 
(H+) 
Input C 
(hν) 
Output A 
(F377) 
Output B 
(F680) 
Output C 
(1O2) 
1 0 0 0 0 0 0 
2 1 0 0 1 0 0 
3 0 1 0 0 1 0 
4 1 1 0 0 1 0 
5 0 0 1 0 0 0 
6 1 0 1 1 0 1 
7 0 1 1 0 1 1 
8 1 1 1 0 1 1 
 
Most notably, there are combinations of inputs that activate only one output fluorescence 
signal (entries 2 for F377 and 3/4 for F680) with no 1O2 response. In turn, 1O2 production can 
be switched on with three input combinations, together with either F377 (entry 6) or F680 
(entries 7/8). Taken together, this setup would allow for the application of a stimuli 
sequence that first activates imaging at either of the emission wavelengths, followed by 
PDT treatment upon h>530 irradiation, and finally re-imaging of the target at the 
alternative emission wavelength in a separate spectral region. In practice, because the 
kinetics of amino protonation is in the range of seconds and disulfide cleavage in the range 
of hours, while 1O2 sensitization takes minutes, the most favourable situation for 
biomedical studies would be to monitor F680, followed by PDT via irradiation, and 
monitoring F377 at the post-treatment imaging stage.  
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1.5 In vitro photodynamic activity of selected silicon 
phthalocynines 
Subcellular localization and PDT efficacy experiments for the selected SiPc PS have been 
performed in the research group of Prof. Ángeles Juarranz de la Fuente, in collaboration 
with Alicia Zamarrón Moreno. 
For the in vitro studies, cultured Hep-2 cells (a human larynx carcinoma cell line), SCC-13 
cells (a human squamous cell carcinoma cell line) and HeLa cells (a human cervical 
carcinoma cell line) were used. The choice for these cell lines is well-reasoned, since they 
all represent types of cancer that are easily accessible for irradiation and PDT treatment. 
For the SiPcs on the other hand, it was chosen to study SiPc 1, SiPc 3 and SiPc 4, since they 
are the most activatable SiPc, the most hydrophilic SiPc, and the SiPc with the highest φΔ, 
respectively. Stock solutions of the SiPcs were prepared in DMSO, whereas work solutions 
for cell incubations were prepared from the stock solutions using cell medium, making 
sure the final concentration of DMSO was always lower than 0.5% (v/v). 
1.5.1 Subcellular localization  
In order to analyse the localization of the SiPcs inside the cells, Hep-2, SCC-13 and 
HeLa cells were incubated with SiPc 1, SiPc 3, or SiPc 4 (2*10-6 M) for 18 h at 37°C, in the 
dark. Afterwards, cells were washed with PBS, and observed in vivo with a fluorescence 
microscope (Figure 49 - Figure 51).  
The red fluorescence of SiPc 1 and SiPc 3 could be detected in all cell lines. In the case of 
SiPc 4, on the other hand, no fluorescent signal could be observed inside the cells, from 
which it could be deduced that it was not taken up effectively. Furthermore, since the 
intracellular red fluorescence of SiPc 3 was higher than that of SiPc 1, the amount of cell 
uptake could be directly correlated to the hydrophilicity of the PS structure, since SiPc 3, 
bearing four triethylene glycol chains, is the most amphiphilic SiPc, followed by SiPc 1, 
bearing only two triethylene glycol chains. SiPc 4 is purely hydrophobic in nature, which 
could explain the lack of cell uptake. With regards to the subcellular localization of SiPc 1 
and 3, no colocalization with the blue autofluorescence of the mitochondria was observed, 
and a nuclear localization can be ruled out because the nuclei (as seen by phase contrast) 
do not show any red fluorescence. The observed juxtanuclear red fluorescence indicates 
a possible uptake in the Golgi apparatus or endoplasmic reticulum,132 although this should 
be confirmed in subsequent experiments, by the use of well-known markers for the 
endoplasmic reticulum (ER-Tracker®) and the Golgi apparatus (NBD®). 
                                                             
132  E. Deni, A. Zamarrón, P. Bonaccorsi, M. Carmen Carreño, Á. Juarranz, F. Puntoriero, M. T. Sciortino, 
M. Ribagorda, A. Barattucci, Eur. J. Med. Chem. 2016, 111, 58–71. 
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Figure 49. Subcellular localization of SiPc 1, SiPc 3 and SiPc 4 in HEp-2 cells. SiPc 
concentration: 2*10-6 M. Scale bar: 20 µM. 
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Figure 50. Subcellular localization of SiPc 1, SiPc 3 and SiPc 4 in SCC-13 cells. SiPc 
concentration: 2*10-6 M. Scale bar: 20 µM. 
 
Figure 51. Subcellular localization of SiPc 1 and SiPc 3 in HeLa cells. SiPc concentration: 
2*10-6 M. Scale bar: 20 µM. 
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1.5.2 Effects of PDT on cell morphology and cell survival 
For photodynamic treatment, HeLa, SCC-13 and Hep-2 cells were incubated with 
different concentrations of SiPcs and irradiated with a red light emitting diode source.133  
Changes in cell morphology after photodynamic treatment were analysed in vivo by phase 
contrast microscopy. As a result of the photodynamic treatment, cells treated by SiPc 1 
and SiPc 3 revealed different morphological changes, whereas untreated cells showed 
spread morphology and homogeneous nuclei. For cells treated with SiPc 1, a significant 
increase of unbound cells can be observed, with characteristics that indicate an apoptotic 
cell death, such as cell rounding and blebbing (Figure 52a - Figure 54a). Furthermore, for 
those cells that remained bound to the surface, a gradual cytoplasmic cell retraction can 
be observed. The observed results are similar in all treated cell lines, and their extend 
clearly depends on the SiPc concentration and the applied light dose. Photodynamic 
treatment with SiPc 3 resulted more harmful than in the case of SiPc 1, in all the studied 
cell lines, which is in correspondence with their higher cell uptake results observed earlier. 
In general, almost all cells are now unbound to the surface, and show characteristics that 
indicate a necrotic cell death, such as loss of integrity of the plasma membrane (Figure 
55a - Figure 57a). For SiPc 4 on the other hand, no significant effect of the photodynamic 
treatment could be observed. Furthermore, in the phase contrast images, some blue 
precipitates can be clearly observed, explaining the low to non-existing cell uptake results 
mentioned earlier (Figure 58a and Figure 59a).   
The cellular toxicity induced by the different concentrations of the SiPcs 1, 3 and 4 on HEp-
2, SCC-13 and HeLa cells was evaluated by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay,134 and the results obtained are mean values and 
standard deviations from three independent experiments. Dark control experiments were 
carried out in parallel, incubating the cells with the same concentrations of SiPc, for 18h, 
in the dark. For both SiPc 1 and SiPc 3, this resulted in the observation of a low toxicity in 
the absence of light towards Hep-2 cells, at both 1µM and 2µM of PS, whereas in SCC-13 
and HeLa cells the dark cytotoxicity was negligible at both concentrations (Figure 52b - 
Figure 57b). This low dark toxicity in Hep-2 cells is however not problematic, since the 
toxicity upon irradiation of the PS by red light (RL) irradiation for 1 min (0,45 J/cm2) or 2 
min (0,90 J/cm2) was significantly higher in both cases. In the case of SiPc 1, at a 
concentration of 2 µM, a cell survival of only  21.30 ± 2.00% was observed after applying 
a light dose of 0,45 J/cm2 in Hep-2 cells (Figure 52b).  For SiPc 3 the cell survival was even 
lower, with values as low as 10.16 ± 0.17% being obtained at the lowest concentration (1 
µM) and light dose (0,90 J/cm2) in Hep-2 cells (Figure 55b). Similar results were obtained 
                                                             
133  For more information on the irradiation system, developed by Sega Invex at Universidad Autónoma 
de Madrid: http://www.uam.es/ss/Satellite/es/1242671166041/1242677464473/UAM_Desarrollo_ 
FA/Desarrollo/Irradiadores_de_LEDs_para_Terapia_Fotodinamica_(TFD).htm 
134  T. Mosmann, J. Immunol. Methods 1983, 65, 55–63. 
78   Subchapter 1 - Neutral SiPc photosensitizers 
for SCC-13 ( Figure 53b and Figure 56b) and HeLa cells (Figure 54b and Figure 57b). In 
conclusion, SiPc 3 is an extremely efficient PS at low light doses and concentrations, 
accompanied by a negligible dark cytotoxicity. As expected, for SiPc 4 no difference in 
toxicity can be observed before or after photodynamic treatment  (Figure 58b and Figure 
59b), since it was shown above that is was not effectively taken up by the cells.  
 
Figure 52. PDT effect of SiPc 1 on a) cell morphology and b) cell survival of HEp-2 cells 
upon irradiation for 1 or 2 min, corresponding to light doses from 0,45 to 0,90 J/cm2, at 
different concentrations of SiPc (1 µM or 2 µM). 
 
  
Treatment conditions Relative cell survival (%)
SiPc 1 1 µM 75.23 ± 2.90
SiPc 1 2 µM 73.41 ± 3.29
SiPc 1 1 µM + 1 min RL 44.70 ± 1.95
SiPc 1 1 µM + 2 min RL 42.61 ± 1.54
SiPc 1 2 µM + 1 min RL 29.43 ± 3.89
SiPc 1 2 µM + 2 min RL 21.30 ± 2.00
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Figure 53. PDT effect of SiPc 1 on a) cell morphology and b) cell survival of SCC-13 cells 
upon irradiation for 1 or 2 min, corresponding to light doses from 0,45 to 0,90 J/cm2, at 
different concentrations of SiPc (1 µM or 2 µM). 
 
  
Treatment conditions Relative cell survival (%)
SiPc 1 1 µM 94.85 ± 2.45
SiPc 1 2 µM 93.49 ± 2.52
SiPc 1 1 µM + 1 min RL 68.26 ± 1.95
SiPc 1 1 µM + 2 min RL 63.64 ± 2.48
SiPc 1 2 µM + 1 min RL 56.78 ± 3.52
SiPc 1 2 µM + 2 min RL 45.79 ± 4.11
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Figure 54. PDT effect of SiPc 1 on a) cell morphology and b) cell survival of HeLa cells 
upon irradiation for 1 or 2 min, corresponding to light doses from 0,45 to 0,90 J/cm2, at 
different concentrations of SiPc (0.5 µM, 1 µM or 2 µM). 
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Treatment conditions Relative cell survival (%)
SiPc 1 0.5 µM 96.58 ± 4.78
SiPc 1 1 µM 90.30 ± 1.71
SiPc 1 2 µM 87.43 ± 4.34
SiPc 1 0.5 µM + 1 min RL 42.33 ± 3.99
SiPc 1 0.5 µM + 2 min RL 30.22 ± 3.84
SiPc 1 1 µM + 1 min RL 24.19 ± 5.81
SiPc 1 1 µM + 2 min RL 15.93 ± 1.06
SiPc 1 2 µM + 1 min RL 15.21 ± 0.94
SiPc 1 2 µM + 2 min RL 12.15 ± 0.78
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Figure 55. PDT effect of SiPc 3 on a) cell morphology and b) cell survival of HEp-2 cells 
upon irradiation for 1 or 2 min, corresponding to light doses from 0,45 to 0,90 J/cm2, at 
different concentrations of SiPc (1 µM or 2 µM). 
 
 
Treatment conditions Relative ell survival (%) 
SiPc 3 1 µM 75.20 ± 2.03
SiPc 3 2 µM 70.83 ± 1.71
SiPc 3 1 µM + 1 min RL 10.16 ± 0.17
SiPc 3 1 µM + 2 min RL 9.63 ± 0.12
SiPc 3 2 µM + 1 min RL 9.78 ± 0.32
SiPc 3 2 µM + 2 min RL 9.21 ± 0.05
C
el
l s
u
rv
iv
al
/ %
[PS]
(µM)
0
20
40
60
80
100
120
0 1 2 1 1 2 2
Control
1 
m
in
2 
m
in
0 
(D
ar
k
to
xi
ci
ty
)
[PS]
R
ed
 li
gh
t d
os
e
(m
in
)
1x10-6 M 2x10-6 M
a)
b)
82   Subchapter 1 - Neutral SiPc photosensitizers 
 
Figure 56. PDT effect of SiPc 3 on a) cell morphology and b) cell survival of SCC-13 cells 
upon irradiation for 1 or 2 min, corresponding to light doses from 0,45 to 0,90 J/cm2, at 
different concentrations of SiPc (1 µM or 2 µM). 
 
Control
Treatment conditions Relative cell survival (%) 
SiPc 3 1 µM 99.10 ± 3.97
SiPc 3 2 µM 98.93 ± 4.16
SiPc 3 1 µM + 1 min RL 38.20 ± 4.26
SiPc 3 1 µM + 2 min RL 14.75 ± 5.27
SiPc 3 2 µM + 1 min RL 16.48 ± 3.07
SiPc 3 2 µM + 2 min RL 15.87 ± 3.23
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Figure 57. PDT effect of SiPc 3 on a) cell morphology and b) cell survival of HeLa cells 
upon irradiation for 1 or 2 min, corresponding to light doses from 0,45 to 0,90 J/cm2, at 
different concentrations of SiPc (0.5 µM, 1 µM or 2 µM). 
 
Treatment conditions Relative cell survival (%)
SiPc 3 0.5 µM 89.49 ± 4.47
SiPc 3 1 µM 82.82 ± 4.40
SiPc 3 2 µM 77.76 ± 2.88
SiPc 3 0.5 µM + 1 min RL 15.94 ± 1.19
SiPc 3 0.5 µM + 2 min RL 11.49 ± 0.80
SiPc 3 1 µM + 1 min RL 12.14 ± 0.52
SiPc 3 1 µM + 2 min RL 11.23 ± 0.27
SiPc 3 2 µM + 1 min RL 11.33 ± 1.02
SiPc 3 2 µM + 2 min RL 10.22 ± 0.79
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Figure 58. PDT effect of SiPc 4 on a) cell morphology and b) cell survival of HEp-2 cells. 
upon irradiation for 1 or 2 min, corresponding to light doses from 0,45 to 0,90 J/cm2, at 
different concentrations of SiPc (1 µM or 2 µM). 
 
 
Treatment conditions Relative cell survival (%)
SiPc 4 1 µM 80.15 ± 2.12
SiPc 4 2 µM 79.67 ± 4.28
SiPc 4 1 µM + 1 min RL 76.66 ± 1.79
SiPc 4 1 µM + 2 min RL 75.91 ± 0.62
SiPc 4 2 µM + 1 min RL 69.79 ± 5.16
SiPc 4 2 µM + 2 min RL 66.96 ± 2.02
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Figure 59. PDT effect of SiPc 4 on a) cell morphology and b) cell survival of SCC-13 cells. 
upon irradiation for 1 or 2 min, corresponding to light doses from 0,45 to 0,90 J/cm2, at 
different concentrations of SiPc (1 µM or 2 µM). 
 
 
 
 
  
Treatment conditions Relative cell survival (%)
SiPc 4 1 µM 96.59 ± 3.26
SiPc 4 2 µM 95.70 ± 5.30
SiPc 4 1 µM + 1 min RL 95.44 ± 2.55
SiPc 4 1 µM + 2 min RL 94.66 ± 4.85
SiPc 4 2 µM + 1 min RL 94.42 ± 4.50
SiPc 4 2 µM + 2 min RL 93.14 ± 3.23
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2 
Neutral subphthalocyanines as 
photosensitizers for 
photodynamic therapy 
 
2.1 State of the art 
Apart from some cationic SubPc derivatives, which will be discussed in their appropriate 
chapter (Chapter 2 – Subchapter 2), there has been little mention in literature about 
SubPcs in PDT. The early impetus for research into SubPcs stemmed from their use in ring 
expansion reactions to prepare unsymmetrical A3B-type Pcs, which could in principle be 
useful indirectly for PDT since the consequent monofunctionalization of the obtained PS 
would allow them to be coupled with tumor specific antibodies or other target selective 
groups.135 Later on, the focus has shifted towards their technological applications, for 
example, as octupolar non-linear optical materials,136 photovoltaic devices137 and 
photosynthetic models for the study of photoinduced electron and energy transfer 
                                                             
135  a] N. Kobayashi, R. Kondo, S. Nakajima, T. Osa, J. Am. Chem. Soc. 1990, 112, 9640–9641; b) R. G. Senz, 
R. Herter, Proc. SPIE 1995, 2325, 349–350; c] P. M. R. Pereira, B. Korsak, B. Sarmento, R. J. Schneider, 
R. Fernandes, J. P. C. Tomé, Org. Biomol. Chem. 2015, 13, 2518–2529. 
136  a] A. Sastre, T. Torres, M. A. Díaz-García, F. Agulló-López, C. Dhenaut, S. Brasselet, I. Ledoux, J. Zyss, 
J. Am. Chem. Soc. 1996, 118, 2746–2747; b) B. del Rey, U. Keller, T. Torres, G. Rojo, F. Agulló-López, 
S. Nonell, C. Martí, S. Brasselet, I. Ledoux, J. Zyss, J. Am. Chem. Soc. 1998, 120, 12808–12817; c] D. 
Dini, S. Vagin, M. Hanack, V. Amendola, M. Meneghetti, Chem. Commun. 2005, 3796–3798. 
137  K. L. Mutolo, E. I. Mayo, B. P. Rand, S. R. Forrest, M. E. Thompson, J. Am. Chem. Soc. 2006, 128, 8108–
8109. 
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processes.138 Reports on the bio-medical applications of this class of functional dyes, 
however, remain extremely rare.  
Nevertheless, the use of SubPcs in PDT could be of great interest, as they display various 
beneficial characteristics. First, SubPcs are intrinsically cone-shaped, which hinders 𝜋-𝜋 
stacking, resulting in a low aggregation tendency and high solubility. Low aggregation is 
very beneficial in PDT, as it results in less quenching of 1O2 generation. Second, the 
absorption maximum of SubPcs lies around 560-600 nm, close to the optimal therapeutic 
window, so that only a small proportion of the irradiation light would be absorbed by the 
surrounding tissue and the irradiation would be more effective. Finally, preliminary 
photophysical studies have shown that SubPcs can exhibit high φt and φΔ,139 making them 
potentially useful as PS for PDT and other photosensitizing applications. 
The use of SubPcs in PDT was reported for the first time in 2007, when Ng and co-workers, 
published the synthesis, characterization and photophysical properties of a series of 
axially substituted SubPcs and their in vitro photodynamic activity (Figure 60).140 
 
Figure 60. Series of SubPcs substituted axially with an oligoethylene glycol chain or a p-
phenoxy oligoethylene glycol methyl ether chain, as synthesized by Ng. and co-
workers.140 
As axial substituents, Ng and co-workers chose for a series of oligoethylene glycol chains, 
to increase the solubility and biocompatibility of the SubPc compounds. They carried out 
the substitution starting from the commercially available SubPc chloride (SubPcCl) with 
the corresponding alcohols, in the presence of triethylamine in toluene, obtaining the 
alkoxy analogues with very low yields and the phenoxy analogues with slightly higher 
yields. These yields are in accordance to results previously described when using these 
reaction conditions, however better alternatives are now available, especially for the 
substitution with aliphatic alcohols.141 The photodynamic activity of the resulting SubPcs 
was investigated against two different cell lines, namely HepG2 human hepatocarcinoma 
cells and HT29 human colon adenocarcinoma cells. All molecules showed a substantial cell 
                                                             
138  a] D. González-Rodríguez, T. Torres, D. M. Guldi, J. Rivera, L. Echegoyen, Org. Lett. 2002, 4, 335–338; 
b) D. González-Rodríguez, T. Torres, D. M. Guldi, J. Rivera, M. A. Herranz, L. Echegoyen, J. Am. Chem. 
Soc. 2004, 126, 6301–6313; c] R. S. Iglesias, C. G. Claessens, T. Torres, G. M. A. Rahman, D. M. Guldi, 
Chem. Commun. 2005, 2113–2115; d) D. González-Rodríguez, T. Torres, M. M. Olmstead, J. Rivera, 
M. Á. Herranz, L. Echegoyen, C. A. Castellanos, D. M. Guldi, J. Am. Chem. Soc. 2006, 128, 10680–
10681. 
139  S. Nonell, N. Rubio, B. del Rey, T. Torres, J. Chem. Soc. Perkin Trans. 2 2000, 1091–1094. 
140  H. Xu, X.-J. Jiang, E. Y. M. Chan, W.-P. Fong, D. K. P. Ng, Org. Biomol. Chem. 2007, 5, 3987–3992. 
141  J. Guilleme, D. González-Rodríguez, T. Torres, Angew. Chem. Int. Ed. 2011, 123, 3568–3571. 
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uptake, with localization in the cell cytoplasm. However, there was a discrepancy in the 
phototoxicity and in particular that of the alkoxy analogues, who had a higher φΔ as 
compared to the phenoxy analogues but showed almost no phototoxicity. Further tests 
revealed that the alkoxy analogues were highly unstable upon irradiation in the cell 
medium, whereas for the phenoxy analogues the photostability was a lot better, resulting 
in a higher phototoxicity with IC50 values down to 0.02 µM. 
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2.2 Molecular design, synthesis and characterization of a series 
of neutral subphthalocyanine photosensitizers 
In view of the lack of examples about the use of SubPcs in PDT, this is a mostly unexplored 
research field. However, as previously mentioned, the interesting characteristics of SubPcs 
deserve that some more investigation is done in the area. Therefore, the specific objective 
of this subchapter is the design and synthesis of a series of axially substituted SubPc 
derivatives. Taking into account the positive results obtained in the previous subchapter, 
with a series of building blocks for axial substitution designed to impart enhanced 
fluorescence and photodynamic properties in SiPcs, we decided to incorporate the same 
building blocks at the axial positions of SubPcs (Figure 61). Furthermore, we aim to 
investigate the photophysical properties of the obtained SubPcs, and study their in vitro 
photodynamic activity towards a series of tumoral cell lines, including Hep-2, SCC-13 and 
HeLa, enabling in this way a comparison of the in vitro photodynamic behaviour of the 
obtained SubPcs with their SiPc counterparts.  
 
Figure 61. Target compounds of Chapter 1 - Subchapter 2: A series of axially substituted 
SubPcs bearing different axial substituents. 
It is well known that the axial substitution of SubPcs in standard reaction conditions has 
certain limits, since the tetracoordinated boron atom (in which the vacant p orbital is 
occupied by formation of a dative bond with one of the nitrogens in the macrocycle) is 
rather unreactive. Most often, the standard axial reaction with primary alcohols is not 
selective enough and requires high temperatures, which may ultimately lead to SubPc ring 
opening and decomposition. In our research group, a new and versatile strategy was 
developed to this end, which revolutionized the possibilities of axial substitution in 
SubPcs, using triflate-SubPc as a reactive intermediate which readily reacts with a variety 
of nucleophiles (Scheme 12).141 Therefore we decided to follow this methodology, instead 
of the methodology employed by Ng and co-workers, obtaining in this way axially 
substituted alkoxy-SubPcs with much higher yields. The detailed synthesis of compounds 
12-15 is described in the next sections. 
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Scheme 12. New methodology for axial substitution of SubPcs, developed in our 
research group. 
 
2.2.1 Synthesis of target neutral subphthalocyanines 
Although SubPcCl is commercially available, it is quite pricy. However, it is easy to 
synthesize starting from 1,2-dicyanobenzene (also known as phthalonitrile) and boron 
trichloride solution 1.0 M in p-xylene, which despite the low yield of this reaction proves 
to be a lot cheaper (Scheme 13).86c 
 
Scheme 13. Synthesis of SubPcCl (16). 
Once we obtained a reasonable quantity of SubPcCl (16), we continued with the 
incorporation of the series of building blocks for axial substitution that were synthesized 
previously (Subchapter 1 of this chapter). To this end, 16 was first dissolved in dry toluene 
and treated with 1.2 equivalents of silver triflate, to irreversibly remove the axial chlorine 
atom and to obtain a “SubPcB+” species with a weakly coordinating triflate anion. The 
formation of this triflate intermediate was followed by thin layer chromatography (TLC) 
and usually completes after ca. 40 min of reaction at rt. The activated triflate-SubPc 
intermediate shows considerable reactivity towards nucleophilic attack at the boron 
atom, and can be easily reacted with a variety of nucleophiles. Therefore, upon 
completion of the formation of the triflate intermediate, 2 equivalents of the 
corresponding building block for axial substitution were added to the reaction mixture, in 
the presence of 1.2 equivalents of recently distilled DIPEA in order to neutralize the triflic 
acid generated in this step, which could promote unwanted secondary reactions. The 
reaction has to be performed under strictly anhydrous conditions. Otherwise, the 
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presence of traces of water would immediately lead to a mixture of hydroxy-SubPc and 
the µ-oxo dimer.141,142  
The resulting SubPcs (12-15) could be easily purified by column chromatography, generally 
using toluene/THF mixtures of various polarity as the eluent. A second purification step by 
SEC, with Bio-Beads as the stationary phase and toluene as the eluent, was performed to 
remove any traces of free alcohol or µ-oxo dimer. In this way, the resulting SubPcs were 
obtained with reasonable to high yields (ranging from 43% to 64%, Scheme 14). 
 
Scheme 14. Synthesis of SubPcs 12-15.  
As mentioned before, due to their cone-shaped 3D geometry, SubPcs are known to show 
little or no aggregation, leading to an easy and straightforward characterization of SubPcs 
12-15 by 1H- and 13C-NMR spectroscopy. As an example, the 1H-NMR of substituent 5 and 
the corresponding SubPc 12, recorded in CDCl3, are depicted in Figure 62. Just like for the 
SiPcs, the SubPc aromatic protons are well resolved, indicating the complete absence of 
aggregation. Furthermore, the ring current also affects the nearby protons of the axial 
substituent, though to a smaller extent than in the case of SiPcs. 
                                                             
142  a] M. Geyer, F. Plenzig, J. Rauschnabel, M. Hanack, B. del Rey, A. Sastre, T. Torres, Synthesis 1996, 
1996, 1139–1151; b) N. Kobayashi, T. Ishizaki, K. Ishii, H. Konami, J. Am. Chem. Soc. 1999, 121, 9096–
9110. 
Chapter 1 – Design, synthesis and applications of neutrally charged (Sub)Pc in PDT 93 
 
Figure 62. 1H-NMR spectrum of substituent 5 (top) and the SubPc 12 bearing 5 in the as 
axial substituent (bottom) in CDCl3, showing the effect of the ring current on the 
protons of the axial substituent: the closer the protons to the ring, the greater the 
upfield displacement of their chemical shift.  
 
2.2.2 Spectral features and photophysical properties 
The normalized absorption spectra of SubPcs 12-16 were measured in DMF, and 
they all present the typical and intense Q-band, at 566 nm for SubPcBCl 16 and at 562 nm 
for the axially substituted SubPcs 12-15 (Figure 63). Furthermore, they all present the 
typically broad B- or Soret-band with a maximum around 305 nm. For SubPcs 12 and 15, 
additional absorption bands at 329 and 345 nm can be distinguished, characteristic of the 
pyrene moiety they bear at the axial position. Exact values of the electronic absorption 
features for each SubPc can be found in Table 7. 
 
Figure 63. Electronic absorption spectra of SubPcs 12-16 in DMF. 
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Upon excitation at 345 nm, all the SubPcs showed a fluorescence emission around 571 nm 
(F571), varying in intensity, with the pyrene-bearing compounds also showing its 
characteristic fluorescence with maximums around 377 nm (F377). In contrast to Pcs, 
SubPcs tend to display larger Stokes shifts. For SubPcs 12-16,the Stokes shift resulted to 
be between 9-10 nm (Figure 64) (for SiPcs 1-4 the Stokes shift was between 1-5 nm). φF of 
both the pyrene and SubPc moieties were determined in DMF, relative to F12SubPcCl in 
benzonitrile DMF (φF = 0.58) and anthracene in cyclohexane (φF = 0.36), exciting at 520 
nm or 345 nm, respectively. All results are represented in Table 7.  
   
Figure 64. Normalized absorption (full lines) and emission (dashed lines) for SubPcBCl 
14 and SubPcs 15-18, indicating their Stokes shift. 
 
The photosensitizing efficiency of SubPcs 12-16 was determined in the same way as that 
of the SiPcs 1-4, determining their φΔ in DMF following the well-known relative method 
based on the photoinduced decomposition of the chemical scavenger DPBF, which reacts 
readily with 1O2.127 The resulting φΔ are resumed in Table 7.  
Table 7. Electronic absorption and photophysical data in DMF for the reference 
compound 10 and SubPcs 12-16.  
Compound λmax (nm) λem (nm)a φF377 (%)b φF571 (%)c φΔ (%)d 
10 344 377 59.6 -e -e 
12 562 571 1.7 38.1 55.6 
13 562 571  -f 29.2 37.1 
14 562 571 -f 35.9 49.0 
15 562 571 1.0 36.7 50.2 
16 566 575 -f 55.1 47.3 
a Excited at 345 nm. b Excited at 345 nm. Using anthracene in cyclohexane as the reference 
(φF = 0.36). c Excited at 520 nm. Using ClSubPcF12 in benzonitrile DMF (φF = 0.58) as the 
reference. d Using ZnPc in DMF as the reference (φΔ = 0.56). e Not applicable because the 
compound does not contain any SubPc moiety. f Not applicable because the compound does 
not contain any pyrene moiety. 
From the resulting φF and φΔ of SubPcs 12-16 two conclusions can be drawn. First, the 
quenching of F377, probably caused by EET between the pyrene moiety and the SubPc core, 
is extremely effective in both SubPcs bearing a pyrene group (SubPc 12 and 15), much 
better than was the case for the corresponding SiPc bearing two of these pyrene groups 
(SiPc 2, see Table 5 and Figure 36). This more effective EET process can probably be 
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explained by the fact that the emission of the pyrene moiety not only overlaps with the 
Soret-band of the SubPcs (as in case of the SiPcs), but also partially overlaps with the Q-
band of the SubPcs. As a consequence φF377 is reduced from almost 60% in reference 
compound 10 to less than 2% in SubPcs 12 and 15. Second, the quenching of the SubPc 
emission (F571) and the 1O2 generation is only effective for SubPc 13, which bears the 
amino-containing substituent which can quench the singlet excited state of the SubPc by 
PET. For SiPcs 1 and 3, a similar tendency was appreciated, the degree of quenching of 
both F680 and the 1O2 generation depending on the number of pendant amino groups.  
As a result of this ineffective quenching of the 1O2 generation for the majority of SubPcs 
in this series, these SubPcs cannot be classified as activatable PS. Therefore, no studies of 
their behaviour in function of DTT and/or pH have been undertaken. Nevertheless, 
although activatable PS are desirable, selectivity in PDT can also obtained by selectively 
irradiating the malicious tissues, without irradiating healthy tissue. In this way, SubPcs 12-
16 could be outstanding candidates for PS in PDT, since they display extraordinary high φΔ 
values. Furthermore, these excellent φΔ are companied by high φF571 values, which could 
aid in the visualization of the treatment area. For these reasons, the efficiency in PDT of 
different cancer cell lines of selected SubPcs will be tested in vitro. 
 
2.3 In vitro photodynamic activity of selected 
subphthalocyanines 
Subcellular localization and PDT efficacy experiments for the selected SiPc PS are currently 
being performed in the research group of Prof. Ángeles Juarranz de la Fuente, in 
collaboration with Alicia Zamarrón Moreno. 
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3 
A SiPc-(SubPc)2 triad as 
potential photosensitizer for 
photodynamic therapy 
 
3.1 State of the art 
Ever since the fundamental energy exchange processes occurring in multipoprhyrin-
quinone assemblies during natural photosynthesis were discovered, a great deal of 
research has been focussed on the understanding of the mutual interplay between 
energy- and electron-transfer processes.143 For this, a large number of systems based on 
electron-donor and electron-acceptor units, linked by a well-defined spacer, have been 
synthesized. Although extensive work has been dedicated to the study of Por-quinone 
dyads144 mimicking the processes occurring in natural photosynthesis, other photo- or 
electroactive moieties may be employed in such artificial photosynthetic systems. Both 
Pcs and SubPcs are interesting electron-donor and/or electron-acceptor candidates, since 
they both display aromatic delocalization, which gives rise to exceptional optical and 
electronical properties. Therefore, it is of no surprise that many examples of dyads and 
                                                             
143  a] R. Huber, Angew. Chem. Int. Ed. 1989, 28, 829–847; b) J. Deisenhofer, H. Michel, Angew. Chem. 
Int. Ed. 1989, 28, 829–847; c] R. E. Blankenship, Molecular Mechanisms of Photosynthesis, Wiley-VCH, 
Weinheim, 2001. 
144  a] M. R. Wasielewski, Chem. Rev. 1992, 92, 435–461; b) D. Gust, T. A. Moore, A. L. Moore, Acc. Chem. 
Res. 1993, 26, 198–205; c] H. Kurreck, M. Huber, Angew. Chem. Int. Ed. 1995, 34, 849–866; d) D. Gust, 
T. A. Moore, A. L. Moore, Acc. Chem. Res. 2001, 34, 40–48; e] M. Huber, Eur. J. Org. Chem. 2001, 
2001, 4379–4389. 
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triads containing Pcs145 or SubPcs146 have been described in the literature, mostly in 
combination with other chromophores such as fullerenes, BODIPYS, etc.147 Furthermore, 
a substantial amount of covalent and non-covalent tetrapyrollic dyads or triads consisting 
of Pcs and Pors have been reported,148 but SubPcs covalently conjugated with tetrapyrrole 
derivatives remain extremely rare, and only few covalent SubPc-Pc dyads have been 
reported in the literature so far.149  
In 2005, Gonzalez-Rodriguez et al. synthesized a series of SubPc-Pc dyads, prepared by 
means of Pd-catalyzed cross-coupling reactions between monoalkynyl-Pc and different 
monoiodo-SubPc derivatives.149a Electronic coupling between the two photoactive units is 
in this way ensured by a rigid and π-conjugated alkynyl linker. Photoinduced energy- and 
electron -transfer events were precisely studied and tuned by the introduction of different 
peripheral substituents in the SubPc moiety, varying its electronic characteristics (Figure 
65a). Around the same time, Tolbin et al. synthesized a SubPc-Pc dyad, incorporating a 
ZnPc unit at the axial position of the SubPc via a peripheral alcohol at the ZnPc unit (Figure 
65b).149b More recently, two related alkynyl-linked SubPc–Pc dyad were prepared through 
a Pd(II)-catalyzed Sonogashira coupling between a peripheral ethynyl moiety at the Pc and 
the p-iodo-functionalized position of an axial phenoxy ligand at the SubPc moiety (Figure 
65d).149d 
                                                             
145  a] Y. Rio, W. Seitz, A. Gouloumis, P. Vázquez, J. L. Sessler, D. M. Guldi, T. Torres, Chem. Eur. J. 2010, 
16, 1929–1940; b) G. Rotas, J. Ranta, A. Efimov, M. Niemi, H. Lemmetyinen, N. Tkachenko, N. 
Tagmatarchis, ChemPhysChem 2012, 13, 1246–1254; c] C. B. KC, K. Stranius, P. D’Souza, N. K. 
Subbaiyan, H. Lemmetyinen, N. V. Tkachenko, F. D’Souza, J. Phys. Chem. C 2013, 117, 763–773; d) S. 
Zhou, M. Yamamoto, G. A. D. Briggs, H. Imahori, K. Porfyrakis, J. Am. Chem. Soc. 2016, 138, 1313–
1319. 
146  a] D. González-Rodríguez, T. Torres, D. M. Guldi, J. Rivera, L. Echegoyen, Org. Lett. 2002, 4, 335–338; 
b) D. González-Rodríguez, T. Torres, D. M. Guldi, J. Rivera, M. A. Herranz, L. Echegoyen, J. Am. Chem. 
Soc. 2004, 126, 6301–6313; c] R. S. Iglesias, C. G. Claessens, T. Torres, G. M. A. Rahman, D. M. Guldi, 
Chem. Commun. 2005, 2113–2115; d) D. González-Rodríguez, T. Torres, M. M. Olmstead, J. Rivera, 
M. Á. Herranz, L. Echegoyen, C. A. Castellanos, D. M. Guldi, J. Am. Chem. Soc. 2006, 128, 10680–
10681; e] L. C. Kasi Viswanath, L. D. Shirtcliff, S. Krishnan, N. V. Handa, K. Darrell Berlin, Tetrahedron 
Lett. 2014, 55, 4199–4202; f) E. Maligaspe, M. R. Hauwiller, Y. V. Zatsikha, J. A. Hinke, P. V. Solntsev, 
D. A. Blank, V. N. Nemykin, Inorg. Chem. 2014, 53, 9336–9347. 
147  a] G. Bottari, G. de la Torre, D. M. Guldi, T. Torres, Chem. Rev. 2010, 110, 6768–6816; b) G. de la Torre, 
G. Bottari, M. Sekita, A. Hausmann, D. M. Guldi, T. Torres, Chem. Soc. Rev. 2013, 42, 8049–8105; c] 
G. Bottari, G. de la Torre, T. Torres, Acc. Chem. Res. 2015, 48, 900–910. 
148  P.-C. Lo, X. Leng, D. K. P. Ng, Coord. Chem. Rev. 2007, 251, 2334–2353. 
149  a] D. González-Rodríguez, C. G. Claessens, T. Torres, S. Liu, L. Echegoyen, N. Vila, S. Nonell, Chem. Eur. 
J. 2005, 11, 3881–3893; b) A. Y. Tolbin, M. O. Breusova, V. E. Pushkarev, L. G. Tomilova, Russ. Chem. 
Bull. 2005, 54, 2083–2086; c] Z. Zhao, A. N. Cammidge, M. J. Cook, Chem. Commun. 2009, 7530–7532; 
d) N. Shibata, B. Das, E. Tokunaga, M. Shiro, N. Kobayashi, Chem. Eur. J. 2010, 16, 7554–7562. 
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Figure 65. An overview of covalently linked SubPc-Pc dyads, synthesized by a) Gonzalez-
Rodriguez et al.,149a b) Tolbin et al.,149b and c) Shibata et.al.149d 
The first, and, to the best of our knowledge, the only, SubPc-Pc triad containing two SubPc 
units, was reported in 2008 by Cook and co-workers (Figure 66).149c They parted from 
dihydroxy silicon octakis(hexyl) Pc and reacted it with SubPcCl to obtain the µ-oxo-linked 
SubPc-SiPc dyad and triad, expectedly with low yields. The authors indicate the use of 
these systems as antenna molecules for solar photon collection as most foreseen 
application, as a result of their absorbance over the whole visible spectrum. 
 
Figure 66. The first and only reported SubPc-Pc-SubPc triad so far, synthesized by Cook 
and co-workers.149c 
Apart from these covalent dyads, Ng and co-workers also synthesized a series of non-
covalent SubPc-Pc dyads, based on axial complexation of a zinc (II) and ruthenium (II) Pc 
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with two different SubPcs with an axial pyridyl group.150 The complexation processes were 
studied by 1H-NMR and fluorescence spectroscopy methods, indicating a 1:1 
stoichiometry in both cases, which was also confirmed by X-ray diffraction analysis. 
Up to now, all synthesized Pc-SubPc dyads and triads have been designed and studied for 
their exceptional optical and electronical properties, with their use as solar light collectors 
in photovoltaic devices as the ultimate goal. However, apart from their energy- and 
electron-transfer features, these dyads and triads are also of interest due to their 
extraordinary absorptive cross section, displayed across the whole UV-Vis spectrum, 
making them model candidates for application in situations where broadband light 
sources are necessary. In this way, they could serve as exceptional PS in PDT with 
wavelength-independent φΔ, although no research in this direction has been undertaken 
so far. 
 
 
  
                                                             
150  H. Xu, D. K. P. Ng, Inorg. Chem. 2008, 47, 7921–7927. 
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3.2 Molecular design, synthesis and characterization of the SiPc-
(SubPc)2 triad  
The specific objective of the present Subchapter is the design and synthesis of the first 
SubPc-SiPc-SubPc triad (compound 17, Figure 67a), for use as a PS in PDT. Its ability to 
generate 1O2 and fluorescence emission have been designed as tumor responsive (Figure 
67b). More specifically, the PS consists of a SiPc core, axially substituted with two SubPc 
units, covalently linked by a cleavable disulfide linker.  
 
 
Figure 67. a) Chemical structure of 17. B) Schematic representation of the possible 
mechanism of action of PS 17 upon entering a tumor cell. GHS being glutathione, 
indicating the characteristic reducing environment of tumor cells, responsible for the 
cleavage of the disulfide linker of 17 and consequent activation of its 1O2 generation 
and fluorescence. 
The design comes as a logical advance on the previously discussed SiPc derivative bearing 
a pyrene unit as activatable chromophore at the axial position, also linked by the same 
cleavable disulfide linker (Subchapter 1 of this Chapter). This PS presented three output 
signals (fluorescence at 377 and 680 nm, and 1O2 production), potentially enabling 
multifunctional theranostics. However, the fluorescence and 1O2 generation quenching 
before the PS activation was only moderate, mainly due to inefficient EET from the pyrene 
unit to the SiPc core, limiting its practical application. In the present case, it is expected 
that the quenching caused by the SubPc units will be more effective, since the SubPc 
emission band partially overlaps with the SiPc Q-band, increasing the possible use of the 
PS in PDT (Figure 68). Furthermore, as SubPcs are lower homologues of Pcs with 
absorption bands appearing at regions of low SiPc absorption (ca. around 550 nm), their 
conjugation may enable a panchromatic photosensitization that should in principle 
maximize 1O2 generation. Indeed, SubPcs are also able to generate 1O2, and having two 
SubPc units on the SiPc can contribute to the overall φΔ of this PS system upon activation. 
EET 
quenching
1O2
tumor cell
1O2
hν
GHS
GHS
GHS
GHS
a) b)
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Figure 68. Cross-section (purple) of the normalized emission of SubPc 18 (red) and 
absorption of SiPc 4 (blue), in DMF, resulting in an EET in SiPc-SubPc triad 17. 
 
3.2.1 Synthesis of the SubPc building block for axial substitution 
The idea behind the synthesis of the new SiPc-SubPc triad is similar as that used by 
Cook and co-workers, in the way that the SubPc units will be introduced at the axial 
positions of the SiPc.149c However, instead of parting from a dihydroxy SiPc, we wanted to 
part from the commercially available SiPcCl2, to be able to follow our previously applied 
methodology for the axial substitution of the SiPcs. Therefore, the SubPc units must bear 
a primary alcohol available for conjugation. In this respect, the same linker as that used in 
Subchapter 1 of this Chapter could be used. 
SubPcCl 16 was prepared as before86c and its axial chloride substituent replaced by 2-
hydroxyethyl disulfide following the axial substitution procedure developed in our group 
(Scheme 15).141 The progress of the substitution reaction was followed by TLC, and in this 
case the reaction was completed after 6 h. The crude was then subjected to column 
chromatography on silica gel using toluene/THF with a gradient from 30:1 to 10:1 as the 
eluent. Subsequent trituration in water yielded the desired SubPc 18 with a 56% yield. 
 
Scheme 15. Synthesis of the axial SubPc units bearing the appropriate linker for 
incorporation in the SiPcCl2. 
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3.2.2 Synthesis of the target SiPc-(SubPc)2 triad 
The next step involved the nucleophilic displacement of the chlorine atoms in 
SiPcCl2 with the primary alcohol 18. To this end, SiPcCl2 and 5 equivalents of 18 were 
dissolved in pyridine, and DIPEA was added as a base. After refluxing the reaction mixture 
overnight, the SiPc-SubPc triad 17 was formed (Scheme 16).  
 
Scheme 16. Incorporation of SubPc 18 at the axial positions of SiPcCl2, following the 
standard procedure, resulting in formation of SiPc-SubPc triad 17. 
The purification of 17 was difficult and tedious because of the inherent instability 
problems in both standard silica (which is slightly acidic) or silica previously neutralised 
with Et3N. In both cases, the compound decomposed rapidly, probably because the Pc unit 
is acid-sensitive while SubPcs are known to be base-sensitive. Part of the crude reaction 
mixture could finally be purified by SEC with Bio-Beads as the stationary phase and CHCl3 
as the eluent, yielding triad 17 as a dark purple solid. However only a fraction of the 
compound elutes as pure compound, the remaining part eluting together with the starting 
products SiPcCl2 and SubPc 18, and/or decomposition products, for which an estimated 
yield of the product is reported. Because of this inherent instability of the molecule, it was 
not possible to detect the molecular ion by mass spectrometry, yet 1H-NMR 
characterization is conclusive about the purity and identity of the purified fraction of the 
product (see Figure 69). 
 
.. .. . ...
. .
. .
. ...
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Figure 69. 1H-NMR of SiPc-(SubPc)2 triad 17, recorded in CDCl3. 
3.2.3 Spectral features and photophysical properties 
The absorption and photochemical properties of the SiPc-SubPc triad 17, SubPc 18 
and reference SiPc 4 were measured in DMF (Table 8).  
Table 8. Electronic absorption and photophysical data for SiPc 4, SubPc 18 and SiPc-
(SubPc)2 triad 17. 
Compound λmax (nm)  λem (nm)a φF571 (%)b φF680 (%)c φΔ (%)d 
4 679 684 -d 37.1 36.2 
17 675, 562 680, 571 2.4 5.2 11.7 
18 562 571 38.3 -e 49.0 
a Excited at 520 nm. b Excited at 520 nm, using ClSubPcF12 in benzonitrile as the reference (φF = 
0.58). c Excited at 610 nm, using ZnPc in DMF as the reference (φF = 0.28). d Not applicable because 
the compound does not contain any SubPc moiety. e Not applicable because the compound does 
not contain any Pc moiety. 
The UV-Vis spectra of SubPc 18 and SiPc 4 show their typical broad Soret band (at 300-400 
nm) and sharp Q band (at 562 and 675 nm, respectively). Accordingly, the UV-Vis spectrum 
of the SiPc-SubPc triad 17 shows a broad Soret band at 300-400 nm and two Q-bands, the 
first one originating from the two axial SubPc units (at 562 nm) and the second one from 
the SiPc unit (at 675 nm), in an expected 2:1 stoichiometrical ratio (Figure 70).  
 
Figure 70. The sum of spectral features in DMF for the reference compounds 18 and 4, 
in the right stoichiometry (2:1), matches the spectrum of the SubPc-SiPc triad 17. 
φF were measured by exciting the compounds at 520 nm (for SubPcs) or 610 nm (for Pcs). 
φΔ, in turn, were again measured by the relative method, using DPBF as a chemical 
scavenger and excitation with visible light filtered below 455 nm (hν > 455 nm). As 
expected, compared to the reference SiPc 4 and the SubPc 18, the SiPc-SubPc triad 17 
shows a significant deactivation of its fluorescence and 1O2 generation, probably as a 
result of an electronic energy transfer process in which the SubPc emission band and the 
SiPc Q-band partially overlap (Figure 68).  
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3.3 Proposed tumor responsive activation of the SiPc(SubPc)2 
triad 
According to the design of the molecule (Figure 67b), initially the fluorescent and 1O2-
generating properties of 17 are quenched, most probably by electronic energy transfer 
between the SubPc units and the Pc core. Upon entering a reducing environment, e.g., like 
that in tumor cells, the disulfide linker would be cleaved and the quenching would be 
undone, resulting in a sudden generation of 1O2 and a strong fluorescence of both the SiPc 
and SubPc units. In the following subsections, this behavior has been probed in a 
physiologically relevant medium, by means of using DTT as a strong reducing agent to 
achieve the PS activation. In this way we hope to gain understanding of how both the 
fluorescence and 1O2 generation of 17 would be influenced in a tumor like environment.  
 
3.3.1 Effect of DTT concentration on the fluorescence properties of 
the SiPc(SubPc)2 triad 
To investigate the influence of intratumor-like disulfide cleavage on the 
fluorescence properties of 17, its emission spectrum was monitored for 24 h in PBS buffer 
solutions with varying DTT concentrations (Figure 71).  
Sample preparation was as follows: 17 is dissolved in DMF to give a 1 mM solution, which 
was diluted to 0.4 μM with PBS (with 0.5% Cremophor EL). DTT was dissolved in deionized 
water to give a 1 M solution. Mixtures of 17 (0.4 μM) with DTT (2 μM, 5 mM, 10 mM, 20 
mM or 50 mM) or without DTT in PBS (25 mL) were prepared and stirred continuously.  
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Figure 71. Representation of the fluorescence spectra of 17 in PBS (0.5% Cremophor EL) 
with a) 0 μM DTT, b) 2μM DTT, c) 5 mM DTT, d) 20 mM DTT and e) 50 mM DTT, from t = 
0 h to t = 24 h. 
 
  
Figure 72. Normalized emission maximum of 17 in PBS (0.5% Cremophor EL) in function 
of time for a) the SubPc units (F571) and b) the phthalocyanine unit (F680). 
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As can be seen in Figure 72a, the fluorescence intensity of the SiPc unit (at 674 nm - λex = 
345 nm) exhibits approximately a 9-, 12- and 18-fold increment in the presence of 5, 20 
and 50 mM of DTT respectively, while in the absence of DTT or in the presence of only 2 
µM of DTT there is no SiPc fluorescence enhancement. This increase in fluorescence 
intensity reflects that the SiPc emission is recovered upon disulfide cleavage. On the other 
hand, the fluorescence intensity of the SubPc unit (at 571 nm - λex = 345 nm) displays a 
similar initial recovery, but reaches a maximum recovery around 2 hours, after which the 
fluorescence intensity starts decreasing again (Figure 72b).  
To explain this unexpected result, the influence of DTT on the absorption of 17 was studied 
(Figure 73). From this experiment, it became clear that 17 was unstable to the strong 
reducing environment, indicated by a decrease of the SubPc absorption at 562 nm in 
function of time, the extent of the decrease being greater at higher concentrations of DTT. 
This instability, although unexpected and in principle undesired, does not necessarily urge 
to discard the use of 17 as an activatable tumor responsive and theranostic PS for PDT, 
however, as the outcome caused by the actual decomposition of the SubPc unit or by the 
foreseen cleavage of the disulfide linker is the same with respect to both its 1O2 generation 
and the fluorescence of the SiPc unit. Indeed, both outcomes would be activated once 17 
enters the strong reducing environment of a tumor cell, just as they are in solution. 
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Figure 73. UV-Vis spectra of 17 in PBS (0.5% Cremophor EL) with a) 0 µM DTT, b) 2 µM 
DTT, c) 5 mM DTT, d) 20 mM DTT and e) 50 mM DTT, from t = 0 h to t = 24 h.  
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3.3.2 Effect of DTT concentration on 1O2 generation of the  
SiPc(SubPc)2 triad 
To investigate the effect of a reducing environment (as in tumor cells) on the 
capacity of triad 17 for 1O2 generation in physiologically relevant medium, 1O2 studies 
were performed in the same buffer solutions with varying DTT concentrations. The rate of 
DPBF photodegradation upon irradiation of the SiPc-SubPc triad 17, which is proportional 
to the amount of 1O2 formation, is measured in combination with 0 µM, 2 µM, 5 mM, 20 
mM and 50 mM of DTT and represented in Figure 74. 
 
Figure 74. Effect of DTT on the capacity of 17 for 1O2 generation: normalized absorption 
(A/A0) of DPBF at various concentrations of DTT over time, showing its 
photodegradation rate sensitized by 17 upon excitation with light above 455 nm. 
A clear trend can be deduced from this data, demonstrating that more efficient 1O2 
generation results from samples exposed to a higher concentration of DTT. Thus, the 
degree of disulfide cleavage seems to be directly correlated to the 1O2 generation 
efficiency of 17. In the absence of DTT or in the presence of only 2 µM of DTT 
(corresponding to the extracellular glutathione concentration) there is no enhancement 
of the 1O2 generation, which reflects the need of a strong reducing environment to 
promote such activation via disulfide cleavage. Moreover, dark control experiments 
confirm that, under all conditions, compound 17 is unable to produce 1O2 without hν> 455nm 
illumination.  
In summary, SiPc-SubPc triad 17 is a PS with the ability to generate 1O2, the main 
reactive species in PDT, in a substantially higher amount once entered in a reducing 
environment simulating that of tumor cells. However, due to the difficulty in the 
preparation and purification of the SiPc-SubPc triad, and the inherent instability problems, 
no in vitro tests of PDT efficacy are performed for this PS. 
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4 
Summary and conclusions 
 
In the present chapter, the synthesis of different neutral SiPc and SubPc derivatives, 
including SiPc-SubPc triad, has been explored, with their use as PS in PDT of different 
oncological treatments as the final goal. 
Regarding SiPcs, we have synthesized a series of neutral derivatives bearing different 
substituents at the axial positions of the central silicon atom. It was our aim to make use 
of axial substituents that can actively quench the singlet excited state of the PS, and 
therefore their 1O2 generation efficiency and fluorescence, in a reversible way. To this end, 
activation studies of these quenching processes in function of different external stimuli 
were undertaken. The most interesting SiPc derivative (SiPc 1), bears two different of such 
quenching groups that can each selectively be activated, and consequently displays the 
ability to perform multiple logic operations based on three input and three output signals. 
This multi-input/multi-output nature enables single-, double- and triple-mode activation 
pathways of its different molecular functions, through the interplay of various interrelated 
AND, ID and INHIBIT gates. Moreover, the three outputs elicit a high biomedical value 
considering 1O2 is the main reactive species in PDT, while dual fluorescence emissions are 
potentially useful for orthogonal optical imaging protocols. The applied stimuli are also 
relevant from the medical point of view, as low pH and reducing conditions are 
characteristic of tumor tissues. Finally, for selected SiPcs, their efficacy as PS was studied 
in vitro against various tumour cell lines, such as HEp-2 (from a human larynx carcinoma), 
SCC-13 (from a human squamous cell carcinoma of the skin) and HeLa (from a human 
cervical carcinoma), SiPc 1 and SiPc 3 giving rise to excellent results in all studied cell lines.  
SubPcs are equally interesting PS molecules as compared to Pcs, but research in directed 
at the use of SubPcs in PDT is lacking. In view of the interesting results obtained in the first 
subchapter, the same substituents as those used in SiPcs were also incorporated at the 
axial position of the boron atom in SubPcs, and their influence on various properties such 
as fluorescence and 1O2 generation was studied in detail. However, in this case both the 
EET and PET quenching processes resulted less effective than in the case of SiPcs. 
112   Summary and Conclusions 
Nevertheless, it could be noted that all synthesized SubPc derivatives presented high to 
very high φΔ, which is promising for their use as PS in PDT. Therefore, for selected SubPcs 
their efficacy as PS will be studied in vitro against HEp-2, SCC-13 and HeLa, enabling the 
comparison of their results with those obtained for their SiPc counterparts.  
Finally, both macrocycles were combined in one single molecule, in the synthesis of a 
SiPc-(SubPc)2 triad, consisting of a SiPc core axially substituted with two SubPc units. Its 
ability to generate 1O2 and fluorescence emission were designed as tumor responsive, and 
selective activation experiments depending on different external stimuli have been 
undertaken in this direction. Furthermore, since SiPcs and SubPcs possess complementary 
absorption maxima, the SiPc-(SubPc)2 triad displayed a panchromatic photosensitization,  
which contributed to the overall φΔ of this PS system upon activation, outperforming that 
of both of its PS parts.  
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5 
Experimental section 
 
5.1 Materials and methods 
All reagents were used as purchased from commercial sources without further 
purification. Solvents were dried using standard techniques prior to use. The starting 
materials silicon phthalocyanine dichloride (SiPcCl2), 1-pyrene butyric acid, 2-hydroxyethyl 
disulfide, triethylene glycol monomethyl ether, and 3-amino-1-propanol were 
commercially available. All reactions were performed in standard glassware under inert 
argon atmosphere. Reactions were monitored by TLC, using TLC plates pre-coated with 
silica gel 60-F254 (Merck). Column chromatography was carried out on Merck silica gel 60, 
40-63 μm (230-400 mesh). Size Exclusion Chromatography (SEC) was performed using 
Biorad Biobeads SX-1 (200-400 mesh).  
1H and 13C{1H} NMR spectra were recorded using Bruker AC-300 (1H: 300 MHz; 13C: 75 
MHz) instruments, unless mentioned otherwise. Spectra were referenced internally by 
using the residual solvent (1H: δ = 7.26 for CDCl3, δ = 2.49 for DMSO-d6) or solvent 
resonances (13C: δ = 77.0 for CDCl3, δ = 39.5 for DMSO-d6) relative to SiMe4, respectively.  
UV-Vis and fluorescence spectra were recorded with a JASCO V-660 and a JACSO FP-8600 
spectrophotometer, respectively. The logarithm of the molar absorption coefficient ε is 
expressed in between parentheses. 
Matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) MS and high-
resolution (HR-MS) mass spectra were recorded with a Bruker Ultrareflex III spectrometer. 
Fast atom bombardment (FAB) mass spectra were recorded with a VG AutoSpec of Waters 
instrument. All MS experiments were carried out at the Servicio Interdepartmental de 
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Investigación (SIdl) of the Universidad Autónoma de Madrid. All the data are expressed 
with the intensity in percentage between parentheses.  
IR spectra (IR) were recorded on a FTIR IFS66v (Bruker) spectrophotometer using KBr disks, 
in the Servicio Interdepartmental de Investigación (SIdl) of the Universidad Autónoma de 
Madrid (in Subchapter 1) or on a FTIR Cary 630 (Agilent Technologies) using the ATR 
technique (in Subchapter 2 and 3). Spectra intensity were corrected by ATR algorithm and 
subsequent baseline correction. 
Melting points (Mp) were determined in a Buchi 504392-S equipment, in the Department 
of Organic Chemistry of the Universidad Autónoma de Madrid. 
 
5.1.1 Fluorescence and singlet oxygen quantification 
 
Fluorescence quantum yields 
φF were measured in DMF using the comparative method of Williams et al,127 in which φF 
is determined by the equation:  
𝜙𝐹
𝑆 = 𝜙𝐹
𝑅 (
𝐺𝑟𝑎𝑑𝑆
𝐺𝑟𝑎𝑑𝑅
)(
𝜂𝑆
2
𝜂𝑅
2) 
where subscripts R and S denote reference and sample, respectively, 𝜙𝐹 is the 
fluorescence quantum yield, Grad the gradient from the plot of the integrated 
fluorescence intensity (at the specified wavelength) versus the absorption (at the same 
wavelength), and η the refractive index of the solvent. Non-substituted zinc (II) 
phthalocyanine (ZnPc) in DMF (φF = 0.28),151 ClSubPcF12 in benzonitrile DMF (φF = 0.58),152 
and anthracene in cyclohexane (φF = 0.36)153 were used as references for the SiPc, SubPc 
and pyrene emissions, respectively. Excitation took place at 610 nm for SiPcs, at 520 nm 
for SubPcs, and at 310 nm for pyrene moieties. 
 
1O2 quantum yields  
φΔ were measured in DMF following the well-known relative method, based on the 
photoinduced decomposition of a chemical scavenger (i.e., DPBF) that reacts readily with 
                                                             
151  I. Scalise, E. N. Durantini, Bioorg. Med. Chem. 2005, 13, 3037–3045. 
152  C. R. Nieto, J. Guilleme, C. Villegas, J. L. Delgado, D. González-Rodríguez, N. Martin, T. Torres, D. M. 
Guldi, J. Mater. Chem. 2011, 21, 15914–15918. 
153  I. B. Berlman, Handbook of Fluorescence Spectra of Aromatic Molecules, Academic Press, New York, 
1971. 
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1O2. Non-substituted ZnPc was used as reference compound (φΔ(DMF) = 0.56).154 In detail, 
the procedure was as follows: 2.5 mL of a stock solution of DPBF (with an absorption of 
ca. 1) in DMF was transferred into a 10 x 10 mm quartz optical cell and bubbled with 3O2 
for 1 min. A concentrated stock solution of the PS in the same solvent was then added, in 
a defined amount to reach a final Q-band absorbance value of about 0.1. The solution was 
stirred and irradiated for defined time intervals, using a halogen lamp (300 W). The 
duration of these intervals are tuned in each experiment, in order to get a decrease in 
DPBF absorption of about 3-4%. Incident light was filtered through a water filter (6 cm) 
and an additional filter to remove light under 530 nm (Newport filter FSQ-OG530) or 455 
nm (Newport filter 20CGA-455), for SiPcs and SubPcs respectively. Additional neutral 
density filters (FBS-ND03 or FB-ND10) were used when necessary. The decrease of DPBF 
absorbance with irradiation time was monitored at 414 nm. φΔ was calculated through 
the following equation:  
𝜙Δ
𝑆  =  𝜙Δ
𝑅
𝑘𝑆𝐼𝑎𝑇
𝑅
𝑘𝑅𝐼𝑎𝑇
𝑆  
where R and S indicate reference and sample, respectively. k is the slope of a plot of 
ln(A0/At) versus irradiation time t, with A0 and At being the absorbance of scavenger at the 
monitoring wavelength before and after irradiation time t, respectively. IaT is the total 
amount of light absorbed by the dye and is calculated as the sum of intensities of the 
absorbed light Ia from wavelength 530 up to 800 nm. Ia at given wavelength is calculated 
using Beer’s law: 
𝐼𝑎 = 𝐼0(   𝑒
−2.3𝐴)  
where I0 is the transmittance of the filter at a given wavelength and A the absorbance of 
the dye at this wavelength. All experiments are performed three times and the obtained 
data represent mean values of those three experiments.  
 
Fluorescence studies in PBS 
Samples were prepared as following: the corresponding SiPc was dissolved in 
spectroscopic grade DMF to give a 1 mM solution, which was diluted to 0.4 μM with buffer 
solution (PBS with 0.5% Cremophor EL®). DTT was dissolved in deionized water to give a 1 
M solution. Mixtures of the SiPc (25 mL, 0.4 μM) with DTT (2 μM, 5 mM, 10 mM, 20 mM 
or 50 mM) or without DTT in PBS buffer, and adjusted to pH = 7.4, pH = 6.8 or pH = 5 by 
adding concentrated HCl (0, 6 or 16 µL, respectively), were prepared and stirred 
                                                             
154  W. Spiller, H. Kliesch, D. Wöhrle, S. Hackbarth, B. Röder, G. Schnurpfeil, J. Porphyr. Phthalocyanines 
1998, 2, 145–158. 
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continuously. Their absorption and fluorescence spectra (λexc = 345 nm, λem = 355-850 nm) 
were recorded over time, from t = 0h up until t = 24h. 
 
 
 
1O2 generation studies in PBS 
Samples were prepared as following: DPBF was first dissolved in DMF to give a 10 mM 
solution. The corresponding SiPc was dissolved in spectroscopic grade DMF to give a 1 mM 
solution, which was diluted to 0.4 μM with buffer solution (PBS with 0.5% Cremophor EL®). 
Mixtures of the SiPc (25 mL, 0.4 μM) and DTT (0, 2 μM or 20 mM) in PBS, adjusted to pH = 
7.4, pH = 6.8 or pH = 5 by adding concentrated HCl (0, 6 or 16 µL, respectively) were stirred 
continuously for 24 h after which 3 mL of these solutions were mixed with the DPBF 
solution (10 mM, 21 μL) followed by illumination with hν>530nm. The decay of the 
absorbance of DPBF at 414 nm was monitored over time. 
 
5.1.2 In vitro photodynamic therapy experiments 
 
Cell Cultures  
For the in vitro studies, cultured Hep-2 cells (a human larynx carcinoma cell line), SCC-13 
cells (a human squamous cell carcinoma cell line) and HeLa cells (a human cervical 
carcinoma cell line) were used. All cell types were routinely grown as a monolayer in F25 
flasks (Costar, Corning, NY, USA) on culture dishes with or without glass coverslips placed 
inside the dishes. In the case of SCC-13 and HeLa, Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS), 50 units/mL penicillin, 
and 50 μg/mL streptomycin was used. In the case of Hep-2, Roswell Park Memorial 
Institute medium (RPMI), also supplemented with 10% (v/v) fetal bovine serum (FBS), 50 
units/mL penicillin, and 50 μg/mL streptomycin was used. Cells were grown in a HERA cell 
incubator (Heraeus, Kendro, Germany) with a 5% CO2 atmosphere, a 95% relative 
humidity and a constant temperature of 37°C. 
 
Preparation of SiPcs and Incubation of Cells 
Stock solutions of the SiPcs (1.5 x 10−3 M) were prepared in DMSO. Work solutions for cell 
incubations were prepared from the stock solutions using DMEM or RPMI with 10% FBS. 
The final concentration of DMSO was always lower than 0.5% (v/v), and the lack of toxicity 
of this DMSO concentration for Hep-2, SCC-13 and HeLa cells was tested and confirmed.  
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Subcellular Localization of SiPcs  
In order to analyse the localization of the SiPcs inside the cells, Hep-2, SCC-13 and HeLa 
cells were grown on coverslips. When cells reached around 80% of confluence, they were 
incubated with SiPc 1, SiPc 3, or SiPc 4 (diluted in cellular medium (DMEM or RPMI) with 
1% FBS, to a final concentration of 2 x 10-6 M) for 24 h at 37°C, in the dark. Then, cells were 
washed with PBS, mounted on slides, and observed in vivo with a fluorescence microscope 
(Olympus BX61) using an excitation light with a  wavelength of 365 nm (excitation filter: 
UG-1).  
 
Photodynamic Treatments 
HeLa, SCC-13 or Hep-2 cells were seeded in 24-well plates on cover slips until they reached 
around 80% of confluence. They were then incubated with different concentrations of 
SiPcs, ranging from 0.5 x 10−6 M to 2 x 10−6 M (diluted in cellular medium (DMEM or RPMI)), 
for 6 h. After incubation, cells were washed with PBS and then irradiated in complete 
media at 7.5 mW/cm2 for variable times (1 or 2 min, corresponding to light doses from 
0,45 to 0,90 J/cm2) with a red light emitting diode source133 with an emission peak at λ = 
635 nm, as measured with a spectrophotometer. After irradiation, the cells were 
incubated in complete medium in the incubator at 37°C for 24 h. Dark control experiments 
were carried out in parallel, incubating the cells with the same concentrations of SiPc, for 
18h, in the dark. 
 
Cellular Toxicity 
Toxicity of the different concentrations of SiPcs on HEp-2, SCC-13 and HeLa cells was 
evaluated 24 h after photodynamic treatment by the MTT (3-(4,5-dimethylthiazol-2-yl)- 
2,5-diphenyltetrazolium bromide, Sigma, St Louis, MI, USA) assay. This method is widely 
accepted as a quantitative colorimetric assay for mammalian cell toxicity134 based on 
active cell metabolism. A stock MTT solution (1 mg/mL) in PBS was prepared immediately 
prior to use. Then, a solution of MTT with DMEM (10% FBS) was prepared (1 mL MTT-
PBS/10 mL DMEM) and added to the culture dishes to obtain a final concentration of 50 
µg/mL. After incubation at 37°C for 4 h, the culture medium was removed, and the 
precipitated formazan was dissolved in 500 μL of DMSO per well. The absorption was 
measured at 542 nm in a spectrophotometer (Espectra Fluor 4, Tecan). Cellular toxicity 
was expressed as a percentage of formazan absorption from PS-treated cells compared to 
control cells (which received neither PS nor PDT) (cell survival (%) = (mean OD value of 
PDT-treated cells / mean OD value of control cells) x 100%). The results obtained are mean 
values and standard deviations from three independent experiments. 
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Morphological Studies 
HeLa, SCC-13 or Hep-2 cells were grown in coverslips until 80% confluence. Changes in cell 
morphology after photodynamic treatment (SiPc concentration of 1 x 10−6 M or 2 x 10−6 
M for 6 h and a light dose of 0.45-0.90 J/cm2) were analysed in vivo by phase contrast 
microscopy (Olympus BX61). 
 
Optical and Electron Microscopy 
Microscopic observations were carried out using an Olympus BX61 epifluorescence 
microscope equipped with filter sets for fluorescence microscopy: ultraviolet (UV, 365 nm, 
exciting filter UG-1), blue (450−490 nm, exciting filter BP 490), and green (545 nm, exciting 
filter BP 545). Photographs were obtained with the digital camera Olympus DP50 and 
processed using the Adobe PhotoShop CS5 extended version 12.0 software (Adobe 
Systems Inc, USA).  
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5.2 Experimental details synthesis 
5.2.1 Synthesis of building blocks for axial substitution 
 
1-Pyrenebutanoic acid, 2-[(2-hydroxyethyl)dithio]ethyl ester (5):  
1-Pyrene butyric acid (2.00 g, 7 mmol), 2-
hydroxyethyl disulfide (1.28 g, 8 mmol) and 
DMAP (cat.) were dissolved in dry DCM (300 
mL) under argon atmosphere. EDC (0.595 g, 8 mmol) was separately dissolved in dry DCM 
(50 mL) and added. The solution was stirred at rt overnight, after which it was washed 
with water to remove the water-soluble EDC side-product. The organic phases were 
collected and dried on anhydrous MgSO4. The solvent was removed under reduced 
pressure and the crude product purified by column chromatography using 
chloroform/methanol (100:1) as the eluent to yield 5 (2.30 g, 77%) as a light yellowish oil.  
1H-NMR (300 MHz, CDCl3): δ(ppm) 8.39 – 7.76 (m, 9H, Hpy), 4.36 (t, J = 6.6 Hz, 2H, H5), 3.85 
(t, J = 5.8 Hz, 2H, H8), 3.40 (t, 2H, H3), 2.87 (dt, J = 14.9, 6.2 Hz, 4H, H6, H7), 2.48 (t, J = 7.2 
Hz, 2H, H1), 2.21 (quin, J = 7.3 Hz, 2H, H2). 
13C-NMR (75 MHz, CDCl3): δ(ppm) 173.43 (C4), 135.68 (Cpy), 131.55 (Cpy), 131.02(Cpy), 
130.14 (Cpy), 128.88 (Cpy), 127.60 (Cpy), 127.55 (Cpy), 127.49 (Cpy), 126.88 (Cpy), 125.99 (Cpy), 
125.23 (Cpy), 125.11 (Cpy), 125.08 (Cpy), 124.94 (Cpy), 124.92 (Cpy), 123.41 (Cpy), 62.43 (C5), 
60.37 (C8), 41.76 (C7), 37.17 (C6), 33.88 (C1), 32.84 (C3), 26.81 (C2).  
MS (FAB, m-NBA): m/z = 424.1 [M]+ (100), 215 [pyrene+CH3]+ (35).  
HR-MS (FAB, m-NBA): [M]+ Calcd. for C24H24O3S2: 424.1167; Found: 424.1156. 
FT-IR (neat)  (cm-1): 3608 (O-H), 3045, 2947, 2878, 1732 (C=O), 1603, 1587, 1458, 1416, 
1384, 1184, 1161, 1056, 848. 
 
Triethylene glycol monomethyl ether tosylate (6):155  
Triethylene glycol monomethyl ether (15.0 g, 0.091 mol) and 
NaOH (5.09 g, 0.127 mol) were dissolved in a mixture of THF (23 
mL) and water (27 mL) under argon atmosphere. At 0°C, a solution of p-toluenesulfonyl 
chloride (15.6 g, 0.082 mol) in THF (27 mL) was added dropwise and the mixture was 
stirred for 3h at 0°C. The crude was poured into ice-water (90 mL) and the aqueous phase 
extracted several times with DCM and diethyl ether. The organic phases were collected 
                                                             
155  D. A. Sheik, L. Brooks, K. Frantzen, S. Dewhurst, J. Yang, ACS Nano 2015, 9, 1829–1836. 
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and washed once with HCl 1 M and once with brine. The organic phase was dried on 
anhydrous MgSO4 and the solvent removed under reduced pressure to yield the tosylate 
6 (23.77 g, 82%) as a colorless oil. Characterization as reported in literature. 
1H-NMR (300 MHz, CDCl3): δ(ppm) 7.75 (d, J = 8.2, 2H), 7.30 (d, 2H), 4.12 (t, J = 6.1 Hz, 2H), 
3.64 (t, J = 6.1 Hz, 2H), 3.60 – 3.52 (m, 6H), 3.49 (t, J = 6.4 Hz, 2H), 3.33 (s, 3H), 2.41 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ(ppm) 144.76, 133.07, 129.80, 127.96, 71.91, 70.75, 70.55, 
69.22, 68.68, 59.01, 21.62.  
 
3-[bis(methoxy(diethylenoxy)ethyl)amino]-1-propanol (7):  
3-amino-1-propanol (0.50 g, 6.6 mmol), 6 (6.33 g, 19.9 
mmol), Et3N (3.2 mL, 2.66 mmol) and molecular sieves 
(3Å) were heated in acetonitrile (33 mL) under reflux 
and argon atmosphere for 36h. The solvent was removed under reduced pressure, the 
residue dissolved in CHCl3, washed with a saturated solution of NaHCO3 and extracted 
with DCM. The organic phase was dried on anhydrous MgSO4, the solvent removed under 
reduced pressure and the crude purified by column chromatography using DCM/methanol 
(20:1) as the eluent to yield 7 (1.15 g, 61%) as a colorless oil. 
1H-NMR (300 MHz, CDCl3): δ(ppm) 3.73 (t, J = 8.1 Hz, 2H, H1), 3.66 – 3.50 (m, 20H, H5-9), 
3.35 (s, 6H, H10), 2.77 – 2.66 (m, 6H, H3-4), 1.64 (quin, J = 4.8 Hz, 2H, H2). 
13C-NMR (75 MHz, CDCl3): δ(ppm) 72.00 (C9), 70.67 (C6-8), 70.58 (C6-8), 70.48 (C6-8), 69.47 
(C5), 63.87 (C1), 59.09 (C10), 55.41 (C3), 53.94 (C5,6), 28.56 (C2).  
MS (FAB, m-NBA): m/z = 368.4 [M]+ (100), 143.3 (30), 133.0 (30), 59.1 (40).  
HR-MS (FAB, m-NBA): [M]+ Calcd. for C17H38NO7: 368.2648; Found: 368.2641. 
FT-IR (neat) ν (cm-1): 3448 (O-H), 2882, 1456, 1351, 1277, 1199, 1105 (C-O), 850. 
 
2-[(2-hydroxyethyl)disulfanyl]ethyl acetate (8):156  
2-Hydroxyethyl disulfide (1.0 g, 6.5 mmol) was dissolved in dry 
DCM (50 mL) and triethylamine (1.36 mL, 9.7 mmol) was added 
under argon atmosphere. The reaction mixture was cooled to 0°C and acetyl chloride (0.46 
mL, 6.5 mmol) was added dropwise. The solution was allowed to warm up to rt and the 
reaction was followed by TLC. Upon completion of the reaction (30 min), the reaction 
mixture was quenched with a saturated solution of NaHCO3 and extracted with DCM. The 
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organic phases were collected and dried on anhydrous MgSO4. The solvent was removed 
under reduced pressure and the crude purified by column chromatography using 
DCM/methanol (100:1) as the eluent. 8 was isolated as a colorless oil (0.43 g, 33%). 
Characterization as reported in literature. 
1H-NMR (300 MHz, CDCl3): δ(ppm) 4.32 (t, J = 6.6 Hz, 2H), 3.86 (q, J = 5.7 Hz, 2H), 2.99 – 
2.81 (m, 4H), 2.06 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ(ppm) 58.88, 24.06, 19.70, 13.64.  
 
3-aminopropyl (tert-butyl)dimethylsilyl ether (9):157 
3-amino-1-propanol (8.4 mL, 0.11 mol) and tert-butyldimethylsilyl 
chloride (18.2 g, 1.12 mol) were dissolved in dry DCM (200 mL) under 
argon atmosphere. Triethylamine (23 mL) was added and the cloudy 
mixture was vigorously stirred at rt for 12 h. The resulting clear solution was washed with 
water and the organic layer dried on anhydrous MgSO4, filtered and concentrated to yield 
compound 9 as colorless oil (20.4 g, 98%). Characterization as reported in literature. 
1H-NMR (300 MHz, CDCl3): δ(ppm) 3.67 (t, J = 6.1 Hz, 2H), 2.76 (t, J = 6.8 Hz, 2H), 1.62 
(quin, J = 6.71 Hz, 2H), 0.86 (s, 8H), 0.02 (s, 6H). 
13C-NMR (75 MHz, CDCl3): δ(ppm) 61.35, 39.48, 36.26, 26.04, 18.39, -5.26.  
 
1-Pyrenebutanoic acid, N-(3-((tert-butyldimethylsilyl)oxy)propyl) amide (10):  
1-Pyrene butyric acid (2.000 g, 7 mmol), 9 
(1.576 g, 8 mmol) and DMAP (cat.) were 
dissolved in dry DCM (400 mL) under argon 
atmosphere. EDC (1.595 g, 8 mmol) was 
separately dissolved in dry DCM (50 mL) and added. The solution was stirred at rt 
overnight, after which it was washed with water to remove the water-soluble EDC side-
product. The organic phases were collected and dried on anhydrous MgSO4. The solvent 
was removed under reduced pressure and the crude product purified by column 
chromatography using chloroform/methanol (100:1) as the eluent to yield 10 (3.517 g, 
96%) as a light yellowish oil.  
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1H-NMR (300 MHz, CDCl3): δ(ppm) 8.64 – 7.70 (m, 9H, Hpy), 3.70 (t, J = 5.6 Hz, 2H, H7), 3.44 
– 3.31 (m, 4H, H1, H5), 2.28 – 2.13 (m, 4H, H3, H2), 1.70 (quin, J = 11.8 Hz, 2H, H6), 0.81 (s, 
9H, H10), -0.01 (s, 6H, H8). 
13C-NMR (75 MHz, CDCl3): δ(ppm) 172.38 (C4), 136.10 (Cpy), 131.57 (Cpy), 131.08 (Cpy), 
130.08 (Cpy), 128.93 (Cpy), 127.61 (Cpy), 127.49 (Cpy), 126.80 (Cpy), 125.94 (Cpy), 125.26 (Cpy), 
125.16 (Cpy), 124.99 (Cpy), 124.92 (Cpy), 124.87 (Cpy), 123.58 (Cpy), 62.87 (C7), 38.56 (C5), 
36.33 (C3), 33.00 (C1), 31.59 (C6), 27.70 (C2), 25.96 (C10), 18.25 (C9), -5.36 (C8). 
MS (FAB, m-NBA): m/z = 460.4 [M + H]+ (30), 402.3 [M – t-Bu]+ (30), 73.1 [M – TBDMS]+ 
(100).  
HR-MS (FAB, m-NBA): [M+H]+ Calcd. for C29H38NO2Si: 460.2672; Found: 460.2661. 
FT-IR (neat)  (cm-1): 2955, 2931, 2857, 1666 (C=O), 1516, 1092, 848. 
 
1-Pyrenebutanoic acid, N-(3-hydroxypropyl) amide (11):  
10 (3.517 g, 0.007 mol) is added to a dry flask 
flushed with argon. Dry methanol (30 mL) is added 
and the reaction mixture is cooled to 0°C. Acetyl 
chloride (0.001 mol, 0.082 mL) is added dropwise under vigorous stirring. Completion of 
the reaction is followed by TLC. After 2h, the reaction is complete and the solvent is 
evaporated. The residue is dissolved in DCM and washed with water. The organic phases 
are collected and dried on anhydrous MgSO4. The solvent is removed under reduced 
pressure and the crude product purified by column chromatography using a gradient of 
Chloroform to chloroform/methanol (10:1) as the eluent to yield 11 (1.899 g, 69%) as 
viscous brown oil.  
1H-NMR (300 MHz, CDCl3): δ(ppm) 8.44 – 7.55 (m, 9H, Hpy), 6.01 (s, 1H, NH), 3.55 (t, J = 5.6 
Hz, 2H, H7), 3.37 – 3.19 (m, 4H, H1, H5), 2.27 – 2.05 (m, 4H, H2, H3), 1.57 (p, J = 5.8 Hz, 2H, 
H6). 
13C-NMR (75 MHz, CDCl3): δ(ppm) 173.99 (C4), 135.70 (Cpy), 131.38 (Cpy), 130.86 (Cpy), 
129.93 (Cpy), 128.72 (Cpy), 127.45 (Cpy), 127.38 (Cpy), 127.29 (Cpy), 126.71 (Cpy), 125.87 (Cpy), 
125.05 (Cpy), 124.93 (Cpy), 124.78 (Cpy), 123.29 (Cpy), 59.29 (C7), 36.28 (C5), 35.90 (C3), 32.70 
(C1), 32.18 (C6), 27.46 (C2). 
MS (FAB, m-NBA): m/z = 691.3 [2M]+ (20), 346.2 [M+H]+ (100), 154 [matrix] (40), 137 
[matrix] (30).  
HR-MS (FAB, m-NBA): [M]+ Calcd. for C23H24NO2: 346.1807; Found: 346.1804.  
FT-IR (neat)  (cm-1): XXX 
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5.2.2 Synthesis of silicon phthalocyanines 
 
Silicon (IV) phthalocyanine 1:  
SiPcCl2 (0.100 g, 0.164 mmol), alcohol 
5 (0.174 g, 0.409 mmol), alcohol 7 
(0.150 g, 0.409 mmol) and pyridine 
(0.3 mL) in dry toluene (15 mL) were 
heated under reflux and argon 
atmosphere for 18 h. The solvent was 
removed under reduced pressure 
and the crude purified by column 
chromatography using silica gel, 
previously neutralized with 
triethylamine, and DCM/methanol 
(50:1) as the eluent. After further SEC 
with Bio-Beads in DCM, 1 (0.030 g, 
16%) was obtained as a dark blue 
sticky paste. 
1H-NMR (300 MHz, CDCl3): δ(ppm) = 
9.64 (dd, J = 5.7, 3.1 Hz, 8H, H3), 8.34 
(dd, J = 5.7, 2.9 Hz, 8H, H4), 8.21 – 
7.77 (m, 9H, Hpy), 3.49 (t, J = 6.2 Hz, 
2H, H4’), 3.35 (t, 2H, H8’), 3.33 – 3.01 (m, 22H, H6’’-10’’), 2.19 (t, J = 6.7 Hz, 2H, H6’), 2.01 (quin, 
J = 7.8 Hz, 2H, H7’), 1.63 (t, 2H, H3’), 1.44 – 1.38 (m, 4H, H5’’), 1.25 (s, 4H, H4’’), 0.19 (br s, 
2H, H3’’), -0.41 (t, J = 6.3 Hz, 2H,H2’), -1.01 (br s, 2H, H2’’), -1.78 (t, J = 7.2 Hz, 2H, H1’), -2.08 
(t, J = 5.5 Hz, 2H, H1’’). 
13C-NMR (75 MHz, CDCl3): δ(ppm) = 173.36 (C5’), 149.86 (C1), 136.45 (C2), 131.61 (C4), 
129.26 (Cpy), 128.05 (Cpy), 127.87 (Cpy), 127.28 (Cpy), 126.40 (Cpy), 125.48 (Cpy), 125.34 (Cpy), 
124.31 (Cpy), 123.82 (C3), 72.29, 70.77, 70.38, 62.21, 59.44, 54.46, 53.99, 51.46, 39.55, 
39.32, 36.81, 33.17, 30.17, 23.26, 11.98.  
MS (MALDI-TOF, DCTB): m/z = 1352.4 [M+Na]+ (40), 963.3 [M-Laxial(S3)]+ (100). 
HR-MS (MALDI-TOF, DCTB): [M+Na]+ Calcd. for C73H75N9O10S2SiNa: 1352.4740; Found: 
1352.4708. 
UV-VIS (DMF): λmax (nm) (log ε): 675 (5.30), 645 (sh), 607 (4.50), 356 (sh), 344 (4.77), 328 
(4.77). 
FT-IR (neat)  (cm-1): 2929, 2880, 2361, 2340, 1733 (C=O), 1334, 1291, 1123, 1081, 911, 
848. 
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Silicon (IV) phthalocyanine 2:  
SiPcCl2 (0.100 g, 0.164 mmol), 
alcohol 5 (0.347 g, 0.817 mmol) 
and pyridine (0.3 mL) in dry 
toluene (15 mL) were heated 
under reflux and argon 
atmosphere for 18 h. The 
solvent was removed under 
reduced pressure and the 
crude purified by column 
chromatography using silica 
gel, previously neutralized with 
triethylamine, and DCM as the 
eluent. After trituration in 
methanol and recrystallization 
from toluene, 2 (0.061 g, 32%) 
was obtained as a dark blue 
solid. 
1H-NMR (300 MHz, CDCl3): 
δ(ppm) 9.65 (dd, J = 5.7, 3.1 Hz, 8H, H3), 8.30 (dd, J = 6.0, 2.8 Hz, 8H, H4), 8.24 – 7.75 (m, 
18H, Hpy), 3.52 (t, J = 6.5 Hz, 4H, H4’), 3.28 (t, J = 7.7 Hz, 4H, H8’), 2.23 (t, J = 7.2 Hz, 4H, H6’), 
2.04 (q, J = 7.2 Hz, 4H, H7’), 1.64 (t, J = 6.5 Hz, 4H, H3’), -0.38 (t, J = 6.5 Hz, 4H, H2’), -1.75 (t, 
J = 6.5 Hz, 4H, H1’). 
13C-NMR (75 MHz, CDCl3): δ(ppm) 172.82 (C5’), 149.38 (C1), 135.98 (C2), 135.62 (Cpy), 
131.42 (Cpy), 130.95 (C4), 130.88 (Cpy), 129.96 (Cpy), 128.70 (Cpy), 127.49 (Cpy), 127.36 (Cpy), 
127.32 (Cpy), 126.72 (Cpy), 125.84 (Cpy), 125.08 (Cpy), 124.98 (Cpy), 124.92 (Cpy), 124.78 (Cpy), 
123.70 (C3), 123.27 (Cpy), 53.91 (C1’), 50.93 (C4’), 38.70 (C2’), 36.27 (C3’), 33.53 (C6’), 32.62 
(C8’), 26.58 (C7’). 
MS (MALDI-TOF, DCTB): m/z = 1387.3 [M+H]+ (24), 963.2 [M-Laxial]+ (100).  
HR-MS (MALDI-TOF, DCTB): [M]+ Calcd. for C80H62N8O6S4Si: 1386.3425; Found: 1386.3439. 
UV-VIS (DMF): λmax (nm) (log ε (dm3 mol-1 cm-1)): 676 (5.38), 644 (sh), 607 (4.58), 356 (sh), 
344 (5.14), 328 (5.02). 
FT-IR (neat)  (cm-1): 2929, 2880, 2361, 2340, 1733 (C=O), 1334, 1291, 1123, 1081, 911, 
848. 
Mp: 282°C. 
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Silicon (IV) phthalocyanine 3:  
SiPcCl2 (0.100 g, 0.164 mmol), alcohol 7 (0.293 
g, 0.817 mmol) and pyridine (0.3 mL) in dry 
toluene (15 mL) were heated under reflux and 
argon atmosphere for 18 h. The solvent was 
removed under reduced pressure and the crude 
purified by column chromatography using silica 
gel, previously neutralized with triethylamine, 
and DCM/methanol (20:1) as the eluent. After 
further SEC with Bio-Beads in DCM, 3 (0.041 g, 
24%) was obtained as a dark blue solid. 
1H-NMR (300 MHz, CDCl3): δ(ppm) = 9.64 (dd, J 
= 5.6, 2.7 Hz, 8H, H3), 8.35 (dd, J = 5.6, 3.0 Hz, 
8H, H4), 3.46 – 3.38 (m, 12H, H4’-10’), 3.35 – 3.26 
(m, 16H, H4’-10’), 3.09 (t, J = 4.8 Hz, 8H, H4’-10’), 
2.51 (br s, 8H, H4’-10’), 1.49 (br s, 8H, H4’-10’), -0.39 
(br s, 4H, H3’), -1.48 (br s, 4H, H2’), -2.11 (t, J = 
5.8 Hz, 4H, H1’). 
13C-NMR (75 MHz, CDCl3): δ(ppm) = 149.35 (C1), 
136.08 (C2), 131.06 (C4), 123.84 (C3), 72.10 (C4’-
10’), 71.96 (C4’-10’), 70.69 (C4’-10’), 70.47 (C4’-10’), 
70.04 (C4’-10’), 68.70 (C4’-10’), 59.20 (C4’-10’), 59.09 
(C4’-10’), 52.81 (C1’), 49.88 (C3’), 29.86 (C2’). 
MS (MALDI-TOF, DCTB): m/z = 1318.6 [M+2Na]+ (50), 1295.6 [M+Na]+ (60), 929.4 [M-
Laxial+Na]+ (100), 906 [M-Laxial]+ (95). 
HR-MS (MALDI-TOF, DCTB): [M+Na]+ Calcd. for C66H88N10O14SiNa: 1295.6143, Found: 
1295.6108. 
UV-VIS (DMF): λmax (nm) (log ε): 673 (5.35), 644 (sh), 605 (4.56), 355 (4.82). 
FT-IR (neat) ν (cm-1): 2933, 2882, 2357, 2342, 1334, 1123, 1081 (C-O), 568. 
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Silicon (IV) phthalocyanine 4:  
SiPcCl2 (0.100 g, 0.164 mmol), alcohol 8 (0.160 g, 
0.817 mmol) and pyridine (0.3 mL) in dry toluene (15 
mL) were heated under reflux and argon atmosphere 
for 18 h. The solvent was removed under reduced 
pressure and the crude purified by column 
chromatography using silica gel, previously 
neutralized with triethylamine, and DCM/methanol 
(100:1) as the eluent. After recrystallization from 
methanol, compound 4 (0.036 g, 28%) was obtained 
as a dark blue solid. 
1H-NMR (300 MHz, CDCl3): δ(ppm) 9.67 (dd, J = 5.7, 
3.1 Hz, 8H, H3), 8.37 (dd, J = 5.7, 3.1 Hz, 8H, H4), 3.46 
(t, J = 6.9 Hz, 4H, H4’), 1.81 (s, 6H, H6’), 1.61 (t, J = 6.6 
Hz, 4H, H3’), -0.40 (t, J = 6.5 Hz, 4H, H2’), -1.77 (t, J = 
6.4 Hz, 4H, H1’). 
13C-NMR (75 MHz, CDCl3): δ(ppm) 170.55 (C5’), 149.52 (C1), 136.16 (C2), 131.11 (C4), 123.88 
(C3), 61.91 (C4’), 54.06 (C1’), 38.87 (C2’), 36.39 (C3’), 20.80 (C6’). 
MS (MALDI-TOF, DCTB): m/z = 930.2 [M]+ (46), 735.2 [M-Laxial]+ (100). 
HR-MS (MALDI-TOF, DCTB): [M]+ Calcd. for C44H38N8O6S4Si: 930.1561; Found: 930.1554. 
UV-VIS (DMF): λmax (nm) (log ε): 675 (5.34), 644 (sh), 607 (4.54), 356 (4.77). 
FT-IR (neat)  (cm-1): 1738 (C=O), 1612, 1520, 1380, 1348, 1334, 1292, 1271, 1258, 1123, 
1081, 911, 572. 
Mp: 212°C. 
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5.2.3 Synthesis of subphthalocyanines 
 
Boron subphthalocyanine chloride 16:86 
BCl3 in p-xylene 1 M (7.8 mL, 0.0078 mmol) was added to 1,2-
dicyanobenzene (1.0 g, 0.0078 mmol) under argon atmosphere 
and the resulting reaction mixture was immediately brought to 
reflux and stirred vigorously at this temperature for 40 min. The 
reaction mixture was then allowed to cool down to rt, after which 
heptane was added to precipitate the resulting SubPc. The solid obtained was washed 
extensively with heptane and methanol, until the filtrate remained completely colorless, 
yielding SubPcCl 16 (0.235 g, 21%) as a dark brown solid. Characterization as reported in 
literature.  
 
1H-NMR (300 MHz, CDCl3): δ(ppm) 8.72-8.63 (dd, J = 5.7, 3.1 Hz, 6H, H3), 7.88-7.78 (dd, J = 
5.8, 3.2 Hz, 6H, H4). 
UV-VIS (CHCl3): λmax (nm) (log ε): 565 (4.4), 529 (h), 308 (4.1), 273 (4.1). 
Mp: >250°C. 
 
Subphthalocyanine 12:  
SubPcCl 16 (0.080 g, 0.190 
mmol) and silver triflate (0.060 g, 
0.230 mmol) were dissolved 
anhydrous toluene (3 mL) and 
the mixture was stirred at rt 
under argon atmosphere for 40 
min until 16 was consumed. 
Once the SubPcBOTf is generated, the nucleophile 5 (0.158 g, 0.380 mmol) and DIPEA (40 
μL, 0.230 mmol) were added. The mixture was stirred at 40°C for 4h until the reaction was 
completed. The solvent was removed by evaporation under reduced pressure and the 
product was directly purified by column chromatography on silica gel using toluene/THF 
(10:1) as the eluent. After further SEC with Bio-Beads in toluene, 12 (0.081 g, 52%) was 
obtained as a dark pink solid. 
1H-NMR (300 MHz, CDCl3): δ(ppm) 8.75 – 8.57 (dd, J = 5.9, 3.2 Hz, 6H, H3), 8.16 – 7.74 (m, 
9H, Hpy), 7.70 – 7.61 (dd, J = 5.8, 3.2 Hz, 6H, H4), 3.94 (t, J = 6.5 Hz, 2H, H4’), 3.21 (t, J = 7.6 
Hz, 2H, H8’), 2.35 (t, J = 6.5 Hz, 2H, H3’), 2.26 (t, J = 7.1 Hz, 2H, H6’), 2.09 – 1.96 (m, 2H, H7’), 
1.70 – 1.59 (m, 4H, H1’-2’). 
13C-NMR (75 MHz, CDCl3): δ(ppm) 172.71 (C5’), 151.07 (C1), 135.31 (Cpy), 130.83 (Cpy), 
130.60 (C2), 129.57 (C4), 129.41 (Cpy), 129.34 (Cpy), 128.66 (Cpy), 128.36 (Cpy), 127.84 (Cpy), 
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127.09 (Cpy), 127.02 (Cpy), 126.99 (Cpy), 126.29 (Cpy), 125.38 (Cpy), 124.56 (Cpy), 124.45 (Cpy), 
124.35 (Cpy), 122.96 (Cpy), 121.73 (C3), 61.78 (C4’), 57.32 (C1’), 39.37 (C2’), 36.67 (C3’), 33.36 
(C6’), 32.37 (C8’), 26.36 (C7’). 
MS (MALDI-TOF, DCTB): m/z = 1104.3 (2), 1068.4 (2), 966.2 (2), 894.2 (2), 818.3 [M]+ (100), 
471.2 [M-C3’-16’’]+ (5), 412.2 [M-Laxial+OH]+ (2), 395.2 [M-Laxial]+ (2) 
HR-MS (MALDI-TOF, DCTB): [M]+ Calcd. for C48H37BN6O3S2: 818.2308; Found: 818.2316. 
UV-VIS (DMF): λmax (nm) (log ε): 562 (4.78), 544 (sh), 505 (sh), 344 (4.57), 327 (4.52), 311 
(4.55). 
FT-IR (neat)  (cm-1): 1726 (C=O), 1455, 1381, 1285, 1171, 1128, 843, 731. 
Mp: >250°C. 
 
Subphthalocyanine 13:  
SubPcCl 16 (0.080 g, 0.190 mmol) and silver 
triflate (0.060 g, 0.230 mmol) were 
dissolved in anhydrous toluene (3 mL) and 
the mixture was stirred at rt under argon 
atmosphere for 40 min until 16 was 
consumed. Once the SubPcBOTf is 
generated, the nucleophile 7 (0.137 g, 
0.380 mmol) and DIPEA (40 μL, 0.230 
mmol) were added. The mixture was stirred at 40°C for 5h until the reaction was 
completed. The solvent was removed by evaporation under reduced pressure and the 
product was directly purified by column chromatography on silica gel using toluene/THF 
(10:1 to 1:1) as the eluent. After further SEC with Bio-Beads in toluene, 13 (0.062 g, 43%) 
was obtained as a dark pink sticky paste. 
1H-NMR (300 MHz, CDCl3): δ(ppm) 8.89 – 8.79 (dd, J = 5.7, 3.1 Hz, 6H, H3), 7.93 – 7.84 (dd, 
J = 5.8, 3.2 Hz, 6H, H4), 3.72 – 3.35 (m, 20H, H5’-9’), 3.31 (br s, 6H, H10’), 2.56 (br s, 4H, H4’), 
2.04 (s, 2H, H3’), 1.49 (t, J = 6.0 Hz, 2H, H1’), 0.77 (br s, 2H, H2’). 
13C-NMR (75 MHz, CDCl3): δ(ppm) 151.60 (C1), 131.04 (C2), 129.94 (C4), 122.25 (C3), 71.87 
(C5’-9’), 70.33 (C5’-9’), 70.30 (C5’-9’), 70.14 (C5’-9’), 59.05 (C10’), 57.11 (C1’), 53.43 (C4’), 51.55 
(C3’), 26.88 (C2’). 
MS (MALDI-TOF, DCTB): m/z = m/z = 784.4 [M+Na]+ (24). 
HR-MS (MALDI-TOF, DCTB): [M]+ Calcd. for C41H48BN7O7: 761.3708; Found: 761.3712. 
UV-VIS (DMF): λmax (nm) (log ε): 562 (4.97), 544 (sh), 506 (sh), 303 (4.70). 
FT-IR (neat)  (cm-1): 2871, 1725, 1465, 1376, 1284, 1249, 1090, 1028, 846, 744. 
Mp: >250°C. 
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Subphthalocyanine 14:  
SubPcCl 16 (0.080 g, 0.190 mmol) and silver triflate 
(0.060 g, 0.230 mmol) were dissolved in anhydrous 
toluene (3 mL) and the mixture was stirred at rt 
under argon atmosphere for 40 min until 16 was 
consumed. Once the SubPcBOTf is generated, the 
nucleophile 8 (0.073 g, 0.380 mmol) and DIPEA (40 
μL, 0.230 mmol) were added. The mixture was stirred at 40°C for 3h until the reaction was 
completed. The solvent was removed by evaporation under reduced pressure and the 
product was directly purified by column chromatography on silica gel using toluene/THF 
(30:1 to 10:1) as the eluent. After further SEC with Bio-Beads in toluene, 14 (0.072 g, 64%) 
was obtained as a dark pink solid. 
1H-NMR (300 MHz, CDCl3): δ(ppm) 8.92 – 8.77 (dd, J = 5.8, 3.1 Hz, 6H, H3), 7.94 – 7.81 (dd, 
J = 5.9, 3.1 Hz, 6H, H4), 4.02 (t, J = 6.6 Hz, 2H, H4’), 2.47 (t, J = 6.6 Hz, 2H, H3’), 1.99 (s, 3H, 
H6’), 1.81 – 1.70 (m, 4H, H1’-2’). 
13C-NMR (75 MHz, CDCl3): δ(ppm) 170.80 (C5’), 151.63 (C1), 131.12 (C2), 129.89 (C4), 122.26 
(C3), 62.34 (C4’), 57.79 (C1’), 39.83 (C2’), 37.08 (C3’), 20.97 (C6’). 
MS (MALDI-TOF, DCTB): m/z = 590.2 [M]+ (100), 471.2 [M-(CH2)2OCOCH3]+ (10), 395.2 [M-
Laxial]+ (5). 
HR-MS (MALDI-TOF, DCTB): [M+Na]+ Calcd. for C30H23BN6O3S2: 590.1366 ; Found: 
590.1385. 
UV-VIS (DMF): λmax (nm) (log ε): 562 (4.86), 545 (sh), 507 (sh), 303 (4.59). 
FT-IR (neat)  (cm-1): 1734 (C=O), 1638, 1455, 1430, 1379, 1323, 1287, 1226, 1193, 1129, 
1027, 738. 
Mp: >250°C. 
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Subphthalocyanine 15:  
SubPcCl 16 (0.080 g, 0.190 mmol) and 
silver triflate (0.060 g, 0.230 mmol) were 
dissolved in anhydrous DCM (3 mL) and 
the mixture was stirred at rt under argon 
atmosphere for 40 min until 16 was 
consumed. Once the SubPcBOTf was 
generated, the nucleophile 11 (0.128 g, 
0.380 mmol) and DIPEA (40 μL, 0.230 mmol) were added. The mixture was stirred at 40°C 
for 4h until the reaction was completed. The solvent was removed by evaporation under 
reduced pressure and the product was directly purified by column chromatography on 
silica gel using toluene/THF (10:1) as the eluent. After trituration in heptane 15 (0.079 g, 
56%) was obtained as a dark pink solid. 
1H-NMR (300 MHz, CDCl3): δ(ppm) 8.87 – 8.75 (dd, J = 5.8, 3.2 Hz, 6H, H3), 8.28 – 7.92 (m, 
9H, Hpy), 7.89 – 7.79 (dd, J = 5.9, 3.2 Hz, 6H, H4), 5.19 (s, 1H, H4’), 3.31 – 3.16 (m, 2H, H6’), 
2.68 – 2.54 (m, 2H, H3’), 2.05 – 1.89 (m, 4H, H7’-8’), 1.60 (t, J = 5.6 Hz, 2H, H1’), 0.82 – 0.68 
(m, 2H, H2’). 
13C-NMR (75 MHz, CDCl3): δ(ppm) 172.08 (C4’), 151.55 (C1), 136.14 (Cpy), 131.54 (Cpy), 
131.07 (C2), 131.02 (C4), 130.01 (Cpy), 129.93 (Cpy), 128.87 (Cpy), 127.65 (Cpy), 127.46 (Cpy), 
127.42 (Cpy), 126.73 (Cpy), 125.87 (Cpy), 124.92 (Cpy), 124.83 (Cpy), 123.65 (Cpy), 122.24 (C3), 
58.48 (C1’), 37.84 (C3’), 36.27 (C7’), 32.95 (C5’), 29.38 (C2’), 27.44 (C6’). 
MS (MALDI-TOF, DCTB): m/z = 762.3 [M+Na]+ (2), 739.4 [M]+ (100), 628.3 (2), 395.2 [M-
Laxial]+ (2).  
HR-MS (MALDI-TOF, DCTB): [M]+ Calcd. for C47H34BN7O2: 739.2869; Found: 739.2874. 
UV-VIS (DMF): λmax (nm) (log ε): 562 (4.78), 543 (sh), 506 (sh), 344 (4.54), 328 (4.49), 303 
(4.56). 
FT-IR (neat)  (cm-1): 2954, 2868, 2359, 1724, 1643 (C=O), 1456, 1431, 1287, 1230, 1177, 
1130, 845, 742. 
Mp: >250°C. 
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5.2.4 Synthesis of SiPc-(SubPc)2 triad 
 
Subphthalocyanine 18:  
SubPcCl 16 (0.080 g, 0.190 mmol) and silver triflate 
(0.060 g, 0.230 mmol) were dissolved in anhydrous 
toluene (3 mL) and the mixture was stirred at rt under 
argon atmosphere for 40 min until 16 was consumed. 
Once the SubPcBOTf is generated, 2-hydroxyethyl 
disulfide (0.058 g, 0.380 mmol) and DIPEA (40 μL, 0.230 
mmol) were added. The mixture was stirred at 40°C for 6h until the reaction was 
completed. The solvent was removed by evaporation under reduced pressure and the 
product was directly purified by column chromatography on silica gel using toluene/THF 
(30:1 to 10:1) as the eluent. After trituration in water, 18 (0.063 g, 56%) was obtained as 
a dark pink solid. 
1H-NMR (300 MHz, CDCl3): δ(ppm) 8.90 – 8.78 (dd, J = 5.8, 3.3 Hz, 6H, H3), 7.96 – 7.81 (dd, 
J = 5.9, 3.2 Hz, 6H, H4), 3.62 (t, J = 5.8 Hz, 2H, H4’), 2.43 (t, J = 5.8 Hz, 2H, H3’), 1.76 (dt, J = 
9.8, 4.9 Hz, 4H, H1’-2’). 
13C-NMR (75 MHz, CDCl3): δ(ppm) 151.61 (C1), 131.11 (C2), 129.96 (C4), 122.29 (C3), 60.22 
(C4’), 58.04 (C1’), 41.50 (C2’), 39.92 (C3’). 
MS (MALDI-TOF, DCTB): m/z = 564.2 (5), 548.2 [M]+ (100), 498.2 (5), 471.2 [M-(CH2)2OH]+ 
(15), 412.2 [M-Laxial+OH]+ (10), 242.3 (20). 
HR-MS (MALDI-TOF, DCTB): [M]+ Calcd. for C28H21BN6O2S2: 548.1260 ; Found: 548.1261. 
UV-VIS (DMF): λmax (nm) (log ε): 562 (4.95), 544 (sh), 507 (sh) 302 (4.68). 
FT-IR (neat)  (cm-1): 2872, 1725, 1669, 1576, 1455, 1377, 1284, 1250, 1029, 847, 744. 
Mp: >250°C. 
 
  
132   Experimental Section 
SiPc-(SubPc)2 triad 17:  
SiPcCl2 (0.027 g, 0.044 mmol), 18 
(0.121 g, 0.222 mmol) and DIPEA 
(0.081 mL) in anhydrous toluene 
(4.1 mL) were heated under reflux 
and argon atmosphere for 18 h. 
The solvent was removed under 
reduced pressure and the crude 
purified by SEC with Bio-Beads in 
Chloroform, to yield 17 (0.008 g, 
estimated yield 11%)158 as a dark 
purple solid.  
 
1H-NMR (300 MHz, CDCl3): δ(ppm) 
9.52 (dd, J = 5.8, 3.0 Hz, 8H, H3), 
8.75 (dd, J = 5.9, 3.1 Hz, 12H, H3’’), 
8.23 (dd, J = 5.7, 3.0 Hz, 8H, H4), 
7.81 (dd, J = 5.9, 3.1 Hz, 12H, H4’’), 0.98 – 0.69 (m, 4H, H4’), 0.42 (t, J = 6.6 Hz, 4H, H3’), -0.97 
(t, J = 6.6 Hz, 4H, H2’), -2.16 (t, J = 6.7 Hz, 4H, H1’). 
13C-NMR (75 MHz, CDCl3): δ(ppm) 151.37 (C1’’), 149.27 (C1), 136.01 (C2), 130.97 (C4, C2’’), 
129.75 (C4’’), 123.75 (C3), 122.13 (C3’’), 57.24 (C4’), 53.57 (C1’), 29.86 (C2’), 22.85 (C3’). 
UV-VIS (DMF): λmax (nm) (log ε): 675 (5.36), 646 (sh), 608 (4.54), 562 (5.23), 544 (sh) , 508 
(sh), 354 (4.95). 
 
                                                             
158  An estimated yield of the product is reported due to the difficulty of purification (after SEC with Bio-
Beads as the stationary phase and chloroform as the mobile phase, only a fraction of the 17 elutes as 
pure compound, the remaining part eluting together with the starting products SiPcCl2 and 18, and/or 
decomposition products). For the same reason (low stability), it was not possible to detect the 
molecular ion by mass spectrometry, yet 1H-NMR characterization is conclusive about the purity and 
identity of the product. 
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1 
Cationic silicon phthalocyanines 
as photosensitizers for 
photodynamic inactivation  
 
1.1 State of the art  
Several photosensitizing agents have proven to induce an efficient inactivation of different 
classes of microbial pathogens. Antimicrobial PS should generally display the same 
characteristics as PS used in PDT, including high extinction coefficients in the NIR region 
of the electromagnetic spectrum, a long-lived triplet state and high φΔ. On the basis of 
biochemical and morphological features of microbial cells, and striving for a broad 
spectrum of action on bacteria, fungi, yeasts and parasitic protozoa, the most effective PS 
in PDI have found to be the cationic ones. To this end, parallel to our series of neutral SiPcs 
synthesized in Chapter 1 – Subchapter 1, which serve as PS for PDT of different cancer 
types, we took up the idea to synthesize a series of cationic SiPcs that could serve as broad 
spectrum PS for PDI of different microorganisms. 
1.1.1 The necessity of positively charged photosensitizers 
As mentioned in the Introduction of this Thesis, the PDI of microorganisms is based 
on causing photoinduced damage to their cytoplasmic membrane, which rapidly results in 
cell death. Therefore, in the search for a general PS that can effectively inactivate a wide 
range of microorganisms, one must take into account that Gram negative bacteria are the 
hardest ones to inactivate. The reason for this is that their cytoplasmic membrane is 
protected by the presence of an impermeable outer cell membrane, which hinders the PS 
to reach the site of action (Figure 75a). On contrary, the cytoplasmic membrane of Gram-
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positive bacteria is surrounded by a relatively porous cell wall composed of peptidoglycan 
that allows for an easy crossing of PS molecules (Figure 75b). 
 
Figure 75. Structure of the cell wall of Gram-negative (left) vs. Gram-positive (right) 
bacteria. 
To be able to permeabilize this outer membrane in Gram-negative bacteria, PS for PDI 
were initially applied in combination with permeabilizing agents such as EDTA, PMNP and 
CaCl2.159 Later, in the 1990s, it was discovered that cationic PS were effective in the 
eradication of both Gram-positive and Gram-negative bacteria, without the necessity of 
additives.160 This can be explained by the fact that the cytoplasmic membrane of both 
Gram-positive and Gram-negative bacteria bears negatively charged carboxylate 
functions,161 and the positive charge on the PS molecule appears to promote a tight 
electrostatic interaction with these negatively charged sites at the outer surface of the 
bacterial cells. As a consequence of these electrostatic interactions, the outer membrane 
of Gram-negative bacteria is disturbed, opening a way for the PS to reach the site of action. 
On the other hand, neutrally or negatively charged PS will never be able to cross this 
barrier and, although they might be able to inactivate Gram positive bacteria, yeast and 
viruses, they will not function for the PDI of Gram negative bacteria.162 Importantly, the 
use of cationic PS has a second highly beneficial property, since it has been demonstrated 
both in vitro and in vivo that cationic charges target for microbial cells selectively over host 
mammalian cells that will also be present in an infected lesion.163  
 
                                                             
159  F. F. Sperandio, Y.-Y. Huang, M. R. Hamblin, Recent Patents Anti-Infect. Drug Disc. 2013, 8, 108–120. 
160  Z. Malik, H. Ladan, Y. Nitzan, J. Photochem. Photobiol. B 1992, 14, 262-266. 
161  L. Bourré, F. Giuntini, I. M. Eggleston, C. A. Mosse, A. J. Macrobert, M. Wilson, Photochem. Photobiol. 
Sci. 2010, 9, 1613–1620. 
162  S. George, M. R. Hamblin, A. Kishen, Photochem. Photobiol. Sci. 2009, 8, 788-795. 
163  a) T. N. Demidova, M. R. Hamblin, Int. J. Immunopathol. Pharmacol. 2004, 17, 245-254; b) L. Huang, 
Y. Y. Huang, P. Mroz, G. P. Tegos, T. Zhiyentayev, S. K. Sharma, Z. Lu, T. Balasubramanian, M. Krayer, 
C. Ruzie, E. Yang, H. L. Kee, C. Kirmaier, J. R. Diers, D. F. Bocian, D. Holten, J. S. Lindsey, M. R. Hamblin, 
Antimicrob. Agents Chemother. 2010, 54, 3834-3841; c) V. Mantareva, V. Kussovski, I. Angelov, D. 
Wöhrle, R. Dimitrov, E.  Popova, S. Dimitrov, Photochem. Photobiol. Sci. 2011, 10, 91-102. 
Outer membrane
Lipoproteins
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Periplasmic
Space
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1.1.2 Approaches towards cationic phthalocyanines 
Cationic Pc derivatives can be obtained by quaternization of aliphatic or aromatic 
nitrogen atoms in their substituents. The quaternization reaction usually takes place as 
the last step in the synthetic route, due to the experimental inconvenience of working 
with pH-independent charged species.  It is worth noting that all methylating agents are 
recognized as carcinogenic, as they are likely to methylate DNA. For this reason, extreme 
precautions must be taken when they are handled. Some of the most commonly used 
quaternizing agents are iodo- or bromomethane, dimethyl sulfate, dimethyl carbonate, 
and tetramethylammonium chloride. Less common but more powerful (and more 
dangerous) methylating reagents include methyl triflate, diazomethane, and methyl 
fluorosulfonate (magic methyl). Iodoalkanes of various chain lengths and iodo-
oligo(ethylene glycol) have also been employed as quaternizing agents, aiming to 
modulate the amphiphilicity of the resulting cationic compounds. Below, some of the most 
common cationic functional groups employed for the design of cationic Pcs will be 
discussed, and are summarized in Figure 76. 
 
Figure 76. Cationic moieties frequently incorporated in the periphery or axial positions 
of cationic Pcs. a) trimethylammonium moiety, b) guanidinium moiety, c) anilinium 
moiety, d) pyridinium moiety, e) piperidinilium moiety, and f) pyrrolidinium moiety. 
 
 (i) Ammonium moieties 
Different Pcs have been functionalized with trimethylammonium groups (Figure 76a), 
either bearing the ammonium moiety directly bound to the Pc core, connected by a linker 
in the periphery or at the axial positions. Trimethylammonium-functionalized Pcs, bearing 
the ammonium moiety directly bound to the Pc core, have been described very recently, 
after dealing with solubility issues of the precursors. This kind of Pcs show strong π-π 
stacking interactions, despite the “a priori” intense cation-cation repulsion,164 and have 
been employed as DNA-labelling molecules and PDI agents.165 Functionalized Pc tertiary 
amines and their hydrochloride salts have been commonly achieved by grafting 2-
                                                             
164  a) W. Duan, Z. Wang and M.J. Cook, J. Porphyrins Phthalocyanines, 2009, 13, 1255-1261; b) H. Yang, 
L. Chen, M. Guo, Y. Deng, P. Huang and D. Li, Anal. Sci., 2015, 31, 543-549. 
165  D.M.G.C. Rocha, N. Venkatramaiah, M.C. Gomes, A. Almeida, M.A.F. Faustino, F.A.A. Paz, A. Cunha 
and J.P.C. Tomé, Photochem. Photobiol. Sci., 2015, 14, 1872-1879. 
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(dimethylamino)ethanethiol,166 2-(diethylamino)ethanethiol,167 1,3-bis(dimethylamino)-
2-propanol,168 2-(dimethylamino)ethanol,169 or 3-aminothiophenol,170 either by ether or 
thioether linkages, resulting in α and/or β mono- and disubstituted phthalonitriles, which 
are subsequently subjected to cyclotetramerization and quaternization reactions.171 
Furthermore, trimethylammonium moieties have also been successfully incorporated at 
the axial positions of SiPcs.112b,172 More complex spacers such as 2,4,6-tris(N,N,N-
trimethylaminomethyl)-phenol have been employed, enabling the inclusion of a higher 
number of ammonium moieties and reducing, at the same time, the natural trend of these 
compounds to aggregate.173 Guanidinium-substituted Pcs (Figure 76b), on the other hand, 
have been synthesized since they demonstrate high specificity in G-quadruplex binding.174 
Methoxy(oligoethylenoxy) spacers have been used in some case, resulting in an increased 
amphiphilicity175 or the possibility to prepare cationic Pc dimers.176  
(ii) Anilinium moieties 
Anilinium moieties bear a quaternized nitrogen atom directly bound to an aromatic ring, 
conjugating its lone pair with the cycle (Figure 76c). Despite this particularity, this 
functional group is suitable to be quaternized in similar conditions as for ammonium 
derivatives. Following such strategy, a Suzuki-Miyaura reaction between 4-
(dimethylamino)phenylboronic acid and 4-iodo- or 4,5-dibromophthalonitrile, and 
subsequent cyclotetramerization and quaternization reactions, led to rigid tetra- and 
                                                             
166  a) S. Dabak, G. Gümus, A. Gül and Ö. Bekaroglu, J. Coord. Chem., 1996, 38, 287-293; b) S. Gürsoy, A. 
Cihan, M.B. Koçak and Ö. Bekaroglu, Monatsh. Chem., 2001, 132, 813-819; c) Y. Arslanoglu and E. 
Hamuryudan, Dyes Pigments, 2007, 75, 150-155; d) B. Manisova, S. Binder, L. Malina, J. Jiravova, K. 
Langova and H. Kolarova, Anticancer Res., 2015, 35, 3943-3951. 
167  a) M. Idowu and T. Nyokong, Polyhedron, 2009, 28, 416-424; b) M. Machacek, A. Cidlina, V. Novakova, 
J. Svec, E. Rudolf, M. Miletin, R. Kucera, T. Simunek and P. Zimcik, J. Med. Chem., 2015, 58, 1736-
1749. 
168  a) M.P. De Filippis, D. Dei, L. Fantetti and G. Roncucci, Tetrahedron Lett., 2000, 41, 9143-9147; b) M. 
Soncin, C. Fabris, A. Busetti, D. Dei, D. Nistri, G. Roncucci and G. Jori, Photochem. Photobiol. Sci., 2002, 
1, 815-819. 
169  a) K. Kasuga, K. Ohmori, H. Tanaka, M. Handa, T. Sugimori, Inorg. Chem. Commun., 2006, 9, 1019-
1022; b) Y. Arslanoglu, E. Hayran and E. Hamuryudan, Dyes Pigments, 2013, 97, 340-346. 
170  F. Giuntini, D. Nistri, G. Chiti, L. Fantetti, G. Jori and G. Roncucci, Tetrahedron Lett., 2003, 44, 515-
517. 
171  L. Zhang, J. Huang, L. Ren, M. Bai, L. Wu, B. Zhai and X. Zhou, Bioorg. Med. Chem., 2008, 16, 303-312. 
172  a] S. Rywkin, E. Ben-Hur, Z. Malik, A. M. Prince, Y. S. Li, M. E. Kenney, N. L. Oleinick, B. Horowitz, 
Photochem. Photobiol. 1994, 60, 165–170; b) E. Ben-Hur, N. E. Geacintov, B. Studamire, M. E. Kenney, 
B. Horowitz, Photochem. Photobiol. 1995, 61, 190–195; c] P.-C. Lo, J.-D. Huang, D. Y. Y. Cheng, E. Y. 
M. Chan, W.-P. Fong, W.-H. Ko, D. K. P. Ng, Chem. Eur. J. 2004, 10, 4831–4838. 
173  a) S.B. Sesalan, A. Koca and A. Gül, Dyes Pigments, 2008, 76, 259-264; b) X.-S. Li, J. Guo, J.-J. Zhuang, 
B.-Y. Zheng, M.-R. Ke and J.-D. Huang, Bioorg. Med. Chem. Lett., 2015, 25, 2386-2389. 
174  a) J. Alzeer, B.R. Vummidi, P.J.C. Roth and N.W. Luedtke, Angew. Chem. Int. Ed., 2009, 48, 9362-9365. 
b) A. Membrino, M. Paramasivam, S. Cogoi, J. Alzeer, N.W. Luedtke and L.E. Xodo, Chem. Commun., 
2010, 46, 625-627. c) J. Alzeer and N.W. Luedtke, Biochemistry., 2010, 49, 4339-4348. 
175  Z. Biyiklioglu, M. Durmus and H. Kantekin, J. Photochem. Photobiol. A, 2011, 222, 87-96. 
176  E. Yabas, E. Bagda and E. Bagda, Dyes Pigments, 2015, 120, 220-227. 
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octacationic Pc derivatives, respectively.177 A range of spacers have been employed 
between the aniline unit and the Pc core, such as ether moieties,178 
methoxy(oligoethylenoxy),179 and more complex conjugated bridges.180 Furthermore, 
anilinium moieties have been incorporated at the axial positions of SiPcs181 or other axial 
substituent bearing Pcs.182 Nonetheless, the anilinium moiety is not a broadly employed 
functionality, since it requires more challenging synthetic routes and shows no remarkable 
advantages in comparison to the synthetically more accessible ammonium derivatives. 
(iii) Pyridinium moieties 
By far the most common cationic moieties encountered in the periphery of Pcs are 
the pyridinium type moieties (Figure 76d), due to their synthetic versatility and 
accessibility. This heterocycle provides a lone nitrogen pair not conjugated within the 
aromatic ring, presenting aromaticity even after quaternization. In particular, the linkage 
of pyridines to phthalonitriles is usually achieved through a ether or thioether bond, by 
nucleophilic substitution of 3- or 4-nitrophthalonitrile (for monosubstituted derivatives), 
or 4,5-dichlorophthalonitrile (for disubstituted ones), with 4- hydroxypyridine,151,183 3-
hydroxypyridine,163c,184 2-hydroxypyridine,185 4-mercapto-pyridine183d,186 or 2-
mercaptopyridine.187 Alternatively, alkynylpyridines can be reacted with halogen bearing 
                                                             
177  T. Sugimori, J. Nojima, T. Ozawa, M. Handa and K. Kasuga, Chem. Lett., 2004, 33, 1014-1015. 
178  B.G. Ongarora, B. Hu, H. Li, F.R. Fronczek and M.G.H. Vicente, Med. Chem. Comm., 2012, 3, 19-194. 
179  a) D. Çakir, V. Çakir, Z. Biyiklioglu, M. Drumus and H. Kantekin, J. Organomet. Chem., 2013, 745-746, 
423-431; b) Z. Biyiklioglu, J. Organomet. Chem., 2014, 752, 59-66. 
180  G.K. Karaoglan, G. Gümrükçü, A. Koca and A. Gül, Dyes Pigments, 2011, 88, 247-256. 
181  a] Z. Bıyıklıoğlu, Dyes Pigments 2013, 99, 59–66; b) Polyhedron 2013, 63, 1–8. 
182  Z. Bıyıklıoğlu, V. Çakır, F. Demir, A. Koca, Synth. Met. 2014, 196, 166–172. 
183  a) S. Banfi, E. Caruso, L. Buccafurni, R. Ravizza, M. Gariboldi and E. Monti, J. Organomet. Chem., 2007, 
692, 1269-1276; b) M.B. Spesia, D.A. Caminos, P. Pons and E.N. Durantini, Photodiagn. Photodyn. 
Ther., 2009, 6, 52-61; c) T.T. Tasso, Y. Yamasaki, T. Furuyama and N. Kobayashi, Dalton Trans., 2014, 
43, 5886-5892; d)  O.J. Achadu, I. Uddin and T. Nyokong, J. Photochem. Photobiol. A, 2016, 317, 12-
25. 
184  a) S. Gaspard and T.T. Thi, J. Chem. Soc., Perkin Trans. II, 1989, 383-389;  b) G. Schneider, D. Wöhrle, 
W. Spiller, J. Stark and G. Schulz-Ekloff, Photochem. Photobiol., 1994, 60, 333-342; c) V. Mantareva, 
D. Petrova, L. Avramov, I. Angelov, E. Borisova, M. Peeva and D. Wöhrle, J. Porphyrins 
Phthalocyanines, 2005, 9, 47-53; d)  M. Durmus and T. Nyokong, Inorg. Chem. Commun. 2007, 10, 
332-338; e) M. Durmus and T. Nyokong, Photochem. Photobiol. Sci., 2007, 6, 659-668; f) H. Li, T.J. 
Jensen, F.R. Fronczek and M.G.H. Vicente, J. Med. Chem., 2008, 51, 502-511.  
185  a) W. Chidawanyika, A. Ogunsipe and T. Nyokong, New. J. Chem., 2007, 31, 377-384; b) N. Masilela 
and T. Nyokong, J. Lumin., 2010, 130, 1787-1793; c) R. Zugle and T. Nyokong, J. Mol. Catal. A, 2012, 
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phthalonitriles or Pcs using the Sonogashira coupling reaction,188 and subsequently be 
quaternized to obtain the cationic Pc derivatives.189 
 (iv) Piperidinilium moieties 
Although a few Pcs with piperidinyl groups in the periphery have been reported,190 none 
of these have been methylated/alkylated to obtain cationic Pcs. The only example until 
now of the use of a piperidinilium moiety (Figure 76e) to introduce a positive charge in a 
Pc is one of a SiPc with two such moieties at its axial positions.191 To this end, SiPcCl2 was 
reacted with 4-hydroxypiperidine using standard axial substitution conditions, and the 
resulting axially substituted SiPc was consequently subjected to methylation.  
(v) Pyrrolidinium moieties 
Examples of Pcs with pyrrolidine or pyrrolidinium moieties (Figure 76f) are even less 
common, and to the best of our knowledge only reported by Uslan et al.,192 who 
incorporated these moieties at the axial positions of SiPcs. Preparation however is 
straightforward, incorporating (1-methylpyrrolidin-2-yl)methanol in SiPcCl2 followed by 
subsequent methylation using standard procedures. 
 
1.1.3 Cationic silicon phthalocyanines for photodynamic 
inactivation 
Although various cationic SiPcs have been synthesized,172,181,182,184f,185b,191,192 their 
PDI efficacy has been investigated only for few of them. Early on, in 1994, Horowitz and 
co-workers studied the use of a cationic SiPc bearing a trimethylammonium moiety as PS 
for the PDI of viruses in blood samples.172a,b The virus sterilization of red blood cells is an 
important issue in improving the safety of blood transfusion. To avoid the loss of 
irradiation due to hemoglobin absorption, the absorption maximum of the PS should be 
greater than 600 nm, which makes SiPcs ideal PS candidates for this purpose. The cationic 
SiPc depicted in Figure 77 resulted in complete inactivation of viruses after 20 min of 
irradiation with red light (30 J/cm2) when applying a PS dose of 6.5 µM in the blood. 
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Importantly, this SiPc is particularly attractive because there is no inhibition of virus 
inactivation in the presence of plasma. 
 
Figure 77. A monocationic SiPc that is an effective PS in the PDI of viruses in blood 
samples.172a,b 
Wöhrle and co-workers synthesized a cationic SiPc bearing four pyridinium moieties, one 
on each isoindole unit (Figure 78a).192a They investigated its uptake and PDI efficacy on 
Candida albicans, a fungus commonly present in infections in the oral cavity, in the 
planktonic phase and in biofilm cultures. Fungal cells in suspension were completely 
inactivated with a PS dose of 1.8 µM and a soft light radiation of 50 J/cm2. Fungal biofilm, 
which is harder to inactivate due to limited penetration depth, could be efficiently 
inactivated using fractionated light irradiation. 
 
Figure 78. a) A tetracationic SiPc as PS for the PDI of C. albicans cultures.192a b) A 
dicationic SiPc with PDI activity against C. albicans. Iodide counterions are not 
represented for clarity.191  
More recently, Huang and co-workers have synthesized a cationic SiPc containing 
piperidinilium moieties at the axial positions (Figure 78b).191 They compared its antifungal 
photoactivity towards C. albicans with that of an analogue di-substituted with cyclohexyl 
groups instead of piperidinilium moieties. As a result, they found that the cationic 
derivative showed the highest photodynamic activity, causing a 4 log CFU (colony forming 
unit) reduction of this fungus at concentrations of 100 µM of PS in combination with a 
light dose of 27 J/cm. This could be attributed to its high φΔ, low aggregation in aqueous 
media, and relatively efficient cellular uptake in comparison to the neutral PS analogue. 
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1.2 Molecular design, synthesis and characterization of a series 
of cationic silicon(IV) phthalocyanine photosensitizers 
The optimization of the synthesis and characterization of the SiPcs described in this chapter 
has been performed in collaboration with Marta Moreno Simoni, a master student under 
my guidance from October 2015 until June 2016. 
As mentioned above, the specific objective of this subchapter is the synthesis of a series 
of cationic SiPcs for use in PDI (Figure 79). Since SiPcs require axial substituents, we aim 
to utilize those employed in Chapter 1 – Subchapter 1, which gave good results in a series 
of neutral SiPcs designed for PDT against cancer cells. To this end, in the present 
Subchapter, the required cationic moieties will be introduced at the peripheral positions 
of the macrocycle, following a strategy which is similar to that applied by Vicente and co-
workers, who synthesized a series of cationic SiPcs for use in PDT.184f In particular, eight 
pyridyloxy groups will be introduced at the β-positions of the SiPc isoindoles. Upon axial 
substitution with the previously synthesized primary alcohol building blocks (5, 7, 8 and 
11), and subsequent methylation of the pyridyloxy groups, the cationic SiPcs 19a-d, 
bearing eight pyridinium oxy moieties, would be obtained. 
 
Figure 79. Molecular structure of target SiPcs 19a-d, a series of cationic SiPcs bearing 
the same axial substituents as those used in Chapter 1 of this thesis. Iodide counterions 
are not represented for clarity. 
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1.2.1 Synthesis of octa(3-pyridyloxy)silicon(IV) phthalocyanine 
dichloride 
The preparation of 4,5-bis(3-pyridyloxy)phthalonitrile (24) and the corresponding 
SiPc (26) is a multistep synthesis that has been previously reported in the literature 
(Scheme 17).184f,193 Noteworthy, it is completely chromatography-free. This is important, 
as column chromatography is often a drawback in pyridinyl Pc compounds, since they tend 
to aggregate and stick to the silica gel, making purification cumbersome and resulting in a 
decrease of yield.  
 
Scheme 17. Synthesis of 4,5-bis(3-pyridyloxy)phthalonitrile (24) and its corresponding 
SiPc (26). 
The synthesis started from the commercially available and inexpensive 4,5-
dichlorophthalic acid, which was refluxed in acetic anhydride. This resulted in the 
formation of 4,5-dichlorophthalic anhydride (20), which was in turn reacted with 
formamide to yield 4,5-dichlorophthalimide (21). Next, a suspension of 21 was stirred for 
48h in aqueous ammonia, resulting in the precipitation of 4,5-dichlorophthalamide (22), 
which can be transformed into 4,5-dichlorophthalonitrile (23) by reaction with freshly 
distilled thionyl chloride.193 23 was then reacted with 3-hydroxypyridine in dry DMF, in the 
presence of anhydrous potassium carbonate, yielding 4,5-bis(3-pyridyloxy) phthalonitrile 
(24) via a nucleophilic aromatic substitution reaction.184f Purification was performed by 
recrystallization in EtOH. 
4,5-bis(3-pyridyloxy)-1,3-diiminoisoindoline (25), the precursor for the formation of our 
target SiPc (26), was formed upon reaction of 24 with ammonia gas in the presence of 
                                                             
193  D. Wöhrle, M. Eskes, K. Shigehara, A. Yamada, Synthesis 1993, 194–196. 
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sodium methoxide, in freshly distilled methanol.184f Finally, standard reaction conditions 
for formation of SiPc dichloride compounds were followed for the formation of 26, by 
refluxing the corresponding 1,3-diiminiosoindoline (25) in freshly distilled quinoline in the 
presence of SiCl4, in which the tetravalent silicon atom acts as a template for the formation 
of the SiPc dichloride. The formation of SiPcCl2 derivatives generally proceeds fast and 
with high yields. Furthermore, due to their low solubility, they can be easily precepitated 
by lowering the temperature of the reaction mixture to rt, avoiding cumbersome column 
chromatography.  
1.2.2 Axial substitution 
In order to obtain the axially substituted SiPcs 27a-d (Scheme 18), various reaction 
conditions were tried (Table 9, Entry 1-5).  
 
Scheme 18. Intended axial substitution of the SiPc 26 with the previously synthesized 
primary alcohol building blocks 5, 7, 8 and 11. 
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Table 9. Various reaction conditions tested for the incorporation of axial substituents 
in the SiPc 26. 
Entry Solventa Basea (v/v%) Temp. Building block  Yield 
1 Toluene Pyridine (2) 111°C 5 0% 
2 Toluene DIPEA (2) 111°C 5 0% 
3 Toluene Pyridine (50) 111°C 5 0% 
4 Toluene Pyridine (2) 111°C 8 0% 
5 Toluene Pyridine (50) 111°C 8 0% 
6 2-methoxy 
ethylether 
- 162°C 4-tert-butyl 
benzoic acid 
0% 
a Anhydrous 
 
Since no axial substitution could be observed when employing the standard reaction 
conditions (Table 9, Entries 1 and 4), the use of a stronger base such as DIPEA was 
considered (Table 9, Entry 2), however without any positive result. At this point, the 
solubility of 26 in the reaction medium was questioned. Since no significant solubility 
could be observed in a series of high-boiling point organic solvents, the proportion of 
pyridine in the reaction mixture was increased (Table 9, Entries 3 and 5). Nevertheless, a 
green precipitate could still be observed in the reaction mixture.  
In all of the aforementioned trials, the remaining green precipitate upon overnight 
reaction was filtered off and confirmed to be the starting product (26) by 1H-NMR 
spectroscopy. The filtrate, which showed a slight green color in some case, was purified 
by column chromatography using DCM/methanol (20:1) as the eluent, to verify if any axial 
substitution had taken place. Surprisingly, the same product was obtained in all cases, 
namely a SiPc derivative with methoxy groups at the axial positions, as characterized by 
1H-NMR (Figure 80).  
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Figure 80. 1H-NMR of the side product obtained by column chromatography of the axial 
substitution reactions detailed in Table 9.  
Upon literature research, it has been found that bulky axial alkoxide substituents can be 
exchanged by other nucleophiles.172b,194 The relative lability of the alkoxide substituent 
decreases with the decreasing bulkiness, with methoxide resulting as the most stable axial 
substituent. In our case, such exchange must have taken place during the column 
chromatography purification, in which methanol was present in the eluent. This indicates 
that during the reaction some axial substitution with the desired ligand had taken place, 
however the resulting Si-alkoxide bond must have been very labile and prone to exchange 
with methanol.  
As a final test another well-known type of axial substitution of SiPcs was tested, by 
reacting the SiPcCl2 (26) with a benzoic acid in an appropriate solvent, like 2-methoxyethyl 
ether, following a procedure described in the literature (Table 9, Entry 6).125 This would 
result in a more stable axial substituent, unable to undergo the aforementioned exchange 
with methanol. However, also in this case no axial substitution could be achieved, 
probably due to the insolubility and low reactivity of compound 26. 
 
 
1.2.3 Hydrolysis of 26 and subsequent axial substitution 
Since the SiPc 26 unfortunately seemed to be unreactive towards nucleophilic 
displacement of its chlorine atoms, another strategy for axial functionalization had to be 
considered. In their publication, in the approach of SiPc systems for PDT of cancer, Vicente 
and co-workers hydrolyse this SiPc dichloride to obtain the SiPc dihydroxy variant, which 
can be reacted with various trialkylchlorosilanes in refluxing pyridine. Therefore, we then 
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undertook this route, and in an attempt to study the influence of the axial substituent on 
the aggregation behaviour and/or PDI efficacy of the resulting octacationic SiPcs, various 
commercial trialkylchlorosilanes of different bulkiness and different chemical nature (e.g., 
aromatic versus aliphatic) were introduced (Scheme 19). To this end, 26 was dissolved in 
a mixture of water and ethanol (5:1) in the presence of sodium methoxide. The reaction 
mixture was refluxed for 5h and 28 could be easily isolated, with 80% yield, by 
precipitation upon addition of water. Importantly, 28 was vacuum dried for 48h in a 
vacuum oven, before using it in the next step. For the axial substitution reaction, 28 was 
refluxed in recently distilled pyridine, and the corresponding trialkylchlorosilane was 
added in two portions with 8h of difference, and in a high excess. Upon overnight reaction, 
the reaction mixture was evaporated to dryness. The remaining solid was washed 
extensively with chloroform, and the filtrate evaporated to dryness and triturated in 
heptane, yielding in this way the pure SiPcs 29a-d, with yields between 20 and 40 %. 
 
Scheme 19. Hydrolysis of SiPc 26 to obtain the dihydroxy SiPc 28 and consequent axial 
substitution of its hydroxyl groups by different trialkylchlorosilanes, resulting in the 
axially substituted SiPcs 29a-d. 
 
1.2.4 Quaternization reactions 
The last step in the synthetic route to obtain the octacationic SiPcs 31a-d was the 
methylation of the eight pyridyloxy groups of SiPcs 29a-d (Scheme 20). Methylation was 
carried out using methyl iodide as methylating agent and DMF as the solvent, in order to 
avoid precipitation of partially methylated products. This would result in a complex 
mixture of products with various degrees of methylation, very hard to purify, and should 
therefore be avoided at all cost.  
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Scheme 20. Quaternization of the SiPcs 29a-d, resulting in the octamethylated SiPcs 30 
and 31a-d. Iodide counterions are not represented for clarity. 
Noteworthy, the procedure published by Vicente and co-workers consisted in methylation 
of the SiPcs in methyl iodide, without any solvent, which in our case resulted in a 
premature precipitation of products. Furthermore, they left the reaction for 1 day at 40°C, 
conditions which in our hands resulted in the removal of the axial ligands and their 
consequent substitution by hydroxyl groups, yielding the SiPc 30. This process can be 
easily followed by 1H-NMR spectroscopy and, based on this, the ideal methylation 
conditions were determined for each SiPc, yielding SiPcs 31a-d in very good yields (Table 
10).  
Table 10. Methylation conditions for obtaining the SiPcs 31a-d. 
Compound Reaction time Temperature Yield 
31a 2h 40°C 91% 
31b 2h rt 95% 
31c 2h rt 94% 
31d 2h 40°C 91% 
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1.3 Spectral features and photophysical properties 
The normalized absorption spectra of the SiPcs 28 and 29a-d were measured in DMF 
(Figure 81a). They all represent the typical spectra of non-aggregated Pcs, with an intense 
and sharp Q-band around 675 nm and a broad Soret band with a maximum around 360 
nm. Furthermore, two typical vibronic bands can be seen around 610 and 643 nm. The 
normalized absorption spectra of the octacationic SiPcs 30 and 31a-d, on the other hand, 
were recorded in Milli-Q water (Figure 81b). They all present nearly identical absorption 
features to that of their non-quaternized precursors. Upon excitation at 345 nm, all the 
SiPcs showed a fluorescence emission around 680 nm (F680), varying in intensity (Table 11). 
     
Figure 81. Electronic absorption spectra of a) the SiPcs 28 and 29a-d in DMF, and b) the 
quaternized SiPcs 30 and 31a-d in Milli-Q water. 
Since for efficient 1O2 generation it is absolutely indispensable that the PS is non-
aggregated in the cellular medium, the solubility of the cationic SiPcs 30 and 31a-d in a 
physiologically relevant medium, such as PBS, was assessed by UV-Vis spectroscopy 
(Figure 82). This analysis was conducted in a range of concentrations between 2 and 10 
µM, achieved by the sequential addition of aliquots of stock solutions of each SiPc. For the 
verification of the Lambert-Beer law, an analysis of linear regression between the intensity 
of the Q-band and the concentration of the SiPcs was conducted. As can be seen from the 
insets in Figure 82, the Lambert-Beer was fulfilled for all of the cationic SiPcs, with R2 
values of 0.98 or greater. Hence, SiPcs 30 and 31a-d seem to be non-aggregated in PBS at 
the concentration range studied, and are therefore potential good PS candidates, to be 
tested in cellular medium. 
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Figure 82. UV-Vis dilution studies of the octacationic SiPcs a) 30, b) 31a, c) 31b, d) 31c, 
e) 31d in physiologically relevant medium (PBS). 
For all SiPcs, φF were determined in DMF and/or water, and the results are represented in 
Table 11 and Table 12. As a general observation, the φF values for the cationic SiPcs 30 
and 31a-d are slightly higher (about 5%) than those of their neutral precursors, 28 and 
29a-d. Furthermore, for the cationic SiPcs, φF presented almost the same values when 
measured in DMF or in water. 
The φΔ of the neutral precursor SiPcs 28 and 29a-d has been determined in DMF using the 
relative method, as explained in Chapter 1 and in the Experimental Section, and are also 
represented in Table 11. During the experiments, decrease in the SiPc Q-band intensity or 
appearance of new absorption bands were not observed in any case, ensuring the PS 
integrity. As can be observed, all neutral SiPcs display similar, and reasonably high, φΔ 
values, ranging from 30 to 50%. 
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Table 11. Electronic absorption and photophysical data for the SiPcs 28 
and 29a-d in DMF. 
Compound λmax (nm) λem (nm)a φF (%)a,b φΔ (%)c 
28 673 681 20.8 32.2 
29a 680 685 24.5 43.6 
29b 676 682 26.7 47.0 
29c 675 680 33.9 50.7 
29d 681 687 23.3 50.0 
a Excited at 610 nm. b Using ZnPc in DMF as the reference (φF = 0.28). c Using ZnPc 
in DMF as the reference (φΔ = 0.56). 
 
Table 12. Electronic absorption and photophysical data for the octacationic SiPcs 
30 and 31a-d in water, unless stated otherwise. 
Compound λmax (nm) λem (nm)a φF(DMF) (%)a,b φF(H2O) (%)a,b 
30  675 681 38.1 40.2 
31a 679 682 30.2 29.9 
31b 675 681 30.9 30.4 
31c 673 679 37.1 38.5 
31d 679 685 29.1 28.2 
a Excited at 610 nm. b Using ZnPc in DMF as the reference (φF = 0.28).  
 
To confirm the positive photosensitizing features of this series of SiPcs, the 1O2 generation 
ability of the cationic SiPcs 30 and 31a-d in cellular medium needed to be assessed. To this 
end, their relative 1O2 generation efficiency in PBS buffer was determined and compared 
with that of the SiPcs 28 and 29a-d, by the qualitative method in which DPBF is degraded 
by 1O2, as explained in Section 1.3 of Chapter 1. The results are depicted in Figure 83a and 
Figure 83b for the neutral precursor SiPcs 28 and 29a-d, and the quaternized derivatives 
30 and 31a-d, respectively. The measurement conditions were the same for both series of 
SiPcs, for which they can be directly compared, even though they are represented in 
different graphs for clarity. 
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Figure 83. Decay of the absorbance of DPBF at 414 nm, sensitized by a) SiPcs 28 and 
29a-d and b) octacationic SiPcs 30 and 31a-d, in function of irradiation time (min). 
As a general observation, the 1O2 generation efficiency of the octacationic SiPcs 30 and 
31a-d is slightly lower than that of their neutral precursors, the SiPcs 28 and 29a-d. This 
may be due to the fact that they possess lower LUMO levels, due to the increased electron 
acceptor character of their peripheral substituents. Importantly, the 1O2 generation 
efficiency of the neutral SiPcs 30 and 31a-d (Figure 83a) is in perfect concordance with 
their φΔ previously measured in DMF (Table 11), being very similar for SiPcs 29a-d and 
significantly lower for SiPc 28. This might be explained by the fact that the SiPc 28, lacking 
axial substituents, might display some kind of aggregation which hinders 1O2 generation, 
or by the different electronical characteristics it displays (also indicated by its absorption 
features in Figure 81). Once quaternized, it shows a similar 1O2 generation efficiency as the 
other cationic SiPcs. Notably, it is now completely lacking aggregation due to electrostatic 
repulsion.  
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1.4 In vitro photodynamic inactivation of microorganisms 
PDI experiments with the cationic SiPcs 30 and 31a-d have been performed in the research 
group of Prof. Ângela Cunha at the Department of Biology of the University of Aveiro 
(Portugal), in collaboration with José Antonio Gonzalez Delgado and Bruna David. 
The microorganisms used in this study were the Gram-positive bacteria Staphylococcus 
aureus and methicillin-resistant Staphylococcus aureus (MRSA), and the Gram-negative 
bacterium Escherichia coli. They are often used model organisms, since they are easy to 
grow in laboratory conditions and present an optimal incubation temperature of 37°C and 
heat resistance. Furthermore, Methicillin-resistant S. aureus is a term used to refer to 
bacteria of any strain of S. aureus that have developed resistance to a variety of 
antibiotics.195 Such resistance makes MRSA infections more difficult to treat with standard 
types of antibiotics than normal S. Aureus infections, and they are thus more dangerous.  
For the PDI treatment, fresh bacterial cultures with a concentration of 107 CFU mL−1 were 
irradiated with red light, coinciding with the maximum absorption of the SiPcs, for 
different time intervals, in the presence of the corresponding SiPc. Experiments are 
performed in triplicate and the concentration of viable cells was calculated as the average 
number of colonies. Generally, a PS is considered as an effective antimicrobial in PDI if the 
inactivation results in at least 4 logs of CFU reduction, corresponding to a cell survival of 
lower than 0.01%. Dark toxicity must be lower than 1 log of CFU reduction, corresponding 
to a cell survival of higher than 10%.  
Since no significant difference in 1O2 generation efficiency can be observed for the 
octacationic SiPcs, all of them (except for 31a, which has been published previously) were 
tested in vitro for their PDI efficiency against Staphylococcus aureus, initially, after which 
the best performing SiPcs were selected for further inactivation experiments. First, the 
SiPcs 30 and 31b-d were tested against S. aureus at a concentration of 20 µM, applying 
different light doses to investigate their efficiency (Figure 84). As a first observation, from 
the light-only studies (without addition of any SiPc) it can be concluded that S. aureus is 
resistant to the light doses used in the experiment, at all irradiation times (Figure 84 – dark 
green data). Additionally, PS-only experiments (without applying light) were performed to 
exclude cytotoxicity of the SiPcs. As a result, the SiPcs 30 and 31b are devoid of any dark 
toxicity, whereas the cytotoxicity of 31c and 31d reaches almost 1 log of CFU reduction 
(Figure 84 – blue data). Although this level of cytotoxicity is still acceptable, the PDI 
efficiency of these two SiPcs upon applying different light doses is very low, only reaching 
2 logs of CFU reduction (Figure 84c,d – red data). As a result of this combined dark 
cytotoxicity and low PDI efficiency, the SiPcs 31c and 31d are considered ineffective PDI 
                                                             
195  J. M. Boyce, B. Cookson, K. Christiansen, S. Hori, J. Vuopio-Varkila, S. Kocagöz, A. Y. Öztop, C. M. 
Vandenbroucke-Grauls, S. Harbarth, D. Pittet, Lancet Infect. Dis. 2005, 5, 653–663. 
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agents and are discarded for any further in vitro experiments. On the other hand, both 30 
and 31b are effective antimicrobials, with photokilling efficiencies higher than 99,99% and 
lacking any cytotoxicity. 31b reaches 4 logs of CFU reduction, and 30 outperforms all the 
tested SiPcs reaching almost 7 logs of CFU reduction, corresponding to the total 
eradication of all bacteria present in the sample. 
 
Figure 84. Photoinactivation of S. aureus with the SiPcs a) 30, b) 31b, c) 31c and d) 31d, 
upon red light irradiation (620–750 nm; 150 mW/cm2). 
Since MRSA is known to be slightly harder to inactivate than S. aureus, and the SiPc 30 was 
the only PS that amply exceeded the 4 log of CFU reduction to be an effective antimicrobial 
against S. aureus, only this PS was tested for its PDI efficiency against MRSA (Figure 85). 
As expected, in this case 30 shows a slightly lower antimicrobial effect. However, it still 
reaches 99,99% killing ratios, which is a very good result. 
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Figure 85. Photoinactivation of S. aureus with SiPc 30, upon red light irradiation (620–
750 nm; 150 mW/cm2). 
At the time of writing, the PDI studies of E. coli with the SiPc 30 were still ongoing.  
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2 
Cationic subphthalocyanines as 
photosensitzers for 
photodynamic inactivation  
 
2.1 State of the art 
Just like it was the case for SubPcs as PS in PDT, the use of cationic SubPcs as PS for PDI 
remains extremely rare. In the last two years, only one paper has been published in which 
a SubPc was successfully used as a PDI agent.196 Nevertheless, SubPcs are interesting 
candidates for use as PS, especially in situations where absorption in the red part of the 
spectrum is not required. This is the case for example for the inactivation of pathogenic 
microorganisms grown in vivo as localized foci of infection, on skin or on accessible 
mucous membranes, which can be easily treated by PDI. Therefore, more research on the 
design of cationic SubPcs as potential PDI agents is warranted.  
2.1.1 Approaches towards cationic subphthalocyanines 
Unlike Pcs, SubPcs result less versatile with regard to peripheral substitution 
possibilities, due to the harsh reaction conditions used in their synthesis. When looking at 
recently published literature concerning SubPcs, most synthetic efforts are directed 
towards the development of new axial substitution methodologies,141,197 and much less 
                                                             
196  I. Roy, D. Shetty, R. Hota, K. Baek, J. Kim, C. Kim, S. Kappert, K. Kim, Angew. Chem. Int. Ed. 2015, 54, 
15152–15155. 
197  a] J. Guilleme, L. Martínez-Fernández, I. Corral, M. Yáñez, D. González-Rodríguez, T. Torres, Org. Lett. 
2015, 17, 4722–4725; b) H. Gotfredsen, M. Jevric, A. Kadziola, M. B. Nielsen, Eur. J. Org. Chem. 2016, 
2016, 17–21; c] H. Gotfredsen, M. Jevric, S. L. Broman, A. U. Petersen, M. B. Nielsen, J. Org. Chem. 
2016, 81, 1–5. 
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research is focussed on peripheral substitution. Moreover, the peripheral substitution of 
SubPcs is generally only conducted with an eye on their possible application in dye 
sensitized solar cells,198 and not directed towards the investigation of new PS. 
Up to now, almost all published cationic SubPcs have exploited the use of alkylated 
pyridinium substituents, located either at the peripheral or axial positions of the SubPc 
macrocycle. As mentioned previously in Subchapter 1 of this Chapter, the linkage of 
pyridines to phthalonitriles can be achieved in various ways, such as by nucleophilic 
substitution with hydroxy- or mercaptopyridines, or by Sonogashira coupling reactions 
with alkynylpyridines. Therefore, these have also been until now the methods of choice 
for their incorporation quaternizable groups into SubPcs. 
The first cationic SubPc was published in 2008 by Durantini and co-workers,199 who 
synthesised the 4-(4-pyridyloxy)phthalonitrile by nucleophilic substitution of 4-
nitrophthalonitrile with 4-hydroxypyridine, and subjected it to boron trichloride induced 
cyclotrimerization. The resulting SubPc was then methylated, to obtain the corresponding 
tricationic SubPc3+ (Figure 86a). Another tricationic SubPc was obtained in our research 
group, by subjecting a tri-iodo-SubPc to a triple Heck cross-coupling reaction with 4-
vinylpyridine in the presence of catalytic amounts of PdCl2 and tris(o-tolyl)phosphine 
(Figure 86b).200 
 
Figure 86. a) The first published tricationic SubPc, as synthesized by Durantini and co-
workers.199 b) Another tricationic SubPc published by I. Sánchez-Molina et al.200 
A more extensive study of the different possibilities for the incorporation of pyridinium 
substituents at both the periphery and axial position of SubPcs has been conducted in our 
research group, by Łapok et al.201 On the one hand, they parted from 4-(3-
pyridyloxy)phthalonitrile, to obtain a tricationic SubPc similar to the one depicted above. 
                                                             
198  a] M. Urbani, F. A. Sarı, M. Grätzel, M. K. Nazeeruddin, T. Torres, M. Ince, Chem. Asian J. 2016, 11, 
1223–1231; b) C. B. Kc, G. N. Lim, F. D’Souza, Chem. Eur. J. 2016, 22, 13301–13311. 
199  M. B. Spesia, E. N. Durantini, Dyes Pigments 2008, 77, 229–237. 
200  I. Sánchez-Molina, A. Soriano, C. G. Claessens, T. Torres, H. J. Bolink, J. Porphyr. Phthalocyanines 2013, 
17, 1016–1021. 
201  Ł. Łapok, C. G. Claessens, D. Wöhrle, T. Torres, Tetrahedron Lett. 2009, 50, 2041–2044. 
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On the other hand they made use of another strategy, namely that of grafting 
pyridylethynyl groups at the periphery of SubPcs by a Sonogashira catalytic cross-coupling 
reaction between a tri-iodo SubPc and an excess of 3-ethynylpyridine (Figure 87a) or 2- 
ethynylpyridine (Figure 87b) in Et3N in the presence of catalytic amounts of Pd(PPh3)2Cl2 
and CuI. Furthermore they made use of different methylation agents, to assess the 
influence of the counter anion on the water solubility of the resulting quaternized SubPcs 
(not depicted in Figure 87). Lastly, they also incorporated a pyridinium moiety at the axial 
SubPc position (Figure 87c). 
 
Figure 87. A series of tricationic SubPcs synthesized previously in our research group 
and published by Łapok et al.201 Counterions are not represented for clarity. 
 
2.1.2 Cationic subphthalocyanines for photodynamic inactivation 
Out of the above-mentioned cationic SubPcs, only that reported by of Durantini and 
co-workers199 was tested for its possible use as PS in the PDI of microorganisms. In 
particular, its PDI efficacy was tested in vitro against the Gram-negative bacterium E. coli 
and resulted promising. The cationic SubPc was found to bind rapidly to E. coli cells, 
reaching around 2 nmol/106 cells after 5 min of incubation with 4 µM of PS in the dark. As 
a result, PDI treatment lead to a 2.5 log CFU reduction of cell survival, corresponding to 
99.7% of cellular inactivation. Furthermore, the growth of E. coli cells was completely 
arrested when cultures were exposed to 8 µM of the cationic SubPc and irradiated, 
whereas a negligible effect was found in the case of the non-charged SubPc.  
More recently, a big advance was made by Kim and co-workers, who synthesized a 
nanosphere whose shell is composed of covalently linked SubPc units (Figure 88). Upon 
methylation of the sulphur atoms in the aliphatic chains of the SubPc, the now cationic 
nanosphere has the ability to target, label and photoinactivate antibiotic-resistant 
bacteria in a single treatment with more than 99% efficiency, using extremely low light 
and drug doses.196 Furthermore, the nanosphere showed a far superior performance 
compared to that of the corresponding monomers, presumably because of its enhanced 
water dispersibility and therefore higher efficiency of 1O2 generation and phototoxicity.  
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Figure 88. Synthesis of a nanosphere, composed of covalently linked cationic SubPc 
units, with exceptionally high PDI efficiency.196 
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2.2 Molecular design, synthesis and characterization of a series 
of cationic subphthalocyanine photosensitizers 
The specific objective of this subchapter is to synthesize SubPcs with cationic 
moieties at the periphery of the macrocycle, similar to our approach used above for 
cationic SiPcs, and to implement various substituents at the axial positions (Figure 89). As 
mentioned in the introduction above, in our group, such cationic SubPcs with pyridinium 
substituents at the periphery of the macrocycle have already been synthesized.201 In this 
previous work, macrocyclization of 4-(3-pyridyloxy)phthalonitrile, followed by subsequent 
methylation, resulted in a tricationic SubPc. In this subchapter, we want to continue with 
this strategy, and take it to the next level. To this end, we aim to perform the 
macrocyclization of 4,5-bis(3-pyridyloxy) phthalonitrile in the presence of boron 
trichloride, in this way obtaining, upon methylation, the first hexacationic SubPc. Next, we 
want to incorporate the building blocks for axial substitution 5, 7, 8 and 11, synthesized in 
Chapter 1, at the axial position of this hexacationic SubPc, in this way obtaining a series of 
axially substituted hexacationic SubPcs with interesting properties for their use in PDT. 
Importantly, in contrast to the tricationic SubPcs published earlier, the resulting 
hexacationic SubPcs will not exist as a mixture of regioisomers, but will be isomerically 
pure molecules, which is advantageous in regard to their possible future use as PS in PDT.  
 
Figure 89. Molecular structure of target SubPcs 32a-d, a series of hexacationic cationic 
SiPcs bearing the same axial substituents as those used in Chapter 1 of this thesis. 
Iodide counterions are not represented for clarity. 
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2.2.1 Synthesis of hexa(3-pyridyloxy) subphthalocyanine chloride 
In the route to hexacationic SubPcs, phthalonitrile 24, synthesized previously in 
Subchapter 1 of this Chapter, was subjected to a macrocyclization reaction in the presence 
of boron trichloride to form SubPc 33 (Scheme 21). Both the starting phthalonitrile and 
the final SubPc (33) display low solubility in various high-boiling point solvents, 
complicating the synthesis. For this reason, it was found that the ideal reaction conditions 
consist of a 1:1 mixture of o-DCB and p-xylene. The macrocyclization reaction proceeded 
extremely fast and resulted in the immediate precipitation of 33 at the bottom of the flask. 
This allowed for an easy decantation of the remaining solvent, which remained completely 
colorless. The crude precipitate was then dissolved in THF and purified by SEC, using Bio-
Beads as the stationary phase and THF as the eluent. 
 
Scheme 21. Macrocyclization reaction of 24 in the presence of BCl3 in a high-boiling 
point solvent mixture, resulting in the formation of 33. 
 
2.2.2 Axial substitution via the triflate-subphthalocyanine 
intermediate 
Once we obtained sufficient quantity of SubPc 33, the axial substitution of its 
chlorine atom by our previously synthesized building blocks for axial substitution (i.e. the 
primary alcohols 5, 7, 8 and 11; Chapter 1 – Subchapter 1) was explored. To this end, the 
same methodology as in Subchapter 2 of Chapter 1 was first applied, namely the use of a 
triflate-SubPc reactive intermediate that readily reacts with a variety of nucleophiles, 
including the primary alcohol compounds (Scheme 22). Unfortunately, the treatment of 
SubPc 33 with AgOTf resulted in the formation of a series of unwanted products, as 
detected by TLC, and did not lead to formation of the desired triflate-SubPc intermediate. 
This can be explained by the fact that the silver cation present in silver triflate possibly 
forms other complexes with 33 by coordinating the pyridine nitrogens, which can act as 
soft donor groups.202 Ag+ usually has a linear bidentate coordination mode but 
                                                             
202  a] H. Tsukube, S. Shinoda, J. ’ichi Uenishi, T. Hiraoka, T. Imakoga, O. Yonemitsu, J. Org. Chem. 1998, 
63, 3884–3894; b) G. V. Moshorin, G. I. Repkin, V. A. Sharnin, Russ. J. Coord. Chem. 2006, 33, 368–
370. 
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occasionally forms tridentate or highly coordinated complexes,203 which might explain the 
great amount of new spots appearing in the TLC. 
 
Scheme 22. Intended axial substitution of the SubPc 33. 
 
2.2.3 Axial substitution with phenols 
As possible alternative axial substitution method, it is generally acknowledged that 
phenols react more efficiently with axial SubPc halides (SubPcX) than aliphatic alcohols, 
despite their lower nucleophilicity. This suggests the assistance of relatively acidic protons 
in the weakening of the B−X bond, circumventing the need of activation of the B-X bond 
by forming the SubPc-triflate intermediate.83d As a matter of fact, the reaction with 
phenols is by far the most widely used approach for the axial functionalization of SubPcs, 
owing to its simple and relatively high-yielding procedure. Hence, we decided to try this 
reaction, which is typically carried out by heating a mixture of the SubPc and the desired 
phenol in a high-boiling point aromatic solvent (toluene, chlorobenzene, etc.), in the 
presence of a base (Et3N, pyridine, DIPEA, etc.) in order to neutralize the acidic hydrogen 
halide released. In this case, we chose to incorporate 3-pyridinol as axial substituent, 201 
along to a series of commercially available phenols with different degrees of bulkiness 
                                                             
203  a] H. C. Kang, A. W. Hanson, B. Eaton, V. Boekelheide, J. Am. Chem. Soc. 1985, 107, 1979–1985; b) F. 
R. Heirtzler, H. Hopf, P. G. Jones, P. Bubenitschek, V. Lehne, J. Org. Chem. 1993, 58, 2781–2784. 
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(Scheme 23). Various reaction conditions were tested (Table 13), yet none of them led to 
the formation of the desired product and the starting product was recovered in all cases.  
 
Scheme 23. Intended axial substitution of the SubPc 33 with 3-pyridinol and various 
phenols with different degrees of bulkiness. 
 
Table 13. Various reaction conditions tested for the axial substitution of the SubPc 33. 
Compound Solvent Base Temperature Reaction time 
36a 
THF/toluene 
1:1 
DIPEA  
(1,3 equiv.) 
120°C 1h 
36b Nitrobenzene 
DIPEA  
(1,3 equiv.) 
120°C 2h 
36c 
THF/toluene 
1:1 
DIPEA  
(1,3 equiv.) 
120°C 2h 
36c DMF 
DIPEA  
(1,3 equiv.) 
120°C 2h 
36d Nitrobenzene 
DIPEA  
(1,3 equiv.) 
120°C 2h 
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2.2.4 Quaternization of hexa(3-pyridyloxy) subphthalocyanine 
chloride 
Since the axial substitution of the SubPc 33 resulted impossible, a new strategy was 
considered, consisting in primarily quaternizing its pyridine moieties and consequently 
trying to incorporate the axial ligands. The same standard methylation conditions used for 
the SiPcs in Subchapter 1 of this Chapter (i.e. an excess of CH3I in dry DMF) were applied 
in the present case (Scheme 24). 
 
Scheme 24. Quaternization reaction of the SubPc 33. Iodide counterions are not 
represented for clarity. 
Upon suspected completion of the reaction, the excess of methyl iodide and the 
solvent were removed by evaporation under reduced pressure. However, during this 
process, the pink solution slowly started losing its color, until a yellow/orange solid 
remained. Suspecting 36 is unstable to heating, an alternative work-up was performed, 
consisting of partitioning the crude reaction mixture between DCM and water, followed 
by lyophylization of the water phase. During this process, the compound effectively 
localized preferably in the water phase, confirming that methylation had been effective 
and rendered the water-soluble hexacationic SubPc. However, during subsequent 
washing of the water phase the DCM layer kept turning yellow increasingly, while the pink 
color of the water layer slowly faded. Furthermore, upon lyophylization of the water layer, 
a yellow/orange solid was again obtained, with no sign of the SubPc. 
As a conclusion, the methylated SubPc 36 is highly unstable and although there are 
indications of its formation (e.g. solubility of the SubPc in water), it has not been possible 
to isolate and characterize it. 
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3 
Summary and conclusions 
 
In the present chapter, the synthesis of different cationic SiPc and SubPc derivatives has 
been explored, with their use as broad-spectrum PDI agents for the photoinactivation of 
various microorganisms as the final goal. 
Regarding SiPcs, we have synthesized a series of cationic derivatives, bearing eight 
positively charged pyridinium units at the macrocycle periphery, while the axial positions 
remained available for incorporation of different types of axial substituents (compounds 
5, 7 and 8), enabling the study of the dependence of the PDI activity on the structure of 
the PS’s axial substituents. The resulting SiPcs were carefully characterized, and their 
electronic and photophysical properties, such as φF and φΔ, were studied. Since no 
significant differences were observed, all of the octacationic SiPc derivatives (except for 
31a, which had been published previously) were tested in vitro for their PDI efficiency 
against S. aureus, a Gram-positive bacterium. Importantly, S. aureus resulted resistant to 
the light doses used in the experiment at all irradiation times, whereas dark toxicity 
experiments showed that the SiPc 30 and 31b are devoid of any dark toxicity. The 
cytotoxicity of SiPc 33c and 33d, on the other hand, reached 1 log of CFU reduction, which 
combined with a low PDI efficacy (reaching only 2 logs of CFU reduction) discarded the 
future use of both PS. 31b reached 4 logs of CFU reduction, and 30 outperformed all the 
tested SiPcs reaching almost 7 logs of CFU reduction, corresponding to the total 
eradication of bacteria present in the sample. Consequently, more resistant bacterial 
culture lines, such as Methicillin-resistant S. aureus (MRSA), were subjected to treatment 
by SiPc 30. From this inactivation, 30 showed a slightly lower antimicrobial effect than in 
the case of S. aureus. However, it still reached 99,99% killing ratios, for which it can be 
considered as an excellent photoantimicrobial agent. At the time of writing, PDI studies 
with the Gram-negative bacterium E. coli were still ongoing. 
Regarding SubPcs, our main synthetic objective was to prepare, for the first time, a 
hexacationic SubPc derivative, bearing pyridinium moieties at the macrocycle periphery, 
with a potential high efficacy against resistant bacteria. Furthermore, these hexacationic 
170   Experimental Section 
derivatives would lack the existence of regioisomers, inherently present in the case of all 
the previously published tricationic systems. In this direction, we first synthesized an 
unprecedented SubPc with six peripheral quaternizable pyridyloxy groups (34). 
Unfortunately, all attempts for axial substitution of this SubPc, either by treatment with 
silver triflate to generate a triflate-SubPc intermediate or by the nucleophilic displacement 
reaction with phenols, were unsuccessful, due to the formation of side products, the 
absence of reproducibility or the low solubility or reactivity of the starting compound. 
Quaternization of 33 lead to the hexacationic SubPc 36, which however resulted too 
unstable to isolate, for which its possible use as PS in PDI was discarded. 
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4 
Experimental section 
 
4.1 Materials and methods 
The materials and methods used in this experimental section are the same as the ones used 
in that of Chapter 1, except for: 
Electrospray Ionization (ESI) mass spectra were recorded with an Applied 
Biosystems QSTAR (ABSciex) using as injection system HPLC1100 (Agilent Technologies), 
at the Servicio Interdepartmental de Investigación (SIdl) of the Universidad Autónoma de 
Madrid. All the data are expressed with the intensity in percentage between parentheses.  
IR spectra (IR) were recorded on a FTIR Cary 630 (Agilent Technologies) using the 
ATR technique. Spectral intensity were corrected by the ATR algorithm and subsequent 
baseline correction. 
 
4.1.1 Fluorescence and singlet oxygen quantification 
The φF and φΔ are determined using the same procedures as those used in Chapter 1. 
 
4.1.2 Photodynamic inactivation of bacteria 
Preparation of SiPc stock solutions 
SiPcs stock solutions used in all the biological experiments were prepared in DMSO at a 
final concentration of 100 µM.  
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Solubility 
The solubility of the cationic SiPcs was assessed by UV-Visible spectroscopy. Analysis was 
conducted in a range of concentrations between 1.0 and 10 μM achieved by the sequential 
addition of aliquots of stock solutions of each SiPc. For the verification of the Beer–
Lambert law, an analysis of linear regression between the intensity of the Q-band and the 
concentration of the Pc was conducted. 
 
 
Photodynamic inactivation  
The microorganisms used in this study were the Gram-positive bacteria Staphylococcus 
aureus and Methicillin-resistant Staphylococcus aureus (MRSA) and the Gram-negative 
bacteria Escherichia coli. The bacteria were isolated from Coimbra University Hospitals 
patients. E. coli was isolated from a sample of urine; S. aureus and MRSA were isolated 
from non-surgical wound exudates. Stock cultures in Tryptic Soy Agar (TSA, Merck) were 
kept at 4°C. Fresh cultures of S. aureus, MRSA and E. coli were prepared before each assay 
by inoculating an isolated colony in 30 mL of Tryptic Soy Broth (TSB, Merck). The cultures 
were incubated for 24 h at 37°C under gentle stirring (120 rpm). From these cultures, 
aliquots of 100 µL were transferred to 10 mL of fresh TSB. The new cultures were 
incubated in the same conditions and used as work cultures for the inactivation assays. 
The work cultures of the yeast were prepared by transferring an aliquot of 100 µL to fresh 
Yeast Extract Glucose Chloramphenicol Agar (YGCA, Merck) and incubating in the same 
conditions. Fresh cultures were 10-fold diluted in PBS (pH = 7.4), to a final concentration 
of 107 CFU mL−1. The bacterial suspension was allowed to stabilize at ambient temperature 
under gentle stirring for 10 min. The suspension was distributed in 12-well plates and 
appropriate quantities of 100 µM stock solutions of the Pc derivatives were added to 
obtain the desired PS concentration, in a total volume of 4 mL per well. The suspensions 
were protected from light with aluminium foil and incubated for 30 min at 37°C, to allow 
for the adsorption of the PS to cellular material. For the irradiation of the samples with 
red light (620–750 nm) an illumination system (LC-122-LumaCare, London) containing a 
halogen/ quartz 250 W lamp was used. The light was delivered at an irradiance of 150 mW 
cm−2, measured with a Power Meter Coherent FieldMaxII-Top combined with a Coherent 
PowerSens PS19Q energy sensor. Samples were irradiated for 60 min, under gentle 
stirring, at ambient temperature. Light and dark controls were included in all experiments. 
Light controls were prepared and treated exactly as the samples but the PS solution was 
replaced by PBS. Dark controls were prepared as the samples corresponding to the highest 
PS concentration (20 µM) but were protected from light during the experiment by 
wrapping the microplates in aluminium foil. Triplicate aliquots of treatments and controls 
were collected at times 0, 30, and 60 min and their serial dilutions were pour-plated in 
TSA. Three independent assays were conducted with each compound. The resulting 
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culture plates were incubated at 37°C for 24 h. Colonies were counted in the most suitable 
dilutions and the concentration of viable cells was calculated as the average number of 
colonies in the most suitable dilution corrected for the dilution factor (CFU mL−1). 
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4.2  Experimental details synthesis 
4.2.1 Synthesis cationic SiPcs 
 
4,5-Dichlorophthalic anhydride (20):193  
 A solution of 4,5-dichlorophthalic acid (15.3 g, 64 mmol) in acetic 
anhydride (25 mL) was heated to reflux while distilling the acetic acid being 
formed in the reaction. After 5 h, the remaining acetic acid was eliminated 
by vacuum distillation. The solid obtained was stirred in heptane over 12 h, 
obtaining a solid that was filtered and thoroughly washed with the same solvent (3 x 20 
mL). The title compound was obtained as a white solid (13.4 g, 98%). Characterization as 
reported in literature.  
1H-NMR (300 MHz, CDCl3): δ(ppm) 8.12 (s, 2H).  
13C-NMR (75 MHz, CDCl3): δ(ppm) 160.6, 141.7, 130.0, 127.3. 
 
4,5-Dichlorophthalimide (21):193  
A mixture of 20 (13.5 g, 63 mmol) and formamide (20 mL) was heated to 
200°C for 3 h. After cooling to rt, the solid obtained was filtered, washed 
with water (1 x 20 mL) and vacuum-dried, yielding 21 (12.4 g, 92%) as a 
white solid. Characterization as reported in literature.  
1H-NMR (300 MHz, DMSO-d6): δ(ppm) 8.10 (s, 2H).  
13C-NMR (75 MHz, DMSO-d6): δ(ppm) 169.7, 137.7, 132.6, 125.3. 
 
4,5-Dichlorophthalamide (22):193 
A suspension of 21 (12.4 g, 58 mmol) in 25% aqueous ammonia (173 mL) 
was stirred at rt for 24 h. At that time, some more 25% ammonium 
hydroxide solution (58 mL) was added and the mixture was further stirred 
for 24 h. The white solid obtained was filtered, washed with water (3 x 
15 mL) and vacuum-dried, yielding 22 (11.9 g, 89%) as a white solid. Characterization as 
reported in literature.  
1H-NMR (300 MHz, DMSO-d6): δ(ppm) 7.95 (s, 2H), 7.72 (s, 2H), 7.45 (s, 2H).  
13C-NMR (75 MHz, DMSO-d6): δ(ppm) 169.6, 136.6, 131.9, 129.2. 
 
Chapter 2 - Design, synthesis and applications of positively charged (Sub)Pc in PDI 175 
4,5-Dichlorophthalonitrile (23):193 
Freshly distilled thionyl chloride (42 mL) was cautiously poured over dry 
DMF (60 mL) at 0°C and under argon atmosphere. The mixture was 
vigorously stirred at that temperature for 2 h and then 22 (11.9 g, 51 mmol) 
was added. After stirring at rt for 12 h, the reaction mixture was poured onto crushed ice 
(100 mL), resulting in the precipitation of a slightly grey solid which was filtered and 
washed with water (1 x 20 mL). Recrystallization from methanol yields 23 (8.8 g, 88%) as 
light yellow needles. Characterization as reported in literature.  
1H-NMR (300 MHz, CDCl3): δ(ppm) 7.94 (s, 2H).  
13C-NMR (75 MHz, CDCl3): δ(ppm) 138.2, 135.7, 115.0, 114.6, 114.0. 
 
4,5-bis(3-pyridyloxy)phthalonitrile (24):184f 
Into a round-bottom flask 23 (2.16 g, 10.9 mmol) and 3-pyridynol (2.52 
g, 26.5 mmol) were dissolved in 15 mL of freshly distilled DMF under 
argon atmosphere. Reaction mixture was warmed up to 40oC and 
anhydrous potassium carbonate (15.0 g, 110 mmol) was added in small 
portions every 5 minutes. The reaction mixture is heated overnight, 
then cooled to rt and poured into 200 mL of ice water. The solid was filtered off and 
purified by dissolving it in chloroform and adding hot ethanol until appearance of cloudy 
solution. After the solution is cooled down, filtration yields 24 (2.91 g, 86%) as a white 
solid. Characterization as reported in literature. 
 
1H-NMR (300 MHz, CDCl3): δ(ppm) 8.54 (dd, J = 3.8, 2.2 Hz, 2H), 8.43 (s, 2H), 7.42-7.39 (m, 
4H), 7.29 (s, 2H). 
13C-NMR (75 MHz, CDCl3): δ(ppm) 151.5, 147.5, 142.2, 127.2, 125.2, 126.8, 115.21, 112.19. 
 
 
4,5-bis(3-pyridyloxy)diiminoisoindoline (25):184f 
24 (3.0 g, 6.4 mmol) and sodium methoxide (0.5 g, 9.3 mmol) were 
dissolved in 100 mL of freshly distilled methanol. Ammonia gas was 
bubbled into the solution for 50 min at rt. The solution was then 
heated to 65°C and refluxed under ammonia gas atmosphere for 5 
h. The solvent was removed under reduced pressure. Water (150 
mL) was added to the concentrated residue to precipitate the product. The product was 
filtered, thoroughly with water and vacuum dried to afford 25 (1.9g, 91%) as light green 
crystals. Characterization as reported in literature. 
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1H-NMR (300 MHz, CDCl3): δ(ppm) 8.32–8.16 (m, 3H), 7.42–7.12 (m, 10H).  
13C-NMR (75 MHz, CDCl3): δ(ppm) 152.97, 148.32, 144.85, 140.13, 124.95, 124.71, 113.63.  
 
Silicon (IV) phthalocyanine 26: 184f  
Vacuum dryed 25 (0.500 g, 1.5 
mmol) was added to 5 mL of freshly 
redistilled quinoline. The reaction 
solution was stirred under argon for 
10 min, and then, silicon 
tetrachloride (0.5mL, 2.2 mmol) was 
added dropwise to the solution. The 
temperature was raised to 220°C 
and maintained for 1 h. The solution 
was cooled to rt, and the solid was 
filtered under vacuum and washed successively with water, methanol, and acetone. The 
title compound 26 (0.5g, 98%) was obtained as a dark green solid. Characterization as 
reported in literature. 
1H-NMR (300 MHz, d-TFA): δ(ppm) 9.66 (s, 8H), 8.98 (d, J=2.7 Hz, 8H), 8.73 (dd, J= 3.5, 1.0 
Hz, 8H), 8.58 (m, 8H), 8.21 (m, 8H).  
13C-NMR (75 MHz, d-TFA): δ(ppm) 158.95, 152.09, 151.43, 139.324, 137.64, 136.40, 
134.08, 131.48, 120.53. 
 
Silicon (IV) phthalocyanine 28:184f 
A mixture of 26 (0.450 g, 0.33 mmol) 
and sodium methoxide (1.5 g, 27 
mmol) in 60 mL of water/ethanol 
(5:1) was heated to reflux for 5h. The 
solvent was removed under reduced 
pressure, and the product was 
isolated by precipitation upon 
addition of 10mL of water. The slurry 
solid was filtered and washed with 
water to yield 28 (0.32 g, 80%) as a 
dark green solid. Characterization as reported in literature. 
1H-NMR (300 MHz, d-TFA): δ(ppm) 9.72 (br s, 8H), 9.03 (br s, 8H), 8.81 (br s, 8H, 8H), 8.64 
(br s, 8H), 8.29 (br s, 8H).  
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13C-NMR (75 MHz, d-TFA): δ(ppm) 159.11, 152.24, 151.58, 139.46, 137.78, 136.55, 134.20, 
131.61, 120.67. 
 
Silicon (IV) phthalocyanine 29a:184f 
SiPc 28 (0.050 g, 0.038 mmol) was 
dissolved in 3 mL of dry pyridine at 
115°C under an argon atmosphere. 
tert-Butyldiphenylchlorosilane 
(0.295 mL, 0.947 mmol) was added 
dropwise to the reaction mixture via 
syringe. After 8h, another portion of 
tert-butyldiphenylchlorosilane 
(0.212 mL, 0.682 mmol) was added. 
The reaction mixture was refluxed 
for another 9h, after which the solvent was evaporated to dryness. The remaining solid 
was washed extensively with chloroform and the filtrate was collected and evaporated to 
dryness and subjected to a trituration in heptane, in which the solid was collected and 
washed with heptane and water to obtain the pure compound 29a (0.015 g, 22%) as a 
green solid. Characterization as reported in literature. 
1H-NMR (300 MHz, DMSO-d6): δ(ppm) 9.09 (s, 8H), 8.78 (d, J=2.7 Hz, 8H), 8.66 (dd, J= 3.5, 
1 Hz, 8H), 7.97 (m, 8H ), 7.77–7.70 (m, 8H), 6.93 (t, J= 7.3 Hz, 4H), 6.46 (t, J= 7.4 Hz, 8H), 
4.79 (d, J= 7.1 Hz, 8H), -1.30 (s, 18H).  
13C-NMR (75 MHz, DMSO-d6): δ(ppm) 154.44, 151.27, 148.62, 146.13, 141.19, 133.79, 
133.30, 133.21, 128.94, 126.94, 126.39, 125.78, 115.95, 24.99, 17.00. 
 
Silicon (IV) phthalocyanine 29b:  
SiPc 28 (0.050 g, 0.038 mmol) was 
dissolved in 3 mL of dry pyridine at 
115°C under an argon atmosphere. 
Triisobutylchlorosilane (0.254 mL, 
0.947 mmol) was added dropwise to 
the reaction mixture via syringe. 
After 8h, another portion of 
triisobutylchlorosilane (0.183 mL, 
0.682 mmol) was added. Purified as 
described above for SiPc 29a, 
yielding 29b (0.025 mg, 38%) as a dark green solid. 
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1H-NMR (300 MHz, CDCl3): δ(ppm) 9.38 (s, 8H, H3), 8.66 (d, J = 2.7 Hz, 8H, H2’), 8.58 (d, J = 
4.6 Hz, 8H, H3’), 7.84 (dd, J = 4.9, 1.8 Hz, 8H, H5’), 7.68-7.63 (m, 8H, H4’), 0.44 (d, 36H, J = 
6.5Hz, H3’’), -0.85 (m, 6H, H2’’), -2.44 (d, 12H, J = 7 Hz, H1’’).  
13C-NMR (75 MHz, CDCl3): δ(ppm) 207.40, 154.28, 150.79, 148.59, 145.80, 141.14, 133.59, 
125.67, 125.05, 116.04, 78.01, 77.79, 77.58, 77.16, 31.43, 25.77, 25.25, 22.91.  
MS (MALDI-TOF, DCTB): m/z = 3374.4 [2M-iBu]+(10), 1715.6 [M]+ (30), 1499.4 [M-Lax]+ 
(100).  
HR-MS (MALDI-TOF, DCTB): [M]+ Calcd. for C96H94N16O10Si3: 1715.6667; Found: 
1715.6561.  
UV-VIS (DMF): λmax (nm) (log ε): 676 (5.29), 646 (4.40), 609 (4.46), 361 (4.85). 
FT-IR (neat)  (cm-1): 2950, 1574, 1458, 1418, 1282, 1214, 1087, 1019. 
Mp: > 250°C 
 
Silicon (IV) phthalocyanine 29c:  
SiPc 28 (0.050 g, 0.038 mmol) was 
dissolved in 10 mL of dry pyridine at 
115°C under an argon atmosphere. n-
Butylchlorosilane (0.252 mL, 0.947 
mmol) was added dropwise to the 
reaction solution via syringe. After 
8h, another portion of n-
butylchlorosilane (0.181 mL, 0.682 
mmol) was added. Purified as 
described above for SiPc 29a, yielding 
29c (0.021 mg, 32%) as a dark green solid. 
1H-NMR (300 MHz, CDCl3): δ(ppm) 9.19 (s, 8H, H3), 8.64 (d, J = 2.7 Hz, 8H, H2’), 8.54 (dd, J 
= 3.5, 1.0 Hz, 8H, H3’), 7.61 (m, 8H, H5’), 7.48-7.44 (m, 8H, H4’), 0.13-0.22 (m, 40H, H3’’-4’’), -
1.19 (m, 12H, H2’’), -2.38 (m, 12H, H1’’).  
13C-NMR (75 MHz, CDCl3): δ(ppm) 153.95, 150.26, 147.98, 144.90, 140.26, 133.14, 125.93, 
124.90, 115.66, 77.58, 77.16, 76.73.  
MS (MALDI-TOF, DCTB): m/z = 3374.4 [2M-iBu]+(1), 1715.6 [M]+ (100), 1500.4 [M– Lax+H]+ 
(40), 375,3 (30).  
HR-MS (MALDI-TOF, DCTB): [M]+ Calcd. for C96H94N16O10Si3: 1715.6667; Found: 
1715.6584. 
 
UV-VIS (DMF): λmax (nm) (log ε): 675 (5.11), 645 (4.28), 608 (4.32), 361 (4.74). 
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FT-IR (neat)  (cm-1): 2953, 2919, 2868, 1575, 1459, 1418, 1284, 1214, 1086, 1036, 899, 
703. 
Mp: > 250°C 
 
Silicon (IV) phthalocyanine 29d:  
SiPc 28 (0.050 g, 0.038 mmol) was 
dissolved in 10 mL of dry pyridine at 
115°C under an argon atmosphere. 
Triphenylchlorosilane (0.279 g, 
0.947 mmol) was added dropwise to 
the reaction solution via syringe. 
After 8h, another portion of 
triphenylchlorosilane (0.201 g, 0.682 
mmol) was added. Purified as 
described above for SiPc 29a, 
yielding 29c (0.024 mg, 34%) as a dark green solid. 
1H-NMR (300 MHz, CDCl3): δ(ppm) 9.04 (s, 8H, H3), 8.68 (s, Hz, 8H, H2’), 8.58 (d, J = 2.6 Hz, 
8H, H3’), 7.65 (dd, J = 5.9 ,2.2 Hz, 8H, H5’), 7.53 (m, 8H, H4’), 6.85 (t, J = 7.4 Hz, 6H, H4’’) , 
6.48 (t, J = 7.4 Hz, 12H, H3’’), 4.87 (d, J = 7.0 Hz, 12H, H2’’) 
13C-NMR (75 MHz, CDCl3): δ(ppm) 154.00, 149.99, 148.05, 144.68, 139.82, 133.78, 132.93, 
132.82, 128.43, 126.51, 126.04, 125.04, 115.74, 77.58, 77.16, 76.74, 31.06.  
MS (MALDI-TOF, DCTB): m/z = 1835.3 [M]+ (100), 1758.3 [M-C5H6]+ (2) 1560.3 [M-Lax]+ 
(10).  
HR-MS (MALDI-TOF, DCTB): [M]+ Calcd. for C108H70N16O10Si3: 1835.4790; Found: 
1835.4770. 
UV-VIS (DMF): λmax (nm) (log ε): 681 (5.10), 649 (4.27), 613 (4.35), 363 (4.26). 
FT-IR (neat)  (cm-1): 3067, 1460, 1428, 1118, 738, 711. 
Mp: > 250°C 
 
  
180   Experimental Section 
Silicon (IV) phthalocyanine 30:  
28 (0.017 g, 0.013 mmol) was 
dissolved in dry DMF (2 mL) under Ar 
atmosphere and CH3I (0,5 mL) was 
added. The mixture was heated at 
50°C for 2h. The solvent was 
evaporated and the crude obtained 
was triturated and washed with 
acetone to yield 30 (0.028 g, 87%) as 
a dark green solid.  
1H-NMR (300 MHz, DMSO-d6): 
δ(ppm) 9.80 (s, 8H, H3), 9.37 (s, 8H, H2’), 8.96 (d, J = 6.0 Hz, 8H, H3’), 8.67 (dd, J = 6.6 ,1.7 
Hz, 8H, H5’), 8.31 (m, 8H, H4’), 4.43 (s, 24H, H1’’).  
13C-NMR (75 MHz, DMSO-d6): δ(ppm) 162.20, 155.51, 148.10, 147.45, 141.52, 136.50, 
133.71, 133.50, 128.99, 117.02, 48.45, 40.26, 35.68, 34.27, 30.60.  
MS (ESI): m/z = 691.10 [M-3I]3+, 486.58 [M-4I]4+, 364.33 [M-5I]5+, 281.32 [M-6I]6+, 224.24 
[M-7I]7+, 179 [M -8I]8+  
HR-MS (ESI): Calc. for C72N16SiO10H42I5C8H24: 691.3380, Found: 691.3315 
 Calc. for C72N16SiO10H42I4C8H24: 486.7774, Found: 486.7776 
 
UV-VIS (H2O): λmax (nm) (log ε): 675 (5.25), 646 (4.40), 608 (4.43), 356 (4.84). 
FT-IR (neat)  (cm-1): 3382 (O-H), 1581, 1497, 1451, 1415, 1262, 1083, 844 (Si-O). 
Mp: 252°C 
 
Silicon (IV) phthalocyanine 31a:184f 
29a (0.025 g, 0.014 mmol) was 
dissolved in dry DMF (2 mL) under Ar 
atmosphere and iodomethane (0,5 
mL) was added. The mixture was 
heated at 50°C for 2h. The solvent 
was evaporated and the crude 
obtained was triturated and washed 
with acetone to yield 31a (0.037 g, 
91%) as a dark green solid. 
Characterization as reported in 
literature.  
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1H-NMR (300 MHz, DMF-d7): δ (ppm) = 9.79 (s, 8H), 9.71 (s, 8H), 9.25 (d, J = 5.3 Hz, 8H), 
8.88 (d, J = 7.8 Hz, 8H), 8.57 (m, 8H), 7.04 (t, J = 7.3 Hz, 4H), 6.68 (t, J = 7.4 Hz, 8H), 4.89 (d, 
J = 7.0 Hz, 8H), 4.76 (s, 24H), -1.24 (s, 18H).  
13C-NMR (75 MHz, DMF-d7): δ (ppm) = 156.47, 149.87, 148.76, 143.06, 138.95, 135.06, 
134.24, 133.70, 133.05, 130.17, 129.32, 127.36, 117.61, 49.61, 25.24, 17.04. 
 
Silicon (IV) phthalocyanine 31b:  
29b 15b (0.025 g, 0.014 mmol) was 
dissolved in dry DMF (2 mL) under Ar 
atmosphere and iodomethane (0,5 
mL) was added. The mixture was 
heated at rt for 2h. The solvent was 
evaporated and the crude obtained 
was triturated and washed with 
acetone to yield 31b (0.038 g, 95%) 
as a dark green solid.   
1H-NMR (300 MHz, DMSO-d6): 
δ(ppm) 9.77 (s, 8H, H3), 9.44 (s, 8H, H2’), 9.02 (d, J = 5.9 Hz, 8H, H3’), 8.59 (d, J = 8.8 Hz, 8H, 
H5’), 8.34 (m, 8H, H4’), 4.49 (s, 24H, H1’’) , -0.43 (d, J = 6.4 Hz, 36H, H3’’’ ), -0.80 (m, 6H, H2’’’), 
-2.47 (d, J = 7.0 Hz, 12H, H1’’’).  
13C-NMR (75 MHz, DMSO-d6): δ(ppm) 162.11, 155.49, 147.40, 147.27, 145.47, 143.10, 
141.48, 141.02, 136.40, 135.98, 133.39, 128.95, 128.82, 126.05, 125.15, 48.39, 48.34, 
35.60, 30.60. 
MS (ESI): m/z = 1298.13 [M-2I]2+, 823.12 [M-3I]3+, 585.62 [M-4I]4+, 443.12 [M-5I]5+, 349.29 
[M-6I]6+, 229.49 [M-8I]8+ 
HR-MS (ESI): Calc. for C104H118N16O10Si3I5: 823.1244, Found: 823.1264 
  Calc. for C104H118N16O10Si3I4: 585.6170, Found: 585.6247 
  Calc. for C104H118N16O10Si3I3: 443.1126, Found: 443.1228 
  Calc. for C104H118N16O10Si3I2: 348.1097, Found: 348.1191 
  Calc. for C104H118N16O10Si3: 229.3560, Found: 229.3623 
 
UV-VIS (H2O): λmax (nm) (log ε): 675 (5.34), 646 (4.45), 608 (4.49), 356 (4.90). 
FT-IR (neat)  (cm-1): 1582, 1497, 1452, 1417, 1262, 1083. 
Mp: 232°C 
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Silicon (IV) phthalocyanine 31c:  
SiPc 29c (0.025 g, 0.014 mmol) was 
dissolved in dry DMF (2 mL) under Ar 
atmosphere and iodomethane (0,5 
mL) was added. The mixture was 
heated at 50°C for 2h. The solvent 
was evaporated and the crude 
obtained was triturated and washed 
with acetone to yield 31c (0.037 g, 
94%) as a dark green solid. 
1H-NMR (300 MHz, CDCl3): δ(ppm) 
9.64 (s, 8H, H3), 9.32 (s, 8H, H2’), 8.88 (d, J = 6.0, 8H, H3’), 8.44 (dd, J = 7.0, 1.3 Hz, 8H, H5’), 
8.20 (m, 8H, H4’), 4.35 (s, 24H, H1’’) , -0.01 (m, 30H, H3’’’-4’’’), -1.38 (m, 12H, H2’’’), -2.56 (m, 
12H, H1’’’).  
13C-NMR (75 MHz, DMSO-d6): δ(ppm) 162.11, 146.11, 142.10, 127.98, 35.62, 34.23, 30.61. 
MS (ESI): m/z = 1298.13 [M-2I]2+, 823.13 [M-3I]3+, 585.62 [M-4I]4+, 443.12 [M-5I]5+, 348.28 
[M-6I]6+, 229.48 [M-8I]8+ 
HR-MS (ESI): Calc. for C104H118N16O10Si3I5: 823.1244, Found: 823.1271 
  Calc. for C104H118N16O10Si3I4: 585.6170, Found: 585.6252 
  Calc. for C104H118N16O10Si3I3: 443.1126, Found: 443.1231 
  Calc. for C104H118N16O10Si3I2: 348.1097, Found: 348.1194 
  Calc. for C104H118N16O10Si3: 229.3560, Found: 229.3629 
 
UV-VIS (H2O): λmax (nm) (log ε): 673 (5.34), 643 (4.47), 606 (4.51), 356 (4.91). 
FT-IR (neat)  (cm-1): 2997, 2920, 1584, 1500, 1454, 1419, 1284, 1174, 1085, 1023. 
Mp: 230°C 
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Silicon (IV) phthalocyanine 31d:  
SiPc 29d (0.025 g, 0.013 mmol) was 
dissolved in dry DMF (2 mL) under Ar 
atmosphere and iodomethane (0,5 
mL) was added. The mixture was 
heated at 50°C for 2h. The solvent 
was evaporated and the crude 
obtained was triturated and washed 
with acetone to yield 31d (0.035 g, 
91%) as a dark green solid. 
1H-NMR (300 MHz, DMSO-d6): 
δ(ppm) 9.65 (s, 8H, H3), 9.48 (s, 8H, H2’), 9.05 (d, J = 6.0 Hz, 8H, H3’), 8,68 (dd, J = 6.9 ,2.0 
Hz, 8H, H5’), 8.40 (m, 8H, H4’), 6.92 (t, J = 7.4 Hz, 6H, H4’’’) , 6.55(t, J =7.4 Hz, 12H, H3’’’), 4.72 
(d, 6.9 Hz, 12H, H2’’’), 4.51 (s, 24H, H1’’).  
13C-NMR (75 MHz, DMSO-d6): δ(ppm) 155.26, 148.91, 147.74, 142.17, 137.75, 133.98, 
132.97, 132.05, 129.39, 128.92, 126.96, 116.64, 77.58, 77.16, 76.74, 48.82.  
MS (ESI): m/z = 1358.53 [M-2I]2+, 863.06 [M-3I]3+, 615.82 [M-4I]4+.  
HR-MS (ESI): [M-2I]2+ Calcd. for C108H70N16O10Si3I6C8H24: 1358.5458; Found: 1358.5832. 
UV-VIS (H2O): λmax (nm) (log ε): 679 (5.20), 648 (4.38), 611 (4.38), 355 (4.70). 
FT-IR (neat)  (cm-1): 2998, 1582, 1498, 1454, 1418, 1283, 1175, 1085, 1036, 955, 886, 
760. 
Mp: 207°C 
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4.2.2 Synthesis cationic SubPcs 
 
Subphthalocyanine 33:  
24 (0.100 g, 0.318 mmol) is dried in a vacuum 
oven and placed in a two neck flask equipped 
with a reflux cooler together with a stirring bar. 
The system is subjected to various vacuum 
cycles, after which o-DCB (1 mL) is added and the 
mixture is heated to 140°C. BCl3 in DCM (0.382 
mL, 0.382 mmol) and another portion of BCl3 in 
p-xylene (0.382 mL, 0.382 mmol) are quickly 
added. Formation of SubPc 33 results in its 
immediate precipitation, and after 10 minutes of 
reaction the remaining solvent is completely colorless and the reaction is stopped. The 
mixture is allowed to cool to rt and the colorless solvent is decanted. The remaining 
solvent is removed by evaporation under reduced pressure and the crude is purified by 
size-exclusion chromatography (SEC) through Bio-Beads in THF, yielding 33 (0.017 mg, 
17%) as a dark pink solid. 
 
1H-NMR: xxx 
MS (ESI): m/z = xxx  
UV-VIS (H2O): λmax (nm) (log ε): xxx 
FT-IR (neat)  (cm-1): 2998 
Mp: xxx 
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1 
Sub(phthalocyanine)-peptide 
biohybrid conjugates for 
improved cellular uptake  
 
1.1 State of the art 
Many biologically active compounds, although very effective on their own, require to be 
conjugated to a site-specific delivery counterpart for intracellular delivery, enabling them 
to exert their therapeutic action inside the cytoplasm, the nucleus, or other specific 
organelles such as mitochondria.204 Similarly, also in the case of PS, conjugation to such a 
biological site-directing molecule can actually be very beneficial and is widely employed.18 
1.1.1  Introduction to photosensitizer-based biohybrids  
As mentioned in the Introduction of this thesis, Pcs and SubPcs belong to the 
second generation of PS. In order to obtain better characteristics, such as less aggregation, 
better solubility in physiological media and selective accumulation within the targeted 
tissue, second-generation PS are often conjugated to site-specific delivery agents and/or 
formulated in or on nanostructured delivery platforms. If such delivery agents or platforms 
are of biological nature, the PS conjugates are classified as biohybrid materials.  
PS-based biohybrids can be divided in different groups, based on the nature of the 
biological unit (Figure 90). Most frequently, the PS is conjugated to a peptidic delivery 
agent, such as cell penetrating peptides, monoclonal antibodies, antibody fragments, 
                                                             
204  B. Gupta, T. S. Levchenko, V. P. Torchilin, Adv. Drug Deliv. Rev. 2005, 57, 637–651. 
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serum proteins, protein cages or single amino acids (Figure 90a). Additionally, a whole 
series of other biological delivery agents have been successfully used, such as liposomes, 
nucleic acids, hormones, folic acid, carbohydrates, etc. (Figure 90b).18 
 
Figure 90. Frequently used biological counterparts for the synthesis of PS-based 
biohybrids with improved delivery and other characteristics. 
Photoactive biohybrids can be obtained either by non-covalent or covalent association of 
the PS with the different biomolecules:18,205 
- Covalent approach: also known as bioconjugation. The vast majority of publications 
 concerning biohybrid conjugates refer to species where the PS is linked to the 
 biomolecule via a covalent bond. In this way, PS have been conjugated to 
 antibodies directed against tumor antigens, sugars, oligonucleotides to enhance 
 photogenotoxicity, aptamers to recognise cell-membrane proteins, hormones, 
 metabolites, cellular signalling species to selectively target an over-expressed 
 enzyme or receptor, and also to peptides and proteins. 
 
- Non-covalent conjugation: offers a much wider choice in terms of the nature of the 
 biological partner. As a consequence, it grants the possibility of interaction with 
 a diversity of targets.  
In this Chapter, a covalent approach for bioconjugation has been follow in Subchapter 1, 
while Subchapter 2 deals with a non-covalent strategy. 
In the case of covalent conjugation, two different classes can be distinguished based on 
the type of functional groups involved in the linkage of the PS and the biomolecule.205 The 
first class is the most evident one, taking advantage of the amino- or carboxylic groups 
                                                             
205  F. Giuntini, C. M. A. Alonso, R. W. Boyle, Photochem. Photobiol. Sci. 2011, 10, 759–791. 
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naturally present on most biomolecules (e.g. amino acids, peptides, proteins, 
oligonucleotides, etc.). In this case, the PS must bare one or more complementary 
carboxylic or amino groups, respectively. A second class of conjugation methods is based 
on reactions between non-naturally occurring (abiotic) functionalities, which are 
introduced in the PS and/or the biomolecule especially for this purpose. Examples are the 
Sonogashira reaction,206 the Suzuki-Miyaura reaction,206c the Buchwald-Hartwig 
amination,206c the Cu-catalyzed Huisgen [3+2] cycloaddition (between an azide and an 
alkyne)207 and the thiol-maleimide Michael addition reaction.160  
Exceptionally popular is the bioconjugation of PS to different kinds of peptides, as it is an 
expedient method to overcome the issues generally associated with the use of PS, such as 
scarce water solubility and prominent aggregation. Additionally, the main benefit of the 
use of natural peptides, peptide analogues and newly designed peptides lies in their high 
selectivity and affinity for biological targets, for which they are ideal drug delivery 
vehicles.208 As they are relatively small in size (<50 amino acid residues) they tend to be 
non-immunogenic and display good tissue penetration, including the possibility to cross 
malfunctioning blood-brain barriers. Furthermore, peptides are readily accessible, both 
from natural sources and by chemical synthesis, and they can be easily modified, allowing 
alterations in the sequence and straightforward conjugation to other chemical entities.205 
Large peptide libraries containing well-known trafficking sequences (e.g. cell-penetrating 
peptides), intracellular localisation sequences (e.g. mitochondria or nuclear localisation 
sequences), receptor binding sequences (e.g. vascular endothelial growth factor) and 
enzymes substrates (e.g. proteases) are available to choose from, making the use of 
peptides as delivery unit for small molecule drugs especially attractive. 
In this first Subchapter, the covalent bioconjugation of two different PS, a SiPc and a 
SubPc, to a cell penetrating peptide have been investigated.  
 
 
  
                                                             
206  a] J. L. Sessler, J. Jayawickramarajah, A. Gouloumis, G. Dan Pantos, T. Torres, D. M. Guldi, Tetrahedron 
2006, 62, 2123–2131; b) M. R. Reddy, N. Shibata, Y. Kondo, S. Nakamura, T. Toru, Angew. Chem. 2006, 
118, 8343–8346; c] H. Ali, S. Ait-Mohand, S. Gosselin, J. E. van Lier, B. Guérin, J. Org. Chem. 2011, 76, 
1887–1890; d) E. Ranyuk, N. Cauchon, K. Klarskov, B. Guérin, J. E. van Lier, J. Med. Chem. 2013, 56, 
1520–1534. 
207  a] M. Mudyiwa, M. W. Ndinguri, S. A. Soper, R. P. Hammer, J. Porphyr. Phthalocyanines 2010, 14, 
891–903; b) N. V. Sokolova, T. Schotten, H. J. Berthold, J. Thiem, V. G. Nenajdenko, Synthesis 2013, 
45, 556–561; c] M.-R. Ke, D. K. P. Ng, P.-C. Lo, Chem. Asian J. 2014, 9, 554–561. 
208  N. Sewald, H.-D. Jaakubke, Application of Peptides and Proteins, Wiley-VCH Verlag GmbH & Co. KGaA, 
Darmstadt, 2009. 
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1.1.2 Cell penetrating peptides 
Cell penetrating peptides (CPP) are a diverse set of short peptide sequences, usually 
consisting of 30 or less amino acids, that possess the remarkable property of being able to 
cross cell membranes and deliver bioactive cargo with molecular weights several times 
greater than their own.209  
The first indications that some proteins are capable of crossing the cell membrane were 
first noted about 30 years ago, when the transcription trans-activating protein (Tat) from 
HIV-1 was found capable of entering cells and even the cell nucleus.210 Shortly after, this 
property of translocation was also found in Antennapedia (Antp), a transcription factor of 
Drosophila,211 and in VP22, a herpes virus protein.212 Later it became clear that their ability 
to translocate across the plasma membranes is confined to short sequences of less than 
20 amino acids, which are highly rich in basic residues. Therefore, CPPs are characterized 
by those sequences, generally containing multiple arginine (Arg) and Lysine (Lys) residues.  
Since their initial discovery, the Tat-peptide and its derivatives are still the most used CPPs, 
although the discovery and design of new CPPs has been increasing rapidly ever since.213 
As a result, there now exist a great variety of CPPs in terms of amino acid composition and 
degree of polarity, and CPPs are generally classified into three categories according to 
their origin (see Table 14). The first group is that of the protein-derived peptides, such as 
Tat and penetratin, which originate from naturally occurring proteins. They are also called 
protein-transduction domains. Another group is that of chimeric peptides, where two 
peptides sequences originating from two different proteins are fused together. The most 
used example from this category is transportan (TP), containing the peptide sequence 
from the amino terminus of the neuropeptide galanin, bound via the lysine residue with 
the membrane-interacting wasp venom peptide, mastoparan. The third group consists of 
synthetic peptides, where the polyarginine family and the model amphipathic peptide 
(MAP) are the best studied members.  
 
 
 
                                                             
209  a] M. Lindgren, M. Hällbrink, A. Prochiantz, U. Langel, Trends Pharmacol. Sci. 2000, 21, 99–103; b) C. 
P. Cerrato, K. Künnapuu, Ü. Langel, Expert Opin. Drug Deliv. 2016, 1–11. 
210  a] M. Green, P. M. Loewenstein, Cell 1988, 55, 1179–1188; b) A. D. Frankel, C. O. Pabo, Cell 1988, 55, 
1189–1193. 
211  E. Vivès, P. Brodin, B. Lebleu, J. Biol. Chem. 1997, 272, 16010–16017. 
212  W. B. Kauffman, T. Fuselier, J. He, W. C. Wimley, Trends Biochem. Sci. 2015, 40, 749–764. 
213  E. Vives, J. Controlled Release 2005, 109, 77–85. 
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Table 14. Sequences of selected CPPs 
CPP Sequencea Origin Ref 
Arg11 RRRRRRRRRRR Synthetic 214 
MAP KLALKLALKALKAALKLAamide Synthetic 215 
Penetratin 
(Antp) 
RQIKIWFQNRRMKWKKb 
Protein- 
derived 
216 
Tat(48-60) GRKKRRQRRRPPQc 
Protein- 
derived 
211 
Transportan 
(TP) 
GWTLNSAGYLLGKINLKALAALAKKILamide Chimeric 217 
VP22 DAATATRGRSAASRPTERPRAPARSASRPRRVD 
Protein- 
derived 
218 
a Peptides are C-terminal free acids unless stated otherwise. b Originally synthesized as C-terminal free acids but later 
also shown to have CPP properties when amidated. c This sequence is included in all Tat fragments with known 
translocation ability [e.g. Tat fragment (37–72) that has been used for intracellular protein delivery]. It should be noted 
that the Tat protein has a high genetic variability so the exact amino acid sequence might differ depending on the viral 
strain. 
 
Different CPPs differ in their rate of uptake and efficiency of membrane perturbation, as 
demonstrated by fluorescence resonance energy transfer (FRET) analysis.219 Hällbrinck et 
al. found that the membrane disturbing potential of the CPPs is proportional to their 
hydrophobic moment, which they calculated using the Kyte and Doolitle scale of 
hydrophobicity, and suggest that future designs of CPPs should aim to minimize their 
hydrophobic moment in order to increase their membrane-disturbing.220 In terms of 
cellular uptake and cargo delivery kinetics, MAP shows the fastest uptake, followed by TP, 
Tat(48-60) and penetratin. However, MAP is also the most potent inducer of membrane 
leakage, whereas TP also causes leakage at higher concentrations, but not at 
concentrations sufficient for cellular uptake and cargo delivery.221 On the other hand, 
                                                             
214  J. B. Rothbard, S. Garlington, Q. Lin, T. Kirschberg, E. Kreider, P. L. McGrane, P. A. Wender, P. A. 
Khavari, Nat. Med. 2000, 6, 1253–1257. 
215  J. Oehlke, A. Scheller, B. Wiesner, E. Krause, M. Beyermann, E. Klauschenz, M. Melzig, M. Bienert, 
BBA - Biomembr. 1998, 1414, 127–139. 
216  D. Derossi, A. H. Joliot, G. Chassaing, A. Prochiantz, J. Biol. Chem. 1994, 269, 10444–10450. 
217  M. Pooga, M. Hällbrink, M. Zorko, U. Langel, FASEB 1998, 12, 67–77. 
218  G. Elliott, P. O’Hare, Cell 1997, 88, 223–233. 
219  R. B. Sekar, A. Periasamy, J. Cell Biol. 2003, 160, 629–633. 
220  M. Hällbrink, A. Florén, A. Elmquist, M. Pooga, T. Bartfai, Ü. Langel, BBA Biomembr. 2001, 1515, 101–
109. 
221  J. Mueller, I. Kretzschmar, R. Volkmer, P. Boisguerin, Bioconjug. Chem. 2008, 19, 2363–2374. 
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there are indications that TP can cause unwanted side effects in biological systems, for 
which Tat-derivatives result as the most interesting, safe and effective CPPs.222 
 
1.1.3 Mechanism of CPP induced cell uptake 
Even though the use of CPPs as delivery vectors is now a widely accepted 
phenomenon, the pathways that CPPs use for cell entry are still subject to debate. The cell 
uptake mechanism of a specific CPP is influenced by the properties of the CPP (length, 
charge distribution, etc.), the physiochemical properties of the cargo molecule and the cell 
type.221 Based on various experiments that indicate that CPP uptake is unaffected when 
inhibiting endocytosis (by depletion of the ATP pool and incubation at 4°C),223 it was 
proposed that a direct penetration (Figure 91a) of the plasma membrane is in general 
more likely than an endocytotic pathway.211,216 However, direct penetration and crack 
formations in the membrane cannot explain the delivery of large complexes, and are 
difficult to reconcile with the low cytotoxicity of most CPPs. A proposed non-endocytotic 
internalization mechanism that has received more attention is the inverted micelle 
mediated model (Figure 91c), suggested for the uptake of e.g. penetratin.224 But although 
this model may explain the translocation of some amphipathic peptides, others like Tat 
and polyarginines, lacking hydrophobic amino acids, are most likely taken up through 
other mechanisms. Furthermore, even though the fact that internalization does not 
involve endocytosis was first generally accepted, it is currently in doubt and an increasing 
number of studies are showing results in favour of the endocytotic uptake of CPPs (Figure 
91b).225  
                                                             
222  S. El-Andaloussi, T. Holm, U. Langel, Curr. Pharm. Des. 2005, 11, 3597–3611. 
223  U. Langel, Cell-Penetrating Peptides: Processes and Applications, 1st Edition, CRC Press, Boca Raton, 
2002. 
224  D. Derossi, S. Calvet, A. Trembleau, A. Brunissen, G. Chassaing, A. Prochiantz, J. Biol. Chem. 1996, 271, 
18188–18193. 
225  a] J. P. Richard, K. Melikov, E. Vives, C. Ramos, B. Verbeure, M. J. Gait, L. V. Chernomordik, B. Lebleu, 
J. Biol. Chem. 2003, 278, 585–590; b) M. Lundberg, S. Wikström, M. Johansson, Mol. Ther. 2003, 8, 
143–150; c] A. Ferrari, V. Pellegrini, C. Arcangeli, A. Fittipaldi, M. Giacca, F. Beltram, Mol. Ther. 2003, 
8, 284–294; d) G. Drin, S. Cottin, E. Blanc, A. R. Rees, J. Temsamani, J. Biol. Chem. 2003, 278, 31192–
31201. 
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Figure 91. Proposed internalization mechanisms for CPPs and CPP-cargo complexes. a) 
Direct penetration, b) endocytosis and c) the inverted micelle model. 
The Tat-based CPPs are the most extensively studied delivery vectors for different 
bioactive cargos, and the mechanism for their delivery, and for most CPPs, is now 
considered to be mediated through temperature dependent endocytosis. However, there 
are conflicting reports concerning what type of endocytosis is involved: a caveolae-
mediated endocytosis,225c,226 clathrin-mediated endocytosis,227 or macropinocytosis228. In 
any case, after internalization through endocytosis, the CPP-cargo complexes end up 
inside endocytic vesicles, allowing for endosomal-lysosomal cargo delivery. If the target of 
the delivered molecule is outside of the vesicles, it must be able to escape into the cytosol 
to reach its target.229  
Even though the exact uptake mechanism of CPPs is still unclear and subject to debate, 
they have been proven useful in the delivery of many otherwise impermeable, large and 
hydrophobic macromolecules across plasma membranes, inducing a variety of biological 
responses independently on the uptake mechanisms. 
 
1.1.4 Photosensitizer-CPP biohybrids 
Most existing PS-CPP conjugates described in literature are based on Pors, although 
some other PS such as two Pcs and a chlorin have also been used. As for the CPP, while 
there literally exist thousands of different sequences, and possibilities are endless, Tat-
derivatives are by far the most popular ones. They are often used by itself or in 
                                                             
226  A. Fittipaldi, A. Ferrari, M. Zoppé, C. Arcangeli, V. Pellegrini, F. Beltram, M. Giacca, J. Biol. Chem. 2003, 
278, 34141–34149. 
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229  E. Koren, V. P. Torchilin, Trends Mol. Med. 2012, 18, 385–393. 
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combination with nuclear localizing sequences (NLS), another type of CPP. As expected, 
most of these conjugates have been applied for PDT applications. Some research groups 
however have taken benefit of the multiply charged conjugates and have tested them also 
for PDI applications, with successful outcomes. 
Pioneers in the field are Vicente and co-workers, synthesizing and publishing several 
papers on Por-CPP conjugates early on. First, and based on the fact that most CPP 
sequences consist mainly of cationic amino acids (such as Lys or Arg), they synthesized a 
series of Por conjugates containing one to four Lys or Arg residues and investigated their 
cell uptake.230 Although the photodynamic efficacy of these conjugates has not been 
demonstrated, all conjugates showed low dark cytotoxicity and localized mainly in cellular 
vesicles and lysosomes, the extent of cellular uptake depending significantly on the 
nature, number and sequence of amino acid residues. As a continuation of this work, they 
later published the first Por-CPP conjugates using NLS SV40 or the fusogenic peptides HIV-
1 Tat (40-60) and octa-Arg.231 Tat (40-60) and octa-Arg were the most effective in 
delivering the conjugates to the cells, while subcellular distribution of the conjugates was 
found to be dependent on the nature of substituents on the Por macrocycle. In an effort 
to improve this design, they later published a series of Por-CPP conjugates containing a 
linear bifunctional sequence containing both a CPP and a NLS.232 Since this approach 
resulted in improved cell uptake, they continued in this line by synthesizing another series 
of Por-CPP conjugates bearing bifunctional CPP-NLS or NLS-CPP sequences (Figure 92).233 
Again, the conjugates containing Tat-derivatives were the most promising ones, showing 
the lowest dark cytotoxicity and highest phototoxicity. In vivo, the conjugates 
accumulated in tumor cells to a higher extent than Hp, which lead to very promising PDT 
results in the treatment of prostate cancer cells.  
 
Figure 92. Por-CPP conjugates synthesized by Vicente et al., containing bifunctional 
CPP-NLS or NLS-CPP sequences.233 The designation of the sequence is indicated by their 
corresponding color in the top right legend. 
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All conjugates by Vicente and co-workers were synthesized using the same methodology, 
that is solid phase synthesis of the desired peptide followed by coupling of the Por (bearing 
a carboxylic acid group) using standard amide coupling reagents (Figure 93). After 
cleavage of the conjugate from the solid phase, it was purified by reversed phase HPLC 
(RP-HPLC).  
 
Figure 93. Synthesis of Por-peptide conjugates following the methodology used by 
Vicente and co-workers. a) Solid Phase Peptide Synthesis (SPPS), b) Solid phase coupling 
of Por-derivative, c) Cleavage of Por-peptide conjugate from the solid phase resin, d) 
RP-HPLC purification of Por-peptide conjugate. 
Other conjugation methods not requiring solid phase coupling of the Por, which 
disadvantageously requires the use of a great excess of it, have been used later on. 
Dmitriev et al. made use of the isothiocyanate (NCS) functional group, which reacts with 
a free amino group on the peptide to form an isothiourea bond (Figure 94a).234 This 
method allows for bioconjugation under soft conditions and without formation of 
intermediates or byproducts. Another promising method is that used by Bourré et al.160 
and Wang et al.,235 applying the thiol-maleimide Michael addition reaction. In this 
methodology, maleimide-substituted PS are conjugated with peptides containing a 
sulfhydryl reactive group, forming a thioether bond (Figure 94b). In both conjugates, the 
popular Tat sequence was used as CPP. Bourré et al. tested the resulting conjugate as an 
antimicrobial agent in PDI, a well thought approach since Tat-derivatives, just like most 
CPP, are cationic and often amphipathic, similar to membrane-active antimicrobial 
peptides.236 On the other hand, Wang et al. focussed on studying the process of 
photochemical internalization (PCI), a site-specific technique for improving the cellular 
delivery of macromolecular drugs. PCI efficacy was tested in combination with various 
small drug molecules, and a significant reduction in cell viability was measured versus the 
drug or PS treatment alone. This demonstrates that CPP-PS bioconjugation is a promising 
and versatile approach for enhancing the therapeutic potential of bioactive agents 
through PCI. 
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Figure 94. Por-peptide conjugation using a) isothiocyanate functional groups and b) 
maleimide functional groups. 
More recently, Li et al. have synthesized a Por-CPP conjugate containing a proteinase-
sensitive CPP for tumor targeted PDT, taking the use of CPPs as delivery agents to the next 
level (Figure 95).237 The CPP R9GPLGLAGE8 consists of a polycationic polyarginine (R9) 
sequence linked to a polyanionic polyglutamic acid sequence (E8) by a proteinase-sensitive 
linker (GPLGLAG). In normal tissues, the cell-penetrating function of polycationic CPP (R9) 
is blocked by the presence of the polyanionic peptide (E8) through intramolecular 
electrostatic attraction. Once exposed to the proteinases present at the tumor site, 
proteolysis of the oligopeptide linker (GPLGLAG) between the CPP and the polyanionic 
peptide dissociates the inhibitory polyanions and releases the CPP-Por conjugate for PDT. 
 
Figure 95. Por conjugated to a CPP by Li et al.237 The CPP consists of a polycationic 
polyarginine sequence (black) linked to a polyanionic polyglutamic acid sequence 
(green) by a proteinase-sensitive linker GPLGLAG (blue). 
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Apart from Pors, CPPs have been successfully conjugated to other dyes and 1O2 generators 
such as a chlorin,238 carboxytetramethylrhodamine,239 and a whole series of strongly 
fluorescent dyes investigated by Ohtsuki et al.240 With Pcs, only a couple of examples have 
been described. In the first case, Vicente and co-workers conjugated a bifunctional 
peptide, consisting of a bipartite NLS nucleoplasmin and a Tat(48-60) peptide, to a zinc 
phthalocyanine (ZnPc) (Figure 96).241 The resulting conjugates were highly phototoxic and 
showed increased cellular uptake, once more proving the concept of using CPP as delivery 
vector. Just like for most PS-CPP conjugates, they were found to preferentially localize 
within the cell lysosomes.  
 
Figure 96. An example of two Pc-CPP conjugate synthesized by Vicente et al.241  
In the second case, published by Yaghini et al., stable nanocomposites of Tat-conjugated 
quantum dots with disulfonated aluminium Pcs (AlPcs) were formed in aqueous solution 
and in human breast cancer cells.242 In cells, the Tat-conjugated quantum dots localize in 
lysosomes and, upon excitation of the quantum dots, a FRET transfer to the AlPc was 
observed, resulting in a FRET-induced release of quantum dots from endo/lysosomes. This 
was attributed to photooxidative damage to the endo/lysosomal membranes mediated 
by the Pc FRET acceptor.  
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1.2 Molecular design, synthesis and characterization of SiPc-CPP 
and SubPc-CPP biohybrids  
From the above paragraph describing the state of the art about PS-CPP conjugates, two 
conclusions can be drawn. First, in every single example of PS-CPP conjugates already 
published, the conjugation of the PS to a CPP greatly enhanced its cellular uptake and 
consequently its photodynamic efficacy. Another promising feature of the conjugates is 
that none of them showed significant dark cytotoxicity, making them ideal candidates for 
PDT or PDI treatments. Second, despite the very encouraging results shown above, only 
few groups have entered in this field and relatively few PS-CPP conjugates have been 
reported. The specific objective of this subchapter is therefore the synthesis, 
characterization and in vitro evaluation of two new PS-CPP conjugates, more specifically a 
SiPc-CPP and a SubPc-CPP conjugate (Figure 97). SiPcs are, among Pcs, one of the best 
candidates for their use as in PS in PDT, and although two Pc-CPP conjugates have been 
reported, none of these was based on SiPcs. As an additional advantage, SiPcs display two 
axial positions available for functionalization, for which it is possible to incorporate up to 
two CPPs, through conjugation with linkers incorporated at the axial positions to this end. 
For SubPcs, there are no antecedents in literature of conjugation to CPP at all. However, 
SubPcs display very beneficial PS characteristics in solution, such as high quantum yields 
and triplet lifetimes (see introduction). Nevertheless, in vitro studies of SubPcs in PDT or 
PDI remain very rare. Furthermore, just like SiPcs, SubPcs allow functionalization at their 
axial position, which also makes them ideal candidates for conjugation to site specific 
delivery agents. Importantly, using primary alcohol type linkers, one single linker can be 
used for incorporation in both SiPcs and the SubPcs, making the synthesis of both 
conjugates very convergent.  
 
Figure 97. Molecular structure of the target biohybrid PS-CPP conjugates 37 and 38, 
based on a SiPc and a SubPc as PS, respectively. 
From the state of the art displayed above, it remains clear that the most used CPPs are Tat 
derivatives. Furthermore, in various cases where more than one CPP was tested, the Tat 
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sequence was almost always the most effective one, the resulting biohybrid conjugates 
showing low dark cytotoxicity and high phototoxicity. With this in mind, a 14 amino acid 
Tat variant (39), with sequence GRKKRRQRRRGYKC (from N to C) (Figure 98), was ordered 
from Biomatik©, a USA-based product and service provider in life sciences and drug 
discovery. The peptide was assembled on a Rink Amide resin, cleaved of and completely 
deprotected. A Cys residue was added at the amidated C-terminus of the peptide for easy 
and straightforward conjugation with the SubPc and SiPc precursors, containing the 
complementary maleimide functionality.  
 
Figure 98. Chemical structure of CPP 39, with sequence GRKKRRQRRRGYKC, a close 
variant of the Tat sequence.  
As can be seen in Figure 98, the peptide contains multiple arginine (blue) and lysine (red) 
residues, which are fundamental for achieving the desired cell uptake. Furthermore, 
studies have highlighted the importance of arginines over lysines, since the guanidinium 
group of arginine seems pivotal for efficient cell uptake.243 
 
1.2.1 Synthesis of maleimide-containing silicon phthalocyanine and 
subphthalocyanine 
For the linkage of the SiPc and SubPc cores to the Tat CPP, it has been chosen to 
make use of the maleimide-thiol type ‘click’ reaction for various reasons. Desirably, solid 
phase synthesis is avoided, since large excesses of valuable PS are required. Amide 
formation, the most widespread conjugation strategy, on the other hand, would require 
either an amine or a carboxylic acid functionality in the primary alcohol linker, which 
would greatly complicate its incorporation into the SiPc and SubPc. Furthermore, amide 
conjugation should be avoided as most peptides contain several NH2 and COOH groups, 
which can result in the formation of multiply conjugated products. Using a maleimide 
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functionality in the linker, to target a cysteine residue in the CPP, allows circumventing 
these problems. 
Thiol-ene reactions are well-established in peptide synthesis, exploiting the naturally 
present thiol groups of cysteine-containing peptides. Although thiols can be reacted with 
a variety of electrophiles, such as isocyanates and epoxides, the nucleophilic Michael 
addition taking place between a thiol and a maleimide is one of the fastest conjugation 
reactions and it is therefore also the most popular one.244 Furthermore, it results in stable 
thio-ether bonds when aliphatic thiols are used as the nucleophile. 
Our synthesis of the axial maleimide-containing linker is based on a peripheral linker used 
by Liu et al.,236 but using a primary alcohol for incorporation into the SiPc or SubPc (Scheme 
25) instead of a primary amine for conjugation with the carboxylic acid functionality of 
protoporphyrin IX.  
 
Scheme 25. Synthesis of the maleimide-containing building block for axial substitution. 
Maleic anhydride, commercially available,245 is an ideal stating product if one wants to 
make use of the maleimide-thiol type click reactions. It can be easily reacted with a 
primary amine, such as in this case 3-aminopropyl (tert-butyl)dimethylsilyl ether (10), 
synthesized in Chapter 1, to yield the protected precursor 40. Special caution should be 
taken during its deprotection and the work-up of the final product (41), since the 
unprotected alcohol can react with the maleimide, resulting in a polymerization reaction. 
For deprotection of the (tert-butyl)dimethylsilyl group, a catalytic amount of acetyl 
chloride was added to a mixture of 40 in anhydrous methanol at 0°C, and the reaction was 
followed by TLC. Upon completion of the reaction, the solvent was evaporated at low 
pressure without heating of the rotary evaporator bath, to avoid the aforementioned 
polymerization problems. Furthermore, the incorporation of 41 into the SiPc and SubPc 
cores must be performed immediately after the isolation 41, since conservation of this 
compound, even at -18°C under argon atmosphere, provokes a decrease in purity.  
For axial SiPc substitution with 41, the same conditions as those used in Chapter 1 were 
first tested (Entry 1 - Table 15). However, the yield was very disappointing, for which 
various other conditions and reaction times were tested (Entries 2-5 - Table 15). Notably, 
when trying to dissolve 41 in the reaction mixture prior to adding the SiPcCl2, the yield 
dropped even further. This can probably be explained by polymerization of 41. By using 
                                                             
244  L.-T. T. Nguyen, M. T. Gokmen, F. E. D. Prez, Polym. Chem. 2013, 4, 5527–5536. 
245  “Maleic anhydride puriss., ≥99.0%,” can be found under http://www.sigmaaldrich.com/catalog/, 
2016. 
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more sterically hindered bases, the yield could be significantly increased from pyridine to 
Et3N and DIPEA. Finally, the reaction of SiPcCl2 with 5 equivalents of 41 in anhydrous 
toluene, with DIPEA as base, resulted in the desired product 42 with an acceptable 51% 
yield (Scheme 26). 
Table 15. Various reaction conditions tested for the reaction of 41 with SiPcCl2. 
Entry Solventa Basea Reaction time Yield 
1 Toluene Pyridine 18hb 4% 
2 Toluene Pyridine 5hb 3% 
3 Toluene Pyridine 18hc 0.5% 
4 Toluene Et3N 18hb 18% 
5 Toluene DIPEA 18hb 51% 
a Anhydrous. b Standard procedure. c Preheating 41 in toluene/pyridine, in order to 
overcome solubility problems. 
 
 
Scheme 26. Incorporation of the axial maleimide-containing linker into the SiPc 
structure. 
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Similarly, 41 was reacted with the SubPcCl 16, under the same conditions for axial 
substitution as those employed in Chapter 1. This process gave rise to the final product 43 
with 38% yield (Scheme 27). 
Scheme 27. Incorporation of the axial maleimide-containing linker into the SubPcCl 16 structure. 
 
1.2.2 Synthesis and characterization of the PS-CPP biohybrids 
The synthesis of the PS-CPP biohybrid conjugates has been performed during a predoctoral 
stay in the research group of Prof. Annemieke Madder at the Laboratory for Organic and 
Biomimetic Chemistry of the University of Ghent (Belgium), in collaboration with Eva 
Marina Llamas Garcinuño. 
For the conjugation of the SiPc 42 and the SubPc 43 with the 39, a procedure 
adopted from that used by Bourré et al. was followed.161 In general, the thiol is 
deprotonated by a tertiary amine catalyst, in this case pyridine, resulting in the formation 
of a strongly nucleophilic thiolate anion (Figure 99). The anion adds to the double bound 
of the maleimide, generating an enolate intermediate with a delocalized negative charge. 
In the last step, the proton is subtracted again from the amine catalyst, resulting in a stable 
thio-ether adduct.  
 
Figure 99. General mechanism of the thiol-maleimide reaction, catalyzed by a tertiary 
amine (in this case pyridine), with the formation of a thio-ether bond. 
Since the conjugation of the SubPc 43 with 39 implies the incorporation of one single 
peptide, in comparison to two in the case of the SiPc 42, it represents an easier scenario. 
For this reason, we decided to explore it prior to tackling the double conjugation of the 
SiPc 42. 
 
  
Chapter 3 - Design, synthesis and applications of (Sub)Pc-biohybrids in PDT and PDI 205 
 
1.2.2.1 SubPc-CPP conjugate 38 
For the conjugation of SubPc 43 with the CPP, both the SubPc and the peptide were 
dissolved in a small quantity of DMSO. Pyridine was added to the SubPc solution, after 
which both solutions were mixed, shielded from light, and allowed to stand overnight at 
rt (Scheme 28). Since 39 is the most costly starting product, a 3 equiv. excess of SubPc 43 
was used.  
 
Scheme 28. Synthesis of the SubPc-CPP conjugate 38. 
After reaction, the mixture was partitioned between ethyl acetate and deionised 0.1% 
aqueous TFA. The non-conjugated free SubPc 43 remained in the organic phase, while the 
conjugate 37, which is water soluble, remained in the water phase, together with any non-
conjugated peptide. The aqueous layer was then evaporated to a small volume, and 
applied to a Discovery DSC-18 solid phase extraction cartridge, from which the conjugate 
was eluted with a gradient (from 5% acetonitrile 0.1% aq. TFA to 20% acetonitrile 0.1% aq. 
TFA) mobile phase. Finally, the conjugate was lyophilised to give the pure conjugated 
product 38 in a 95% yield.  
The reaction and purification were also followed by RP-HPLC, using a gradient of 0.1% TFA 
in water and 0.1% TFA in acetonitrile, from 0 to 100%, over 25 min. UV-Vis detection was 
performed at 214, 254, 280 and 560 nm. The first three wavelengths are used standardly 
when eluting peptides, visualizing the peptide bond (214 nm) and some aromatic residues 
such as tyrosine, tryptophan and phenylalanine (254 and 280 nm).246 The fourth 
wavelength, hν = 560 nm, coincides with the Q-band of the SubPc and was chosen to 
visualize the elution of the SubPc-CPP conjugate 38. Peptides do not absorb at this 
wavelength. The resulting chromatograms of the peptide, the crude aqueous phase and 
the DSC-18 purified conjugate 38 can be seen in Figure 100a-c, respectively. 
                                                             
246  M.-I. Aguilar, HPLC of Peptides and Proteins: Methods and Protocols, © Humana Press Inc., 2004. 
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Figure 100. RP-HPLC chromatograms of a) 39, b) the crude aqueous phase, c) the DSC-
18 purified conjugate 38, and d) the solvent mixture used to elute the compounds, 
consisting of 0.1% TFA in water (Solvent A) and 0.1% TFA in acetonitrile (Solvent B) with 
a gradient from 0 to 100%B in 25 min. The elution of all compounds is followed at hν = 
214, 254, 280 and 560 nm. 
 
In the chromatogram of 39 (Figure 100a) two peaks can be observed, one at retention 
time tr=10,8 min, which is the peptide, and an impurity at tr=13,2 min. The second peak 
could probably be the result of dimerization of the peptide, since its free sulfhydryl group 
could react with that of a second peptide, forming a disulfide bridge between two peptide 
a)
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b)
c)
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λ = 560 nm
λ = 214 nm
λ = 254 nm
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moieties. The formation of SubPc-CPP conjugate 38 can clearly be detected in the 
chromatogram of the aqueous phase obtained by extraction of the crude reaction mixture 
(Figure 100b), since a new elution peak appears at tr=12,2 min and absorbs both at the 
typical peptide wavelengths (i.e. 214, 254 and 280 nm ) and at 560 nm, the wavelength of 
maximal absorption of the SubPc. As desired, no unbound peptide was detected, as a 
three-fold excess of SubPc 43 was used in order to fully consume the peptide. Notably, 
the impurity at tr=13,2 min also present in the chromatogram of the peptide, confirms it 
could be the peptide dimer, which has no longer a free sulfhydryl group to bind to the 
SubPc 43. Finally, in the chromatogram of the DSC-18 purified conjugate 38 (Figure 100c) 
it is clear that the conjugate is now completely pure.  
The mass of conjugate 38 could be confirmed by MALDI-TOF spectrometry (Figure 101), 
detecting the molecular ion [M]+ as the most intense peak. Besides, two fragments that 
can from by fragmentation of the molecular ion (i.e. F1 and F2, Figure 102) were also 
detected. 
 
Figure 101. MALDI-TOF spectrum of DSC-18 purified conjugate 38. 
[M]+
[MF1+H]
+
[MF2+H]
+
2395.6959
2001.9917
1846.0838
Mass (m/z)
%
 In
te
n
si
ty
208   Subchapter 1 – PS-peptide biohybrid conjugates for PDT 
 
 
Figure 102. Structural formula and molecular mass corresponding to the molecular ion 
and its fragments F1 and F2, detected in MALDI-TOF spectrum, of the conjugate 38.  
 
1.2.2.2 SiPc-CPP conjugate 37 
After the successful synthesis of the SubPc-CPP conjugate, the double conjugation 
of the 39 to SiPc 42 was attempted. In this case, the peptide cannot be used as the limiting 
reagent, since this would result in a mixture of mono- and di-substituted SiPc-CPP 
conjugates. Therefore, in a first trial, the same reaction conditions as before, but using a 
threefold excess of peptide, were tested (Scheme 29, Entry 1 - Table 16). However, due to 
the large excess of peptide utilized in this case, solubility problems arized and, upon 
reaction overnight, no conjugate was formed. The process was then repeated in a bigger 
amount of DMSO (Entry 2 - Table 16), obtaining a better solubility of the starting products. 
 
Scheme 29. Synthesis of the SiPc-CPP conjugate 37. 
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Table 16. Reaction conditions for the double conjugation of 39 to SiPc 42. 
Entry Solvent 
42  
(equiv.) 
39  
(equiv.) 
Base Conditions 
1 
DMSO 
(400 µL) 
1 3 Pyridine 
rt, 
overnight 
2 
DMSO 
(1000 µL) 
1 3 Pyridine 
rt, 
overnight 
3 DMSO 1 3 DIPEA 
40°C, 
overnight 
4 DMF 1 3 DIPEA 
rt, vortex, 
overnight 
 
The same workup as for the SubPc conjugate was applied in the present case, that is 
partitioning the reaction mixture between ethyl acetate and deionised 0.1% aqueous TFA. 
Initially, the water phase turns blue, which would mean conjugation did take place and 
conjugate 37 is water-soluble. However, upon concentrating the water phase and applying 
it to a Discovery DSC-18 solid phase extraction cartridge for separation, no conjugate 
eluted (all blue color remained at the front of the column), even when increasing the 
gradient of the mobile phase from 5% acetonitrile 0.1% aq. TFA to 100% acetonitrile 0.1% 
aq. TFA.  
The RP-HPLC chromatogram of the water phase was also recorded, using the same 
parameters as in the previous section but with 676 nm as the fourth wavelength of 
detection, coinciding with the Q-band of the SiPc, to visualize the elution of SiPc-CPP 
conjugates (Figure 103b). At 214 nm the formation of a new product with tR = 18 min can 
be observed, indicating the formation of some kind of conjugate. However, from the 
chromatogram recorded at 676 nm, it is clear that some kind of decomposition has taken 
place, since a mixture of products eluted from tR = 15 to 20 min. 
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Figure 103. RP-HPLC chromatograms of a) 39, b) the crude aqueous phase, and c) the 
solvent mixture used to elute the compounds, consisting of 0.1% TFA in water (Solvent 
A) and 0.1% TFA in acetonitrile (Solvent B) with a gradient from 0 to 100%B in 25 min. 
The elution of all compounds is followed at hν= 214, 254, 280 and 676 nm.  
Two more reaction conditions were tested (Entries 3 and 4 - Table 16), with the same 
results: the water phase initially turned blue upon extraction, indicating the formation of 
some kind of conjugate, but its blue color faded slowly and no conjugate could be detected 
by RP-HPLC. Both observations indicate that if the conjugate was formed, it decomposed 
during the work-up and/or during the RP-HPLC measurement. With this in mind, the 
stability of compound 42 to acids was tested by 1H-NMR spectroscopy (Figure 104), 
conforming that it doesn’t resist even a small 0.1% proportion of TFA. 
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Figure 104. Stability test of compound 42 to slightly acidic (0.1% aq. TFA) conditions. 
Up: 1H-NMR spectrum of compound 42 in DMSO-d6. Down: 1H-NMR spectrum of 
compound 42 after a 5 min treatment with 0.1% aq. TFA, in DMSO-d6, clearly missing 
the SiPc aromatic signals. 
From this experiment, it became clear that the conjugate had probably been formed in all 
of the previous trials, but we simply did not detect it because of instability issues. 
Therefore, for Entry 3 and Entry 4 (Table 15), an alternative work-up was attempted, 
avoiding the use of 0.1% aq. TFA. Upon reaction overnight, 10 mL of diethyl ether were 
added to the reaction mixture, resulting in a blue precipitate. After centrifugation, the 
colorless supernatant was removed and the remaining solid was dissolved in distilled 
water and extracted with DCM to remove any remaining unreacted SiPc 42. After this 
treatment, a MALDI-TOF analysis was performed (Figure 105). 
 
Figure 105. MALDI-TOF analysis of the crude obtained from entries a) 3 and b) 4 of 
Table 15. 
The molecular ion of the conjugate 37 ([M+] = 4540,41) was not observed, yet fragment 
F2 can be detected in both cases. This fragment was also present in the MALDI-TOF 
analysis of SubPc-CPP conjugate 38 (Figure 101), and can only exist if conjugation has 
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effectively taken place. This confirmed our suspicions of the instability of SiPc-CPP 
conjugate 37 to TFA, and the fact that most likely the molecular ion cannot be observed 
because of the slightly acidic matrix (α-cyano-4-hydroxycinnamic acid) that is used for the 
MALDI-TOF analysis.  
Although the results obtained from this analysis indicate that some conjugate has been 
formed, they give no decisive answer about whether there exists a mixture of mono- and 
bi-conjugated product or only the desired compound 37. Since an excess of peptide was 
used and since the thiol-maleimide Michael addition is a fast and efficient reaction,244 it 
can be expected that only di-conjugated product has been formed, but this needs to be 
confirmed. Therefore, a final purification step was performed by SEC using Sephadex 
beads as the stationary phase and water as the eluent. Since the peptide is large (MW = 
1846.07 g/mol), it is expected that the mono- and di-substituted products would have 
different elution times. However, only one product eluted, either using G10 or G15 size 
Sephadex beads. 
In a last experiment to prove the purity of the conjugate 37, RP-HPLC analysis was 
performed under the same conditions as above, but without using 0.1% TFA in the mobile 
phase. This is normally not done, because TFA serves as ion-pair reagent, both for the 
stationary phase and the peptide. Without using TFA in the mobile phase it is expected to 
see broad peaks, unless the column is packed with high purity silica with few metal ion 
impurities that could lower the resolution.247 The obtained results can be seen in Figure 
106. In the chromatogram of the peptide (Figure 106a), it can be observed that the peptide 
elutes together with the injection peak, because this peak, at tR = 2 min, is a lot broader 
than normal. The injection peak returned to its normal shape in Figure 106b, the 
chromatogram of conjugate 37, indicating there was no remaining free peptide. 
Furthermore, only one more product could be observed, eluting at tR = 12.5 min. 
Importantly this product absorbs both at the typical peptide wavelengths (i.e. 214, 254 
and 280 nm) and at 676 nm, the wavelength of maximal absorption of the SiPc, confirming 
this is indeed pure SiPc-CPP conjugate 37.  
                                                             
247  D. Carr, A Guide to the Analysis and Purification of Proteins and Peptides by Reversed-Phase HPLC, 
ACE® HPLC Columns, 2010. 
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Figure 106. RP-HPLC chromatograms of a) 39, b) the purified SiPc-CPP conjugate 37, and 
c) the solvent mixture used to elute the compounds, consisting of water (Solvent A) and 
acetonitrile (Solvent B) with a gradient from 50 to 100%B in 25 min. The elution of all 
compounds is followed at hν= 214, 254, 280 and 676 nm.  
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1.3 Spectral features and photophysical properties 
The normalized absorption spectra of conjugates 37 and 38 and their maleimide-
containing precursors 42 and 43 were measured in DMF (Figure 107a – full lines). They all 
represent the typical spectrum of non-aggregated SiPcs (37 and 42) and SubPcs (38 and 
43) and, with an intense and sharp Q-band around 562 nm and 673 nm respectively, and 
a broad Soret band with maxima around 300 nm and 360 nm, respectively. For the water-
soluble conjugates 37 and 38, the normalized absorption spectra were also recorded in 
deionised water (Figure 107a – dashed lines). In this medium, conjugates are also 
essentially non-aggregated. Their Q-bands show a small bathochromic shift: 10 nm for the 
SiPc-CPP conjugate 37 (Q-band at 683 nm) and 4 nm for the SubPc-CPP conjugate 38 (Q-
band at 566 nm), with respect to their Q-bands in DMF. 
The fluorescence emission spectra of all compounds are displayed in Figure 107b. Upon 
excitation at 520 nm, the SubPcs showed a fluorescence emission around 573 nm in DMF 
and 580 nm in water. In turn, the SiPcs showed, upon excitation at 610 nm, a fluorescence 
emission around 683 nm in DMF and 694 nm in water. φF were determined both in DMF 
and in water, the results being represented in Table 17 and Table 18, respectively.  
 
Figure 107. a) Electronic absorption and b) emission spectra of conjugates 37 and 38 
and their maleimide-containing precursors 42 and 43 in DMF (full lines) and water 
(dashed lines). 
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Table 17. Electronic absorption and photophysical data for conjugates 37 
and 38 and their maleimide-containing precursors 42 and 43 in DMF. 
Compound λmax (nm) λem (nm)a φF (%)a φΔ (%)b 
42 674 683 34.0 34.4 
43 562 571 14.4 27.6 
37 671 683 33.4 38.3 
38 560 576 29.7 67.6 
a Excited at 520 nm, using F12SubPcCl in benzonitrile (φΔ = 0.58) as the reference for 
SubPcs; Excited at 610 nm, using ZnPc in DMF as the reference (φF = 0.28) for SiPcs. 
b Using ZnPc in DMF as the reference (φΔ = 0.56).  
 
Table 18. Electronic absorption and photophysical data for 
conjugates 37 and 38 in water. 
Compound λmax (nm) λem (nm)a φF (%)a 
37 682 694 9.2 
38 565 580 29.9 
a Excited at 520 nm, using F12SubPcC in benzonitrile (φΔ = 0.58) as 
the reference for SubPcs; Excited at 610 nm, using ZnPc in DMF as 
the reference (φF = 0.28) for SiPcs. b Using ZnPc in DMF as the 
reference (φΔ = 0.56).  
 
The φΔ of conjugates 37 and 38 and their maleimide-containing precursors 42 and 43 in 
DMF is also shown in Table 17, and was determined by the relative method based on the 
photoinduced decomposition of the chemical scavenger DPBF, as described in Chapter 1. 
On the other hand, similarly as in Chapter 2, φΔ of cationic compounds 37 and 38 could 
not be determined in aqueous medium. Thus, in order to examine their relative 1O2 
generation efficiency in physiological medium, their relative 1O2 generation capacity was 
evaluated in PBS (Figure 108).  
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Figure 108. Decay of the absorbance of DPBF at 414 nm, sensitized by conjugates 37 
and 38 and their maleimide-containing precursors 42 and 43, in function of irradiation 
time (min), in PBS (0.5% Cremophor EL) buffer. 
As a first observation, from the obtained data it can be seen that the results for the relative 
1O2 generation of all compounds in PBS buffer are in complete concordance with the φΔ 
obtained in DMF (Table 17). The SubPc 43 has the lowest capacity for 1O2 generation, 
followed by SiPc 42 and SiPc-CPP conjugate 37, which has a slightly higher quantum yield 
than its precursor. Surprisingly, the φΔ of SubPc-CPP conjugate 38 is more than double 
than that of its precursor. This trend is confirmed in the study in PBS buffer, where 
conjugate 38 is by far the most effective 1O2 generator. Importantly, dark control 
experiments confirm that, under all conditions, conjugates 37 and 38 are unable to 
produce 1O2 without hν>455nm illumination.  
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1.4 In vitro test of cellular uptake 
Cell uptake experiments with the prepared PS-CPP biohybrid conjugates have been 
performed in collaboration with the research groups of Prof. Annemieke Madder and Prof. 
Bruno de Geest at the University of Ghent (Belgium), in collaboration with Eva Marina 
Llamas Garcinuño and Alexandra van Driessche. 
 The most common method to study the internalization of CPP-bearing compounds 
consists in quantifying their cell uptake by flow cytometry analysis and visualizing it by 
fluorescence microscopy. In general, fluorophore-labelled peptides are used for this 
reason, however in our case the PS serves as fluorophore.  
1.4.1 Flow cytometry 
The flow cytometry analysis to quantify cell uptake is generally performed with cells 
incubated in the presence of the CPP-containing compounds at both 4°C and at 37°C.222 In 
theory, at 37°C both active transport (receptor-mediated, endocytosis) and passive 
transport (permeation) through the cell membrane can take place, whereas at low 
temperature endocytosis is inhibited. If any cell uptake does take place at 4°C, it almost 
surely has occurred through passive transport induced by the cell penetration capacity of 
the CPP. 
For the experiment chinese hamster ovary (CHO) cells, an epithelial cell line often used in 
biological and medical research, were grown, counted and plated in 24-well plates with a 
final concentration of 15 x 104 cells in 900 µL of cell medium per well. The plates were 
incubated at 37°C for 24h after which half of the cells were cooled on ice for 1 hour. At 
that time, 100 µL of a 1 µM PBS solution of the PS-CPP biohybrid conjugates was added to 
the wells, both at 37°C and at 4°C. The plates were left to incubate for another 4h, again 
either in an incubator at 37°C or on ice, after which the cell medium was removed and a 
cell dissociation buffer was added to detach the cells from the well bottom. After 15 more 
min of incubation, the cells were transferred to Eppendorf, centrifuged to remove the cell 
dissociation buffer, and dissolved in PBS for injection into the flow cytometer.  
Inside the flow cytometer, the flow with cells passes through a fluorescence measuring 
station where the light scattering and fluorescent characteristics of each cell of interest is 
measured, one cell at a time and up to thousands of cells per second. In this way a fast, 
objective and quantitative recording of fluorescent signals from individual cells in which 
uptake of the PS-CPP biohybrid conjugate has taken place (fluorescent) or not (non-
fluorescent) are counted separately, quantifying the degree of cell uptake (Figure 109). 
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Figure 109. Cell uptake (%) of the precursor compounds 42 and 43 and CPP-PS 
biohybrid conjugates 37 and 38, at 4°C and 37°C. 
The results indicate that the precursor compounds containing the maleimide moiety but 
not the CPP (42 and 43) show some uptake at 37°C, but their uptake at 4°C is negligible 
(<10%). The CPP-containing compounds (37 and 38), however, show great uptake at both 
37°C and 4°C. Uptake at 4°C, where no active transport such as endocytosis is possible, is 
higher than 90% in both cases, indicating that the CPP moieties are indeed very effective 
in destabilizing the cell membrane and are successfully introducing the PS inside the cells. 
 
1.4.2 Confocal imaging 
In some cases, the fluorescence signal generated in the flow cytometry experiment 
can be caused by cell binding of the CPP-containing compounds (due to electrostatic 
interactions between the cationic peptide and the negatively charged cell membrane) 
instead of actual cell uptake. To confirm cell uptake does take place, it is usually visualized 
by fluorescence microscopy.  
Similarly as for the flow cytometry experiment, for the confocal imaging experiment the 
CHO cells were grown, counted and plated in 24-well plates, this time with a concentration 
of 5 x 103 cells in 200 µL of cell medium per well. After 24h of incubation at 37°C (with 5% 
CO2) half of the cells was cooled on ice for 1h prior to adding 10 µL of a 1 µM PBS solution 
of the PS-CPP biohybrid conjugates to the wells, both at 37°C and at 4°C. After 4h of 
incubation, the cells are stained with Hoechst and Phalloidine stain for visualization of the 
cell nucleus and cell membrane, respectively, by fluorescence microscopy. In a first trial, 
however, no fluorescence signal could be observed, neither inside the cell or on the 
surface, due to the compounds being insufficiently fluorescent to allow for proper 
detection at the excitation wavelength and concentration used in this experiment. Since 
the excitation wavelength cannot be changed, the confocal imaging experiment will be 
repeated at higher concentration of PS. Furthermore, in vitro PDT experiments are also 
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planned in the near-feature, in order to assess the efficacy of conjugates 37 and 38 as PS 
in relation to internalization.  
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2 
Photoantimicrobial biohybrids by 
supramolecular immobilization 
of cationic zinc phthalocyanines 
onto cellulose nanocrystals  
 
2.1 State of the art 
Cellulose, made up of some 1500 glucose rings chained together, belongs to the family of 
carbohydrates which, as mentioned in the introduction of this chapter, are suitable agents 
for the biological delivery of PS. Since wood consists mostly of cellulose, it is the most 
abundant biopolymer produced in the biosphere and, as a consequence, it has been 
industrially processed and consumed for nearly 150 years. In the last two decades, 
nanoscience has enabled the development of new high-end cellulose derivatives from 
renewable resources. Rod-shaped cellulose nanocrystals (CNC) have attracted growing 
attention due to their extraordinary mechanical properties, high aspect ratio and surface 
area, colloidal stability, biocompatible sugar-based chemical structure, and cheap 
processing as a well-defined nanomaterial.248  
                                                             
248  a) M. Pääkkö, J. Vapaavuori, R. Silvennoinen, H. Kosonen, M. Ankerfors, T. Lindström, L.A. Berglund 
and O. Ikkala, Soft Matter, 2008, 4, 2492-2499. b) S.J. Eichhorn, A. Dufresne, M. Aranguren, N.E. 
Marcovich, J.R. Capadona, S.J. Rowan, C. Weder, W. Thielemans, M. Roman, S. Renneckar, W. Gindl, 
S. Veigel, J. Keckes, H. Yano, K. Abe, M. Nogi, A.N. Nakagaito, A. Mangalam, J. Simonsen, A.S. Benight, 
A. Bismarck, L.A. Berglund and T. Peijs, J. Mater. Sci., 2010, 45, 1-33. c) Y. Habibi, L.A. Lucia and O.J. 
Rojas, Chem. Rev., 2010, 110, 3479-3500. d) R.J. Moon, A. Martini, J. Nairn, J. Simonsen and J. 
Youngblood, Chem. Soc. Rev., 2011, 40, 3941-3994. e) H. Rosilo, E. Kontturi, J. Seitsonen, E. 
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CNCs have been prepared since the mid-20th century, by acid hydrolysis of cellulose 
employing strong acids, mainly sulfuric and hydrochloric acids. In this way, the amorphous 
domains are broken and only the crystalline domains remain (Figure 110).249 The 
hydrolysis conditions haves thereafter been optimized in order to improve the recovery 
yield and to tailor the CNCs dimensions.250  
 
Figure 110. Preparation of CNC from cellulose by acidic hydrolysis with H2SO4. 
The application potential of these CNCs can be significantly enhanced by surface 
modification, either by covalent or non-covalent approaches. The latter can be based on 
hydrophilic affinity, electrostatic attractions, hydrogen bonds or van der Waals forces. The 
non-covalent approach has mainly been exploited for the adsorption of surfactants to the 
cellulose surface, to improve the dispersibility of CNCs in organic solvents and 
hydrophobic matrices.251 Until now, all examples of non-covalent grafting of molecules to 
the surface of CNC implicate a previous synthetic modification of the CNC with 
supramolecular or electrostatic recognition motifs,251a,252 while the direct non-covalent 
modification of CNC remains unexplored. The covalent modification of CNC, on the other 
hand, is mainly based on the introduction of different functional groups such as allyl, thiol, 
alkyne, and azide functionalities, enabling “click” reactions.251 
The grafting of CNC with PS molecules leads to photoactive biohybrids that can be used as 
1O2 generators for both PDT and/or PDI. Ghiladi and co-workers described the covalent 
modification of CNC with a cationic Por derivative, employing the Cu(I)-catalyzed Huisgen 
                                                             
Kolehmainen and O. Ikkala, Biomacromolecules, 2013, 14, 1547-1554. f) J.R. McKee, E.A. Appel, J. 
Seitsonen, E. Kontturi, O.A. Scherman and O. Ikkala, Adv. Funct. Mater., 2014, 43, 2706-2713. g) M. 
Giese, L.K. Blusch, M.K. Khan and M.J. MacLachlan, Angew. Chem. Int. Ed., 2015, 54, 2888-2910. h) A. 
Boujemaoui, S. Mongkhontreerat, E. Malmström and A. Carlmark, Carbohydr. Polym., 2015, 115, 457-
464. 
249  B. G. Rånby, Discuss. Faraday Soc. 1951, 11, 158–164. 
250  D. Bondeson, A. Mathew, K. Oksman, Cellulose 2006, 13, 171. 
251  a] Y. Habibi, Chem. Soc. Rev. 2014, 43, 1519–1542; b) A. Boujemaoui, S. Mongkhontreerat, E. 
Malmström, A. Carlmark, Carbohydr. Polym. 2015, 115, 457–464. 
252  a) S. Eyley and W. Thielemans, Nanoscale, 2014, 6, 7764-7779. b) J. Zoppe, L. Johansson and J. 
Seppälä, Carbohydr. Polym., 2015, 126, 23-31. 
Amorphous 
domain
Crystalline 
domain
H2SO4
Chapter 3 - Design, synthesis and applications of (Sub)Pc-biohybrids in PDT and PDI 223 
 
1,3-dipolar cycloaddition (Figure 111).253 To this end, an azide group had to be introduced 
onto the CNC, which could be achieved by tosylating the surface hydroxyl groups and 
reacting them with sodium azide. The resulting Por-CNC biohybrids showed excellent 
efficacy in the PDI of the Gram-positive bacteria M. smegmatis and S. aureus and the 
Gram-negative bacterium A. baumannii. Nevertheless, they were ineffective against the 
Gram negative E. coli and P. aeruginosa bacteria. 
 
Figure 111. Covalent modification of CNC with Por molecules employing the Cu(I)-
catalyzed Huisgen 1,3-dipolar cycloaddition, as published by Ghiladi and co-workers.253 
Another PS-CNC biohybrid, based on a chlorin, was described by Sol and co-workers 
(Figure 112).254 It’s in vitro PDT efficacy was tested against a HaCat cell line displaying IC50 
values within the nanomolar range, pointing out the possible applicability of this system. 
However, as with most of the previously described covalent approaches to modify CNC, 
the conjugation of the PS on the CNC was tedious and significantly increased production 
efforts and costs. The conjugation strategy consisted of first oxidizing the glucose units by 
sodium periodate, and then reacting the resulting carbonyl functions with the amine 
groups of polyethylenimine by means of reductive amination using sodium 
cyanoborohydride. 
 
                                                             
253  a] E. Feese, H. Sadeghifar, H. S. Gracz, D. S. Argyropoulos, R. A. Ghiladi, Biomacromolecules 2011, 12, 
3528–3539; b) B. L. Carpenter, E. Feese, H. Sadeghifar, D. S. Argyropoulos, R. A. Ghiladi, Photochem. 
Photobiol. 2012, 88, 527–536. 
254  N. Drogat, R. Granet, C. Le Morvan, G. Bégaud-Grimaud, P. Krausz, V. Sol, Bioorg. Med. Chem. Lett. 
2012, 22, 3648–3652. 
224   Subchapter 2 – Pc-Cellulose Nanocrystal biohybrids for PDT 
 
 
Figure 112. Covalent modification of CNC with chlorin molecules by oxidizing the 
glucose units and reacting the resulting carbonyl groups with the amine groups 
incorporated in the chlorine derivative, as published by Sol and co-workers.254 
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2.2 Molecular design, synthesis and characterization of zinc 
phthalocyanine-CNC biohybrids 
To circumvent the above mentioned limitations of covalently attaching PS to CNC, in this 
chapter we aim to immobilize PS on the surface of sulfated CNC through an easy, non-
covalent approach based on electrostatic interactions between positively charged PS and 
the negatively charged CNC surface (Figure 113). Two cationic ZnPc (44 and 45) will be 
immobilized, whereas a third anionic ZnPc (46) was employed as negative control for 
confirming that binding proceeds through electrostatic interactions.  
 
 
Figure 113. Chemical structure of the cationic ZnPc derivatives 44 and 45, and the 
schematic representation of their supramolecular immobilization onto the surface of 
sulfate-decorated CNC. The anionic ZnPc 46 is a negative control.  
 
The synthesis of the ZnPc derivatives (44-46) used in the preparation of the ZnPc-CNC 
biohybrids has been previously reported by Dr. Eduardo Anaya-Plaza, and will therefore 
not be detailed in the present thesis. The synthesis of the biohybrids and their 
characterization has been performed in collaboration with the group of Mauri A. Kostianen 
from the Aalto University in Espoo (Finland). 
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2.2.1 Synthesis and characterization of the ZnPc-CNC biohybrids 
CNC with negatively charged surface sulfate groups were isolated from filter paper by 
sulfuric acid hydrolysis.255 The ZnPc-CNC hybrids, in turn, were easily prepared by 
ultrasound bath-assisted dispersion of the CNC (5 mg mL-1, 3 mL) in the corresponding 
ZnPc aqueous solution (ca. 0.1 mM, 12 mL) for 30 min. The sample was then centrifuged 
at 10000 rpm (9391 rfc) for 10 min and the pellet was washed five times with water and 
centrifuged again, until no color was observed in the supernatant (Figure 114). 
             44-CNC       45-CNC 
 
Figure 114. Images of 44-CNC and 45-CNC suspensions in PBS before and after 
centrifugation. 
The ZnPc payload in the hybrids was determined through elemental analysis and 
calculated to be 1.0 x 10-5 and 1.7 x 10-5 mol of ZnPc per gram of CNC for 44-CNC and 45-
CNC, respectively. Dynamic light scattering (DLS) was used to estimate the hydrodynamic 
diameter of pristine CNC (128 ± 8 nm), 44-CNC (234 ± 17 nm) and 45-CNC (216 ± 17 nm), 
at low concentration (0.05 mg mL-1) to minimize the absorption of the ZnPc (Figure 115a, 
Table 19). A significant increase in size can be observed for the complexes in comparison 
to pristine CNC. We ascribe this size increase to a slight CNC aggregation and electrostatic 
cross-linking induced by the immobilized ZnPc. Yet the particle sizes remain in the range 
of a few hundreds of nanometers and have moderate polydispersity index (PDI) values.  
The electric double layer of the system was evaluated by measuring the electrophoretic 
mobility and ζ-potentials of the hybrid particles at 0.05 mg mL-1 (Figure 115b, Table 19). 
The value found for 44-CNC (-3.20 x 10-8 m2 V-1 s-1) closely resembles that of the pristine 
CNC (-3.23 x 10-8 m2 V-1 s-1), as a consequence of the low percentage of interacting sulfate 
esters (13.5%) in 45-CNC, which leaves the electrostatic surface of the particles very 
similar to that in the absence of ZnPc. On the contrary, the electrophoretic mobility of 45-
CNC (-0.93 x 10-8 m2 V-1 s-1) drops drastically, as compared to pristine CNC. We ascribe this 
effect to the methoxy(triethylenoxy) chains, which render a more neutral solvation sphere 
and colloidal stabilization of the particle surface. 
 
 
                                                             
255  C. D. Edgar, D. G. Gray, Cellulose 2003, 10, 299–306. 
Chapter 3 - Design, synthesis and applications of (Sub)Pc-biohybrids in PDT and PDI 227 
 
Table 19. Z-average size and PDI from DLS, mobility and ζ-potential 
measurements of CNC, 43-CNC and 44-CNC. 
 
Z-avg.  
(nm) 
PDI 
Mobility 
(10-8 m2·V-1·s-1) 
ζ-Pot.  
(mV) 
CNC 128 ± 8 0.18 -3.23 ± 0.04 -41.3± 5.5 
44-CNC 234 ± 17 0.34 -3.20 ± 0.2 -40.4 ± 2.3 
45-CNC 216 ± 17 0.24 -0.93 ± 0.12 -12.0 ± 1.5 
     
 
Figure 115. (a) DLS results showing the increase in intensity-averaged size distribution 
when CNC are coated with 44 (44-CNC) and 45 (45-CNC) in 5 µg/L solutions. Inset: 
correlograms of selected spectra. (b) ζ-potential of CNC showing no variation in 44-CNC 
and a decrease of 29.3 mV in absolute value for 45-CNC.  
 
In order to characterize aggregation of the ZnPc-decorated CNCs, suggested above by DLS 
data, electron microscopy studies were also conducted. Cryogenic transmission electron 
microscopy (cryo-TEM) images of 44-CNC show clusters of slightly aggregated rod-shaped 
nanocrystals in different orientations (Figure 116a). This behavior differs from 45-CNC 
where all the nanocrystals are shown in flat, highly orientated, well-packed sheets (Figure 
116b). We ascribe these differences to the presence of PEG chains in the chemical 
structure of 45 that hinder the binding to the CNC, yielding thermodynamically favored 
closed-packed assemblies. In opposition, 44 binds faster due to the exposed cationic 
surface, yielding kinetically trapped amorphous aggregates. 
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Figure 116. Cryo-TEM image of (a) 44-CNC and (b) 45-CNC at 0.5 mg/mL in water. Scale 
bars: 200 nm. Insets show magnifications of the areas marked by dashed lines. 
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2.2.2 Electronic absorption and photophysical properties 
The electronic absorption and photophysical properties of the CNC-ZnPc biohybrids have 
been investigated during a predoctoral stay in the research group of Prof. Santi Nonell 
Marrugat at the Institut Químic de Sarrià of the Universitat Ramon Llull (Barcelona), in 
collaboration with Roger Bresolí-Obach. 
 
2.2.2.1  Aggregation behaviour 
The aggregation behaviour of 44 and 45, both in solution and bound onto the CNC 
(44-CNC and 45-CNC, respectively), is assessed by UV-Vis spectroscopy in different 
solvents (Figure 117).  
 
Figure 117. Absorption spectra of compounds a) 44 and b) 45 in methanol (blue), water 
(red) and PBS (black), as compared to those of hybrids c) 44-CNC and d) 45-CNC. 
In methanol, both ZnPcs 44 and 45 exist in their monomeric form, displaying a 
characteristic sharp and intense absorption band at 670 nm and 674 nm, respectively, as 
is also the case for 44 in water. 45 on the other hand shows the appearance of a strong 
absorption band at 635 nm in water, an indication of H-type ZnPc aggregation.256 In 
aqueous phosphate buffer saline (PBS), a physiologically relevant medium, the intensity 
of this band increases at the expense of the monomer band. Interestingly, 44 appears to 
be more aggregated than 45.  
The absorption spectra of the ZnPc-CNC hybrids 44-CNC and 45-CNC in methanol and 
water, on the other hand, show the characteristics of non-aggregated ZnPc (i.e., lack of 
the absorption band at 635 nm), as well as the typical scattering from CNC over the whole 
                                                             
256  T. Nyokong, Coord. Chem. Rev. 2007, 251, 1707–1722. 
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spectral range. In PBS all CNCs showed aggregation, though to a lower extent than 44 and 
45.  
 
2.2.2.2  1O2 generation efficiency 
To demonstrate the photoactive character of the ZnPc-CNC complexes, we 
proceeded to study their efficacy for photoinduced 1O2 production and to compare it with 
that of the corresponding free ZnPc derivatives. To this end, time-resolved near-IR 
spectroscopy was used to monitor the phosphorescence of 1O2 at 1275 nm and compare 
it to that of suitable references (see Table 20 and Figure 118).257 The results show that 44 
is an intrinsically better PS than 45 in methanol, where both are in monomeric form. In 
PBS both compounds lose their photosensitising ability due to extensive aggregation. An 
intermediate behaviour is observed in neat D2O, used instead of water to increase the 1O2 
lifetime, namely 44 behaves as in methanol but 45 is closer to PBS due to its more 
hydrophobic character.  
Table 20. φΔ of 44, 45, 44-CNC and 45-CNC in various solvents. All 
φΔ values were determined as the average of three different 
measurements. 
 φΔ [MeOH] φΔ [D2O] φΔ [PBS] 
44 0.62±0.03 0.74±0.06 0.04±0.01 
45 0.02±0.01 0.01 <0.01 
44-CNC 0.20±0.04 0.04±0.01 <0.01 
45-CNC 0.02±0.01 0.01 <0.01 
                                                             
257  A. Jiménez-Banzo, X. Ragàs, P. Kapusta, S. Nonell, Photochem. Photobiol. Sci. 2008, 7, 1003–1010. 
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Figure 118. Time-resolved near-IR emission signals at 1275 nm for the free Pcs 44 and 
45 and the biohybrids 44-CNC and 45-CNC (red lines) as well as for the reference PS 
used to determine φΔvalues (blue lines). For the biohybrids an additional green line 
shows the effect of 50 mM NaN3. a) 44 in methanol, b) 44 in water, c) 44 in PBS, d) 45 in 
methanol, e) 45 in water, f) 45 in PBS, g) 44-CNC in methanol, h) 44-CNC in D2O, i) 44-
CNC in deuterated-PBS, j) 45-CNC in methanol, k) 45-CNC in D2O and l) 45-CNC in 
deuterated-PBS. The insets in G-L show the same data in log scale to facilitate 
visualization. 
Contrary to what could perhaps be expected in view of the almost pure monomeric 
absorption spectra (Figure 117), the CNC biohybrids show almost no 1O2 production in any 
solvent. This was thoroughly investigated and the underlying reason seems to be the 
severe loss of efficiency of oxygen trapping of the Pc’s triplet state (3Pc) upon anchoring 
to the CNC surface, a prerequisite for 1O2 production. This is evidenced by the long 3Pc 
lifetime in the biohybrids compared to the free molecules in solution (Figure 119; compare 
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panels A vs E and B vs F) and by the minor effect of sodium azide, a potent 1O2 quencher,258 
on the emission signals at 1275 nm (cf. panels C vs G and D vs H).  
 
Figure 119. Comparison of the time-resolved near-IR emission signals in D2O at 1110 nm 
(3Pc; red line) and 1275 nm (3Pc and 1O2; blue line) for the free phthalocyanines 44 (A, 
C) and 45 (B, D), and for the biohybrids 44-CNC (E, G) and 45-CNC (F, H). The green line 
shows the effect of 50 mM NaN3 on the 1275 nm emission. The phthalocyanine 
concentration was 3 µM in all cases. 
It is worth mentioning that the signals at 1275 nm are a combination of 3Pc 
phosphorescence and 1O2 emission, as demonstrated by the remaining emission observed 
after adding sodium azide. The actual contribution of 1O2 to the 1275 nm signals can thus 
be gauged by comparing the signals recorded in the absence and in the presence of azide. 
It is clear that it is much larger for the free molecules than for the CNC biohybrids, in which 
the 1275 nm signals are largely dominated by 3Pc phosphorescence. The conclusion from 
these experiments is that anchoring the Pcs to the CNC surface almost completely inhibits 
their ability to produce 1O2. Similar results were observed in methanol and PBS (Figure 120 
and Figure 121, respectively).  
                                                             
258  M. Y. Li, C. S. Cline, E. B. Koker, H. H. Carmichael, C. F. Chignell, P. Bilski, Photochem. Photobiol. 2001, 
74, 760–764. 
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Figure 120. Comparison of the time-resolved near-IR emission signals in methanol at 
1110 nm (red line) and 1275 nm (blue line) for the free phthalocyanines 44 (A, C) and 45 
(B, D), and for the biohybrids 44-CNC (E, G) and 45-CNC (F, H). For the biohybrids, an 
additional green line shows the effect of 50 mM NaN3 on the 1275 nm, emission. The 
phthalocyanine concentration was 3 M in all cases. 
 
Figure 121. Comparison of the time-resolved near-IR emission signals in deuterated-PBS 
at 1110 nm (red line) and 1275 nm (in absence (blue line) and in presence (green line) 
of 50 mM NaN3) for the biohybrids 44-CNC (A, C) and 45-CNC (B, D). The phthalocyanine 
concentration was 3 M in all cases. 
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These results are consistent with the tight packing observed for the two ZnPc-CNC hybrids 
(see cryo-TEM results, Figure 116), which limits the diffusion of molecular O2 through the 
CNC bundles.259 Thus only the ZnPc molecules in close contact with the solvent (i.e. located 
at the surface of those bundles) can effectively produce 1O2. The different modes of 
packing observed for 44-CNC and 45-CNC do not alter this general picture.  
  
                                                             
259  A. J. Svagan, C. Bender Koch, M. S. Hedenqvist, F. Nilsson, G. Glasser, S. Baluschev, M. L. Andersen, 
Carbohydr. Polym. 2016, 136, 292–299. 
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2.3 In vitro photodynamic inactivation of microorganisms 
PDI experiments for the CNC-ZnPc biohybrids have been performed during a predoctoral 
stay in the research groups of Dra. Montserrat Agut Bonsfills at the Institut Químic de 
Sarrià of the Universitat Ramon Llull (Barcelona), in collaboration with Oscar Gulías.   
The microorganisms used in this study were the Gram-positive bacteria 
Staphylococcus aureus, Gram-negative bacterium Escherichia coli and the pathogenic 
yeast C. albicans.  
In general, fresh bacterial or yeast cultures with a concentration between 1.5 and 3 x 108 
CFU mL−1, in the presence of the PS,  were irradiated by means of a LED-lamp with red light 
(625 ± 25 nm), coinciding with the absorption maximum of the ZnPcs. Light alone controls 
without PS, and dark toxicity control with PS in dark were performed in order to rule out 
any inactivation effect due to the light or the PS alone. Triplicate aliquots of treatments 
and controls were collected at various time intervals and survival fractions were expressed 
as ratios of CFUs of cells treated with light and PS to CFUs of untreated cells.  
First and foremost, before initiating any photoinactivation study of the newly designed 
biohybrids, the toxicity of the pristine CNCs on S. aureus is investigated (Figure 122). 
Favourably, at both low and high concentration (0.5 µM and 5 µM), and both in the dark 
or upon 30 minutes of irradiation, the CNCs are devoid of any cytotoxity. 
 
Figure 122. Photoinactivation studies of S. Aureus. Working compounds concentrations: 
0.5 µM (brown) and 5µM (green). 
Consequently, the PDI properties of these new biohybrids were tested against S. aureus, 
a Gram-positive bacterium, and compared with that of the free ZnPc counterparts (Figure 
123). Both 44-CNC and 45-CNC proved to be highly efficient in inactivating S. aureus, 
resulting in 6 logs and 3 logs CFU reduction, respectively, at concentrations as low as 0,5 
µM and light fluencies of only a few J/cm2. Remarkably, both CNC hybrids showed a 
greater photoinduced antimicrobial effect than the free ZnPcs 44 and 45, highlighting the 
importance of their formulation onto CNC. Importantly, 44-CNC is devoid of any dark 
toxicity, while that of 45-CNC is non-zero but almost negligible (1 log CFU reduction). 
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Figure 123. Photoinactivation studies of S. aureus with a) 44 and 44-CNC or b) 45 and 
45-CNC upon red light irradiation (620-645 nm; 18 mW/cm2). Working compounds 
concentration: 0.5 µM. 44-CNC and 45-CNC are represented with red lines and circle 
marks, while plain ZnPc 44 and 45 inactivations are depicted in blue with triangle marks. 
Dark controls are represented with solid marks. 
Similar results as those for S. aureus were obtained against the Gram-negative E. coli. 44-
CNC showed no dark toxicity and reached 8 logs of CFU reduction, i.e., complete 
eradication, at approximately 3 M and 64 J/cm2 (Figure 124a). On the other hand, 45-
CNC induced up to 6 logs CFU reduction under the same conditions, however its dark 
cytotoxicity was very high (4 logs of CFU reduction; Figure 124b). Significantly, the free 
compounds 44 and 45 were again 3-4 logs less effective, clearly indicating the added value 
of their covalent attachment to the CNCs.  
 
Figure 124. Photoinactivation studies of E. coli with a) 44 and 44-CNC or b) 45 and 45-
CNC upon red light irradiation (620-645 nm; 18 mW/cm2). Working compounds 
concentration: 3 µM. 44-CNC and 45-CNC are represented with red lines and circle 
marks, while plain ZnPc 44 and 45 inactivations are depicted in blue with triangle marks. 
Dark controls are represented with solid marks. 
Finally, both 44 and 44-CNC were also tested against C. albicans (Figure 125), whereas 45 
and 45-CNC were discarded in view of the high dark toxicity the biohybrid displayed in 
both S. aureus and E. coli. Neither 44 or 44-CNC showed any dark toxicity. Interestingly, 
44 did not show any phototoxicity either, while 44-CNC was highly phototoxic, reaching 
more than 6.5 logs CFU reduction at 3 M and 64 J/cm2.  
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Figure 125. Photoinactivation studies of C. albicans with 44 and 44-CNC upon red light 
irradiation (620-645 nm; 18 mW/cm2). Working compounds concentration: 3 µM. 44-
CNC is represented with red lines and circle marks, while plain ZnPc 44 is depicted in 
blue with triangle marks. Dark controls are represented with solid marks. 
In sum, 44-CNC is a very efficient and broad spectrum photoantimicrobial agent, devoid 
of any dark toxicity and worth of further consideration. Importantly, the PS concentrations 
and light doses applied for the PDI of both S. aureus and E. coli are one- to two order of 
magnitudes lower than those reported in the literature for similar, but covalently linked 
systems.253 The substantial loss of 1O2 photosensitisation ability of 44 and 45 when they 
are anchored to the CNC surface (see results section 2.3.2) may explain the modest 
performance of these previously published covalently linked systems. Thus, in our case, 
the excellent photoantimicrobial ability of 44-CNC and 45-CNC suggests that the Pcs, being 
only non-covalently attached, can be transferred from the negatively charged CNC surface 
to the negatively charged cell wall of the microorganisms, and in this way result in 
significantly greater photodamage. 
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3 
Summary and Conclusions 
 
In the present chapter, we have developed two different kinds of PS-based 
biohybrid systems for PDT and PDI. They are differentiated by both the type of biological 
delivery agent and the synthetic approach that was employed in each subchapter. 
In the first subchapter, the conjugation of a well-known CPP with two different PS, 
a SiPc and a SubPc, has been discussed. The conjugation strategy was covalent, by 
incorporation of a cysteine functionality at the C-terminus of the CPP and a maleimide 
functionality in the PS structure, which allowed the CPP and the PS to react through a 
maleimide-thiol Michael addition “click” reaction. The resulting PS-CPP biohybrids are 
water-soluble and their absorption, fluorescence and 1O2 generation capacity have been 
carefully evaluated in water and/or PBS. These experiments confirmed that both 
conjugates are efficient 1O2 generators, 37 being a better PS than 38. Finally, in order to 
evaluate the cell uptake properties of these PS-CPP conjugates, their cellular 
internalization properties was quantified in vitro, using chinese hamster ovary cells as a 
model system, by flow cytometry analysis. Both biohybrids were taken up by the cells 
efficiently at 4°C, where only passive transport is possible, indicating the CPP is responsible 
for the cell uptake and confirming the utility of our strategy. The visualization of cell 
uptake by fluorescence microscopy is pending. 
In the second subchapter, we have studied supramolecular complexes of Pc 
molecules and CNC, as a type of optically active biohybrid nanostructures. Preparation of 
such materials represents a challenging goal from the nanotechnology point of view. Our 
strategy is based on the immobilization of cationic ZnPc derivatives onto unmodified CNC 
through an easy and straightforward non-covalent methodology, which is driven by 
electrostatic interactions. The resulting biohybrids have been characterized by UV-Vis 
spectroscopy, DLS and cryo-TEM, proving that ZnPc stacking and CNC clustering are key 
processes that need to be prevented for an optimal photoinduced 1O2 production. To this 
end, the 1O2 generation of both the ZnPcs and the ZnPc-CPP biohybrids was studied in 
depth by monitoring the phosphorescence of 1O2 by time-resolved near-IR spectroscopy. 
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Importantly, 1O2 is a key species in photodynamic therapy, water treatments, diagnostic 
arrays and photocatalytic technologies. The photodynamic inactivation of bacteria by 44-
CNC and 45-CNC, for example, show clear advantages of these nanohybrids compared to 
the free ZnPc and to related nanosystems in which the PS is covalently linked to the CNC 
surface. The hybrids developed herein are therefore promising photoactive biomaterials, 
which may find useful applications in biomedicine and nanotechnology. 
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4 
Experimental section 
4.1 Materials and methods 
The materials and methods used in this experimental section are the same as the ones used 
in that of Chapter 1, except for: 
IR spectra (IR) were recorded on a FTIR Cary 630 (Agilent Technologies) using the ATR 
technique. Spectral intensity were corrected by the ATR algorism and subsequent baseline 
correction. 
GC-EI spectra were recorded using an GCT Agilent Technologies 6890N spectrometer 
(Waters), at the Servicio Interdepartmental de Investigación (SIdl) of the Universidad 
Autónoma de Madrid. The data are expressed with the intensity in percentage between 
parentheses. 
The MALDI-TOF spectra of CPP conjugates (Subchapter 1) were recorded on an Applied 
Biosystems Voyager-DE STR Biospectrometry Workstation, using freshly prepared α-
cyano-4-hydroxycinnamic acid as matrix, in the department of Organic Chemistry at 
University of Ghent, Belgium. For peptidic compounds, the exact mass, rather than the 
molecular weight of the compound, is stated, as this allows for an easier evaluation of 
mass spectrometric data. The data are expressed with the intensity in percentage 
between parentheses. 
RP-HPLC analyses were performed on an Agilent 1100 Series instrument with a 
Phenomenex Luna C18(2) column (250 x 4.6 mm, 5 µm at 35°C). A flow rate of 1 mL/min 
and with the following solvent systems: 
- For SiPc-CPP 37: water (A) and acetonitrile (B). The column was flushed for 10 
min with 100% B followed by 10 minutes of flushing with 100% A, then a 
gradient from 50 to 100% B over 25 min was used, followed by 10 min of 
flushing with 100% B. Samples were dissolved in water (A) and filtered (0.45 
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μm pore size, Millipore nylon filters) prior to injection. UV-detection was 
performed at 214, 254, 280 and 676 nm.  
 
- For SubPc-CPP 38: 0.1% TFA in water (A) and 0.1% TFA in acetonitrile (B). The 
column was flushed for 10 min with 100% B followed by 10 minutes of flushing 
with 100% A, then a gradient from 0 to 100% B over 25 min was used, followed 
by 10 min of flushing with 100% B. Samples were dissolved in 0.1% TFA in water 
(A) and filtered (0.45 μm pore size, Millipore nylon filters) prior to injection. 
UV-detection was performed at 214, 254, 280 and 650 nm.  
Elemental analysis was carried out in a LECO CHNS-932 analyser. A Zetasizer Nano ZS90 
analyzer (Malvern Instruments) with a He–Ne laser of 633 nm was used for measuring the 
particle size distributions, electrophoretic mobilities and -potentials at a 90° scattering 
angle. Disposable PMMA cuvettes (Plastibrand) were used for DLS measurements and 
Universal 'Dip' cell (ZEN1002) for -potential measurements. Cryogenic transmission 
electron microscopy (cryo-TEM) imaging was carried out with JEOL JEM-3200FSC 
equipment. 
 
4.1.1 Fluorescence and singlet oxygen quantification 
The φF and φΔ in Subchapter 1 are determined using the same procedures as those used in 
Chapter 1. The φΔ in Subchapter 2 on the other hand are determined by time-resolved near-
IR spectroscopy. 
The specific near-infrared phosphorescence kinetics were detected by means of a 
PicoQuant Fluotime 200 lifetime system customized as follows: a diode-pumped pulsed 
Nd:YAG laser (FTSS355-Q, Crystal Laser, Berlin, Germany) working at 10 or 1 kHz repetition 
rate at 355 nm (0.5 μJ per pulse) was used for excitation. A 1064 nm rugate notch filter 
(Edmund Optics, York, UK) and an uncoated SKG-5 filter (CVI Laser Corporation, 
Albuquerque, USA) were placed at the exit port of the laser to remove any residual 
component of its fundamental emission in the near-infrared (NIR) region. The 
luminescence exiting from the sample was filtered by a 1100 nm long-pass filter (Edmund 
Optics, York, UK) and narrow bandpass filters at either 1110 nm (BP-1110-070-B, 
Spectrogon, Täby, Sweden) to detect the phthalocyanine phosphorescence emission, or 
at 1275 nm (BK-1270-70-B, bk Interferenzoptik, Nabburg, Germany) to detect the 1O2 
emission. A TE-cooled near-IR sensitive photomultiplier tube assembly (H9170-45, 
Hamamatsu Photonics, Hamamatsu City, Japan) was used as detector. Photon counting 
was achieved with a multichannel scaler (NanoHarp 250, PicoQuant, Berlin, Germany).  
φΔ is defined as the number of photosensitized 1O2 molecules per absorbed photon and 
was determined by fitting the kinetic model below to the time-resolved phosphorescence 
intensity at 1275 nm, which contains both 1O2 and triplet phthalocyanine emission 
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components.260 The pre-exponential factors S(0) and S(0) are proportional to φΔ and φt, 
respectively 
𝑆(𝑡) = 𝑆∆(0) ×
𝜏∆
𝜏𝑇  𝜏∆
× (𝑒−𝑡/𝜏𝑇  𝑒−𝑡/𝜏∆)     𝑆𝑇(0)𝑒
−𝑡/𝜏𝑇 
For the free phthalocyanines φΔ was determined by comparison of their S(0) values to 
that of an optically-matched reference in the same solvent and at the same excitation 
wavelength. The references used were 1H-phenalen-1-one in methanol ( = 0.98)261 and 
1H-phenalen-1-one-2-sulphonate in water or PBS (φΔ = 0.97).262 For the biohybrids, the 
references were the corresponding free phthalocyanines at the same concentration. 
𝜙∆(𝑠𝑎𝑚𝑝𝑙𝑒) =  
𝑆∆(0)𝑠𝑎𝑚𝑝𝑙𝑒
𝑆∆(0)𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒
 ×  𝜙∆(𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒) 
 
4.1.2 Flow cytometry 
The cell medium of a cell suspension of CHO cells was removed and the cells were washed 
with PBS and incubated for 15 minutes in the presence of trypsine. PBS was added for 
centrifugation of the cells, the supernatant removed and the cells resuspended in cell 
medium. 180 µL of Trypan blue was added to 20 µL of cell suspension, in order to visualize 
the cells for cell counting. 
Cells were subsequently plated in 24-well plates with a concentration of 15*104 cells 
in 900 µL per well. Half of the cells was maintained in an incubator at 37°C (5% CO2), 
whereas the other half was cooled on ice. After 1h, 100 µL of a PBS solution of the PS-CPP 
biohybrid conjugates was added to the wells. For each measurement condition two blanks 
were performed without adding any PS-CPP biohybrids to the cells. The plates were left 
to incubate for another 4h, again either in an incubator at 37°C (5% CO2) or on ice, after 
which the cell medium was removed and 500 µL of cell dissociation buffer was added to 
detach the cells from the well bottom. After 15 more minutes of incubation the cells were 
transferred to Eppendorf, centrifuged to remove the cell dissociation buffer, and dissolved 
in 300 µL of PBS for injection into the flow cytometer. Flow cytometry experiments are 
performed on a BD Accuri C6 from BD Biosciences with serial number 3863.  
                                                             
260  S. Nonell. and Flors. C., in Singlet Oxygen: Applications in Biosciences and Nanosciences Vol. 2, The 
Royal Society of Chemistry, London, 2016, pp. 7–26. 
261  a) E. Oliveros, P. Suardi-Murasecco, T. Aminian-Saghafi, A. M. Braun and H.-J. Hansen, Helv. Chim. 
Acta, 1991, 74, 79–90; b) R. Schmidt, C. Tanielian, R. Dunsbach and C. Wolff, J. Photochem. Photobiol. 
A Chem., 1994, 79, 11–17; c) C. Martí, O. Jürgens, O. Cuenca, M. Casals and S. Nonell, J. Photochem. 
Photobiol. A Chem., 1996, 97, 11–18. 
262  S. Nonell, M. González and F. R. Trull:, Afinidad, 1993, 44, 445–450. 
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4.1.3 Confocal imaging 
Cells were plated in 24-well plates with a concentration of 5*103 cells in 200 µL per well. 
Half of the cells was maintained in an incubator at 37°C (5% CO2), whereas the other half 
was cooled on ice. After 1h, 10 µL of a PBS solution of the PS-CPP biohybrid conjugates 
was added to the wells. For each measurement condition two blanks were performed 
without adding any PS-CPP biohybrids to the cells. After 4 more hours of incubation, the 
cells were stained with Hoechst and Phalloidine stain for visualization of the cell nucleus 
and cell membrane, respectively, by fluorescence microscopy.  
For staining, a dye solution consisting of 2 mL PBS BSA 1% + 5 µL CTB 488 stock + 10 µL 
Hoechst stock 1 mg/mL was prepared. The cell medium was removed and the cells were 
washed with 2 x 200 µL PBS, after which 200 µL PFA 4% was added for cell fixation. The 
cells were incubated for 15 minutes (37°C, 5% CO2) and washed with 2 x 200 µL PBS before 
adding the dye solution and incubating another 30 minutes (37°C, 5% CO2). Upon removal 
of the dye solution, the cells were again washed and resuspended in PBS, and kept in the 
dark until the confocal imaging experiment. 
Confocal imaging experiments were performed on a Leica DMI6000 B inverted microscope 
equipped with a Zeiss 63x NA 1.40 oil immersion objective and an Andor DSD2 confocal 
scanner. Images were treated with Imaris software. 
 
4.1.4 Photoinactivation studies  
Three strains obtained from the American Type Culture Collection (S. aureus 29213, E. coli 
ATCC 25922 and C. albicans ATCC 18804) were tested in this study. All the isolated strains 
were deposited and maintained at IQS (Institut Químic de Sarrià). 
 
Inactivation of bacterial strains:  
Bacteria were grown aerobically overnight at 37°C in Tryptic Soy Broth (TSB, Panreac 
413820.1210, Castellar del Vallès, Spain) in an orbital shaking incubator. 10µl of the pre 
inoculum was added to 10ml of sterile TSB and incubated, until the culture reached an 
optical density of 0,2 at 600 nm, corresponding to between 1.5 to 3 ·108 CFU ml-1.  
The suspensions were then centrifuged (10 minutes, 3000 g) and suspended with sterile 
phosphate-buffered saline at pH4 (PBS, Fisher BP399, New Jersey, USA) at the same 
cellular concentration in the presence of 0.5µM (S. aureus) or 3 µM (E. coli) of the 
appropriate compound. Then, bacterial suspensions were incubated in the dark in an 
orbital shaking incubator at 37°C for 15 minutes. 
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Next, 300 µl aliquots of the bacterial suspensions were placed in 96-well plates. The plates 
were illuminated by means of a LED-lamp (Sorisa Photocare) with red light (625 ± 25 nm) 
from the top of the plates at a fluence of 18 mW/cm2. At the time point when the requisite 
fluence had been delivered (0, 5, 15, 30 or 60 minutes), the aliquots were serially diluted 
in PBS, and 10 µl of each dilution were streaked on Tryptic Soy Agar plates (TSA, TSB added 
with 1,5% agar-agar, Fisher BP9744, Geel, Belgium) and incubated in the dark for 24 hours 
at 37°C. After the incubation period, the number of CFU ml-1 was determined.  
Experiments were carried out in triplicate for each condition. Light alone controls without 
PS, and dark toxicity control with PS in dark were performed in order to rule out any 
inactivation effect due to the light or the PS alone. Survival fractions were expressed as 
ratios of CFU of bacteria treated with light and photo-sensitizer to CFU of untreated 
bacteria. 
 
Inactivation of Candida albicans:  
Pre inoculum suspensions were prepared from an overnight culture of the yeast grown in 
glucose Sabouraud broth (Panreac 413804.1210, Castellar del Vallès, Spain) incubated 
aerobically at 30ºC in an orbital shaking incubator. 100 µL of the pre inoculum were added 
to 10 mL of sterile glucose Sabouraud broth and incubated at 30°C until the culture 
reached an optical density of 0.25 at 600 nm, corresponding to 1 x 108 to 2 x 108 CFU ml-
1. After the incubation period, yeast cultures were centrifuged for 10 minutes and 3,000g 
and re-suspended in 10 mL of sterile PBS at pH 4 with 3 µM of the desired compound. The 
suspensions were then incubated in the dark in an orbital shaking incubator at 30°C for 15 
minutes. After this, 300 µL aliquots of the suspensions were placed in 96-well plates and 
illuminated with red light (625 ± 25 nm, 18 mW/cm2) from the top of the plates. When the 
desired fluence had been delivered (0, 15, 30 or 60 minutes), the aliquots were serially 
diluted in PBS and 10 µL of each dilution were streaked on glucose Sabouraud agar 
(Panreac 4138021210, Castellar del Vallès, Spain) and incubated in the dark for 48 hours 
at 30°C. After the incubation period, the number of CFU ml-1 was determined.  
Experiments were carried out in triplicate. Survival fractions were expressed as ratios of 
CFUs of cells treated with light and PS to CFUs of untreated yeasts. Light-only and PS-only 
controls were performed. 
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4.2 Experimental details synthesis  
4.2.1 Synthesis of maleimide-containing SiPc and SubPc derivatives 
1-(3-((tert-butyldimethylsilyl)oxy)propyl)-1H-pyrrole-2,5-dione (40):  
Maleic anhydride (3.500 g, 0.036 mol) was dissolved in ethanol (300 
ml) and added dropwise to a solution of 9 (8.101 g, 0.042 mol) and 
triethylamine (4.9 mL, 0.036 mol) in ethanol (200 mL) at 0°C under 
vigourous stirring. The reaction mixture was stirred for 4h. The 
solvent was removed, the residue was redissolved in acetic anhydride (70 mL) and sodium 
acetate (2.920 g, 0.036 mol) was added. The reaction mixture was heated for 30 min at 
60-70°C and cooled to rt. The solvent was evaporated and the crude product purified by 
column chromatography using EtOAc/heptane (6:1) as the eluent to yield 40 (4.486 g, 
47%) as a viscous colorless oil. 
1H-NMR (300 MHz, CDCl3): δ(ppm) 6.63 (s, 2H, H1), 3.68 – 3.46 (m, 4H, H3, H5), 1.72 (p, J = 
7.0 Hz, 2H, H4), 0.82 (s, 9H, H8), -0.03 (s, 6H, H6). 
13C-NMR (75 MHz, CDCl3): δ(ppm) 170.32 (C2), 133.69 (C1), 60.23 (C5), 34.93 (C3), 31.06 
(C4), 25.49 (C8), 17.85 (C7), -5.81 (C6). 
MS (GC-EI): 254.1 [M–CH3]+ (10), 212.1 [M–t-Bu]+ (100), 156.0 [M–TBDMS+2H]+ (60), 
154.0 [M–TBDMS]+ (40), 110 (10), 75 (10). 
HR-MS (GC-EI): [M]+ Calcd. for C12H20NO3Si: 254.1119; Found: 254.1203. 
FT-IR (neat)  (cm-1): 2856, 1701 (C=O), 1444, 1406, 1253, 1152, 1095, 1005, 826, 775. 
 
1-(3-hydroxypropyl)-1H-pyrrole-2,5-dione (41):  
40 (0.121 g, 0.4 mmol) was dissolved in dry methanol (1.7 mL) and the 
reaction mixture was cooled to 0°C. Acetyl chloride (5 µL, 0.07 mmol) 
was added dropwise under vigorous stirring. Upon completion of the 
reaction (30 minutes) the solvent was evaporated at 0°C to yield compound 41 as a 
colorless oil (0.176 g, 87%). Compound 41 was directly used in the next step without 
further purification, to reduce the risk of polymerization. 
1H-NMR (300 MHz, CDCl3): δ(ppm) 6.98 (s, 2H, H1), 4.23 (s, 1H, OH), 3.44 (t, J = 7.3 Hz, 2H, 
H5), 3.38 (t, J = 6.2 Hz, 2H, H3), 1.62 (p, J = 6.8 Hz, 2H, H4). 
13C-NMR (75 MHz, CDCl3): δ(ppm) 171.08 5 (C2), 134.50 (C1), 58.43 (C5), 34.83 (C3), 31.25 
(C4). 
MS (GC-EI): m/z = 155.0 [M]+ (10), 137.0 (40), 125.0 (40), 110.0 (100), 99.0 (30), 87.0 (30). 
HR-MS (GC-EI): [M]+ Calcd for C7H9NO3: 155.0582; Found: 155.0590. 
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Subphthalocyanine 42:  
16 (0.080 g, 0.190 mmol) and silver triflate (0.060 g, 0.230 
mmol) were dissolved in anhydrous toluene (3 mL) and the 
mixture was stirred at rt under argon atmosphere 16 is 
consumed (approx. 40 min). Once the SubPcBOTf was 
generated, the nucleophile 41 (0.058 g, 0.380 mmol.) and 
DIPEA (40 μL, 0.230 mmol) were added. The mixture was 
stirred at 40°C until the reaction is completed. The solvent was removed by evaporation 
under reduced pressure and the product was directly purified by chromatography on silica 
gel using a gradient of toluene/THF (30:1 to 10:1) as the eluent. After further SEC 
purification with Bio-Beads 42 (0.039 g, 38%) was obtained as a dark pink solid. 
1H-NMR (300 MHz, CDCl3): δ(ppm) 8.80 – 8.72 (AA’BB’ system, 6H, H3), 7.84 – 7.75 (AA’BB’ 
system, 6H, H4), 6.30 (s, 2H, H5’), 2.73 (t, J = 6.8 Hz, 2H, H3’), 1.43 (t, J = 6.0 Hz, 2H, H1’), 
0.73 (p, J = 6.4 Hz, 2H, H2’). 
13C-NMR (75 MHz, CDCl3): δ(ppm) 170.39 (C1’’, C4’’), 151.59 (C5, C7, C12, C14, C19, C21), 133.71 
(C2’’, C3’’), 131.11 (C4a, C7a, C11a, C14a, C18a, C21a), 129.79 (C2, C3, C9, C10, C16, C17), 122.23 (C1, 
C4, C8, C11, C15, C18), 56.63 (C1’), 34.91 (C3’), 28.99 (C2’). 
MS (MALDI-TOF, DCTB): m/z = 806.3 (2), 643.3 (2), 584.3 (2), 549.2 [M]+ (100), 395.2 [M-
Laxial]+ (2) 
HR-MS (FAB, m-NB MALDI-TOF, DCTB A): [M]+ Calcd. for C31H20BN7O3: 549.1721 ; Found: 
549.1714.  
FT-IR (neat)  (cm-1): 2924, 1702 (C=O), 1612, 1455, 1430, 1388, 1286, 1229, 1176, 1128, 
825, 737, 695. 
Mp: >250°C. 
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Silicon (IV) phthalocyanine 43:  
SiPcCl2 (0.025 g, 0.041 mmol), alcohol 41 (0.032 g, 
0.204 mmol) and DIPEA (0.15 mL) were heated in dry 
toluene (5 mL) under reflux and argon atmosphere for 
18 h. The solvent was removed under reduced 
pressure and the crude purified by column 
chromatography using silica gel, previously 
neutralized with triethylamine, and DCM as the 
eluent. After precipitation in methanol, 43 (0.017 g, 
51%) was obtained as a dark blue solid. 
1H-NMR (300 MHz, CDCl3): δ(ppm) 9.64 (dd, J = 5.8, 
2.9 Hz, 8H, H3), 8.34 (dd, J = 5.9, 2.8 Hz, 8H, H4), 5.85 
(s, 4H, H5’), 1.08 (t, J = 6.9 Hz, 4H, H3’), -1.35 (p, J = 6.4 Hz, 4H, H2’), -2.13 (t, J = 5.9 Hz, 4H, 
H1’). 
13C-NMR (75 MHz, CDCl3): δ(ppm) 168.86 (C4’), 148.88 (C1), 135.77 (C2), 132.34 (C5’), 
130.56 (C4), 123.42 (C3), 52.73 (C1), 33.35 (C3), 27.50 (C2). 
MS (MALDI-TOF, DCTB): m/z = 894.2 [M+2Na]+ (40), 871.3 [M+Na]+ (100), 848.3 [M]+ (10), 
734.2 (10), 717.2 (10), 694.2 (100). 
HR-MS (MALDI-TOF, DCTB): [M+Na]+ Calcd. for C46H32N10NaO6Si: 871.2168; Found: 
871.2151. 
FT-IR (neat)  (cm-1): 1701 (C=O), 1519, 1333, 1287, 1159, 1120, 1080, 920, 839, 758, 733, 
694. 
Mp: >250°C. 
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4.2.2 Conjugation with the CPP 
Subphthalocyanine 37:  
5.0 mg of peptide (2.707 nmol) were 
dissolved in DMSO (200 mL) and the 
resulting solution was added to a solution 
of 42 (4.219 mg, 7.680 nmol) in DMSO 
(200 mL), containing pyridine (3 µL). The 
mixture was shielded from light, and was 
allowed to stand overnight at rt. The 
mixture was then partitioned between ethyl acetate and deionised 0.1% aq. TFA. The 
aqueous layer was evaporated to a small volume, and applied to a Discovery DSC-18 solid 
phase extraction cartridge (Supelco, Gillingham, UK). The desired compound was eluted 
with a gradient from 5% acetonitrile 01% aq. TFA to 20% acetonitrile 0.1% aq. TFA mobile 
phase, and then lyophilised to yield 37 (6.201 mg, 95%) as a pink solid. 
 
MS (MALDI-TOF, CHCA): m/z = 2395.7 [M]+ (100), 2002.0 [MF2+H]+ (55), 1846.1 [MF1+H]+ 
(48). 
HR-MS (MALDI-TOF, CHCA): [M+] Calcd. for C106H160B1N44O19S1: 2396.2730; Found: 
2396.2731. 
UV-VIS (DMF): λmax (nm) (log ε): 560 (4.74), 508 (sh), 298 (4.66) 
              (H2O): λmax (nm) (log ε): 565 (4.78), 513 (sh), 303 (4.55) 
FT-IR (neat)  (cm-1): XXX 
Mp: >250°C  
RP-HPLC: tr=12,2 min 
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Silicon (IV) phthalocyanine 38:  
40.0 mg of peptide (0.0216 mmol) 
were dissolved in DMSO (800 mL), and 
the resulting solution was added to a 
solution of 43 (4.219 mg, 0.0072 
mmol) in DMSO (200 mL), containing 
pyridine (3 µL). The mixture was 
shielded from light, and was allowed 
to stand overnight at rt. Addition of 
diethyl ether (10 mL) results in the 
formation of a blue precipitate. After 
centrifugation the colorless 
supernatant was removed and the 
remaining solid was dissolved in 
distilled water and washed with DCM. The aqueous phase was lyophilised to yield 38 (15.3 
mg, 48%) as a dark blue solid. 
MS (MALDI-TOF, CHCA): m/z = 2002.0 [MF2+H]+ (100), 1113.1  (64). 
UV-VIS (DMF): λmax (nm) (log ε): 671 (5.33), 644 (sh), 606 (4.51), 353 (4.88) 
              (H2O): λmax (nm) (log ε): 682 (4.88), 618 (4.40), 353 (4.67) 
FT-IR (neat)  (cm-1): XXX 
Mp: >250°C  
RP-HPLC: tR = 12.5 min 
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4.2.3 Preparation ZnPc-CNC biohybrids 
The ZnPc-CNC hybrids were easily prepared by ultrasound bath-assisted dispersion of 
the pristine CNC (in PBS, 5 mg mL-1, 3 mL) in the corresponding ZnPc aqueous solution (ca. 
0.1 mM, 12 mL) for 30 min. Because of its low water solubility, ZnPc 45 had to be dissolved 
first in a concentrated solution in DMSO (ca. 10 mM) and subsequently injected into water, 
with a final DMSO proportion lower than 1%. After sonication of the ZnPc-CNC mixture, 
the resulting dispersion was centrifuged at 10000 rpm (9391 rfc) for 10 minutes. Colored 
supernatant was removed and the pellet was washed by adding 10 mL of milli-Q water, 
re-dispersed by 2 minutes sonication and centrifuged for 10 extra minutes at 10000 rpm 
(9391 rfc). This procedure was repeated 5 times until no color was observed in the 
supernatant. In the case of ZnPc 46, the pellet was colored white, just like the pristine 
CNC, indicating no dye had been retained. In contrast, in the case of ZnPc 44 and 45 the 
pellet was blue or green colored, respectively, indicating binding had taken place. 
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Introducción y Objetivos  
El principal objetivo de esta Tesis Doctoral es la síntesis de nuevas ftalocianinas (Pc) y 
subftalocianinas (SubPc) para su aplicación como fotosensibilizadores (PS) en terapia 
fotodinámica (PDT: photodynamic therapy).  
La PDT es una forma de fototerapia aprobada clínicamente que se emplea tanto en el 
tratamiento de enfermedades oncológicas como en la inactivación de microorganismos. 
En este último caso, también se puede utilizar el término aPDT (antimicrobial PDT) o PDI 
(photodynamic inactivation).  
 
Aparte de un PS, el elemento central en PDT, el tratamiento requiere la presencia de dos 
componentes más: luz de una longitud de onda adecuada y la presencia de oxígeno 
molecular (3O2). Tras la irradiación del PS en su máximo de absorción, éste se excita a su 
estado singlete excitado (1PS*), un estado inestable y de corta duración que, a su vez, 
puede sufrir una inversión del spin del electrón excitado (ISC, intersystem crossing) dando 
lugar al primer estado triplete excitado (3PS*), un estado más estable y con tiempo de vida 
más largo. En consecuencia, en este estado el PS tiene la posibilidad de interactuar con el 
3O2 presente en el medio biológico, un triplete en su estado fundamental, generando así 
formas reactivas de oxígeno (ROS, reactive oxygen species) y oxígeno singlete (1O2). 
Ambos causan daño oxidativo dentro de los tejidos diana, resultando así en la destrucción 
de células tumorales en el caso de la PDT, y en la inactivación de microorganismos en el 
caso de la PDI.  
Como es bien sabido, el PS ideal debe cumplir con una serie de requisitos básicos para 
producir resultados óptimos. Debe presentar por ejemplo una elevada estabilidad 
química y fotoquímica, solubilidad en medios biológicos, y altos rendimientos cuánticos 
del estado triplete y de generación de 1O2. Además, el PS debe carecer de toxicidad en 
ausencia de luz y debe mostrar selectividad hacia los tejidos diana. En este sentido, el 
desarrollo de nuevos PS con mejores propiedades y específicamente diseñados para su 
aplicación en PDT y/o PDI es un campo de investigación de gran actualidad. En general, 
los PS se dividen en dos grandes familias: los no porfirinoides y los porfirinoides. Hasta 
ahora, los porfirinoides han sido la familia más estudiada y con más éxito, dando lugar a 
varios PS aprobados clínicamente en los últimos años. Por lo tanto, en esta tesis nos 
PDIPDT
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centramos en el desarrollo y el estudio de derivados porfirinoides como PS, más concreto 
en ftalocianinas de silicio (SiPcs) y SubPcs.  
 
Las Pcs son macrociclos aromáticos constituidos por cuatro unidades de isoindol unidas 
entre sí por puentes de nitrógeno, cuya nube de 18 electrones π sufre una deslocalización 
sobre los 16 átomos del anillo interno. En consecuencia, las Pcs poseen una banda Q muy 
intensa a longitudes de onda relativamente largas (650-750 nm), que se encuentran 
dentro de la ventana óptica terapéutica, permitiendo así una penetración de luz más 
profunda en los tejidos. Además, las Pcs presentan una gran versatilidad estructural 
gracias a que pueden alojar en su cavidad central hasta 70 elementos de la tabla periódica, 
y a que poseen 16 posiciones periféricas en los anillos bencénicos, en las cuales se pueden 
introducir diversos sustituyentes. Según la naturaleza del metal alojado, es también 
posible introducir diferentes sustituyentes en posición axial. Gracias a esta versatilidad 
química y a sus excelentes propiedades fotofísicas, las Pcs son candidatos prometedores 
como PS. Sin embargo, debido a su inherente superficie aromática hidrófoba, las Pcs 
presentan dos principales limitaciones para su uso como PS, como son la ausencia de 
solubilidad en medio acuoso y la elevada tendencia a formar agregados. Ambos restringen 
la eficiencia de los procesos relacionados con el estado excitado tales como la 
fluorescencia o la producción eficiente de 1O2 a través del estado triplete. No obstante, la 
agregación se evita fácilmente empleando sustituyentes voluminosos en la periferia o en 
las posiciones axiales del macrociclo. En este sentido, las SiPcs son empleadas con éxito 
en PDT, ya que permiten la introducción de dos sustituyentes en las posiciones axiales, lo 
que suprime su tendencia a agregar. Además, una buena selección de los sustituyentes 
axiales puede proporcionar a la SiPc un aumento de solubilidad en medio acuoso.  
Las SubPcs, por otro lado, son homólogos inferiores de las Pcs, constituidas por tres 
unidades de isoindol unidas entre sí por puentes de nitrógeno. En su cavidad central 
siempre se aloja un átomo de boro tetracoordinado, que se halla unido a tres átomos de 
nitrógeno de las unidades de isoindol y a un sustituyente que ocupa la posición axial de 
la molécula. Parecido a las Pcs, su sistema aromático consta de una nube de 14 electrones 
π que están deslocalizados sobre el anillo aromático interno, resultando en una banda Q 
muy intensa a longitudes de onda ligeramente más cortas. Por rayos X se ha determinado 
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que, a diferencia de las Pcs, las SubPcs no son planas, sino que muestran una estructura 
cónica. Esto, junto con la presencia del sustituyente axial, implica que las SubPcs son 
menos susceptibles a agregarse, lo cual es una gran ventaja para su uso como PS. Además, 
estos macrociclos presentan varias características que justifican su uso como PS, tales 
como su accesibilidad sintética, altos coeficientes de absorción molar y altos rendimientos 
cuánticos del estado triplete, de fluorescencia y de generación de 1O2. No obstante, hasta 
ahora las SubPcs han sido exploradas sobre todo para su aplicación en dispositivos 
fotovoltaicos y materiales ópticos no lineales, mientras que su uso en aplicaciones 
biomédicas permanece poco estudiado.  
Por otro lado, una nueva tendencia en el desarrollo de PS son los PS de tercera 
generación, es decir PS conjugados covalentemente, o de modo no covalente, con 
agentes transportadores para su liberación y acumulación especifica dentro de los tejidos 
diana, o nanoestructuras biohíbridas que optimizan su solubilidad en medio acuoso, 
rompen la agregación y proporcionan una elevada biocompatibilidad. 
 
 
Con el objetivo de extender el conocimiento sobre las propiedades y la 
eficacia in vitro de las SiPcs y SubPcs como PS, en esta tesis hemos 
preparado varios derivados de ambos, sustituidos con una gran variedad de 
sustituyentes en las posiciones axiales, y presentando o no cargas positivas 
en la periferia. Además, algunos de esos PS han sido conjugados con 
agentes transportadores o nanovehículos en sistemas biohíbridos que 
mejoran su distribución y liberación en los tejidos diana. Finalmente, se ha 
investigado la eficacia in vitro de los PS obtenidos, tanto para PDT como 
para PDI. Así, esta tesis se encuentra dividida en tres grandes capítulos. 
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Capítulo 1: Diseño, síntesis y evaluación in vitro de fotosensibilizadores 
neutros para su uso en terapia fotodinámica 
En el Capítulo 1 se describe la síntesis de nuevos derivados de SiPcs y SubPcs para su 
aplicación en PDT, más específicamente en el tratamiento de enfermedades oncológicas.  
 
 En el Subcapítulo 1, se ha sintetizado una serie de SiPcs que presentan una 
variedad de sustituyentes con diferentes características, tanto de manera simétrica como 
asimétrica. 
 
En concreto, los sustituyentes axiales que han sido introducidos tienen la capacidad de 
inhibir el estado excitado de la SiPc, y como consecuencia su generación de 1O2 y su 
fluorescencia. Por un lado, se han empleado sustituyentes portadores de grupos pireno, 
que actuarán como grupos dadores en un proceso de transferencia electrónica de energía 
(EET: electronic energy transfer) en la cual la SiPc actúa como aceptor. Por otro lado, se 
ha empleado un sustituyente con un grupo amino (6), que participará en un fenómeno 
de transferencia de electrones fotoinducida (PET: photoinduced electron transfer). Para 
todas las SiPcs sintetizadas (SiPc 1-3), tanto su rendimiento cuántico de 1O2 (φΔ) como de 
fluorescencia (φF680) han sido evaluados y comparados con los rendimientos cuánticos de 
una SiPc de referencia desprovista de dichas unidades inhibidoras (SiPc 4), confirmando 
la estrategia empleada. Además, en el caso de las SiPcs portadoras de grupos pireno 
también la fluorescencia de los propios grupos pireno (φF377) está inhibida de manera muy 
eficaz, permitiendo su uso en teranóstica.  
En el caso de los grupos amino, la inhibición es claramente reversible; una vez protonado 
el grupo amino ya no puede producirse el proceso de PET, y la SiPc recupera su capacidad 
para generar 1O2 y su fluorescencia. En el caso de los grupos pireno, la eficacia de la EET 
depende de la distancia entre el dador y el aceptor. De este modo, se puede revertir la 
inhibición rompiendo el puente disulfuro que enlaza el pireno y la SiPc, empleando un 
reductor. Así, la SiPc asimétrica que presenta ambas unidades inhibidoras (SiPc 1) es la 
molécula con mayor interés, y su comportamiento en función de los dos parámetros que 
suprimen la inhibición (medio ácido y presencia de un reductor) ha sido estudiado en 
detalle en la Seccion 1.3. Hay que destacar que ambas vías para invertir la inhibición son 
particularmente relevantes para la aplicación final de este PS, ya que un medio 
ligeramente ácido y un ambiente reductor son dos características de las células 
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tumorales. De esta manera, tanto la generación de 1O2 como la fluorescencia de la SiPc y 
de los grupos pirenos (F377) se activarían solo una vez dentro del tejido diana, las células 
tumorales, incrementando la selectividad del PS estudiado. 
 
Para algunas SiPcs seleccionadas (SiPc 1, 3 y 4), su eficacia in vitro ha sido estudiada en 
varias líneas de células tumorales, durante una colaboración con el laboratorio de 
microbiología de Ángeles Juarranz de la Fuente, en el Departamento de Biología de 
nuestra propia universidad. Tal y como se describe en la Sección 1.4, la SiPc 3, la más 
anfifílica de la serie, es la que ha dado lugar a los mejores resultados, tanto en cantidad 
de absorción celular como en eliminación de las células tumorales.  
 
 En el Subcapítulo 2, se ha llevado a cabo el diseño, la preparación y la 
caracterización de una serie de SubPcs para su uso como PS en PDT.  
 
Tanto los rendimientos cuánticos de fluorescencia (φF571 y φF377) como de generación de 
1O2 (φΔ) de todas las SubPcs de esa serie han sido determinados, indicando que en este 
caso la inhibición de F377 causada por EET entre los pirenos y la SubPc es muy efectiva, 
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más que en el caso de las SiPcs, lo cual permite el uso de estas SubPcs (15 y 16) en 
diagnóstica. Por otro lado, aunque la inhibición de la fluorescencia de la SubPc (F571) y de 
la generación de 1O2 (φΔ) no es tan efectiva, toda la serie de SubPcs resulta interesante 
para su uso como PS en PDT, ya que los valores de φΔ son muy altos y prometedores. En 
consecuencia, la eficacia de esos compuesto in vitro se está estudiando en el laboratorio 
de Ángeles Juarranz, y se espera obtener los primeros resultados próximamente. 
 
 En el Subcapítulo 3, se han combinado los dos PS usados en las secciones 
anteriores en una sola molécula. En concreto, se ha sintetizado una tríada compuesta por 
una SiPc portadora de dos SubPcs en sus posiciones axiales. Su generación de 1O2 y su 
fluorescencia han sido diseñadas para ser sensibles al ambiente de las células tumorales, 
de manera similar al caso de las SiPc del Subcapítulo 1. Con la intención de mejorar la 
eficacia del proceso de inhibición por EET, se han elegido las SubPcs como unidades 
dadoras en vez de los grupos pirenos, ya que su espectro de emisión solapa con la banda 
Q de la SiPc, en vez de con la banda Soret, lo cual ha resultado en una inhibición de su 
estado singlete excitado más eficaz, tal como se ha estudiado en la Sección 3.3. Además, 
hay que destacar que las SubPcs absorben en regiones de baja absorción de las SiPcs, por 
lo cual la conjugación de ambos macrociclos permite obtener una fotosensibilización 
pancromática que en principio debe maximizar la generación de 1O2. No obstante, la 
estabilidad de la triada ha resultado ser baja, por lo cual no se han podido llevar a cabo 
estudios de su eficacia in vitro. 
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Capítulo 2:  Diseño, síntesis y evaluación in vitro de fotosensibilizadores 
catiónicos para su uso en la inactivación fotodinámica de microorganismos 
En el Capítulo 2, se describe la síntesis de nuevos derivados de SiPcs y SubPcs catiónicas, 
para su aplicación en PDI.  
Para su uso en PDI, es favorable que los PS estén cargados positivamente, ya que la 
inactivación de microorganismos está basada en causar daño a la membrana 
citoplasmática de los microorganismos, la cual suele estar cargada negativamente. De 
esta manera, los PS catiónicos son en principio capaces de inactivar una gran variedad de 
microorganismos, tales como hongos, levaduras, protozoos parásitos, bacterias Gram-
positivas e incluso bacterias Gram-negativas. Estas últimas son, debido a la presencia de 
una segunda membrana celular, las especias más difíciles de inactivar, e imposibles de 
inactivar con PS neutros o cargados negativamente. Aparte de ser catiónicos, los PS deben 
demostrar las características generales requeridas para PDT, tales como coeficientes de 
absorción altos en la zona del infrarrojo cercano (NIR: near infrared) y altos rendimientos 
cuánticos de formación del estado triplete y generación de 1O2. 
 Con esto en mente, en el Subcapítulo 1 de este capítulo se ha sintetizado una 
serie de SiPcs catiónicas. En paralelo a la serie de SiPcs neutras descrita en el Capítulo 1, 
se ha introducido una variedad de sustituyentes axiales, mientras que la periferia de las 
SiPcs presenta invariablemente ocho grupos de tipo piridinio, resultando en una serie de 
SiPcs octacatiónicas. 
 
La influencia del ligando axial ha sido evaluada en detalle, determinando el estado de 
agregación y los rendimientos cuánticos de fluorescencia y 1O2 para toda la serie. 
Además, se ha valorado la eficiencia de la inactivación de los PS frente a S. aureus, una 
bacteria Gram-positiva, y Methicillin-resistant S. aureus, una variante más resistente a 
varios tipos de antibióticos. En ambos casos, la SiPc 30, desprovista de toxicidad en 
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oscuridad y con niveles de inactivación de los microorganismos de hasta el 99,99%, ha 
dado los mejores resultados.  
 
 En el Subcapítulo 2, por otro lado, se ha expuesto la idea de sintetizar una serie 
de SubPcs hexacatiónicas, para el mismo fin. Sin embargo, tras sintetizar el derivado  
clorado de la SubPc hexacatiónica, con seis grupos piridinio en la periferia, ha quedado 
claro que este tipo de SubPc es inestable y su uso como PS en PDT ha sido descartado. 
 
 
 
 
Capítulo 3: Diseño, síntesis y evaluación in vitro de sistemas 
fotosensibilizadores biohíbridos para su uso en terapia fotodinámica y/o la 
inactivación fotodinámica de microorganismos 
El Capítulo 3 se ha dedicado a la preparación de diferentes materiales biohíbridos, para su 
aplicación en PDT y/o PDI, mediante la combinación de un PS con dos biomoléculas 
diferentes. Estas biomoléculas han sido seleccionadas cuidadosamente, con el objetivo de 
mantener o incluso mejorar las características de los PS, mediante desagregación de los 
mismos en medios acuosos, además de resultar en materiales biocompatibles y 
monodispersos que dan lugar a sistemas fotoactivos nanoestructurados.  
 En el Subcapítulo 1 se describe la conjugación de una SiPc y una SubPc con un 
péptido de penetración celular (CPP: cell penetrating peptide). La conjugación y 
subsiguiente caracterización han sido llevadas a cabo durante una estancia predoctoral 
en el laboratorio de Annemieke Madder en la Universidad de Gante (Bélgica). Para este 
fin, se han sintetizado previamente una una SiPc (42) y SubPc (43) portadoras de un 
sustituyente con un grupo maleimida en la posición axial. La elección de este grupo 
funcional se basa en que puede reaccionar de manera sencilla y eficaz con una unidad de 
cisteína, presente en el péptido, mediante una reacción tiol-eno de tipo “click”. Los 
biohíbridos resultantes (37 y 38) son totalmente solubles en agua, y sus propiedades 
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fotofísicas, tales como su fluorescencia y generación de 1O2, han sido examinadas tanto 
en agua como en tampón fosfato salino (PBS: phosphate buffered saline), un medio 
representativo desde el punto de vista biológico. Su elevada tendencia a la internalización 
ha sido confirmada por análisis de citometría de flujo (FACS, fluorescence activated cell 
sorting) en el laboratorio de Bruno de Geest, también en la Universidad de Gante, 
confirmando la utilidad de esta estrategia. Queda pendiente la visualización de la 
absorción celular por microscopía de fluorescencia confocal. Estos PS biohíbridos podrían 
ser utilizados tanto en el tratamiento de enfermedades oncológicas (PDT) como en la 
inactivación fotodinámica de microorganismos (PDI).  
 
 
 En el Subcapítulo 2 se describe la preparación y caracterización de complejos 
supramoleculares de ftalocianinas de zinc (ZnPcs) catiónicas y nanocristales de celulosa 
(CNCs, cellulose nanocrystals), como una nueva clase de PS nanoestructurados para la 
fotogeneración de 1O2. Este trabajo sigue una estrategia basada en la inmovilización 
mediante interacciones electrostáticas entre derivados catiónicos de ZnPc (44 y 45) y la 
superficie no modificada de los CNCs, que presentan grupos sulfónicos como 
consecuencia de su síntesis. Los híbridos resultantes han sido caracterizados mediante 
diversas técnicas, demostrando que no solo la agregación de la ZnPc, sino también la 
tendencia a la agregación de los CNCs juegan un papel clave en la producción de 1O2. Las 
propiedades fotofísicas de estos compuestos, junto con su eficacia in vitro frente a una 
serie de microorganismos, han sido estudiadas en detalle durante una estancia 
predoctoral en los laboratorios de Santi Nonell Marrugat y Montserrat Agut Bonsfills en 
el Institut Químic de Sarrià de la Universitat Ramon Llull (Barcelona), tal y como se 
describe en las Secciones 2.3 y 2.4. En consecuencia, la inactivación fotodinámica de 
microorganismos por 44-CNC y 45-CNC muestra mejoras evidentes en comparación con 
la inactivación causada por las ZnPcs libres. Además, es importante destacar que los 
sistemas 44-CNC y 45-CNC demuestran una eficacia significativamente mayor que otros 
sistemas biohíbridos previamente mencionados en la literatura, en los cuales el PS se ha 
unido covalentemente a la superficie de los CNC. En este sentido, los biohíbridos 
desarollados en esta Sección han demostrado ser biomateriales fotoactivos muy 
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prometedores, que pueden encontrar aplicaciones útiles en biomedicina y 
nanotecnología.  
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